|

Browse by Drug & Therapy

11,723 drugs and therapies in actively recruiting clinical trials

Pembrolizumab441 trials Cyclophosphamide325 trials carboplatin316 trials Cisplatin252 trials Paclitaxel211 trials Bevacizumab194 trials Venetoclax190 trials Fludarabine186 trials Gemcitabine181 trials Nivolumab175 trials Dexamethasone159 trials Capecitabine156 trials Oxaliplatin146 trials Docetaxel142 trials Rituximab135 trials Nab paclitaxel124 trials Durvalumab119 trials Pemetrexed115 trials Atezolizumab111 trials Etoposide99 trials Doxorubicin96 trials Cytarabine90 trials Tislelizumab87 trials Prednisone87 trials Lenalidomide87 trials Cetuximab83 trials Irinotecan79 trials Azacitidine79 trials Toripalimab78 trials Ipilimumab77 trials Temozolomide74 trials Methotrexate72 trials Lenvatinib68 trials Trastuzumab67 trials Cemiplimab67 trials Olaparib66 trials Vincristine66 trials Fulvestrant63 trials Obinutuzumab:62 trials Sintilimab60 trials Metformin58 trials Abemaciclib58 trials Fluorouracil55 trials leucovorin55 trials Trastuzumab Deruxtecan54 trials Enzalutamide49 trials camrelizumab48 trials Letrozole47 trials Daratumumab46 trials Sacituzumab govitecan43 trials Bortezomib42 trials Cabozantinib42 trials Palbociclib41 trials Osimertinib41 trials Adebrelimab41 trials Zanubrutinib39 trials 5-fluorouracil38 trials Melphalan38 trials Ribociclib37 trials Pertuzumab35 trials Ruxolitinib34 trials Blinatumomab34 trials Acalabrutinib33 trials Tremelimumab32 trials Immunotherapy32 trials Topotecan32 trials Pomalidomide32 trials Tocilizumab31 trials Fruquintinib30 trials enfortumab vedotin30 trials Decitabine30 trials BL-B01D129 trials Ketamine28 trials Glofitamab28 trials Cadonilimab28 trials Bendamustine27 trials Ibrutinib27 trials Everolimus27 trials Pirtobrutinib26 trials Tirzepatide26 trials Serplulimab26 trials Interleukin-225 trials Daunorubicin25 trials Niraparib25 trials Placebo Administration25 trials Mosunetuzumab24 trials Epcoritamab24 trials Psilocybin24 trials Mycophenolate Mofetil24 trials Ivonescimab24 trials Ifosfamide24 trials Elranatamab24 trials Dasatinib24 trials Fludarabine phosphate23 trials Tamoxifen23 trials Tacrolimus23 trials Blood sample23 trials Rilvegostomig23 trials Darolutamide23 trials Trametinib23 trials Semaglutide22 trials Dostarlimab22 trials Carfilzomib22 trials Panitumumab22 trials Regorafenib22 trials Thiotepa22 trials Teclistamab21 trials Aldesleukin21 trials Anlotinib21 trials SHR-A181121 trials Busulfan21 trials Sacituzumab tirumotecan21 trials Selinexor21 trials Propofol20 trials Apalutamide20 trials Anastrozole20 trials Dexmedetomidine20 trials Chidamide20 trials Placebo oral tablet20 trials Apatinib20 trials Ramucirumab19 trials Isatuximab19 trials Talazoparib19 trials Balstilimab19 trials Pyrotinib19 trials Abiraterone Acetate19 trials Epirubicin19 trials Filgrastim18 trials Sirolimus18 trials Trifluridine-tipiracil17 trials Alectinib17 trials PD-1 inhibitor17 trials Iberdomide17 trials Methylprednisolone17 trials Prednisolone17 trials Talquetamab17 trials Aspirin17 trials Orelabrutinib17 trials Sotorasib17 trials Exemestane17 trials Empagliflozin17 trials Abiraterone17 trials Empagliflozin 10 MG16 trials Blood sampling16 trials Polatuzumab vedotin16 trials Mesna16 trials Mercaptopurine16 trials Inavolisib16 trials Gilteritinib16 trials Vinorelbine16 trials Eribulin16 trials Nimotuzumab16 trials Avelumab16 trials Albumin-Bound Paclitaxel16 trials FOLFOX16 trials Pegfilgrastim15 trials Tafasitamab15 trials Idarubicin15 trials S-115 trials Zanzalintinib15 trials Disitamab vedotin15 trials Indocyanine green15 trials Elacestrant14 trials Trastuzumab emtansine14 trials Neoadjuvant chemotherapy14 trials Tucatinib14 trials Binimetinib14 trials Capivasertib14 trials 18F-FDG14 trials Volrustomig14 trials Furmonertinib14 trials Gemcitabine Hydrochloride for Injection14 trials 5-FU14 trials Botensilimab14 trials Tarlatamab14 trials Brentuximab Vedotin14 trials Retifanlimab14 trials Cladribine14 trials Dabrafenib14 trials QL170614 trials Zimberelimab13 trials Ivosidenib13 trials Inotuzumab Ozogamicin13 trials Pembrolizumab (KEYTRUDA® )13 trials Pegaspargase13 trials Lurbinectedin13 trials Chemotherapy drug13 trials Encorafenib13 trials AK11213 trials Amivantamab13 trials Sorafenib13 trials Anti-PD-1 monoclonal antibody13 trials Tumor Infiltrating Lymphocytes (TIL)13 trials Axitinib13 trials AK10413 trials Doxorubicin Hydrochloride13 trials Leucovorin Calcium13 trials mFOLFIRINOX13 trials Colchicine12 trials Insulin12 trials Esketamine12 trials XELOX12 trials Celecoxib12 trials Tazemetostat12 trials Fluzoparib12 trials Concurrent chemotherapy12 trials BL-M07D112 trials Zanidatamab12 trials Immune checkpoint inhibitor12 trials Gemcitabine Hydrochloride12 trials FOLFIRI12 trials Imatinib12 trials Pumitamig12 trials ketamine hydrochloride11 trials Empagliflozin 25 MG11 trials Dupilumab11 trials Hydroxychloroquine11 trials Apixaban11 trials Itraconazole11 trials Entrectinib11 trials Dalpiciclib11 trials Sunitinib11 trials Afatinib11 trials Paclitaxel Injection11 trials Linvoseltamab11 trials Revumenib11 trials Belantamab mafodotin11 trials Adjuvant chemotherapy11 trials Rescue Medication11 trials Cisplatin injection11 trials Carboplatin Injection11 trials Relatlimab11 trials CAPOX11 trials Platinum based chemotherapy11 trials Dapagliflozin11 trials Decitabine and Cedazuridine11 trials Pemigatinib11 trials Degarelix11 trials Crizotinib11 trials Relugolix11 trials G-CSF11 trials Escitalopram10 trials Fluoxetine10 trials Dapagliflozin 10mg Tab10 trials SHR-A210210 trials Blood samples10 trials SI-B00310 trials Enasidenib10 trials Temozolomide (TMZ)10 trials Sevoflurane10 trials Gemtuzumab Ozogamicin10 trials Axicabtagene Ciloleucel10 trials Pioglitazone10 trials Defactinib10 trials Vismodegib10 trials Mezigdomide10 trials CAR-T10 trials Letrozole 2.5mg10 trials Elotuzumab10 trials Lomustine10 trials FOLFIRINOX10 trials Neratinib10 trials Azacitidine (AZA)10 trials Hyperpolarized 13C-Pyruvate10 trials Androgen deprivation therapy (ADT)10 trials 5-fluorouracil (5-FU)10 trials PD-1 antibody10 trials Goserelin10 trials Dacarbazine10 trials Fianlimab10 trials Ocrelizumab9 trials Matching placebo9 trials Baricitinib9 trials Sertraline9 trials Calaspargase Pegol9 trials HS-200939 trials Keytruda9 trials Midazolam9 trials Docetaxel Injection9 trials Ziftomenib9 trials 9MW28219 trials Ceralasertib9 trials PD-1 Monoclonal Antibody9 trials Olverembatinib9 trials Belzutifan9 trials Liposome-encapsulated Daunorubicin-Cytarabine9 trials Olanzapine9 trials Apatinib Mesylate9 trials Cabozantinib S-malate9 trials Avutometinib9 trials tranexamic acid9 trials FOLFOX regimen9 trials Tiragolumab9 trials Gemcitabine/Cisplatin9 trials Sacubitril-valsartan9 trials mFOLFOX69 trials ASTX7279 trials Datopotamab Deruxtecan9 trials Sonrotoclax9 trials Vincristine Sulfate9 trials Alpelisib9 trials Patritumab deruxtecan9 trials Guselkumab8 trials Tezepelumab8 trials SGLT2 inhibitor8 trials Insulin aspart8 trials Semaglutide Pen Injector8 trials SKB2648 trials Almonertinib8 trials Tebentafusp8 trials CAR-T cells8 trials Adebrelimab Injection8 trials duloxetine8 trials Sacituzumab Govitecan (SG)8 trials Dato-DXd8 trials Carvedilol8 trials Olutasidenib8 trials Avapritinib8 trials CD19 CAR-T-cells8 trials Endocrine therapy8 trials Granulocyte Colony-Stimulating Factor8 trials Propranolol8 trials Pembrolizumab injection8 trials Albumin Paclitaxel8 trials Anifrolumab8 trials Androgen Deprivation Therapy8 trials Loncastuximab tesirine8 trials Ipatasertib8 trials Mogamulizumab8 trials CapeOx8 trials Irinotecan Liposome8 trials Lutetium Lu 177 Dotatate8 trials Dapagliflozin 10 mg8 trials Mitomycin8 trials Envafolimab8 trials BET Bromodomain Inhibitor ZEN-36948 trials Capecitabine Tablets8 trials Fulvestrant injection8 trials Pacritinib8 trials Telisotuzumab Adizutecan8 trials Bevacizumab Injection8 trials Mavacamten7 trials Clopidogrel7 trials Vasopressin7 trials AlloRx7 trials Leflunomide7 trials Sargramostim7 trials Cabazitaxel7 trials Ponatinib7 trials Trilaciclib7 trials 6-Mercaptopurine7 trials Ifinatamab Deruxtecan7 trials Thioguanine7 trials CAR-T Cell Therapy7 trials Etoposide Phosphate7 trials Vemurafenib7 trials Rivaroxaban7 trials BNT3277 trials Calcium Folinate7 trials Daunorubicin Hydrochloride7 trials Amoxicillin7 trials Lazertinib7 trials Trabectedin7 trials Surufatinib7 trials Palbociclib 125mg7 trials PD-1 Inhibitors7 trials Mitoxantrone Hydrochloride Liposome7 trials Cobimetinib7 trials Adagrasib7 trials HLX43 DOSE 27 trials HLX43 DOSE 17 trials KEYTRUDA® (pembrolizumab)7 trials liposomal irinotecan7 trials Mirdametinib7 trials TQB2102 for injection7 trials YL2017 trials ADT7 trials Donafenib7 trials Lutetium Lu 177 Vipivotide Tetraxetan7 trials Lisocabtagene maraleucel7 trials Vinblastine7 trials Leuprolide7 trials Bicalutamide7 trials Toripalimab Injection7 trials Irinotecan Hydrochloride7 trials IBI3637 trials Chimeric Antigen Receptor T-Cell Therapy7 trials Spironolactone7 trials Quizartinib7 trials Bulevirtide6 trials Adalimumab6 trials KarXT6 trials Ticagrelor6 trials Finerenone6 trials Sotagliflozin6 trials GLP-1 receptor agonist6 trials Montelukast6 trials [18F]Florbetaben6 trials Testosterone Cypionate6 trials N-8036 trials CDK4/6 inhibitor6 trials Mitomycin-C6 trials Bupivacaine6 trials Panitumumab-IRDye8006 trials Hydroxyurea6 trials Anti-PD-1 antibody6 trials Cannabidiol6 trials Lorlatinib6 trials Famitinib6 trials Nemtabrutinib6 trials nab-paclitaxel + gemcitabine6 trials Abraxane6 trials nab-Sirolimus6 trials PF-086344046 trials Mitoxantrone6 trials Sacituzumab govitecan-hziy6 trials anti-BCMA CAR-T6 trials Fenofibrate6 trials Gemcitabine-nab-paclitaxel6 trials Folinic acid6 trials Sarilumab6 trials Peposertib6 trials homoharringtonine6 trials Tepotinib6 trials 68Ga-PSMA-116 trials Naxitamab6 trials Telitacicept6 trials Iadademstat6 trials ZG0066 trials SHR-13166 trials Erlotinib6 trials Leuprolide Acetate6 trials zolbetuximab6 trials Rezvilutamide6 trials Golidocitinib6 trials Cyclosporine6 trials Bleomycin6 trials Liposomal doxorubicin6 trials BGB-166736 trials 18F-DCFpyL6 trials HLX43 DOSE 36 trials RMC-62366 trials SHR-80686 trials Acetaminophen6 trials Nivolumab + Relatlimab6 trials CAR-T Therapy6 trials Iparomlimab and Tuvonralimab6 trials IL-26 trials Emavusertib6 trials Clofarabine6 trials JS2076 trials Tagraxofusp6 trials BMS-9865046 trials 177Lu-PSMA-6176 trials Cisplatin/ Carboplatin6 trials Metronidazole6 trials Budigalimab6 trials Trastuzumab deruxtecan (T-DXd)6 trials Giredestrant6 trials Dabrafenib+Trametinib6 trials Sunvozertinib6 trials Divarasib6 trials Odronextamab6 trials Rescue Medications6 trials Ublituximab5 trials YTS109 cell5 trials Adenosine5 trials Warfarin5 trials Colchicine 0.5 MG5 trials placebo capsule5 trials NBI-10658455 trials Orforglipron5 trials Eloralintide5 trials N-Acetylcysteine5 trials Remimazolam5 trials Nipocalimab5 trials Medical therapy5 trials JNJ-796353225 trials Control5 trials Etanercept5 trials Atorvastatin5 trials Carboplatin or Cisplatin5 trials Allopurinol5 trials Hyperpolarized Carbon C 13 Pyruvate5 trials PLD5 trials APG-25755 trials Lidocaine5 trials Daratumumab and Hyaluronidase-fihj5 trials Levetiracetam5 trials 5Fluorouracil5 trials Infliximab5 trials IN100185 trials OH2 injection5 trials Futibatinib5 trials Pazopanib5 trials Abatacept5 trials Asparaginase Erwinia chrysanthemi5 trials ICP-2485 trials Neoadjuvant therapy5 trials Belimumab5 trials Ofatumumab5 trials DFMO5 trials SHR-A1811 for Injection5 trials Siltuximab5 trials AZD09015 trials Cadonilimab (AK104)5 trials Cetrelimab5 trials GSK57642275 trials Rapamycin5 trials Paclitaxel-albumin5 trials T-DXd5 trials Belinostat5 trials Calderasib5 trials CEA-targeted CAR-T cells5 trials Efgartigimod5 trials Nirogacestat5 trials Trastuzumab+Pertuzumab5 trials LBL-024 for Injection5 trials Quercetin5 trials AAA6175 trials NALIRIFOX5 trials Xaluritamig5 trials Morphine5 trials Diphenhydramine5 trials ZG005 for Injection5 trials Hydrocortisone5 trials Daraxonrasib5 trials Hormone Therapy5 trials Temsirolimus5 trials Rituximab (R)5 trials Pegylated liposomal doxorubicin5 trials Ropivacaine5 trials Liposomal Bupivacaine5 trials Cyclophosphamid5 trials Tegafur5 trials KC10365 trials Posaconazole5 trials Recombinant Granulocyte Colony-Stimulating Factor5 trials Nivolumab Injection [Opdivo]5 trials anti-CD19 CAR-T cells5 trials Ixazomib5 trials GM-CSF5 trials Cytokine-Induced Memory-like Natural Killer Cells5 trials Ketorolac5 trials Magnesium sulfate5 trials Standard Therapy5 trials Poly-ICLC5 trials Zilovertamab vedotin5 trials SHR-1316 Injection5 trials Fecal Microbiota Transplantation5 trials H2 receptor antagonist5 trials Canakinumab5 trials Memantine5 trials Nilotinib5 trials Omeprazole5 trials Immune Checkpoint Inhibitors5 trials 18F-Fluciclovine5 trials Carmustine5 trials Triptorelin5 trials Pralsetinib5 trials Zongertinib5 trials HLX105 trials Plerixafor5 trials Cyclophosphamide (CTX)5 trials Ensartinib5 trials intrathecal chemotherapy5 trials NAs4 trials PEG-IFNα4 trials Lunsekimig4 trials Depemokimab4 trials Placebo tablet4 trials Vericiguat4 trials Inclisiran4 trials Colchicine 0.6 mg4 trials Donepezil4 trials Bimekizumab4 trials Secukinumab4 trials Brexpiprazole4 trials Bupropion4 trials Quetiapine4 trials Fingolimod4 trials Frexalimab4 trials Enavogliflozin4 trials Semaglutide Injectable Product4 trials Phenylephrine4 trials Semaglutide (Rybelsus®)4 trials Beta blocker4 trials Insulin icodec4 trials Oral Semaglutide4 trials Oxytocin nasal spray4 trials Retatrutide4 trials insulin glargine4 trials Liraglutide4 trials Placebo Comparator4 trials Entecavir4 trials Placebos4 trials Cannabidiol (CBD)4 trials AZD01204 trials Venlafaxine4 trials Verteporfin4 trials Anlotinib hydrochloride4 trials Ustekinumab4 trials Repotrectinib4 trials Telmisartan4 trials Saruparib4 trials CAR-T cell4 trials JY231 Injection4 trials Asciminib4 trials KN0464 trials Vitamin D34 trials tofacitinib4 trials SOX chemotherapy4 trials Tuvusertib4 trials Ulixertinib4 trials Cirtuvivint4 trials Simvastatin 40mg4 trials Cisplatin-based induction chemotherapy4 trials Gadolinium4 trials Cytarabine (Ara-C)4 trials Fluorouracil (5-FU)4 trials Sintilimab injection4 trials JAB 218224 trials Nedaplatin4 trials Saline Solution4 trials 68Ga-Dotatate4 trials CC3124 trials Valproic Acid4 trials Onvansertib4 trials ADI-PEG204 trials PLB10044 trials APG-1154 trials Lithium4 trials Sulfasalazine4 trials DZD60084 trials utidelone4 trials Cobicistat4 trials Metformin Hydrochloride4 trials Gabapentin4 trials Tumor-draining lymph node-derived lymphocyte (LNL)4 trials Cevostamab4 trials QL1706 (bispecific antibody targeting PD-1 and CLTA-4)4 trials 64Cu-SAR-bisPSMA4 trials Neoadjuvant immunochemotherapy4 trials Dactinomycin4 trials Capmatinib4 trials Vorinostat4 trials SHR-8068 Injection4 trials REGN56784 trials Dinutuximab4 trials Irinotecan (CPT-11)4 trials HER3-DXd4 trials Etentamig4 trials Targeted CEA CAR-T4 trials Multi-peptide CMV-Modified Vaccinia Ankara Vaccine4 trials Penpulimab4 trials Arsenic trioxide4 trials Methotrexate (MTX)4 trials Lifileucel4 trials Pucotenlimab4 trials TAS-1024 trials PM80024 trials Irinotecan hydrochloride liposome Injection4 trials all-trans retinoic acid4 trials ADG1264 trials Risankizumab4 trials AZD13904 trials Sipuleucel-T4 trials Cilostazol4 trials Systemic Therapy4 trials CD70 CAR-T cells4 trials Paxalisib4 trials Atezolizumab & Bevacizumab4 trials Standard of Care (SoC)4 trials SHR-A19214 trials Rina-S4 trials PD-14 trials Ubamatamab4 trials Immunotherapy (Pembrolizumab)4 trials IBI3434 trials Epinephrine4 trials Domvanalimab4 trials Standard of Care Chemotherapy4 trials Befotertinib4 trials Golcadomide4 trials SX-6824 trials Temozolomide capsule4 trials BGB-433954 trials DZD85864 trials Opevesostat4 trials Goserelin Acetate4 trials Duvelisib4 trials Treosulfan4 trials Levoleucovorin4 trials TPC4 trials Trimethoprim Sulfamethoxazole4 trials Cyclosporine-A4 trials Pembrolizumab Injection [Keytruda]4 trials Regorafenib (BAY 73-4506)4 trials Neoantigen-loaded DC vaccine4 trials Supportive care measures4 trials Teclistamab (Tec)4 trials Corticosteroid injection4 trials Metabolically Armed CD19 CAR-T cells4 trials SHR-A1811 Injection4 trials Datopotamab Deruxtecan (Dato-DXd)4 trials Ciltacabtagene Autoleucel4 trials RMC-98054 trials Neoantigen-based peptide vaccine4 trials Personalized neoantigen tumor vaccine4 trials Propranolol hydrochloride4 trials Rimiducid4 trials Carboplatin/Paclitaxel4 trials pemetrexed /carboplatin4 trials acetylsalicylic acid4 trials Camizestrant4 trials Saruparib (AZD5305)4 trials Treatment of Physician's Choice4 trials Pertuzumab Injection4 trials Pemetrexed (Alimta)4 trials Mycophenolate mofetil (MMF)4 trials Denosumab4 trials Valemetostat4 trials Vincristin4 trials Paclitaxel (albumin-bound)4 trials Huaier Granule4 trials Methylphenidate4 trials Melatonin4 trials Anlotinib Hydrochloride Capsule4 trials Steroid mouthwash (dexamethasone or equivalent)4 trials Dexamethasone (or equivalent)4 trials Acetaminophen (or equivalent)4 trials Axatilimab4 trials LV4 trials Polatuzumab4 trials Losartan4 trials Azeliragon4 trials Mirvetuximab Soravtansine4 trials Carboplatin（ neoadjuvant）4 trials single dose of CNCT194 trials Savolitinib4 trials Larotrectinib4 trials Palazestrant4 trials Tovorafenib4 trials Paclitaxel for Injection (Albumin Bound)4 trials Medical Cannabis4 trials Aromatase Inhibitor4 trials Daratumumab Injection4 trials Antiandrogen Therapy4 trials Saroglitazar Magnesium 1 mg3 trials Tenofovir Alafenamide3 trials Standard Medical treatment3 trials Ozanimod3 trials Clemastine Fumarate3 trials Tenofovir Disoproxil Fumarate3 trials levodopa-carbidopa3 trials Rapcabtagene autoleucel3 trials Alemtuzumab3 trials CLN-9783 trials Upadacitinib3 trials [StroMed + platelet rich plasma (PRP)]3 trials Dexamethasone 4mg3 trials Ropivacaine 0.2% Injectable Solution3 trials Filgotinib3 trials Mepolizumab3 trials Budesonide3 trials Omalizumab3 trials benralizumab3 trials Budesonide/formoterol3 trials Evolocumab3 trials Anakinra3 trials Ramipril3 trials Rifaximin3 trials Angiotensin II3 trials Heparin3 trials Ziltivekimab3 trials Oxygen3 trials Rosuvastatin3 trials Ticagrelor 90 mg3 trials 11C-ER1763 trials [18F]-PI-26203 trials Daridorexant 50 mg3 trials [18F]MK62403 trials KarX-EC3 trials Azetukalner3 trials Psilocybin (drug)3 trials CBD3 trials Placebo Group3 trials Pimavanserin3 trials NMRA-3351403 trials Placebo Cap3 trials NMDAE3 trials Xenon3 trials Zuranolone3 trials Transdermal Placebo Patch3 trials Esketamine hydrochloride3 trials Dobutamine3 trials Duloxetine 30 MG3 trials CYB0033 trials Apremilast3 trials Psilocybin 25 mg3 trials Dapansutrile3 trials saline placebo3 trials Sodium Chloride 0.9% Inj3 trials Placebo oral capsule3 trials GLP-13 trials Sodium chloride3 trials Vicadrostat3 trials Colchicine Placebo3 trials Norepinephrine3 trials HDM1005 23 trials HDM1005 13 trials Teplizumab3 trials KAI-95313 trials Medication3 trials Naltrexone3 trials UCAR T-cell3 trials Therapeutic Hydrocortisone3 trials Platinum3 trials Clonidine3 trials Canagliflozin3 trials Rituximab and Hyaluronidase Human3 trials MK-10453 trials Consolidative immunotherapy3 trials Golimumab3 trials PF-072200603 trials NaCl 0,9%3 trials Perampanel3 trials HRS-46423 trials Placebo IV3 trials Pentoxifylline3 trials Exemestane 25 MG3 trials Eribulin mesylate injection3 trials Peripheral Blood Stem Cell3 trials valemetostat tosylate3 trials AZD95743 trials Zoledronic Acid3 trials Perflutren Lipid Microspheres3 trials 68Ga-FAPI3 trials Rituximab Injection3 trials INCA338903 trials Benmelstobart3 trials Experimental3 trials SHR-18263 trials Coenzyme Q103 trials BTX-A513 trials Ritonavir3 trials Pegylated Liposomal Doxorubicin Hydrochloride3 trials Idecabtagene vicleucel3 trials Peg IFN-α-2b3 trials Active Comparator3 trials Antibody-Drug Conjugate3 trials Sitagliptin3 trials Rocbrutinib3 trials JSKN0033 trials Cholestyramine3 trials Atezolizumab plus Bevacizumab3 trials Pioglitazone 30 mg3 trials GPRC5D/CD3 BiTEs3 trials BCMA CAR-T3 trials 177Lu-DOTATOC3 trials ZG0053 trials Saline (NaCl 0,9 %) (placebo)3 trials nab-Paclitaxel+carboplatin3 trials Vebreltinib3 trials Carboplatin (AUC 5)3 trials Digoxin3 trials Chemotherapy Drugs, Cancer3 trials Efgartigimod IV3 trials Ravulizumab3 trials HC0103 trials Tislelizumab (BGB-A317)3 trials Cizutamig3 trials Everolimus 10 mg3 trials GC012F Injection3 trials Enoxaparin3 trials AZD04863 trials BEY11073 trials YK0123 trials Famotidine3 trials Nelarabine3 trials VRT1063 trials Nano-crystalline Megestrol Acetate Oral Suspension3 trials Trastuzumab Rezetecan3 trials ZL-13103 trials [68Ga]Ga-PentixaFor3 trials GNC-0383 trials Biological collection3 trials CC-992823 trials RC483 trials Sodium Thiosulfate3 trials Standard lymphodepletion regimen3 trials Standard of Care Treatment3 trials PARP inhibitor3 trials Isotretinoin3 trials Dexrazoxane Hydrochloride3 trials PEEL-2243 trials M78243 trials GK01 Injection3 trials Selumetinib3 trials HS-200893 trials Anthracycline3 trials CC-975403 trials Ferric derisomaltose3 trials R-DXD3 trials Opdualag3 trials ZG005 Powder for Injection3 trials Hetrombopag3 trials Tunlametinib3 trials Sugemalimab3 trials 9-valent HPV vaccine3 trials Azenosertib3 trials Disitamab Vedotin (RC48)3 trials MK-48303 trials 2141-V113 trials D2C7-IT3 trials Low-dose aspirin3 trials Eltrombopag3 trials N-Acetyl cysteine3 trials Azacitidine Injection3 trials [18F]F-RESCA-RT43 trials Consolidation Chemotherapy3 trials IBI363 + chemotherapy3 trials PD-1inhibitor3 trials Human papillomavirus 9-valent vaccine, recombinant3 trials Fentanyl3 trials anti-CD19 CAR T cell therapy3 trials Sigvotatug Vedotin3 trials Lanreotide3 trials ONC2013 trials bleximenib3 trials Ifinatamab deruxtecan (I-DXd)3 trials AMG 1933 trials Surovatamig3 trials EXL013 trials LHRH agonist3 trials Oxaliplatin injection3 trials SI-B0013 trials Pegylated liposomal Doxorubicin (PLD)3 trials AZD53353 trials AK1303 trials Pasritamig3 trials Iparomlimab and Tuvonralimab Injection (QL1706)3 trials 18F-MFBG3 trials Ferumoxytol3 trials HDM20053 trials BL-M24D13 trials Tulmimetostat3 trials Neoadjuvant Chemotherapy in Combination with Toripalimab3 trials Livmoniplimab3 trials Anti-CD19-CAR CMV-specific T-lymphocytes3 trials Osimertinib Mesylate Tablets3 trials FOLFOXIRI3 trials Romiplostim N013 trials Selpercatinib3 trials Neoantigen Peptide Vaccine3 trials Simvastatin 20mg3 trials TAS64173 trials Idarubicin Hydrochloride3 trials PDS01ADC3 trials GV20-02513 trials Ipilimumab Injection3 trials Actinomycin-D3 trials HCB1013 trials Paclitaxel, Cisplatin3 trials NW-301D3 trials NW-301V3 trials TNG4623 trials chemotherapy drugs3 trials GT2013 trials Gemcitabine and Cisplatin3 trials JMT1083 trials Vorasidenib3 trials Iza-bren3 trials 68Ga-PSMA3 trials Granulocyte Colony-Stimulating Factor (G-CSF)3 trials Darolutamide (Nubeqa, BAY1841788)3 trials Pralatrexate3 trials Zalifrelimab3 trials Oxytocin3 trials Darolutamide 300 mg3 trials Hyperbaric oxygen3 trials Nivolumab & Ipilimumab3 trials SYS60433 trials young TIL3 trials ZEN0036943 trials Bupivacain3 trials IBI3543 trials Hyperthermic Intraperitoneal Chemotherapy3 trials T-DM13 trials Phesgo3 trials Adebelimab injection3 trials mFOLFOX3 trials Exparel3 trials Raludotatug deruxtecan3 trials Standard Chemotherapy3 trials LN-1453 trials Irinotecan (drug)3 trials Dinutuximab beta3 trials roginolisib3 trials [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G.3 trials 177Lu-Dotatate3 trials vindesine3 trials control group3 trials Alisertib3 trials Fisetin3 trials Combination Therapy3 trials Nicotinamide3 trials Nadofaragene Firadenovec3 trials SSGJ-7073 trials Taletrectinib3 trials Cytoxan3 trials Induction therapy3 trials mFOLFIRINOX Treatment Regimen3 trials Monoclonal antibody3 trials Idelalisib3 trials Furosemide Injection3 trials 18F-DOPA3 trials ONC2063 trials Ciprofloxacin3 trials Fludrocortisone acetate3 trials Minocycline3 trials Doxycycline3 trials MMF Immunosuppression3 trials MK-31203 trials BL-B16D13 trials Opdivo®3 trials Bortezomib Injection3 trials Bosutinib3 trials Bevacizumab Biosimilar3 trials [18F]F-RESCA-T43 trials [68Ga]Ga-NOTA-T43 trials [18F]FluorThanatrace3 trials Thymoglobulin3 trials Adjuvant therapy3 trials Dexamethasone Oral3 trials I-DXd3 trials Immune Globulin Intravenous3 trials cis-platinum3 trials Curcumin3 trials B7-H3-CAR T cells3 trials BCNU3 trials Tyrosine kinase inhibitor3 trials Pidnarulex3 trials PEG-rhG-CSF3 trials Doxorubicin Hydrochloride Liposome Injection3 trials Normal Saline (Placebo)3 trials JNJ-782783433 trials DC Vaccine3 trials Modified FOLFIRINOX3 trials Fezolinetant3 trials Nivolumab Injectable Product3 trials Megestrol Acetate3 trials JSB4623 trials Terlipressin3 trials Dalpiciclib 150mg3 trials Venetoclax Oral Tablet3 trials Statin3 trials Piflufolastat F183 trials [177Lu]Lu-PSMA I&T3 trials L19TNF3 trials Brigatinib3 trials Z-endoxifen3 trials Carboplatin plus Paclitaxel3 trials Goserelin 3.6 MG3 trials Disitamab Vedotin Injection3 trials Etoposide injection3 trials CHOP3 trials ATG3 trials PD-1 / PD-L1 monoclonal antibody3 trials Sacituzumab Govitecan-hziy (SG)3 trials Peg-asparaginase3 trials Tadalafil 5mg3 trials Intismeran autogene3 trials iNeo-Vac-R013 trials Vinorelbine Tartrate Injection3 trials Paclitaxel Polymeric Micelles for Injection3 trials Cyclophosphamide injection3 trials Tegavivint3 trials Floxuridine3 trials GT307 injection3 trials H1 receptor antagonist3 trials Cisplatin for injection3 trials Pemetrexed Disodium for Injection3 trials Natural Killer Cell Therapy3 trials 68Ga-FAPI/18F-FDG3 trials Tivozanib3 trials Functional tests3 trials Aumolertinib3 trials SHR-98393 trials MHB039A for Injection3 trials MHB088C for Injection3 trials SOX3 trials CDX-3013 trials CD4CAR3 trials QL21073 trials Mirabegron3 trials Investigator's choice of chemotherapy3 trials Sulfur Hexafluoride Lipid Microspheres3 trials Bendamustine Hydrochloride3 trials HB18013 trials Monalizumab3 trials Atirmociclib3 trials Hydromorphone3 trials Paclitaxel for Injection3 trials XL0923 trials MK-10843 trials Letrozole tablets3 trials Efimosfermin alfa2 trials UDCA2 trials albumin2 trials Glecaprevir/pibrentasvir2 trials UDCA (Ursodeoxycholic acid)2 trials HepB mAb192 trials Pegozafermin2 trials Fazirsiran Injection2 trials Cellgram-LC2 trials Survodutide2 trials TAF2 trials Bepirovirsen2 trials Lactulose2 trials Rifaximin 550 MG2 trials Brelovitug 300 mg2 trials Tenofovir alafenamide Fumarate2 trials Placebo (PB)2 trials Diroximel Fumarate2 trials MRI contrast-enhancing agents2 trials Intravenous steroid2 trials rapcabtagene autoleucel (YTB323)2 trials Obecabtagene autoleucel (obe-cel)2 trials CD19 Universal CAR-T cells2 trials P-CD19CD20-ALLO1 Cells2 trials Ianalumab2 trials Cenerimod2 trials NKX0192 trials CREXONT ER2 trials Human Dopaminergic Progenitor Cells2 trials DPA-714-PET/MRI2 trials Silymarin2 trials MM120 (LSD D-Tartrate)2 trials Nitrous oxide2 trials Xanax2 trials ITI-1284 20 mg2 trials ITI-1284 10 mg2 trials Buagafuran capsules mimic, 0mg/ capsule2 trials Buagafuran capsules, 15mg/ capsule2 trials Tadalafil2 trials Placebo for TQC3721 inhalation powder2 trials TQC3721 inhalation powder2 trials BBT0022 trials Astegolimab2 trials A-3192 trials Fexofenadine2 trials anti CD19 CAR NK cells2 trials ADI-0012 trials Upadacitinib 15 MG [Rinvoq]2 trials Vutiglabridin2 trials Icotrokinra2 trials Febuxostat2 trials Sodium hyaluronate injection2 trials FMT2 trials Dotinurad2 trials Platelet-rich plasma2 trials Zasocitinib2 trials Iguratimod2 trials PIT5652 trials Lutikizumab2 trials 2.5% Diclofenac Patches2 trials SHR-3045 Injection2 trials Faecal microbiota transplantation2 trials Solumedrol2 trials Allocetra2 trials Verekitug2 trials Matching placebo in prefilled syringe2 trials Azithromycin2 trials Comparator2 trials Inhaled corticosteroid (ICS)2 trials fluticasone/salmeterol2 trials ICS/LABA2 trials GB-08952 trials PA9159 Metered-Dose Inhaler, 120 μg per day for 28 days2 trials IBI30022 trials PERICAPSULAR NERVE BLOCK2 trials Angiotensin Receptor Blockers2 trials Mavorixafor2 trials USG GUIDED SUPRA-INGUINAL FASCIA ILIACA BLOCK2 trials Fluvoxamine2 trials Optimal Medical Therapy2 trials Amlodipine2 trials Ferinject2 trials Guideline directed statin therapy2 trials standard treatment2 trials JK072 trials Sotatercept2 trials Clopidogrel monotherapy2 trials Edoxaban2 trials Aspirin + Clopidogrel2 trials Fluid bolus2 trials Influenza vaccine2 trials CDR132L2 trials Butylphthalide and Sodium Chloride Injection2 trials TNX-1032 trials Biocollection2 trials Standard DAPT2 trials Standart medical treatment2 trials Sacubitril / Valsartan Oral Tablet [Entresto]2 trials Maralixibat2 trials Spironolactone 25mg2 trials Genistein2 trials PPI2 trials Amiodarone2 trials DOAC2 trials 6 months treatment with a single antiplatelet agent2 trials long-term treatment with a single antiplatelet agent2 trials extended postimplantation dual antiplatelet therapy2 trials short postimplantation dual antiplatelet therapy2 trials Aspirin plus clopidogrel2 trials Azathioprine2 trials Mannitol2 trials PCSK9 inhibitor2 trials Anticoagulants2 trials Thiamine2 trials Colchicine Pill2 trials 17-beta estradiol2 trials Esmolol2 trials Candesartan2 trials Flecainide2 trials Guideline Directed Medical Therapy for Heart Failure (GDMT)2 trials Delayed anticoagulation2 trials Early anticoagulation2 trials Isosorbide Dinitrate2 trials Vericiguat tablet2 trials Allogeneic umbilical cord mesenchymal stem cells2 trials Low Dose Colchicine2 trials Single antiplatelet therapy (SAPT)2 trials KPL-3872 trials Guideline-Directed Medical Therapy2 trials Supportive therapies2 trials Immunosuppressive therapy2 trials Antiarrhythmic drug2 trials Guideline-directed medical treatment2 trials IBI3622 trials Colchicine 0.5 MG Oral Tablet2 trials Human albumin2 trials Prasugrel 5 mg2 trials gender-affirming hormone therapy2 trials Landiolol2 trials Dapagliflozin 10 MG Oral Tablet2 trials Ocrelizumab (US)2 trials NIO7522 trials 0.9% NaCl2 trials Xanomeline Enteric Capsule2 trials Xanomeline/Trospium Chloride Capsule2 trials Placebo Drug2 trials Bumetanide2 trials dimethyl fumarate2 trials Trontinemab2 trials Siponimod2 trials Lumbar puncture2 trials Foralumab TZLS-401 100 µg2 trials Donanemab2 trials Lecanemab2 trials Matching Placebo (Remternetug)2 trials buntanetap/posiphen2 trials SNK012 trials BMS-9863682 trials ITI-12842 trials Cariprazine2 trials Transdermal Estradiol2 trials SSRIs2 trials Remimazolam besylate2 trials Pregnenolone2 trials [11C]-Pittsburgh Compound B ([11C]PiB)2 trials F 18 AV-1451 (Flortaucipir)2 trials Sertraline Pill2 trials Lumateperone2 trials Conventional Anemia Management2 trials Roxadustat2 trials Placebo for Icalcaprant2 trials Icalcaprant2 trials Vortioxetine2 trials Zelquistinel2 trials Second-line Antidepressants2 trials Esketamine Nasal Product2 trials OSU61622 trials Valproate acid2 trials Racemic ketamine2 trials Lorazepam2 trials ABX-0022 trials Nicotine Patch2 trials SP-6242 trials TAU2 trials Galcanezumab2 trials Risperidone 1 MG2 trials Metreleptin2 trials GIP2 trials Semaglutide Pen Injector [Ozempic]2 trials Menopausal Hormone Therapy2 trials Basal Insulin2 trials SGLT-2 inhibitor2 trials Umbilical Cord Mesenchymal Stem Cells2 trials Semaglutide Pill2 trials Aminohippurate Sodium Inj 20%2 trials Drug:10 mg BGM0504 Administered SC2 trials Drug: 5 mg BGM0504 Administered SC2 trials Acetylcholine2 trials Ixekizumab2 trials Metformin HCl 1000 mg2 trials Dapagliflozin 10 mg/Pioglitazone 30 mg/Metformin HCl 1000 mg2 trials EMPAGLIFLOZIN + LINAGLIPTIN2 trials Mirabegron 50 MG2 trials Ondansetron 8mg2 trials Insulin detemir2 trials Insulin degludec2 trials NNC0363-10632 trials dapagliflozin tablet2 trials HRS-7535 tablet2 trials Kerendia (Finerenone, BAY94-8862)2 trials HDM1002 400 mg2 trials HDM1002 200 mg2 trials HRS95312 trials Mesenchymal stem cells2 trials Dapagliflozin (DAPA)2 trials Nicotinic Acid2 trials Intravenous Vancomycin2 trials LY39385772 trials Finerenone (Kerendia, BAY94-8862)2 trials Maridebart cafraglutide2 trials Placebo injection2 trials human umbilical cord mesenchymal stem cells2 trials Semaglutide, 1.0 mg/mL2 trials AZD67932 trials insulin NPH2 trials Allogenic islet cells (human, U. Chicago)2 trials Acipimox 250 mg Oral Capsule2 trials 0.9% sodium chloride2 trials Dapagliflozin (Forxiga)2 trials Semaglutide 14 MG [Rybelsus]2 trials Placebo SC2 trials Dulaglutide2 trials Finerenone (BAY 94-8862)2 trials Exendin 9-392 trials Blood test2 trials Pioglitazone 45 mg2 trials Saline (0.9% NaCl)2 trials Lyumjev U-100 Insulin2 trials Saline Injection2 trials Bacillus Calmette-Guérin2 trials HDM1005 injection or placebo2 trials THC2 trials Renal Autologous Cell Therapy (REACT)2 trials CTX1122 trials [64Cu]FBP82 trials IMVT-14022 trials Firmonertinib2 trials General anesthesia2 trials Carboplatin (adjuvant）2 trials Tislelizumab（adjuvant）2 trials Cisplatin（adjuvant）2 trials Nab-paclitaxel （neoadjuvant）2 trials Cisplatin （neoadjuvant）2 trials Tislelizumab（neoadjuvant）2 trials CD19-CAR T cell Infusion2 trials YL201 for Injection2 trials tumor vaccine2 trials Clostridium butyricum2 trials ATRA2 trials Plixorafenib2 trials WTX212A injection2 trials Gonadotropin-releasing Hormone Analog2 trials Loratadine2 trials Celecoxib 400mg2 trials Later-line therapy2 trials Viral Specific VST Infusion2 trials RP22 trials MC-1-502 trials JAB-33122 trials GPC2 CAR T cells2 trials Placebo tablets2 trials RLY-26082 trials INCA0339892 trials Oxygen (placebo)2 trials Ozone therapy2 trials 5-azacytidine2 trials Tumor vaccine-induced specific T-cell injection2 trials XH001 Injection2 trials Namodenoson2 trials Tisagenlecleucel2 trials Hemay1812 trials PF-077999332 trials TQB24502 trials Empasiprubart IV2 trials 5FU2 trials JS0042 trials albuterol inhaler2 trials Iruplinalkib tablets2 trials PD(L)-1 inhibitor2 trials Chimeric antigen receptor T cells2 trials CD19/CD22-CAR T cells2 trials Tramadol2 trials sulforaphane2 trials Albumin-paclitaxel Injection2 trials FKC2882 trials PD-L1 inhibitor2 trials raltitrexed2 trials GT719 Injection2 trials GNC-0772 trials Alvimopan2 trials Pirfenidone2 trials TGRX-6782 trials AZD54922 trials WX3902 trials AZD34702 trials Ropeginterferon alfa-2b2 trials Lu-PSMA-6172 trials 225Ac-LNC10112 trials Adebrelimab，Fruquintinib2 trials senicapoc2 trials AK1312 trials Thymosin Alpha12 trials Celecoxib 200mg2 trials NeoVax2 trials YL202 should be intravenously infused2 trials Fish oil2 trials Ruxolitinib Oral Tablet [Jakafi]2 trials Inebilizumab2 trials TQB6411 Injection2 trials Vinorelbine Tartrate Oral2 trials BMS-9862532 trials HRS-50412 trials Pamiparib2 trials Pembrolizumab 25 MG/ML [Keytruda]2 trials QLP21172 trials Oxaliplatin for injection2 trials Nitazoxanide2 trials Individual Patient TCR-Transduced PBL2 trials MB-CART19.12 trials Inetetamab2 trials PLZ4-coated paclitaxel-loaded micelles (PPM)2 trials Ivosidenib Oral Tablet2 trials Venetoclax (VEN)2 trials NY-ESO-1 TCR/IL-15 NK2 trials BMS-9861652 trials BPI-11782 trials Total neoadjuvant therapy (TNT)2 trials SGN12 trials KSH01 injection2 trials FOLFOX chemotherapy regimen2 trials rezatapopt2 trials Iparomlimab and Tuvonralimab injection2 trials NM66032 trials AMXT 1501 Dicaprate2 trials FLOT Chemotherapy2 trials Gadobutrol2 trials BL-M17D12 trials Gemcitabine 1000 mg/m^22 trials Relacorilant 150 mg once daily (QD)2 trials Hydroxychloroquine Sulfate Tablets2 trials Remibrutinib (Open Label)2 trials Remibrutinib (Blinded)2 trials Odetiglucan2 trials rabbit ATG2 trials anti-PSMA CAR-NK2 trials casdatifan2 trials Combination drug2 trials Hydrocortisone Sodium Succinate2 trials Sapanisertib2 trials individualized anti-tumor new antigen iNeo-Vac-R01 injection2 trials Mecapegfilgrastim Injection2 trials Imetelstat2 trials Gemcitabine alone2 trials BCMA/CD19 CAR T cells2 trials BCMA CAR T cells2 trials BTM-35662 trials Motixafortide2 trials LB14102 trials VA2 trials Imatinib 400 MG2 trials Tazemetostat Pill2 trials CHS-1142 trials Vancomycin2 trials MHB036C for Injection2 trials Sildenafil2 trials Metfomin2 trials Trastuzumab and Pertuzumab2 trials NK cells2 trials Fluorouracil Injection2 trials CEB-012 trials AK138D12 trials Deucravacitinib2 trials SGM-1012 trials AZD95922 trials AZD67382 trials Azithromycin Pill2 trials Misoprostol2 trials Pantoprazole2 trials ADV/HSV-tk (gene therapy)2 trials Intra-arterial Mannitol2 trials Intra-arterial Cetuximab2 trials mFOLFOXIRI plus Bevacizumab2 trials V9402 trials SEphB4-HSA2 trials MCLA-1292 trials Riluzole2 trials AMT-1162 trials Imipramine2 trials sunvozertinib in combination with Anlotinib2 trials Iodine-1242 trials Estradiol2 trials Imatinib Mesylate2 trials BEBT-209 capsules2 trials HBI0101 CART2 trials Newly matched donor-derived CD5 CAR T-cells2 trials Autologous CD5 CAR T-cells2 trials Temozolomide+Irinotecan+Vincristine2 trials IMiD treatment2 trials Proteasome Inhibitor2 trials Bispecific antibody2 trials Atezolizumab 1200 mg in 20 ML Injection2 trials Steroid Therapy2 trials R-CHOP Protocol2 trials CAPOX chemotherapy2 trials Dual-Function Antibody PD-1/CTLA-42 trials NXP9002 trials AZD22872 trials Trastuzumab emtansine (T-DM1)2 trials F-18 16 Alpha-Fluoroestradiol2 trials Anti-Tumor Drugs2 trials MB-CART2019.12 trials Doxycyclin2 trials BCG for Therapeutic Use2 trials Exemestane tablets2 trials KB7072 trials JS0152 trials SNDX-56132 trials IFx-Hu2.02 trials ProAgio Dose Levels (DL) 1,2,3,42 trials Gedatolisib2 trials Etrumadenant2 trials Allogeneic T cell progenitors, cultured ex-vivo2 trials Eplerenone2 trials Bomedemstat2 trials Esomeprazole2 trials NWRD09 administered by intramuscular injection2 trials Berzosertib2 trials Ixazomib Citrate2 trials Sabestomig2 trials tolododekin alfa2 trials 5-FU (5-fluorouracil)2 trials [212Pb]VMT-alpha-NET2 trials [203Pb]VMT-alpha-NET2 trials Lorigerlimab2 trials BG-898942 trials Pirarubicin2 trials Full course of PD-1/PD-L1 blockades2 trials AAA8172 trials Lu-177-DOTATATE2 trials M92412 trials anti-PD-1 antibody and chemotherapy2 trials Fludarabine + Cyclophosphamide2 trials umbilical cord blood NK cells2 trials Fenretinide2 trials BI 7645322 trials CD22CART Infusion2 trials Papaverine2 trials Targeted agent2 trials L19IL22 trials Aspirin 100mg2 trials BCMA/GPRC5D CAR-T cells2 trials Atorvastatin 20mg2 trials fhB7H3.CAR-Ts2 trials TTI-1012 trials SPH4336 Tablets2 trials Gocatamig2 trials GH212 trials R-mini-CHOP2 trials Bintrafusp alfa2 trials GR1803 injection2 trials CD70-targeting CAR-T cells2 trials Luteinizing hormone-releasing hormone (LHRH) analogue2 trials Disulfiram2 trials HCQ2 trials Obecabtagene autoleucel2 trials Darovasertib2 trials PM142 trials PF-072481442 trials PD-L1 t-haNK2 trials RC48-ADC2 trials Memantine Hydrochloride2 trials Camrelizumab Plus Chemotherapy2 trials Trametinib tablet2 trials REM-4222 trials Physician's Choice2 trials Gemcitabine injection2 trials Carboplatin/etoposide2 trials TROP2-CAR-NK Cells2 trials EV2 trials Paclitaxel+Carboplatin2 trials Carotuximab2 trials 68Ga-DOTATOC2 trials ONO-46852 trials Docetaxel for Injection (Albumin-bound)2 trials FOLFOXIRI Protocol2 trials HLX222 trials Progesterone2 trials Cyclophosphamide (C)2 trials Oral Azacitidine2 trials Somatostatin analog2 trials Atovaquone2 trials ADT (Standard of Care)2 trials CD5 CAR T-cells2 trials XNW50042 trials Gemcitabine+Albumin-bound paclitaxel2 trials Cytarabine IT2 trials Control Arm2 trials DB107-FC2 trials SCTC21C2 trials Vitamin D2 trials JAK Inhibitor2 trials ADC2 trials WSD0922-FU2 trials Proleukin2 trials pNGVL4aCRTE6E7L22 trials Fast CAR T cells2 trials JAB-23E732 trials Proflavine hemisulfate2 trials Bevacizumab 10 mg/kg2 trials KYV-1012 trials Troriluzole2 trials TORIPALIMAB INJECTION(JS001 )2 trials ST-1898 tablets2 trials Ivonescimab Injection2 trials Irinotecan Sucrosofate2 trials Taxotere (docetaxel)2 trials Anti-PD-L1 Monoclonal Antibody2 trials Sonidegib2 trials Sasanlimab2 trials DB-1305/BNT3252 trials US-sourced Keytruda®2 trials Durvalumab Injection2 trials iparomlimab + tuvonralimab2 trials TKI2 trials TROP2 ADC2 trials Platinum-based doublet chemotherapy2 trials REGN70752 trials Topotecan Hydrochloride2 trials Pemetrexed injection2 trials APG-24492 trials Lutetium [177Lu] BL-ARC0012 trials Tislelizumab Injection2 trials NMS-033052932 trials ICG (Indocyanine Green)2 trials bsCBD Cannabidiol2 trials fsCBD Cannabidiol2 trials Olanzapine 2.5 MG2 trials Roflumilast2 trials BL-M09D12 trials Bevacizumab (or biosimilar)2 trials CD19 CAR-T cells injection2 trials Pembrolizumab 200 mg2 trials LP-1182 trials Romidepsin2 trials Orelabrutinib Placebo2 trials SON-DP2 trials Pemetrexed Disodium2 trials [177Lu]Lu-NeoB2 trials [68Ga]Ga-NeoB2 trials TLN-2542 trials HLX042 trials Rapidly generated virus specific T (R-MVST) cells2 trials DRP-1042 trials 68Ga-FAPi-462 trials Bleomycin Sulfate2 trials Vinblastine Sulfate2 trials Cancer Therapeutic Procedure2 trials Pegcetacoplan2 trials Oral Dexamethasone2 trials Ad-TD-nsIL122 trials Lifei Xiaoji Wan2 trials Axatilimab (SNDX-6352)2 trials Olaparib (300 mg BID)2 trials Nelfinavir2 trials PEP072 trials Pimonidazole2 trials Pembrolizumab infusion2 trials Neladalkib (NVL-655)2 trials Olaparib 150 MG2 trials Rozanolixizumab2 trials RC48+Carboplatin+Bevacizumab2 trials quaratusugene ozeplasmid2 trials GT3162 trials Naldemedine2 trials Neratinib Maleate2 trials CPX-3512 trials PD-1/PD-L1 inhibitor2 trials Rituximab Biosimilar2 trials Darolutamide (Nubeqa®) 300 mg tablets2 trials Apalutamide (Erleada™) 60 mg or 240 mg tablets2 trials HRS-4508 tablet2 trials Thalidomide2 trials Nadunolimab2 trials Quemliclustat2 trials AK1172 trials ELVN-0012 trials AVZO-0212 trials MRTX17192 trials Tucidinostat2 trials LM-24C52 trials Trastuzumab Injection2 trials Sodium Chloride solution 0.9%2 trials 68Ga-JH042 trials Metabolically Armed TIL cells2 trials Loperamide2 trials HC0062 trials Chiauranib2 trials Carboplatin/Cisplatin2 trials Metformin XR2 trials CAPEOX/XELOX2 trials TYK-005402 trials Chemotherapy: Pemetrexed2 trials CHT1012 trials Emapalumab2 trials Zilucoplan2 trials Encorafenib + Binimetinib2 trials Direct Oral Anticoagulants2 trials SR-8541A2 trials T30112 trials Crizotinib 250 MG2 trials Alectinib 150 MG2 trials LY35379822 trials HSK423602 trials BL-M14D12 trials Clarithromycin 500 mg2 trials Bismuth2 trials chimeric antigen receptor gene modified T cells2 trials ASP55412 trials [68Ga]Ga-NOTA-RT42 trials Standard systemic therapy2 trials Intraperitoneal Paclitaxel2 trials AU-0112 trials Pneumococcal Polyvalent Vaccine2 trials Pneumococcal 20-valent Conjugate Vaccine2 trials PRJ1-30242 trials Lymphodepleting chemotherapy2 trials entinostat2 trials Bivalent HPV vaccine2 trials Granulocyte-Macrophage Colony-Stimulating Factor2 trials 7MW49112 trials AG chemotherapy2 trials RBS24182 trials Rosuvastatin 10 mg tablet.2 trials PAS-004 Tablets2 trials Recombinant oncolytic herpes simplex virus type 1 (R130)2 trials DR302062 trials Golytely2 trials Akt/ERK Inhibitor ONC2012 trials Dexrazoxane2 trials Dronabinol2 trials Blood-stage infection of P.vivax2 trials HRS-11672 trials Abexinostat2 trials Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B102 trials Glutathione2 trials PF-068214972 trials Taxane Chemotherapy2 trials Talazoparib Tosylate2 trials Levo-Leucovorin2 trials KD01(the recombinant oncolytic adenovirus)2 trials Camrelizumab + Nab-paclitaxel + Cisplatin2 trials MTX2 trials Bevacizumab-Awwb2 trials Testosterone Enanthate2 trials TCR-T cells2 trials Erdafitinib2 trials Dacomitinib2 trials Rucaparib2 trials mFOLFOX-62 trials CXCR1/2 Inhibitor SX-6822 trials paclitaxel plus carboplatin2 trials IMA2032 trials Paroxetine2 trials Bendamustin2 trials Metformin Hydrochloride 500 MG2 trials Belvarafenib2 trials Nivolumab + chemotherapy2 trials Icotinib2 trials LCAR-AIO T cells2 trials Mitotane2 trials Anti-VEGF2 trials Mazdutide2 trials SHR2554 tablets2 trials HRS-1167 tablets2 trials Prednisone Acetate tablets2 trials Abiraterone Acetate tablets（II）2 trials Immunochemotherapy2 trials Luspatercept2 trials Trilaciclib Injection [Cosela]2 trials CYAD-1012 trials Vyxeos2 trials Niraparib 200/300 MG2 trials RP-35002 trials Desflurane2 trials Filgrastim-sndz2 trials Penpulimab Injection2 trials JNJ-903019002 trials GVHD prophylaxis2 trials RIC2 trials Bicalutamide 50 mg2 trials Triptorelin Embonate2 trials [177Lu]Lu-XT1172 trials Disitamab Vedotin for injection2 trials Telisotuzumab Vedotin2 trials SHR-A20092 trials mFOLFOX6 regimen2 trials Doxil2 trials Mosunetuzumab (SC)2 trials Fluorodopa F 182 trials BCG Solution2 trials RET Inhibitor2 trials Ferric carboxymaltose2 trials Sugemalimab and Chemotherapy2 trials Relatlimab + Nivolumab2 trials [68Ga]CBP82 trials Sodium Fluoride F-182 trials TORL-1-232 trials CD19/BCMA Targeted CAR T-cells2 trials Trastuzumab (Herceptin)2 trials Nanoliposomal Irinotecan2 trials BCG2 trials Definity2 trials UAE Inhibitor TAK-2432 trials Paclitaxel Chemotherapy2 trials INBRX-1062 trials Arm B2 trials Arm A2 trials Neoadjuvant chemo-immunotherapy2 trials Vedolizumab2 trials PCNA Inhibitor AOH19962 trials Gemcitabine 1000 mg2 trials Ezabenlimab2 trials BI 7650492 trials ABSK-0112 trials M91402 trials VRD-based regimen2 trials IDE3972 trials Bevacizumab (Avastin)2 trials JNJ-869746802 trials BL-M05D12 trials Leuprorelin2 trials SAR4458772 trials FOLFIRI Protocol2 trials BAY29270882 trials [68Ga]Ga-FAPI-46 PET/CT2 trials Paracetamol2 trials Lutathera2 trials 68GA-DOTA-dPNE2 trials SBRT combined with Tislelizumab followed by Tislelizumab2 trials CYTALUX™ (pafolacianine)2 trials Daratumumab SC2 trials adjuvant immunotherapy2 trials 68Ga-pentixafor2 trials Alnuctamab2 trials BMS-9863932 trials BL-M08D12 trials BMS-986213 (Relatlimab-Nivolumab FDC)2 trials 68-Gallium DOTATATE2 trials Combination Agent 12 trials TIL2 trials Fam-Trastuzumab Deruxtecan-Nxki (TDxD)2 trials INCMGA000122 trials Rivaroxaban 10 MG2 trials WX-0593 Tablets2 trials Gecacitinib Hydrochloride Tablets2 trials Platinum doublet chemotherapy2 trials Olaparib tablet2 trials PD-1 inhibitior2 trials ASP21382 trials AK146D1 for injection2 trials ANS0140042 trials RYZ1012 trials Capecitabine Oral Product2 trials Toripalimab+Chemotherapy2 trials Onfekafusp alfa2 trials NK5202 trials IDRX-422 trials Olomorasib2 trials GP2 trials PD-1 blocking antibody2 trials DP303c2 trials sirolimus (albumin-bound)2 trials Lenalidomide (Revlimid)2 trials ciprofol2 trials SPH4336 Tablets Placebo2 trials Exenatide2 trials CD19/CD22-bispecific CAR-T cells2 trials Tiragolumab and atezolizumab2 trials GSK57335842 trials Axi-cel2 trials GT1012 trials HRS-13582 trials EIK10012 trials FWD18022 trials Lamivudine2 trials Belantamab Mafodotin-Blmf2 trials Letermovir2 trials Dendritic Cell Vaccine2 trials 68Ga-P16-0932 trials Ribociclib 600mg2 trials EBV-TCR-T cells2 trials Autologous tumor infiltrating lymphocyte injection（GT201）2 trials Universal Donor Expanded TGF-beta-imprinted NK Cells2 trials anti-CD70-CAR-T cells2 trials VEN (Venetoclax)2 trials SoC2 trials BNT3262 trials Aspirin 325mg2 trials Osimertinib mesylate2 trials Glumetinib2 trials CAR19TIF cells2 trials S12 trials [18F]F-AraG2 trials zamtocabtagene autoleucel (MB-CART2019.1)2 trials Orca-T2 trials Petosemtamab2 trials 18F-fluorofuranylnorprogesterone2 trials Checkpoint Inhibitor, Immune2 trials GnRH antagonist2 trials Xeloda2 trials Ameluz 10% Topical Gel2 trials Cilta-cel2 trials Vitamin D3 (Cholecalciferol)2 trials BAFF CAR-T2 trials Tislelizumab Combined With Chemotherapy2 trials RVU1202 trials Flotufolastat F-18 Injection2 trials Cisplatin-based chemotherapy2 trials Allogenic CD19 CAR-γδT cell2 trials Dalpiciclib 100mg2 trials Pembrolizumab and Lenvatinib2 trials Diagnostic Test: 68Ga-DOTATATE2 trials Diagnostic Test: Al18F-NOTA-LM32 trials GFH0092 trials SSGJ-7052 trials Targeted therapy2 trials Nivolumab Injection2 trials Certolizumab2 trials Fluconazole2 trials Cefuroxime2 trials Amoxicillin clavulanic acid2 trials ZGGS18 for Injection2 trials Equecabtagene Autoleucel Injection2 trials Amivantamab IV2 trials TY-95912 trials Epirubicin (E)2 trials Elironrasib2 trials Cretostimogene Grenadenorepvec2 trials PIN +anti-PD12 trials Lisaftoclax (APG-2575)2 trials Claudin18.2 Targeted CAR-T Cells2 trials [18F]PSMA-10072 trials ZN-c32 trials ACR-3682 trials [18F]F-RESCA-RB142 trials Definity Suspension for Injection2 trials Fulvestrant/AI2 trials Prednisone/ prednisolone2 trials Leucovorin LV2 trials SHR-A2102 for injection2 trials Mycophenolate Sodium2 trials IAP09712 trials Tebentafusp-Tebn2 trials 6-Thio-2'-Deoxyguanosine2 trials Lysogenic HSV virus.2 trials LP-1682 trials ArabinoFuranosylGuanine [18F]F-AraG2 trials Topotecan Hydrochloride for Injection2 trials PF-080460542 trials First-line Chemotherapy2 trials Fludara2 trials Peginterferon α-2b injection2 trials Recombinant Human Thyroid Stimulating Hormone2 trials Cemsidomide2 trials Simvastatin2 trials Momelotinib2 trials Larotrectinib (Vitrakvi, BAY2757556)2 trials Liposomal paclitaxel2 trials Systemic Therapy/Standard of Care2 trials Imiquimod2 trials Autologous Tumor Infiltrating Lymphocytes2 trials FluBHPVE6E72 trials Oxycodone2 trials Tumor Infiltrating Lymphocyte2 trials AL8326 tablets2 trials Stupp protocol2 trials THEO-2602 trials Cladribine (CLAD)2 trials SYS60102 trials RC1482 trials BMS-9864532 trials CAR-T cells Infusion chimeric antigen receptor T cells2 trials Taxane2 trials ABL1032 trials [68Ga]P32 trials Tamoxifen 20 mg2 trials Megestrol Acetate 160 MG Oral Tablet2 trials PD-1 Inhibitor + Chemotherapy2 trials ABBV-3192 trials Ribociclib 400mg2 trials Serplulimab Injection2 trials Tumor Associated Lymph node T cell2 trials Neoantigen polypeptide vaccine2 trials Candonilimab2 trials Setidegrasib2 trials HH2853 Tablets2 trials NX-59482 trials 68Ga-RGD2 trials 68Ga-RM262 trials [225Ac]Ac-DOTATATE2 trials Trifluridine and Tipiracil Hydrochloride2 trials PYX-2012 trials SHR-7787 Injection2 trials Pralatrexate Injection2 trials TP regimen2 trials PRL3-ZUMAB2 trials FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan)2 trials Midostaurin2 trials Personalized Neoantigen DNA vaccine2 trials Radiation Therapy2 trials GLB-0012 trials RD1332 trials ESG4012 trials Oral Placebo2 trials Docetaxel/Carboplatin2 trials Leucovorin calcium/Levoleucovorin2 trials E7 TCR-T cells2 trials SGN-LIV1A2 trials Eflornithine2 trials apatinib plus camrelizumab2 trials Bevacizumab Biosimilar IBI305 plus sintilimab2 trials Bevacizumab plus Atezolizumab2 trials C-CAR0312 trials DOC10212 trials tirapazamine2 trials KQB1982 trials Osimertinib 80 MG2 trials mFOLFOXIRI2 trials Recombinant oncolytic herpes simplex virus type Ⅰ (R130)2 trials Selumetinib Sulfate2 trials Eribulin Mesylate2 trials Docetaxel or Paclitaxel2 trials ONO-45382 trials AWT0202 trials Cisplatin or Carboplatin2 trials HNF4α srRNA2 trials No intervention2 trials Anti-CD40 Agonist Monoclonal Antibody CDX-11402 trials Sutetinib Maleate Capsule2 trials Relma-cel2 trials Sunitinib Malate2 trials BL-M11D12 trials MDMA2 trials Dextromethorphan2 trials Corticosteroid2 trials HIPEC2 trials Indium In 111-DOTA-Daratumumab2 trials Actinium Ac 225-DOTA-Daratumumab2 trials CDX-11402 trials FOLFOX Protocol2 trials Ascorbic acid2 trials Neoadjuvant Chemotherapy (NAC)2 trials MK-34752 trials pemetrexed+cisplatin2 trials [18F]-FAPI-742 trials Tagraxofusp-erzs2 trials INCB1236672 trials Anti-PD-1 Drugs2 trials Paclitaxel （neoadjuvant）2 trials HC-73662 trials STP9382 trials Oral repotrectinib (TPX-0005)2 trials ICP-7232 trials Paclitaxel based chemotherapy2 trials Cord blood graft2 trials Conditioning Chemotherapy2 trials Histrelin2 trials Flutamide2 trials KN0262 trials JS1052 trials CLLS522 trials Methadone2 trials TRK-9502 trials TAS-1202 trials Carboplatin/Pemetrexed2 trials [18F]F-PSMA-N52 trials Micronized progesterone2 trials STAR06022 trials Pregabalin2 trials Local Standard of Care2 trials Tirelizumab2 trials tabelecleucel2 trials Methylphenidate (MPH)2 trials QLS320152 trials ssCART-192 trials SHR-17012 trials Icaritin2 trials FOLFOX42 trials Nivolumab 10 MG/ML Intravenous Solution2 trials Olvimulogene nanivacirepvec2 trials hiHep bioartificial liver therapy1 trials B13441 trials LYG-LIV00011 trials Liver biopsy1 trials Pemvidutide1 trials Diluted I.V.-Hepabig inj(GC5103)1 trials Undiluted I.V.-Hepabig inj(GC5103)1 trials PegIFNα2b+Nucleoside analog1 trials SAMe 400 mg tablet1 trials Vonoprazan 20 mg1 trials Conventional transfusion algorithm1 trials Transfusion algorithm based on Quantra®1 trials INI-822 (A)1 trials Rifaximin-α (Alfa Wassermann S.p.A., Italy)1 trials hUC-MSC_Prolonged1 trials hUC-MSC1 trials RTX0011 trials Encapsulated FMT1 trials DISC-14591 trials Aspirin 81 mg Enteric Coated Tab - 1 tablet1 trials BAR502 multiple doses1 trials Placebo single dose1 trials BAR502 single dose1 trials ALN-PNP1 trials Inhaled amikacin1 trials nucleos(t)ide1 trials peginterferon alpha based regimen1 trials Ambrisentan1 trials Isotonic Sodium Chloride injection1 trials Hecolin® Recombinant Hepatitis E Vaccine1 trials Droxidopa capsules1 trials Nucleoside Analogs1 trials Peginterferon Alfa-2B1 trials AAV8hAAT(AVL)1 trials Alpha 1-Antitrypsin1 trials SN20011 trials Ademetionine 1,4-Butanedisulfonate1 trials Ursodeoxycholic acid capsules1 trials Polyene Phosphatidylcholine1 trials Magnesium isoglycyrrhizinate1 trials GIGA-23391 trials 2% Fat Cow's Milk1 trials Standard Soy Milk1 trials GZR18 injection1 trials INT-7871 trials IB-0011 trials Estradiol patch1 trials Choline Chloride for Injection1 trials The placebo capsules1 trials Hydronidone capsules1 trials Tenofovir1 trials Terbinafine1 trials Creation of a serum biobank1 trials bis-octanoyl (R)-1,3-butanediol (C8 ketone di-ester)1 trials Sofosbuvir / Velpatasvir Oral Tablet [Epclusa]1 trials Coenzyme Q10 Forte® capsules1 trials Custodiol HTK Solution1 trials Custodiol-N Solution1 trials SHAPE measurement (Definity ultrasoud contrast agent)1 trials SHAPE measurement (Sonazoid ultrasoud contrast agent)1 trials Brelovitug (BJT-778)1 trials 18F-DPA-7141 trials PEGylated recombinant human interferon alpha-2b injection1 trials Bulevirtide 2 mg and Brelovitug - 300 mg1 trials Placebo matching survodutide1 trials Carvedilol alone1 trials Fenofibrate 200mg1 trials Peripheral iv1 trials RVF Vaccine1 trials Midodrine1 trials orphenadrine1 trials DNP0071 trials IVA3371 trials WVE-0061 trials Sulfasalazine enteric-coated tablets1 trials Lidocaine aerosol 2.4% topical1 trials Cisatracurium 0.15 mg/kg IV1 trials Cisatracurium 0.05 mg/kg IV1 trials Prograf (SOC)1 trials Envarsus Oral Product1 trials Miricorilant1 trials Placebo to match GST-HG1311 trials GST-HG1311 trials Defibrotide1 trials Ademetionine1 trials ursodeoxycholic acid1 trials 2mg CS01591 trials Peg-Interferon α1 trials Siplizumab1 trials Albumin Infusion1 trials AHB-1371 trials Niacin (250mg)1 trials Milk thistle (MT)1 trials Prothrombin1 trials Lactulose 667 milligram/milliliter Oral Solution1 trials Rifaximin 550 milligram Oral Tablet [XIFAXAN]1 trials Volixibat1 trials Placebo (NNC0581-0001)1 trials NNC0581-00011 trials Pevifoscorvir Sodium (ALG-000184)1 trials ECC05091 trials ECC47031 trials Commensal Bacteria Strains1 trials Sodium Hyaluronate1 trials Prednisolone 40 mg1 trials Lusutrombopag combined with recombinant human thrombopoietin1 trials Carbocysteine 375 MG1 trials golexanolone1 trials Rosuvastatin 10mg1 trials Atorvastatin 20 mg1 trials Entecavir or Tenofovir1 trials BI 38028761 trials TYNADOTE1 trials Larsucosterol1 trials Arginine1 trials Branched-Chain Amino Acids1 trials Ornithine Aspartate1 trials Human albumin infusion at a routine dosage1 trials Human albumin infusion at a modified dosage1 trials Hemay0051 trials GSK45329901 trials LioCyx-M1 trials BEAM-3021 trials Placebo of HP515 20mg Tablet1 trials HP515 20 mg Tablet1 trials Placebo of HP515 10 mg Tablet1 trials HP515 10 mg Tablet1 trials KB408 (Nebulization)1 trials IDB-011 dose level 51 trials IDB-011 dose level 41 trials IDB-011 dose level 31 trials IDB-011 dose level 21 trials IDB-011 dose level 11 trials Vimseltinib1 trials sofosbuvir/velpatasvir (SOF/VEL)1 trials HAVRIX1 trials Stem Cell1 trials Fenofibrate in Combination With Ursodeoxycholic Acid1 trials Efruxifermin1 trials TherVacB1 trials HEPLISAV B; TherVacB1 trials Sterilizing water for injection1 trials F573 for injection1 trials VIR-2218 and peginterferon alfa-2a1 trials Danazol1 trials 20% Reduced Dose Albumin1 trials 20% High Dose Albumin1 trials Keep current treatment (anti-HBV neucleos(t)ides)1 trials Stop current treatment (anti-HBV neucleos(t)ides)1 trials Saroglitazar Magnesium 2 mg1 trials ETV/TAF/TDF/TMF1 trials ETV/TAF/TDF/TMF/IFN1 trials Lepodisiran1 trials Ertapenem1 trials PN201 trials Elebsiran1 trials Tobevibart1 trials Goserelin Acetate 3.6 mg inj, implant1 trials Group 3: DSL101 High dose1 trials Group 2: DSL101 Medium dose1 trials Group 1: DSL101 Low dose1 trials antiviral treatment1 trials Non- specialist - Epclusa 400Mg-100Mg Tablet1 trials Specialist - Epclusa 400Mg-100Mg Tablet1 trials BI 15848621 trials Placebo ( FE)1 trials IMM-H014 ( FE)1 trials IMM-H0141 trials Fenofibrate (drug)1 trials IFNα-2a1 trials AZVUDINE1 trials Belimumab Auto-Injector [Benlysta]1 trials Apixaban 2.5 mg Oral Tablet1 trials Rivaroxaban 10 mg Oral Tablet1 trials Rifaximin (Xifaxan)1 trials Essential Amino Acid Supplement by Amino Co1 trials TLC-2716 Dose 21 trials TLC-2716 Dose 11 trials TQA2225/AP025 or TQA2225/AP025 Placebo 50mg1 trials TQA2225/AP025 or TQA2225/AP025 Placebo 25mg1 trials NAs monotherapy group1 trials Peginterferon α-2b based treatment group1 trials Incretin-Based Therapy1 trials Placebo oral oil1 trials Cannabidiol oral oil1 trials Prothrombin Complex Concentrate1 trials Platelet Concentrate1 trials Heplisav-B Injectable Product, 3-dose regimen1 trials Heplisav-B Injectable Product, 2-dose regimen1 trials Erdosteine1 trials HBIG1 trials GS-4321 Placebo1 trials GS-43211 trials LAENNEC (Human Placenta Hydrolysate) SC1 trials LAENNEC (Human Placenta Hydrolysate) IV1 trials Pentavalent vaccine and Inactivated Polio vaccine1 trials LBVD1 trials Fenofibrate Combined With Ursodeoxycholic Acid1 trials Placebo Combined With Ursodeoxycholic Acid1 trials Nucleoside analog+probiotics1 trials Nucleoside analog1 trials PegIFNα2b+probiotics1 trials PegIFNα2b1 trials TDF group1 trials TAF group1 trials AZD23891 trials : Placebo for Probiotic1 trials Alirocumab1 trials Omeprazol 40 mg IV1 trials BMN 3491 trials PHIN-214 Subcutaneous injection1 trials IL-22 (F-652) Placebo1 trials Prednisone placebo1 trials Acamprosate1 trials IL-221 trials PBGENE-HBV1 trials 0.9 % saline1 trials HRS-5635 Injection with Peg-IFN-α1 trials HRS-5635 Injection (high dose) and Peg-IFN-α1 trials HRS-5635 Injection (low dose) and Peg-IFN-α1 trials HRS-5635 Injection1 trials NNC4005-0011 trials Edoxaban 60 MG [Lixiana]1 trials Apixaban 5 MG [Eliquis]1 trials Danazol Pill1 trials TDF1 trials ALG-0001841 trials SA1211 injection placebo1 trials SA1211 injection1 trials Tenofovir Alafenamide Tablets1 trials Placebo Capsules1 trials Intestinal Microbiota Transplant (IMT) Capsules1 trials Inactivated hepatitis A vaccine (I-HAV)1 trials Sofosbuvir-Velpatasvir1 trials Bemnifosbuvir-Ruzasvir1 trials Bone marrow mesenchymal stem cells (high dose)1 trials Bone marrow mesenchymal stem cells (medium dose)1 trials Solvent of CG-BM11 trials Bone marrow mesenchymal stem cells (low dose)1 trials Synthroid1 trials Placebo of BRII-8351 trials Placebo of BRII-1791 trials BRII-835 (VIR-2218)1 trials BRII-1791 trials S-6060011 trials Tranexamic Acid and vitamin K1 trials SAR4475371 trials Oral Vancomycin1 trials Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]1 trials Therapeutic Plasma Excahnge1 trials Placebo+NUC1 trials TQA3810 tablets+NUC1 trials Peginterferon alfa-2b Injection1 trials Hepatitis B Vaccine (Recombinant)1 trials Albumin administration1 trials Esomeprazole 20mg1 trials GST-HG141 Placebo1 trials GST-HG1411 trials Tacrolimus Extended Release Oral Tablet1 trials Tacrolimus, Immediate Release, Oral1 trials Placebo for infusions1 trials Placebo for prednisolone1 trials Equine anti-thymocyte globulin1 trials High-dose methylprednisolone1 trials ALN-HSD1 trials Resistant Potato Starch1 trials Hydrochloroquine1 trials Herombopag placebo tablets1 trials Herombopag tablets1 trials ALN-CIDEB1 trials VIR-34341 trials NST-6179 Part B1 trials NST-6179 Part A1 trials Sofosbuvir/Velpatasvir 400 MG-100 MG Oral Tablet1 trials Seladelpar1 trials Placebo for Rifaximin 550mg1 trials Placebo for BCAA1 trials Oral Branched chain Amino acid1 trials BRS2011 trials Delayed Treatment with Brelovitug 300mg1 trials Brelovitug 900 mg1 trials BI 4569061 trials LY35370311 trials Nucleos(t)ide Analogs (NA)1 trials Non-selective beta-blockers1 trials baseline anti-HBs titer1 trials Elafibranor1 trials Imdusiran (AB-729)1 trials Direct Acting Antivirals1 trials recombinant hepatitis B vaccine1 trials Calculus bovis sativus (CBS)1 trials IVL40021 trials IVL30041 trials Vivitrol Injectable Product1 trials Fenebrutinib1 trials Ponesimod1 trials Peginterferon beta-1a1 trials Natalizumab1 trials Interferon beta1 trials Glatiramer acetate1 trials Lithium Carbonate 400 MG1 trials Anti-CD20 antibody1 trials ALN-SOD1 trials Best Available Therapy (BAT)1 trials PLL001 or placebo daily subcutaneous injections1 trials Tyruko Injectable Product1 trials Ocrelizumab Injection [Ocrevus]1 trials Tacrolimus 1Mg Cap1 trials Amantadine Hydrochloride Oral Solution1 trials Placebo oral solution1 trials Trazodone Hydrochloride oral solution1 trials Memantine Hydrochloride Oral Solution1 trials [F-18]FDG1 trials Tamsulosin1 trials Adipose tissue-derived Mesenchymal Stromal Cells1 trials Perfusion of treatment Ocrelizumab1 trials Perfusion of treatment Rituximab1 trials Etifoxine1 trials XBD1731 trials Tibulizumab1 trials Dantrolene1 trials recombinant zoster vaccine1 trials anti-CD20 MS treatment1 trials Dalfampridine 10 MG [Ampyra]1 trials Placebo for Ocrelizumab1 trials Ixazomib (NINLARO®) capsules / Matching placebo capsules1 trials LY35418601 trials LY42569841 trials Solriamfetol1 trials [F-18]SDM-81 trials Modafinil Generis 100 mg1 trials [C-11]Methylreboxetine1 trials Anti-Mullerian hormone (AMH) level1 trials MRI contrast-enhancing preparations1 trials 0.9% Chloride Injection Sodium1 trials Cladribine Subcutaneous Injection1 trials COYA 3021 trials Cellular therapy with EBV specific autologous CTL infusion1 trials RO72684891 trials Ofatunumab1 trials TOP-N53 vehicle1 trials TOP-N531 trials EU-Ocrevus1 trials US-Ocrevus1 trials CT-P531 trials KYV-101 anti-CD19 CAR-T cell therapy1 trials Amyvid radiopharmaceutical1 trials RO7121932 SC1 trials RO7121932 IV1 trials Disease-Modifying Therapies (DMTs)1 trials Foralumab1 trials F-18 3F4AP1 trials Placebo 4 mL Solution for Injection1 trials Ocrelizumab at home1 trials 89 Zr-Df-crefmirlimab1 trials Tysabri1 trials Avonex1 trials RC18 240mg1 trials RC18 160mg1 trials Remibrutinib oral treatment1 trials prosetin1 trials Efgartigimod Alfa1 trials DMT continuation1 trials Clemastine1 trials Riluzole (100 mg)1 trials Cromolyn Sodium (17.1 mg BID)1 trials Cromolyn Sodium (34.2 mg BID)1 trials Ocrelizumab Reference Formulation1 trials Ocrelizumab Test Formulation1 trials Ocrevus-US1 trials Ocrevus-EU1 trials CYB7041 trials mRNA-11951 trials Placebo THC1 trials Placebo CBD1 trials Tetrahydrocannabinol (THC)1 trials Activated charcoal1 trials Placebo infusion1 trials Teriflunomide1 trials AZD0120 - Regimen 21 trials AZD0120 - Regimen 11 trials Fludarabine Phosphate for Injection1 trials ABP 6921 trials Ocrelizumab (EU)1 trials cerebro-spinal fluid1 trials [18F] FZTA1 trials GC012F CAR-T Cell Injection1 trials Cannabis oil vs placebo1 trials Bacille Calmette-Guerin vaccine1 trials AMX01141 trials Amisodin1 trials VT72081 trials BCD-2811 trials IMS0011 trials PTOC11 trials Cyclophosphamide (CYC)1 trials Telitacicept Freeze-dried powder Injection 80mg1 trials Immunosuppressant other than CYC1 trials Methylprednisolone (Corticosteroid)1 trials Saccharum Lactis1 trials Isoniazid/Pyridoxine1 trials PRG-23111 trials IPG114061 trials BMS-9863261 trials Voclosporin1 trials SOF-SKN 2%1 trials SOF-SKN 1%1 trials SOF-SKN 0.5%1 trials SOF-SKN 0.25%1 trials CTX-AZA1 trials MMF-MMF1 trials Belimumab/Placebo1 trials UCAR T-cell group1 trials Glucocorticoids1 trials Litifilimab1 trials single dose of UC-MSCs1 trials Voclosporin (LUPKYNIS)1 trials 6261 trials Cyclophosphamide 100 mg/Kg1 trials Cyclophosphamide 1200 mg/Kg1 trials CD19/CD22/BCMA CAR-T cells(BZE2204)1 trials Budoprutug1 trials High-dose CAR-T cells group1 trials Low-dose CAR-T cells group1 trials IMIQUIMOD cream 50mg/g1 trials SCRI-CAR19v31 trials CD19-CAR-DNT cells1 trials SG301 SC Placebo1 trials SG301 SC Injection1 trials Diphenhydramine hydrochloride (HCl)1 trials Acetaminophen/paracetamol1 trials HSK39297 300mgQD1 trials HSK39297 200mgQD1 trials Obinutuzumab administration1 trials Voclosporin（QL1074）1 trials Glucocorticoid1 trials Vunakizumab (IL-17A inhibitor)1 trials HLX79 30mg/kg/placebo+HLX011 trials HLX79 20mg/kg/Placebo + HLX011 trials HLX79 10mg/kg/Placebo+HLX011 trials OL-1081 trials LUCAR-G79D T cells1 trials DZP1 trials Obexelimab1 trials DB-23041 trials IM19 CAR-T cells1 trials RO75070621 trials Orelabrutinib (High Dose)1 trials Orelabrutinib (Low Dose)1 trials Certolizumab Pegol1 trials UB-VV4101 trials CD19/BCMA CAR-T cell therapy1 trials Iptacopan + placebo1 trials Placebo + standard of care1 trials Iptacopan (part 2)1 trials Iptacopan (part 1)1 trials Placebo matching GSK45273631 trials GSK45273631 trials FT8191 trials Divozilimab1 trials BCD-2561 trials QT-019B Cell Injection1 trials Without Anticoagulation1 trials Anticoagulation1 trials anti-CD19/BCMA CAR NK cells (KN5601)1 trials SCTB35 injection1 trials Cyclophosphamide LD1 trials QT-019C1 trials Current standard of care treatment options1 trials anti-BCMA/CD70-CAR-T cells1 trials SAR441344 SC1 trials SAR441344 IV1 trials Basic treatment1 trials RY_SW01 cell injection1 trials TQB3702 placebo1 trials TQB3702 tablets1 trials Mesenchymal stem cells (MSC)1 trials Topical and systemic drugs1 trials umbilical cord blood CD19-BCMA CAR-T cells infusion1 trials Telitacicept 160 mg1 trials Telitacicept 240 mg1 trials LMY-9201 trials Cyclophophamide1 trials hUC-MSCs treatment （Double dose）1 trials hUC-MSCs treatment (high dose)1 trials hUC-MSCs treatment (medium dose)1 trials hUC-MSCs treatment (low dose)1 trials Standard maintenance therapy1 trials ONT01 is a small molecule CD11b modulator.1 trials SHR-2173 Injection Blank Preparation1 trials SHR-2173 Injection1 trials Herpes Zoster Subunit (HZ/su) Vaccine1 trials Tafasitamab and NK cells1 trials CD19/BCMA Lupus Nephritis Targeted CAR T-cells injection1 trials PRG-18011 trials LBL-047 placebo for injection1 trials LBL-047 for Injection1 trials Anti-CD19 IL-10/IL15 CAR-NK1 trials YTS109 cell injection1 trials BRL-3011 trials anti-CD19 CAR NK cells (KN5501)1 trials CD19-BCMA CAR-T cells infusion1 trials Remainders of samples taken as part of the treatment1 trials HC0221 trials Inaticabtagene autoleucel Injection1 trials PRG-1801 （CAR-T against BCMA）1 trials T cell injection targeting CD19 chimeric antigen receptor1 trials Corticosteroids1 trials CART191 trials Vonsetamig1 trials Blinatumomab 9ug1 trials Depletion of CD3/CD19 in an autologous stem cell transplant1 trials VIS1711 trials Antimalarial with or without oral glucocorticosteroid1 trials Placebo for VIB49201 trials VIB49201 trials Descartes-081 trials CABA-2011 trials BCMA/CD70 CAR-T cells1 trials Universal anti-CD70 CAR-T (CHT101)1 trials VENT-031 trials V001-BCMA1 trials placebo s.c.1 trials ianalumab s.c. q12w1 trials ianalumab s.c. q4w1 trials NK 010 or NK0421 trials Ruxolitinib 1.5% cream1 trials Belimumab (GSK1550188)1 trials interleukin 231 trials CVN424 150 mg1 trials CVN424 75 mg1 trials Anti-Parkinson medication1 trials Gamma- glutamylcysteine1 trials PDR0011 trials LY39626811 trials Fasting blood test1 trials EC5026 oral tablet1 trials Atomoxetine1 trials Lipopolysaccharide1 trials TB0061 trials MED ON plus1 trials Allogeneic dopaminergic neural precursor cell(NCR201)1 trials Safinamide1 trials Opicapone 50 mg1 trials Tenapanor1 trials AGB1011 trials bioactivated GRA for pediatric patients1 trials bioactivated GRA for adult patients1 trials levodopa/carbidopa oral formulation B1 trials levodopa/carbidopa oral formulation A1 trials Conscious sedation1 trials Healthy donor-derived FMT capsule1 trials Best Medical Treatment1 trials XJN010 Nasal Spray1 trials Terazosin (Hytrin)1 trials LBT-36271 trials LY38849611 trials Radotinib HCl 50 mg1 trials Miyarisan-BM (Clostridium Butyricum Miyairi)1 trials ALN-SNCA1 trials AlloEx1 trials AAV2-GDNF gene therapy1 trials iRBD1 trials PD-RBD1 trials Levodopa1 trials GT-022871 trials C11-SY081 trials KP4051 trials RNDP-0011 trials SL-APO1 trials LY40068961 trials NEU-4111 trials bemdaneprocel1 trials Inosine1 trials [18F]MK-09471 trials Matched Placebos1 trials INS-GSH1 trials Donepezil (Aricept)1 trials oral anti-Parkinson's drugs1 trials oral anti-Parkinson drugs and injection of botulinum toxin1 trials exidavnemab1 trials [18F] AV-133 PET Imaging1 trials SER-252 (PEOZ-apomorphine)1 trials 11C-M503 PET1 trials BIIB122 225 mg1 trials DPA-714 Metabolite Analysis1 trials 5-year Follow-up DPA-714-PET/MRI1 trials VT-50061 trials Lenrispodun1 trials BHV-80001 trials Prasinezumab1 trials Carbidopa 25/Levodopa 100Mg Tab1 trials autologous dopaminergic cell implantation1 trials Sustained-release Carbidopa/Levodopa; HRG2010 placebo1 trials NE31071 trials RGL-193（high-dose）1 trials RGL-193（low-dose）1 trials Tributyrin1 trials RR-HNK/Hydroxynorketamine1 trials Ketamine 50 MG/ML Open Label1 trials Ketamine 50 MG/ML Blinded1 trials Dexamethasone 8Mg Solution for Injection1 trials Dexamethasone 4 Mg/mL Injectable Solution1 trials Crisugabalin capsules mimic 0mg/capsule bid1 trials Venlafaxine-XR 75mg bid1 trials Crisugabalin 20mg bid1 trials Pregabalin capsule1 trials Melatonin capsule1 trials Hemp Derived Cannabidiol Extract1 trials microcurrent stimulation1 trials Intranasal Ketamine1 trials Intranasal Dexmedetomidine1 trials Intranasal Midazolam1 trials Midazolam Nasal Spray 0.9 mg/spray1 trials Midazolam Nasal Spray 0.45 mg/spray1 trials Placebo Nasal Spray 0 mg/spray1 trials Tolcapone1 trials distraction using intranasal Midazolam1 trials Disulfiram 250 mg1 trials VQW-7651 trials Nitrogen1 trials Pramipexole 0.35 mg/tid1 trials Pramipexole 0.18 mg/tid1 trials Pramipexole 0.088mg/tid1 trials Midazolam Hcl 2Mg/Ml Syrup1 trials Ketamine 50 MG/ML1 trials Verapamil Only Product in Oral Dose Form1 trials Telmisartan Only Product in Oral Dose Form1 trials HB-11 trials Shugan Jieyu Capsules Placebo1 trials Shugan Jieyu Capsules1 trials melatonin (Circadin ®) 0.4 mg/kg1 trials melatonin (Circadin ®) 0.2 mg/kg1 trials Triazolam 0.25 MG Oral Tablet1 trials Buspirone 10 Mg Oral Tablet1 trials Psilocybin 30 mg1 trials Psilocybin 20 mg1 trials Psilocybin 10 mg1 trials Methamphetamine1 trials 3,4-Methyl enedioxy methamphetamine1 trials Centanafadine1 trials Augment with Aripiprazole1 trials Augment with Memantine1 trials Sertraline 300 milligram(mg)1 trials Sertraline 200 milligram(mg)1 trials Cannabidiol Oral Product1 trials Sertraline (Oral Antidepressant)1 trials lemongrass essential oil inhaled using face mask1 trials lavender essential oil inhaled using face mask1 trials Fluoxetine - delayed treatment1 trials Fluoxetine - immediate treatment1 trials Buspirone tablets mimic, 0mg/ tablet1 trials Buspirone tablets, 5mg/ tablet1 trials Glycerol Tributyrate1 trials Afobazole1 trials Ranquilon1 trials Sublingual Placebo1 trials Sublingual Melatonin1 trials Esketamine and remimazolam1 trials Naltrexone Pill1 trials ibuprofen 100mg/ml oral suspension syrup1 trials Placebo Nasal Spray - Placebo Nasal Spray1 trials Fasedienol Nasal Spray - Fasedienol Nasal Spray1 trials Fasedienol Nasal Spray - Placebo Nasal Spray1 trials NTX-14721 trials Valbenazine Oral Capsule1 trials Antidepressant Therapy (ADT)1 trials Placebo for ABBV-9321 trials ABBV-9321 trials Losartan potassium1 trials Mirtazapine 15 MG1 trials Preoperative midazolam1 trials Placebo Nasal Spray1 trials Fasedienol Nasal Spray1 trials L-methylfolate1 trials Syrup Prospan1 trials Biological: Solrikitug high dose1 trials Biological: Solrikitug low dose1 trials Glycopyrrolate 42.5 mcg1 trials Glycopyrrolate 21.25 mcg1 trials Ensifentrine 3 mg1 trials Bretzri1 trials Bevespi1 trials Dronabinol 2.5mg Capsule1 trials TRIXEO AEROSPHERE1 trials GSK3862995B1 trials Oxygen gas1 trials Stem cells1 trials JKN2403 Tablets1 trials Marrow-derived mesenchymal stromal cell1 trials Doxapram1 trials Hyperpolarized 129Xe1 trials Standard Oxygen1 trials Titrated Oxygen1 trials Trelegy or Anoro1 trials Inhaled Treprostinil (Tyvaso Nebulizer)1 trials multi-inhaler triple therapy (Qvar + Bevespi)1 trials single-inhaler triple therapy (Trimbow)1 trials CM326 dose 21 trials CM326 dose 11 trials Bronpass Tab.1 trials GFF MDI 14.4/9.6 μg1 trials BGF MDI 320/14.4/9.6 μg1 trials Ultibro 110μg/50 μg1 trials HL231 Solution for Inhalation1 trials Administering propofol1 trials Administering remimazolam1 trials Short-acting bronchodilator therapy (SABD)1 trials Long-acting bronchodilator therapy (LABD)1 trials Bronchodilators inhalation1 trials 6111 trials Atorvastatin 40mg1 trials TQC3302 inhalation spray1 trials Budesonide / Formoterol / Glycopyrronyum 160/4.8/7.2 mcg1 trials Beclomethasone / Formoterol / Glycopyrronyum 100/6/12.5 mcg1 trials Fluthicasone / Vilanterol / Umeclidinium (100/25/62.5 mcg)1 trials Vilanterol / Umeclidinium (25/62.5 mcg)1 trials Sildenafil Citrate1 trials Moxifloxacin Hydrochloride Tablets1 trials Radioactive Xenon-133 scintigraphy (Active Comparator)1 trials Hyperpolarized Xenon-129 MRI (Experimental)1 trials Bailing Capsules in combination Guben Kechuan Granules1 trials pharmacological treatment1 trials TCM syndrome differentiation treatment1 trials Conventional Western medicine treatment1 trials 20-valent pneumococcal conjugate vaccine1 trials Azithromycin according to rheology or symptoms1 trials Azithropycin according to symptoms1 trials Quercetin 500 MG1 trials Quercetin 1000 mg1 trials Morphine hydrochloride1 trials Aspirin 162 mg1 trials Aspirin 81mg1 trials MMR Vaccine1 trials BCG vaccine (Danish strain 1331)1 trials Inhaled nitroglycerin1 trials Ensifentrine1 trials GDC-69881 trials CD3/CD19 negative hematopoietic stem cells1 trials Placebo DPI1 trials Placebo ( Revefenacin and Formoterol )1 trials Revefenacin 175 µg, Formoterol 20 µg1 trials umeclidinium 62.5 µg and vilanterol 25 µg1 trials Sodium Chloride (NaCl) 0.9 %1 trials Omalizumab (Xolair®)1 trials Phase II placebo1 trials 9MW19111 trials Sarilumab SAR153191 (REGN88)1 trials Oral antibiotic treatment1 trials dnaJP11 trials SclerFIX-IP1 trials Adalimumab Injection1 trials BBM-A1011 trials Ethiodized Oil-based emulsion1 trials TNFi (Tumor Necrosis Factor inhibitor) medication1 trials [PRP] platelet rich plasma1 trials Artrodar1 trials Baricitinib 4 MG1 trials Intraosseous Vancomycin Injection1 trials Placebo Oral1 trials LY3857210 ISA1 trials LY3526318 ISA1 trials LY3556050 ISA1 trials LY3016859 ISA1 trials bacteriostatic saline placebo1 trials Somatropin (recombinant human growth hormone)1 trials Methotrexate + targeted therapy administration1 trials To continue NSAIDs therapy1 trials To withdraw NSAIDs therapy1 trials active FMT1 trials Vancomycin + Tobramycin1 trials PRX-1151 trials Methotrexate Combined With Tofacitinib1 trials Fascia Iliaca Nerve Block1 trials Vehicle Control1 trials Recombinant Human Proteoglycan 41 trials FBL-MTX1 trials QLS120101 trials Anti-CD19 CART cells will be given IV at split doses.1 trials Triamcinolone Acetonide Standard Dose1 trials Triamcinolone Acetonide Low Dose1 trials IA-140691 trials OA-SYS1 trials CND2611 trials F8IL101 trials GlyNAC (combination of glycine and n-acetylcysteine)1 trials Serum collection1 trials DNA sample1 trials CIT-013 medium dose1 trials CIT-013 high dose1 trials CIT-013 low dose1 trials Placebo+AK1111 trials AK1111 trials Xeljanz1 trials GenSci048 placebo1 trials GenSci0481 trials Peficitinib1 trials ZB0021 trials COVID-19 Vaccines at a 6-month interval1 trials Inactivated influenza vaccine at Month 11 trials COVID-19 Vaccines at a 3-month interval1 trials Inactivated influenza vaccine (IIV) at baseline1 trials Aspirin 81mg tablet1 trials naproxen sodium 550mg tablet1 trials celecoxib 200mg capsule1 trials Chinese herbal tea TBDESJS1 trials D-25701 trials Autologous cell therapy1 trials Corticosteroid injections1 trials Dazodalibep1 trials Intra-articular corticosteroid injections1 trials Rupatadine1 trials SBT7771011 trials Purified Cortophin Gel 80 U1 trials Purified Cortophin Gel, 40 U1 trials Autologous CD19-BCMA Dual-Target CAR T-Cell Therapy1 trials Glucocorticoid Effect1 trials Humira1 trials Pegylated Recombinant Candida Utilis Uricase for Injection1 trials Ilaris1 trials 6081 trials conventional synthetic antirheumatic drugs1 trials Nicotinamide Tablet1 trials SHR-1314 injection1 trials Remimazolam (Byfavo)1 trials SURGICEL® Powder1 trials Naloxone infusion1 trials Normal saline infusion1 trials Standard-of-care corticosteroid injections1 trials Botulinum toxin1 trials Bone Marrow Aspirate, Lipoaspirate Concentrate1 trials TLL-0181 trials Will take 200mg/day magnesium oxide placebo.1 trials hyaluronate injection1 trials oral hyaluronate and injection1 trials JNJ-885452231 trials SPY002-0721 trials BCMA/CD70-targetd CAR-T1 trials Triamcinolone acetonide-Ketorolac-Ropivacaine1 trials Dextrose 5% and Lidocaine1 trials Synovian®1 trials Triamcinolone Injection1 trials Tofacitinib 5Mg Tab,Oral1 trials HS-10374-matched placebo tablets1 trials HS-103741 trials Conventional Synthetic DMARD1 trials 608 dose1 trials Secukinumab 150mg s.c.1 trials Secukinumab 300mg s.c.1 trials Limbal Stem Cell Derived Exosomes Eye Drop1 trials UTAA91 injection1 trials IL-17i1 trials TNF-inhibition1 trials Topical Diclofenac gel 1%1 trials GenaKumab1 trials Placebo Capsule (Part 3)1 trials iN1011-N17 Mesylate Capsule (Part 3)1 trials iN1011-N17 HCl Capsule (Part 3)1 trials iN1011-N17 Mesylate Capsule (Part 2)1 trials iN1011-N17 HCl Capsule (Part 2)1 trials Placebo Capsule (Part 1)1 trials iN1011-N17 HCl Capsule (Part 1)1 trials iN1011-N17 HCl Suspension (Part 1)1 trials Tofacitinib 5 MG1 trials biologics treatment1 trials Tranexamic Acid (TXA) treatment1 trials low-dose epinephrine and tranexamic acid1 trials Multiprofen-CC™ plus standard treatment1 trials Joint puncture1 trials Celecoxi + Acetaminophen1 trials Celecoxib + Acetaminohen1 trials Dextrose prolotherapy1 trials Prednisone 40 mg1 trials Naproxen 500 Mg1 trials Colchicine 1.2 mg1 trials Naproxen 250 MG1 trials Faecal sampling1 trials Vitamin K2 (MK-7) 300 µg1 trials K1 1000 µg1 trials Vitamin K1 500 µg1 trials 150-day taper prednisone1 trials 15-day taper prednisone1 trials CD19- BCMA CAR-T cells1 trials Rituximab 1g/6months1 trials Rituximab 200mg/6months1 trials Triamcinolone1 trials Hyaluronic and corticosteroid injection1 trials Herbal medicine1 trials BGB-450351 trials Cryopreserved Devitalized Adipose Tissue Allograft1 trials Tofacitinib XR1 trials Placebo (NaCl 0.9%)1 trials 4P0041 trials Magnesium Threonate1 trials Allogenic adipose derived mesenchymal stem cells (AD-MSC)1 trials data collection1 trials CD19 targeted CAR-T cells1 trials Step Wedge trial1 trials Clinical tapering strategy1 trials Bimekizumab regimen 3 sc1 trials Bimekizumab regimen 2 iv1 trials Bimekizumab regimen 1 iv1 trials ASP55021 trials embolization therapy1 trials Adalimumab-800CW1 trials Triamcinolone Acetonide extended release suspension1 trials TNF Inhibitor1 trials Iguratimod Tablets1 trials CIGB-814 placebo (multiple-dose group)1 trials CIGB-814 (multiple-dose group)1 trials CIGB-814 placebo (single-dose group)1 trials CIGB-814 (single-dose group)1 trials Carbomer Gel/Jelly1 trials LNK010011 trials PRP injection1 trials uric-acid-lowering drug1 trials Potassium Citrate Tablets1 trials Sodium Bicarbonate Oral Capsule1 trials Normal saline injection group1 trials HA injection group1 trials ASA injection 20 mg group1 trials ASA injection 40 mg group1 trials Biologic Agent1 trials Bioinductive implant1 trials Telitacicept Tofacitinib1 trials Kenalog with bupivacaine Injection1 trials CD19 or CD19-BCMA CAR-T1 trials Fecal Microbial transplant1 trials MFAT + HA right knee - MFAT + placebo left knee1 trials MAS8251 trials Febuxostat Tablets1 trials Control saline injection1 trials Platelet-Rich Plasma (PRP) Injections1 trials Reference Drug1 trials PTP-011 trials Active reference comparator1 trials LPX-TI6411 trials traditional peri-articular injection1 trials Exosome1 trials Probiotic Formula1 trials IPACK block with Bupivacaine 0.25% with adrenaline1 trials Bone marrow aspirate concentrate injection1 trials Epidiolex oral solution1 trials Extracellular vesicles1 trials High dose mesenchymal stem cells1 trials Low dose mesenchymal stem cells1 trials Other anti-psoriatic systemic treatments1 trials Fumaric acids1 trials Allogeneic NK Cells1 trials JAKi dose reduction strategy1 trials Benzathine Penicillin1 trials Wangbi granules simulant1 trials Wangbi granules1 trials KBP-3361 trials AB-1011 trials Adenuric1 trials Anti-IL-17 therapy1 trials R-2487 DP1 trials XmAb136761 trials IV cefazolin or IV flucloxacillin followed by oral cefalexin1 trials Oral cefalexin only1 trials Enbrel (etanercept)1 trials MB04 (proposed biosimilar to etanercept)1 trials Lumbar Injections with 10cc's of Wharton's Jelly Allograft1 trials hiSCs1 trials ABP-745 Dose B1 trials ABP-745 Dose A1 trials allogeneic engineered Gingival Fibroblasts (aeGF)1 trials Mirogabalin1 trials 99Tc-MDP1 trials Intra-articular injection of microfat and PRP1 trials Biologic or targeted synthetic DMARD1 trials Sterile Normal Saline (IV Solution)1 trials PRP Concentrate Arm 21 trials PRP Concentrate Arm 11 trials Promestriene Vaginal1 trials JAKi1 trials Anti-IL61 trials TNFi1 trials Cannabidiol (CBD) Extract1 trials TI-0032-III injection1 trials NTR10111 trials HN2301 injection1 trials Statins1 trials Mesenchymal Stromal Cells (MSC) Dose Level 11 trials Mesenchymal Stromal Cells (MSC) Dose Level 01 trials PENG block1 trials Adductor canal block1 trials Bone Marrow Aspirate Concentrate1 trials Oral Prednisone1 trials LFD-2001 trials Anakinra injection1 trials 0.9% Sodium Chloride Injection1 trials Saline Water (Control)1 trials MSC1 trials Injection of corticosteroids (Diprostène®)1 trials UC-MSCs1 trials DR-02011 trials Triamcinolone Hexacetonide1 trials Triamcinolone Hexacetonide and hyaluronic acid1 trials GS-01511 trials non-TNFi-biologic class1 trials targeted synthetic DMARD class1 trials SHR-3045 Injection Placebo1 trials UC-MSC sEV1 trials Ketorolac injection to the shoulder, elbow, wrist, or hand1 trials Ravagalimab1 trials Ketamine group1 trials GenSci1201 trials BCMA-CD19 CAR-T therapy1 trials Injection of triamcinolone acetonide into the CMC-1 joint1 trials LY42136631 trials SHR-3045 Placebo Injection1 trials anti-TNF therapy1 trials baricitinib treatment1 trials Glucocorticoid treatment1 trials a simulated agent of Jitongning tablets1 trials Jitongning tablets1 trials Part C - Safety expansion cohort in participants with axSpA1 trials TNF Inhibitor (W0-W12)1 trials TNF Inhibitor (W12-W48)1 trials Abatacept (W12-W48)1 trials Anti-Tumor Necrosis Factor Alpha Drug (Product)1 trials Diosmin and Hesperidin Combination1 trials CLS2901C (human [allogeneic] chondrocyte sheets)1 trials XOI High Dose1 trials XOI Low Dose1 trials AR882 75 mg1 trials BMAC1 trials Bone Marrow Aspirate (BMA)1 trials AP1189 matching placebo1 trials AP1189, 100 mg1 trials AP1189, 70 mg1 trials AP1189, 40 mg1 trials Bone marrow aspirate concentrate (BMAC)1 trials Enekinragene Inzadenovec (PCRX-201)1 trials Disease-modifying anti-rheumatic drugs1 trials Carnitine1 trials AZD11631 trials SIBP-R0021 trials Etoricoxib fixed dose1 trials Etoricoxib + Betamethasone fixed dose1 trials Anti-CD19-CD3E-CAR-T cells1 trials Allocetra - Randomization phase1 trials Allocetra - Safety run-in phase1 trials HA Treatment1 trials PRP Treatment1 trials anti-CD19/BCMA U CAR T cells1 trials LY38718011 trials Background Treatment1 trials Tulisokibart1 trials JointStem1 trials Remsima SC1 trials Remsima IV1 trials Pentosan Polysulfate Sodium twice weekly1 trials Brenipatide1 trials WIN3781 trials FF/VI1 trials FF/UMEC/VI1 trials Allergen Immunotherapy Extract1 trials Xenon-129 and Perfluoropropane (19F)1 trials Levocetirizine Dihydrochloride1 trials Adenosine 5'-triphosphate1 trials LP-003 Injection1 trials n-acetylcystine (NAC)+ albuterol1 trials CM512 injection1 trials Soy isoflavone1 trials R8481 trials ENV-2941 trials L-citrulline1 trials RSS0343 Tabella1 trials FB704A1 trials FB704A placebo1 trials KT-6211 trials MG-K10/Placebo1 trials Albuterol1 trials Montelukast Oral Granules1 trials 3. Reversibility test with salbutamol1 trials Budesonide/Formoterol fumarate dihydrate1 trials HDM SLIT-tablet (12 SQ-HDM)1 trials Mepolizumab 100 MG [Nucala]1 trials Placebo 60 MG1 trials Placebo 30 MG1 trials Amitriptyline 50 MG1 trials Amitriptyline 25 MG1 trials Duloxetine 60 MG1 trials Oral Corticosteroid (OCS)1 trials CM3101 trials Benralizumab 30 mg/ml1 trials Ventoline® Evohaler® 100 µg/inhalation pMDI alone1 trials NSI-82261 trials placebo treatment during 3 days1 trials Dexamethasone treatment during 3 days1 trials ETH471 trials ABS1 trials FP1 trials Fp/ABS1 trials Continuation of OMA treatment1 trials Pharmacological therapy1 trials SHR-1703 Injection1 trials Azithromycin Oral Liquid Product1 trials Albuterol sulfate1 trials TEV-562481 trials TQC2731 injection1 trials Magnesium Sulfate within the first hour1 trials Mannitol Inhalation Kit1 trials Methacholine (MCh) Challenge Testing1 trials Celestone + Celestone1 trials Celestone + placebo1 trials Hyperpolarized Xe1291 trials Dupilumab Injectable Product1 trials povorcitinib1 trials Albuterol Sulfate inhalation aerosol 108 mcg per actuation1 trials PF-072753151 trials HRV-391 trials Glycopyrronium bromide 12.5ug1 trials Glycopyrronium bromide 25ug1 trials 30,000 MG01 + 10,000 T5171 trials 10,000 MG01 + 10,000 T5171 trials Budesonide/Albuterol1 trials Short-Acting Beta Agonists (SABA)1 trials mometasone/formoterol1 trials SHR-1905 Placebo Injection1 trials SHR-1905 Injection1 trials fluticasone/salmeterol in all asthmatics1 trials Dupilumab Prefilled Syringe1 trials CDX-6221 trials Inulin1 trials Semaglutide Pen Injector 2.4mg weekly1 trials AMG 6911 trials IgE monoclonal antibody1 trials L-ctirulline1 trials FB8251 trials SIM0718 injection of placebo1 trials SIM0718 injection1 trials 6101 trials Placebo subcutaneous1 trials 30,000 MM091 trials 10,000 MM091 trials Salbutamol HFA-134a1 trials Salbutamol HFA-152a1 trials QMF1491 trials CXA-101 trials CHF718 pMDI with HFA-134a1 trials CHF5993 pMDI with HFA-134a1 trials CHF5993 pMDI with HFA-152a1 trials Biological Treatment for severe asthma patients1 trials Metformin hydrochloride extended-release tablets1 trials PRA-2161 trials Tozorakimab1 trials Research Grade RG-RV1 trials Whole lung antigen challenge (WLAC)1 trials Benralizumab Prefilled Syringe1 trials PA9159 Metered-Dose Inhaler, 240 μg per day for 28 days1 trials PA9159 Metered-Dose Inhaler, 60 μg per day for 28 days1 trials 30,000 MG01 +10,000 T5211 trials 10,000 MG01 +10,000 T5211 trials HR-17031 trials norepinephrine weaning protocol and guided by the HPI1 trials norepinephrine weaning protocol1 trials early rhythm control group1 trials Bivalirudin1 trials Atibuclimab (IC14), 20 mg/kg intravenously, once1 trials BMS-9864351 trials Milrinone1 trials Fexofenadine 60 Mg Oral Tablet1 trials methylphenidate, fluoxetin, risperidone1 trials NNC0537-14821 trials Natriumchlorid1 trials Diagnosis of LVNC1 trials Diagnosis of RCM1 trials Diagnosis of NDLVC1 trials Diagnosis of ARVC1 trials Diagnosis of DCM1 trials Diagnosis of HCM1 trials 4D-3101 trials Usual medications1 trials Vitamin K antagonist(warfarin)1 trials Rivaroxaban Oral Tablet1 trials AGP1001 trials Crystalloid solutions1 trials Albumin solution1 trials Bisoprolol1 trials Verapamil1 trials Empagliflozin 25 MG Oral Tablet1 trials Conventional anti-heart failure therapy1 trials Cyproheptadine 4 Mg Oral Tablet1 trials Dexmedetomidine Hydrochloride1 trials Βeta-Blockers discontinued (with tapering)1 trials Allogeneic Neonatal mesenchymal stromal cells (nMSCs)1 trials P2Y12 inhibitor1 trials Gadolinium DOTA Meglumine1 trials Conestat alfa (Ruconest®)1 trials Routine blood-pressure management1 trials Targeted blood-pressure management1 trials Prasugrel1 trials Routine use of P-CAB on DAPT1 trials umbilical cord-derived mesenchymal stromal cells (UC-MSCs)1 trials Empagliflozin 10 mg daily dosing1 trials Empagliflozin 25 mg thrice-weekly post-hemodialysis dosing1 trials Dextrose 5% in water1 trials prasugrel or ticagrelor1 trials Amiodarone Hydrochloride 100 MG1 trials Amiodarone Hydrochloride 200 MG1 trials Vosoritide Injection1 trials statins, ezetimibe1 trials Olpasiran1 trials Carvedilol 3.125 mg1 trials Biomarker guided therapy1 trials Prasugrel based standard DAPT1 trials Prasugrel based short DAPT1 trials Non-vitamin K oral anticoagulant (NOAC)1 trials REGN99331 trials REGN75081 trials Tailored anti-platelet therapy1 trials Optimal medication treatment1 trials Tirofiban1 trials rhTNK-tPA, 4-8 mg1 trials KNO31 trials SGT-2121 trials noradrenaline infusion for management blood pressure1 trials Ranolazine1 trials Nicorandil1 trials Antipaletet drug1 trials Conservative treatment1 trials High Calcium, High Sodium (HCHS) Crystalloid Therapy1 trials High Calcium, Low Sodium (HCLS) Crystalloid Therapy1 trials Olanzapine 10 MG1 trials Isotonic sodium chloride (0.9%)1 trials Dexamethasone phosphate1 trials Omecamtiv Mecarbil (OM)1 trials IV Loop Diuretics1 trials intramuscular benzathine penicillin G (BPG) prophylaxis1 trials phenoxymethyl penicillin1 trials Berberine1 trials Lasix ONYU1 trials Placebo to match CK-40215861 trials CK-4021586 (150 mg, 300 mg, 450 mg, and 600 mg)1 trials Aldosterone1 trials Lexiscan1 trials [13N]NH31 trials CRD-47301 trials CD34+ stem cell therapy1 trials Labetalol or Nifedipine1 trials Eplereone1 trials Samtasu for I.V. infusion1 trials Tideglusib1 trials statin ± ezetimibe1 trials alirocumab 75mg/2week1 trials Metolazone1 trials Ertugliflozin1 trials Acoramidis (356 mg film-coated tablets)1 trials NOAC1 trials Nitric Oxide1 trials Hematopoietic stem cell transplant (HSCT)1 trials Jia Shen Tablet1 trials air/oxygen1 trials Empagliflozin + Carvedilol1 trials USG GUIDED INFRA-INGUINAL FASCIA ILIACA BLOCK1 trials Plain aspirin1 trials Enteric-coated aspirin1 trials Ivabradine1 trials enavogliflozin Placebo1 trials enavogliflozin 0.3mg1 trials Colchicine 0.375 mg1 trials Protamine sulfate1 trials Empagliflozin10Mg Tab1 trials Sacubitril/Valsartan 49 MG-51 MG Oral Tablet [ENTRESTO]1 trials obicetrapib 10 mg + ezetimibe 10 mg FDC daily1 trials Guideline-directed medical therapy (GDMT) for heart failure1 trials Oxygen Therapy1 trials Micronized Progesterone 100 MG1 trials Micronized progesterone 200 MG1 trials Furosemide intravenous titration based on natriuresis1 trials EHM implantation1 trials Enalapril1 trials Pitavastatin 2 mg with aspirin 100 mg, taken once daily.1 trials Pitavastatin 4mg and ezetimibe 10mg, taken once daily1 trials diltiazem1 trials anti-seizure medication + sedative agent(s)1 trials Vicagrel1 trials Superparamagnetic Iron Oxide Nanoparticles1 trials Guideline-Directed Medical Therapy(GDMT)1 trials Beta-blocker treatment group1 trials Udenafil1 trials Control (Standard treatment)1 trials Apixaban 2.5 MG PO BID1 trials Conventional DAPT1 trials CYP2C19 Genotype Guided DAPT1 trials Buckberg Cardi-Braun1 trials Custodiol Htk Soln1 trials HRS-1893 Placebo Tablets1 trials HRS-1893 Tablets1 trials Autologous stem cell therapy1 trials Low-dose ferric derisomaltose1 trials High-dose ferric derisomaltose1 trials Oral Anticoagulant plus background antiplatelet therapy1 trials Antiplatelet-only strategy1 trials LSALT Peptide1 trials Mydfrin1 trials Tranexamic acid at a dose of 30 mg/kg1 trials Tranexamic acid at a dose of 20 mg/kg1 trials Tranexamic acid at a dose of 10 mg/kg followed by 1 mg/kg/h1 trials glecaprevir/pibrentasivir1 trials blood and urine sampling1 trials optimal medical therapy ：aspirin, clopidogrel, statins.1 trials L-arginine and liposomal vitamin C1 trials Placebo atorvastatin1 trials Atorvastatin 80 mg/day1 trials High Dose PF-073289481 trials Medium Dose PF-073289481 trials Low Dose PF-073289481 trials Matching placebo control1 trials RTN-0011 trials Non-antithrombotic group1 trials Aspirin group1 trials Tenecteplase (1/3 systemic weight based dose)1 trials Statin and SGLT2i1 trials Regadenoson1 trials Atorvastatin 40 mg1 trials Rosuvastatin 20 mg/day1 trials Ferrous Sulfate1 trials Dose 2 YN0011 trials Dose 1 YN0011 trials Xuesaitong Soft Capsule1 trials Mavacamten in clinical routine use1 trials Pharmacological rhythm management1 trials Anti-arrhythmic Drugs (AADs)1 trials FİB1 trials PENG1 trials local infiltration1 trials High-intensity statin1 trials Ketamine and Midazolam1 trials Dexmedetomidine and Midazolam1 trials Group B: Placebo CoQ10 orally and Placebo Glutathione orally1 trials CoQ10 1200 mg orally with Glutathione 1000 mg orally1 trials OMT1 trials TXA administration1 trials Vosoritide1 trials Bone marrow derived mononuclear cells and G-CSF1 trials Statin+Ezetimibe/Hybutimibe compound1 trials Epclusa1 trials Rocuronium1 trials Metoprolol1 trials Bacteriophage1 trials Tertinat1 trials Bromocriptine mesylate plus standard GDMT1 trials Sodium Lactate Solution1 trials Venous ethanol1 trials 1.5% standard PD fluid1 trials 5% Dextrose/Water1 trials [68Ga]Ga-PentixaFor PET/CT1 trials Rosuvastatin 40mg1 trials Ticagrelor + aspirin1 trials Ticagrelor + placebo1 trials Dapagliflozin 10 MG [Farxiga]1 trials Atorvastatin 80mg1 trials Ketamine Hcl 50Mg/Ml Inj1 trials Reduced noradrenaline use1 trials Ataciguat1 trials Orticumab1 trials Dual Antiplatelet (DAPT) Therapy1 trials Dapagliflozin 10 mg once daily1 trials Ticagrelor 60mg1 trials Anticoagulation group(Apixaban group)1 trials P-CAB 501 trials Flozin1 trials Nebivolol1 trials Empagliflozin 25 milgrams (Mg)1 trials Intravenous 0.9% Sodium Chloride1 trials Venous blood sampling prior to CCTA.1 trials OMT strategy1 trials Intermittent Furosemide Infusion1 trials Continuous Furosemide Infusion1 trials Riociguat1 trials Selexipag1 trials Losartan 50 mg1 trials Levosimendan 2.5 MG/ML Injectable Solution1 trials Esketamine hydrochloride injection1 trials Standard-dose rivaroxaban1 trials low-dose rivaroxaban1 trials Antagonization of heparin with protamine sulfate1 trials Immediate release torsemide placebo1 trials Extended release torsemide placebo1 trials Immediate release torsemide1 trials Extended release torsemide1 trials Colchicine 0.5 MG Oral Tablet Once Daily1 trials Magnesium Sulfate 4 G1 trials Magnesium Sulfate 2 G1 trials Dobutrex1 trials PCSK 9 Inhibitor plus high-intensity statin1 trials Placebo plus high-intensity statin1 trials finerenone (BAY94-8862)1 trials High intensity statin plus ezetimibe therapy1 trials Standard Medical Care1 trials Iron sucrose, Human Erythropoietin Injection, Vitamin C1 trials Apixaban 2.5 milligram Oral Tablet1 trials Acetaminophen Injection1 trials HRS-1893 tablet B1 trials HRS-1893 tablet A1 trials COVID-19 vaccines1 trials Rivaroxaban (Xarelto)1 trials Placebo 1 bag, three times a day1 trials Qishenyiqi dripping pills 1 bag, three times a day1 trials AP319691 trials Human plasma derived antithrombin1 trials Compound Danshen Dropping Pills1 trials Precision Dose - Ibuprofen oral suspension1 trials Standard Dose - Ibuprofen oral suspension1 trials Other1 trials Ampicillin-sulbactam1 trials Entresto Pill1 trials Furosemide 20 Milligrams1 trials Rivaroxaban 2.5mg1 trials Rivaroxaban 10mg1 trials Clopidogrel 75mg1 trials Rivaroxaban 15mg1 trials Guideline-directed therapy1 trials 30-day DAPT1 trials Magnesium glucoheptonate1 trials Magnesium oxide1 trials Magnesium sulfate administration1 trials T89 capsule1 trials Late Resumption of Oral Anticoagulation Therapy1 trials Early Resumption of Oral Anticoagulation Therapy1 trials Deferiprone1 trials Deferasirox1 trials Deferoxamine1 trials Vitamin C (Laroscorbine) + Vitamin B1 (Bevitine)1 trials Aspirin + Clopidogrel + Rivaroxaban1 trials Standard of care treatment (RAASi therapy)1 trials Sodium Zirconium Cyclosilicate1 trials Packed Red Blood Cells (2 units)1 trials Packed Red Blood Cells (1 unit)1 trials SRD-0011 trials Recombinant Human Brain Natriuretic Peptide1 trials vasodilator-based PAH therapy1 trials L-Arginine hydrochloride1 trials Aspirin monotherapy1 trials Potassium1 trials Chlorthalidone1 trials Metoprolol Tartrate1 trials Saline (NaCl)1 trials Pelacarsen (TQJ230) 80mg1 trials Calcium Chloride1 trials use Amiodarone, Bisoprolol and Digoxin1 trials [68Ga]CBP8 PET/MRI1 trials OPT-CAD score guided DAPT de-escalation1 trials Low-Dose Aspirin 75 mg1 trials DAPT (Low-Dose Aspirin 75 mg + Prasugrel 10 mg)1 trials High-Dose Aspirin 300 mg1 trials Adrenaline1 trials Calcium channel blocker1 trials Verapamil Injection1 trials Rivaroxaban + Clopidogre1 trials Antiplatelet Drug1 trials Calcium carbonate1 trials Sevelamer1 trials Bendroflumethiazide1 trials Amiloride1 trials Mono drug group of Rosuvastatin 20 mg1 trials Combination drug group of Ezetimibe 10 mg/Rosuvastatin 5 mg1 trials topical amiodarone1 trials Hyperpolarized (13) Pyruvate Injection1 trials 12-month DAPT1 trials No aspirin (Prasugurel monotherapy)1 trials Lab test1 trials UDP-0031 trials Cangrelor 50 MG1 trials AK1967 (Procizumab)1 trials Metoprolol Succinate1 trials Finerenone Oral Tablet1 trials SGLT2 inhibitors1 trials Immedate Release Torsemide Tablets1 trials Extended Release Torsemide Tablets1 trials Rivaroxaban 15 MG1 trials Rivaroxaban 20 MG1 trials Standard of Care Pharmacologic Therapy1 trials Sodium chloride solution 3,5%1 trials Phentolamine1 trials Huperzine A Injection1 trials Sodium Chloride Injection1 trials Non-mavacamten symptomatic oHCM therapy1 trials Chloroquine Phosphate1 trials Recombinant staphylokinase1 trials Baxdrostat and dapagliflozin1 trials Tafalgin (tyrosyl-D-arginyl-phenylalanyl-glycine amide)1 trials Etripamil NS1 trials Apixaban 5 mg Oral Tablet1 trials Dipyridamole 200 mg1 trials Brezavvy 20Mg Oral Tablet1 trials 12-month DAPT (Standard of care)1 trials 1-month DAPT1 trials MT1002 Injection1 trials Statins with or without ezetimibe1 trials PCSK9 inhibitors and statins with or without ezetimibe1 trials Optimal treatment1 trials iPSC-CL1 trials Placebo matching BI 6905171 trials BI 6905171 trials Extended DAPT1 trials Short DAPT1 trials PHARM-PAL21 trials Canagliflozin 300Mg Tab1 trials Colchicine combined with Guideline-Directed Medical Therapy1 trials PET/MR with 18F-FDG1 trials simvastatin therapy1 trials VTX27351 trials Diuretic therapy1 trials Letermovir 480 MG [Prevymis]1 trials ACEI/ARB1 trials Vitamin K antagonist high intensity1 trials Vitamin K antagonist standard intensity1 trials Combined antithrombotic therapy1 trials Dual antiplatelet therapy1 trials ShengXian-QuYu Decoction1 trials Dalcetrapib1 trials Anticoagulant Oral1 trials Second Placebo1 trials Bromocriptine1 trials Ropivacaine + dexamethasone1 trials Ropivacaine + Dexmedetomidine1 trials high-intensity statin monotherapy (atoravastatin 40mg)1 trials One tablet of placebo of dapagliflozin 10 mg1 trials Dapagliflozin 10 MG Oral Tablet [Farxiga]1 trials PCIA with morphine1 trials Plcacebo1 trials Metoprolol (MET)1 trials intravenous midazolam infusion + Standard anesthesia1 trials Intravenous Dexmedetomidine infusion + Standard Anesthesia1 trials Dihydralazine1 trials Optimal Medical Therapy (OMT)1 trials Placebo (Saline)1 trials Dexmedetomidine (DEX)1 trials Nifedipine1 trials Atenolol1 trials Labetalol1 trials Ninerafaxstat 200mg MR1 trials Autologous thyTreg1 trials Conventional duration of aspirin and prasugrel1 trials Short duration of aspirin and prasugrel1 trials NOAC continuation1 trials NOAC discontinuation1 trials Placebo arm1 trials Active arm 1000 mg1 trials Magnesium sulfate and then Digoxin1 trials Amiodarone Injectable Solution1 trials Flecainide Injectable Solution1 trials 68Ga-citrate PET/CT1 trials Pepcid (Famotidine) 20 mg q 12 hrs for 3 days1 trials Protonix (Pantoprazole) 40 mg q 12 hrs for 3 days1 trials Bisoprolol 2.5 mg1 trials Ziltivekimab Placebo1 trials Hydralazine1 trials Torsemide1 trials Furosemide1 trials Prasugrel/Ticagrelor monotherapy or aspirin plus clopidogrel1 trials Unfractionated heparin1 trials GDMT1 trials Rosuvastatin 20mg1 trials Ezetimibe 10mg + Rosuvastatin 5mg1 trials Placebo Azathioprine1 trials Placebo Prednisone1 trials Stellate Ganglion Block1 trials Commercial measles, mumps, and rubella (MMR) vaccine1 trials Novel oral anticoagulant1 trials Aspirin 75-300mg1 trials Ticagrelor 90mg1 trials SGLT-2 inhibitors1 trials Low oxygen therapy (LOT)1 trials HRS-7535 tablet placebo1 trials Norepinephrine intravenous infusion1 trials Vasopressin intravenous infusion1 trials Fresh Frozen Plasma1 trials Prothrombin Complex Concentrate, Human1 trials Noble gas Argon1 trials OAC will be discontinued for the duration of the trial1 trials Clemastine Fumarate Tablets1 trials Rivaroxaban 15 MG Oral Tablet [Xarelto]1 trials Bumetanide Injection1 trials Milrinone infusion1 trials Milrinone inhalation1 trials Prednisone or Prednisolone1 trials Qishen Yiqi Drop Pills1 trials Compound Danshen Dripping Pills1 trials Methylprednisolone group1 trials Cefaclor Capsules1 trials Amoxicillin Capsules1 trials Tedizolid Injection1 trials Tedizolid Oral Tablet1 trials Sulfamethoxazole / Trimethoprim Injectable Product1 trials Sulfamethoxazole / Trimethoprim Oral Tablet [Bactrim]1 trials Rifampicin Only Product in Parenteral Dose Form1 trials Rifampicin Only Product in Oral Dose Form1 trials Moxifloxacin Injectable Product1 trials Moxifloxacin tablet1 trials Linezolid Injectable Product1 trials Linezolid Oral Tablet1 trials Levofloxacin Injection1 trials Levofloxacin Oral Tablet1 trials Fusidic Acid Only Product in Parenteral Dose Form1 trials Fusidic Acid Only Product in Oral Dose Form1 trials Dicloxacillin1 trials Dicloxacillin Oral Capsule1 trials Clindamycin Injection1 trials Clindamycin Oral Capsule1 trials Ciprofloxacin Injection1 trials Ciprofloxacin Tablets1 trials Cefaclor1 trials Valsartan 40 mg1 trials high dose Rifampicin (RIF)1 trials PolyCore (Polydextrin, L-Carnitine, D-xylitol)1 trials Sterile Normal Saline (0.9% NaCl)1 trials Nucresiran1 trials Dexmedetomidine Hydrochloride Group1 trials HRS-1893 Tablet1 trials L-Carnitine1 trials Empiric heart failure drug therapy1 trials VERVE-1021 trials Noradrenalin1 trials Contrast1 trials Discontinuation of β-blocker1 trials Clopidogrel single antiplatelet therapy1 trials Aspirin single antiplatelet therapy1 trials Intravenous ferric carboxymaltose1 trials Antiplatelet therapy1 trials Oral Anticoagulant, Direct-Acting1 trials Clopidogrel treatment group1 trials Riluzole 50 MG1 trials Blood taken1 trials Continuous ketorolac1 trials Etomidate1 trials No aspirin1 trials Teriparatide1 trials Sequential monotherapy of Ticagrelor and clopidogrel1 trials Standard-DAPT of Ticagrelor plus aspirin1 trials Amiodarone Hydrochloride Injection1 trials tadalafil 20 mg then 40 mg if tolerated1 trials Aspirin 81 mg1 trials Standard-of-Care1 trials Epinephrine Injection1 trials Niacinamide1 trials AZD40631 trials standard treatment of heart failure1 trials Collection of biological samples1 trials RTP-0261 trials Glucose-loaded ¹⁸F-FDG PET Myocardial Metabolic Imaging1 trials Fasting XTR003/¹⁸F-FDG PET myocardial metabolic imaging1 trials Acetazolamide 500mg1 trials Sotalol1 trials [O-15]-Water PET Myocardial Perfusion Imaging (MPI)1 trials IV diltiazem1 trials IV adenosine1 trials Dapagliflozin Oral Product1 trials Ramipril Oral Product1 trials Bisoprolol Oral Tablet1 trials Lumason1 trials Fentanyl (IV)1 trials NSAID1 trials Doxycycline Hyclate1 trials Agalsidase beta1 trials Odevixibat1 trials Furosemide and isosorbide dinitrate1 trials Dexmedetomidine nasal spray1 trials Placebo Tab1 trials Dabigatran Etexilate1 trials Phosphocreatine1 trials Ampicillin plus ceftriaxone in continuous infusion1 trials Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA]1 trials Rosuvastatin 20 mg1 trials BX-001N Experimental group 21 trials BX-001N Experimental group 11 trials aspirin 80 mg and clopidogrel 75 mg daily1 trials Indocyanine green (ICG)1 trials Continuous DOAC therapy1 trials 1:1 Randomization to receive milrinone1 trials GDC-82641 trials Estetrol and Drospirenone1 trials Drospirenone1 trials Ethynyl estradiol and Drospirenone1 trials Ammonium Chloride1 trials β -Blockers1 trials ACE Inhibitors1 trials Ivabradine 10mg1 trials Atenolol 25 mg1 trials Cangrelor1 trials Placebo suspension1 trials Vericiguat suspension1 trials Vonoprazan-based dual eradication therapy for two weeks1 trials Botulinum Toxin Type A Injection [Xeomin]1 trials Reduced dosage of beta-blocker1 trials Dapagliflozin propanediol (FORXIGA™/FARXIGA™1)1 trials Iron1 trials Ferric Derisomaltose 100 MG/ML1 trials Dual antiplatelet therapy (DAPT)1 trials TX000045- Dose B1 trials TX000045- Dose A1 trials Lower Dose UFH1 trials Higher Dose UFH1 trials Vasodilator1 trials Gadavist1 trials XTR0041 trials SQIN-Furosemide1 trials Rilonacept1 trials Inclisiran sodium1 trials Esmolol Hcl 10Mg/Ml Inj1 trials Isuzinaxib (APX-115)1 trials DAPT1 trials NOAC+DAPT1 trials Melatonin 10 MG1 trials THRV-12681 trials Florbetaben F181 trials NH002 (Perflutren Lipid Microspheres) Injectable Suspension1 trials Livmarli Oral Product1 trials Prasugrel 10 mg1 trials Saline 0.9%1 trials Intracoronary tirofiban1 trials SGT-5011 trials Seizure Suppression EEG Target Intravenous Anesthesia1 trials Burst Suppression EEG Target Intravenous Anesthesia1 trials Saline control1 trials Intraoperative infusion of esketamine1 trials Intraoperative infusion of dexmedetomidine1 trials Mepolizumab high dose group1 trials Mepolizumab middle dose group1 trials Mepolizumab low dose group1 trials Empagliflozin (SGLT2i)1 trials CardiolRx1 trials BQ-123, MitoQ, BH41 trials Fexofenadine, Ranitidine1 trials BQ-1231 trials Perindopril1 trials Erythropoietin1 trials Hydrogen1 trials Control/Placebo group1 trials SGLT2 inhibitor (Dapagliflozin 10mg)1 trials collection of samples of blood and urine1 trials Aspirin or Clopidogrel1 trials Rivaroxaban Oral Tablet [Xarelto]1 trials clopidogrel 75 mg1 trials Standard lipid-modifying therapy1 trials PCSK9 inhibitors and background lipid-modifying therapy1 trials IVIG1 trials Abelacimab1 trials Ultimaster™ Tansei™ stents1 trials iSGLT21 trials Aspirin interruption1 trials Usual care (standard-of-care) arm1 trials Thiamine Mononitrate 300 mg1 trials Apixaban 5 MG1 trials Inotrope1 trials Vasopressor1 trials IMC-001 placebo and optimal medical treatment1 trials IMC-001 and Optimal medical treatment1 trials Budesonide/Glycopyrronium/Formoterol Fumarate1 trials biomarker1 trials Blank control1 trials Yangxinshi tablet1 trials PKN6051 trials Sivelestat Sodium injection 2 h after OPCABG for 72 h1 trials Polypill of acetylsalicylic acid, ramipril and atorvastatin1 trials Indobufen1 trials Metalyse1 trials GNR-0601 trials AAV1/SERCA2a1 trials Flecainide (monotherapy)1 trials Livmarli1 trials CagriSema (Cagrilintide B + semaglutide I)1 trials Naltrexone-Bupropion Combination1 trials Injectable semaglutide1 trials Sulfadoxine (12.5 mg)/Pyrimethamine (250 mg)1 trials Doravirine + tenofovir DF + lamivudine1 trials Integrase inhibitor1 trials Placebo semaglutide1 trials Placebo cagrilintide1 trials Cagrilintide1 trials Transdermal Estradiol Patch1 trials BMF-6501 trials Efsubaglutide Alfa Injection1 trials Bisphosphonate1 trials Anti-Hypertensive medications1 trials Semaglutide 3.2 MG/ML1 trials Phentermine-Topiramate1 trials Naltrexone and Bupropion medication1 trials Anti-Obesity Pharmacotherapy (Class Effect)1 trials VRB-1011 trials Semaglutide (administered by PDS290 pen-injector)1 trials Mounjaro1 trials Placebo to (S)-pindolol benzoate1 trials (S)-pindolol benzoate1 trials Control (placebo)1 trials Balance Tablet1 trials Spleen Invigorating and Weight Reducing Decoction1 trials Ozempic®1 trials Placebo (Semaglutide 3 mg/ml)1 trials Semaglutide 3 mg/ml1 trials Placebo (matched to NNC0487-0111)1 trials NNC0487-01111 trials Liraglutide Pen Injector [Saxenda]1 trials Alpha-Linolenic Acid (2.6 g/day)1 trials Centella asiatica product1 trials Levetiracetam 500mg1 trials TTYP01 tables 0mg1 trials TTYP01 tables 90mg1 trials TTYP01 tables 60mg1 trials Extended Release Niacin1 trials BnH-015B Placebo (Part II)1 trials BnH-015B 80 mg (Part II)1 trials BnH-015B 40 mg (Part II)1 trials BnH-015B 80 mg (MAD)1 trials BnH-015B 40 mg (MAD)1 trials BnH-015B 160 mg1 trials BnH-015B 80 mg1 trials BnH-015B 40 mg1 trials BnH-015B 40 mg (Dietary impact)1 trials BnH-015B 20 mg1 trials BnH-015B 10 mg1 trials BnH-015B 5 mg1 trials [C-11]PBR281 trials [F-18]PBR061 trials Tau PET scan using MK-62401 trials Remternetug (SC)1 trials MIB-6261 trials Caffeine citrate1 trials Dextrose Water1 trials ALN-52881 trials GnRH, gonadorelin acetate1 trials NPT 2042 (Test formula/Formulation 2)1 trials NPT 2042 (Reference formula/Formulation 1)1 trials EX0391 trials DAOIB plus placebo1 trials DAOIB plus AO1 trials Lecanemab 10 mg/kg1 trials [11C]-CS1P11 trials CORT1082971 trials 18F-JSS20-183A PET1 trials ALN-APP1 trials [18F]RP-115 PET/MRI or PET/CT and MRI1 trials LHP5881 trials GSK45272261 trials [18F]-APN-16071 trials RB-ADSC1 trials Masupirdine 100 mg1 trials Masupirdine 50 mg1 trials Wujia Yizhi granules1 trials 18F-OP-8011 trials Caffeine1 trials ACI-24.060 at Dose D1 trials ACI-24.060 at Dose C1 trials ACI-24.060 at Dose B1 trials ACI-24.060 at Dose A1 trials Combined metabolic activators1 trials GV-9711 trials Rifaximin SSD 40 mg IR tablet1 trials Placebo (MAD)1 trials Placebo (SAD)1 trials DDN-A-0101 (MAD)1 trials DDN-A-0101 (SAD)1 trials Emtriva Capsule1 trials [F-18]Flornaptitril1 trials EXV-8011 trials EXV-8021 trials Conventional anti-dementia treatment group1 trials Lecanemab treatment group1 trials ML-007C-MA1 trials AV-14511 trials Nicotinamide riboside1 trials high CBD/low THC sublingual solution1 trials ARO-MAPT-SC1 trials Allopregnanolone1 trials Leucettinib-211 trials Memantine Hydrochloride 20 MG1 trials DMB-I (INN: Latrepirdine)1 trials VHB9371 trials LY40068951 trials NTRX-071 trials [11C]PBR281 trials [18F]NOS1 trials AMDX-2011P1 trials Nabilone1 trials [C-11]PiB-PET/MRI1 trials MK-11671 trials adMSC1 trials Recognized pharmacological treatments for AD.1 trials Gabapentin Enacarbil1 trials [F-18]AV-1451-PET1 trials Usual Care1 trials BMS-98949231 trials Placebo - MCI/AD1 trials ADEL-Y01 - MCI/AD1 trials Placebo - Healthy Participants1 trials ADEL-Y01 - healty participants1 trials Rotigotine 4Mg/24Hrs Patch1 trials CM3831 trials Foralumab TZLS-401 50 µg1 trials Tylex1 trials Stool samples1 trials ACP-2041 trials Brexpiprazole (Rexulti)1 trials Alzheimer Disease (AD)1 trials F 18 T8071 trials LY030201 trials 18F-PF9741 trials 18F-Fluselenamyl1 trials KDS20101 trials [11C] Pittsburgh Compound-B (PIB)1 trials Choline Alfoscerate 400mg1 trials MK-22141 trials Probiotic Blend Capsule1 trials Placebo Capsules to Match Emtricitabine Capsules, 200mg.1 trials Descovy® (TAF/FTC)1 trials Emtricitabine (FTC)1 trials Suvorexant 20 mg1 trials AChE inhibitor monotherapy1 trials Octaplasma1 trials ExPlas1 trials Acoramidis1 trials XTR0061 trials Recombinant Human Serum Albumin1 trials Flortaucipir F181 trials LY39540681 trials Saline - placebo comparator1 trials Placebo - 2 Placebo DMTS Patches1 trials 6 cm2 - 1 Active and 1 Placebo DMTS Patches1 trials 12 cm2 - 2 Active DMTS Patches1 trials High Dose Benfotiamine1 trials Low Dose Benfotiamine1 trials RO78126531 trials Remternetug1 trials J41 trials AS-S6031 trials Trazodone1 trials AAV2-BDNF Gene Therapy1 trials Lemborexant 20mg1 trials Lemborexant 10 mg1 trials 18F-GTP11 trials [18F]RO-9481 trials Intranasal insulin1 trials ONO-20201 trials CpG10181 trials DNL6281 trials Fecal samples1 trials 18-F-Flortaucipir1 trials THN3911 trials SHR-1707 placebo1 trials SHR-17071 trials 11C-PS131 trials 11C-MC11 trials [11C]PIB1 trials [ 18F]3F4AP1 trials Fluorodeoxyglucose1 trials Florbetaben1 trials Flortaucipir1 trials C-11 PiB1 trials F-18 AV 14511 trials Anti-amyloid Monoclonal Antibodies (mAbs)1 trials hMSC1 trials BPL-0031 trials Pharmacotherapy1 trials Antidepressant Medications1 trials Esketamine group1 trials AXS-051 trials DPP4 Is+metformin1 trials SGLT2 Is+METFORMIN1 trials Antidepressant medication (fluoxetine)1 trials Aripiprazole 5mg1 trials 11CPS131 trials 11C-MCI1 trials Midazolam Hydrochloride1 trials Seltorexant1 trials Nalmefene HCl injection1 trials Naloxone Hydrochloride1 trials Narcan 40 MG/ML Nasal Spray1 trials L-lysine1 trials L-leucine1 trials Sufentanil1 trials Losartan with BA1 trials Apo-levocarb1 trials Perampanel 6 MG1 trials IGC-AD1-Placebo1 trials IGC-AD1-Active1 trials Standard Care (Treatment as Usual)1 trials Experimental: Active "I-Reconstruction" Therapy1 trials dexmedetomidin1 trials Bacillus coagulans1 trials Mirtazapine1 trials LSD1 trials Two Psychedelic Doses Psilocybin1 trials Single Psychedelic Dose Psilocybin1 trials Medical Air1 trials Entonox1 trials Enoxolone1 trials Ketamine-assisted psychotherapy1 trials Minocycline 200mg1 trials SSRI1 trials Mealatonin1 trials Buspirone1 trials GM-25051 trials Nitrous oxide gas for inhalation1 trials Pilot study II: Placebo1 trials Pilot study II: Esketamine1 trials IV Ketamine1 trials Spravato1 trials SPT-3001 trials Fampridine SR1 trials Citalopram hydrobromide combined with zolpidem1 trials 5-hydroxytryptamine balanced antidepressants trazodone1 trials PET Scan with [11C]ABP6881 trials ALTO-1001 trials Esketamine injection group (0.25 mg/kg)1 trials MSP-20201 trials Desvenlafaxine succinate sustained-release tablets1 trials Toludesvenlafaxine hydrochloride sustained-release tablets1 trials Esketamine (Intranasal Spray)1 trials PET radiotracer1 trials Esketamine Treatment as Usual (ESK)1 trials Buprenorphine1 trials high dose PRT042 nasal spray1 trials median Dose PRT042 nasal spray1 trials Low Dose PRT042 nasal spray1 trials Carbidopa Levodopa1 trials Pramipexole1 trials Saliva Samples1 trials Arm 1 and 2 Interventions1 trials Arm 1, 2, 3 drug Interventions1 trials Milsaperidone1 trials Cariprazine (Augmentation Phase)1 trials Bupropion extended release1 trials Mianserin1 trials ARIPiprazole Injection [Abilify]1 trials ALTO-3001 trials ATP Group1 trials antidepressant monotherapy group1 trials stepwise pharmacotherapy1 trials D-Cycloserine1 trials Raclopride C111 trials Matching Placebo Patch1 trials LV232 60mg1 trials LV232 40mg1 trials Isotonic Solution, Intravenous1 trials Apimostinel Infusion, Intravenous1 trials Cipralex (escitalopram)1 trials Ketamine (Ketalar)1 trials Escitalopram 10mg1 trials Prescription Psychotropic Medications1 trials Duavive 0.45Mg-20Mg Tablet1 trials Oral Cariprazine 3 mg/day1 trials Cariprazine Depot MTD1 trials Cariprazine Depot1 trials Minocyclin1 trials TJ01131 trials sertraline 50 mg daily1 trials Bezafibrate1 trials Magnesium vitamin B61 trials N,N-Dimethyltryptamine1 trials LPS1 trials Dextromethorphan and Bupropion Sustained-Release Tablets1 trials PET Scan with [18F] VAT1 trials Nicotine transdermal patch1 trials DT-1011 trials Rivastigmine Transdermal Product1 trials Oxygen (O2)1 trials 50% N2O plus 50% O21 trials Valbenazine1 trials Antidepressant medication (ADM)1 trials Stool and blood samples1 trials Serotonergic Psychedelic1 trials DEX XL1 trials DEX IR tablets1 trials THC-Low Dose1 trials THC-Medium Dose1 trials DMT-Low Dose1 trials DMT-Medium Dose1 trials Escitalopram combined with sham rTMS1 trials Nitrogen gas1 trials Ibuprofen 800 mg1 trials Suvorexant (dual orexin receptor antagonist)1 trials Guanfacine1 trials standard general anesthesia1 trials Antipsychotics, mood stabilizers, etc.1 trials Ketofol1 trials Methohexital1 trials Transdermal Nicotine Patch1 trials Lithium Carbonate1 trials Aripiprazole1 trials (2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg)1 trials Second-line Antipsychotics1 trials Clozapine1 trials Low-dose psilocybin1 trials Escitalopram Oxalate1 trials Esketamine 84 mg1 trials Esketamine 56 mg1 trials Hypoxia1 trials L-dopa/Carbidopa1 trials Corn Starch capsules1 trials Escitalopram (Lexapro)1 trials FMT capsule1 trials ACP-2111 trials VLS-01-BU Placebo1 trials VLS-01-203 BU1 trials Antidepressant medication1 trials Fluoxetine 20 MG1 trials algorithm-based study medication1 trials JNJ-894951201 trials Losartan potassium 50mg1 trials nebulized ketamine1 trials Patients treated with Esketamine1 trials Placebo of Abilify 2, 5, 10, 15mg (Tablet)1 trials Abilify 2, 5, 10, 15mg (Tablet)1 trials Lysergic Acid Diethylamide Tartrate1 trials Lurasidone1 trials Quetiapine Fumarate Tablets1 trials Escitalopram Oxalate Tablets1 trials Spravato (Esketamine)1 trials Citalopram1 trials Valganciclovir1 trials Transdermal patch placebo1 trials Transdermal patch estradiol1 trials Creatine monohydrate1 trials Psilocybin and Psilocyn1 trials Lacosamide1 trials Biological sampling1 trials Esketamine hydrochloride (intranasal)1 trials Visbiome1 trials Esketamine Nasal Spray [Spravato]1 trials Contrave1 trials Fremanezumab1 trials Erenumab1 trials Nociceptin Receptor Antagonist1 trials Low dose IV Ketamine vs. IN Esketamine1 trials 18F-PF-064459741 trials High Dose Creatine Monohydrate1 trials Low Dose Creatine Monohydrate1 trials High Dose 5-hydroxytryptophan1 trials Low Dose 5-hydroxytryptophan1 trials Vortioxetine tablets1 trials Placebo Pill1 trials Pramipexole Pill1 trials Insulin Icodec group1 trials GZR41 trials Myfortic1 trials CIR-0602K1 trials Cholestyramine Powder1 trials Administration of hydrocortisone1 trials Administration of placebo hydrocortisone1 trials Administration of placebo AVP1 trials Administration of AVP1 trials 11C-Martinostat1 trials Metoclopramide1 trials Salsalate Oral Tablet1 trials Fish Oil Concentrate, 1000 Mg Oral Capsule1 trials Sulfonylurea1 trials Mesenchymal Stem Cells (MSCs)1 trials Calcium Gluconate1 trials Comirnaty Injectable Product1 trials Formoterol furmarate (20 μg)1 trials MS-5531 trials DME plus ranibizumab levosulpiride1 trials DME plus ranibizumab lactose pill1 trials DR vitrectomy levosulpiride1 trials DR vitrectomy lactose pill1 trials DR levosulpiride1 trials DR lactose pill1 trials DME levosulpiride1 trials DME lactose pill1 trials Metformin Hcl 850Mg Tab1 trials Diazoxide1 trials Placebo matching Dapaglifolzin1 trials C-peptide dosage1 trials blood glucose dosage1 trials Glycated haemoglobin (HbA1C) dosage1 trials beta-cell autoantibody dosage1 trials HLA typing1 trials RNA seq analysis1 trials Phenotype of Treg and Teffs1 trials Frequency of Treg and Teffs1 trials Technosphere Insulin1 trials Denosumab Injection1 trials Insulin glargine + insulin lispro1 trials Insulin glargine alone1 trials RO72042391 trials ARO-ALK71 trials Drug: Placebo Administered SC1 trials HR011408 injection Placebo; HR011408 injection1 trials NovoRapid®; HR011408 injection Placebo1 trials HR011408 injection; HR011408 injection Placebo1 trials PrimePro™/ PrimeMSK™1 trials Placental Membrane1 trials LY34572631 trials Sonlicromanol1 trials cold water1 trials Crocus sativus tepals cold aqueous extract1 trials NNC0194-04991 trials Combined prescription of the individual medications1 trials Polypill1 trials Valsartan 160 mg1 trials Sacubitril, Valsartan 97-103 mg Oral Tablet1 trials Evinacumab placebo1 trials ALN-ANG3 placebo1 trials Evinacumab1 trials ALN-ANG31 trials ASC30 tablets1 trials Aflibercept 2Mg/0.05Ml Inj,Oph1 trials BR1019C-11 trials BR1019B-11 trials BR1019A-11 trials BR1019C1 trials BR1019B1 trials BR1019A1 trials Colchicine Oral Product1 trials PS11 trials Alogliptin1 trials bevacizumab with oral placebo1 trials bevacizumab with oral curcumin1 trials Amlodipine 5mg1 trials Allisartan Isoproxil1 trials Placebo Atherolive1 trials Atherolive1 trials Hyperinsulinemic-euglycemic clamp1 trials Metformin + Insulin1 trials SGLT2i+Metformin+Linagliptin1 trials SGLT2i+Metformin+Cofrogliptin1 trials Chonline Alphoscerate1 trials blood draw1 trials Intranasal Oxytocin (IN-OXT)1 trials VK27351 trials Diamyd1 trials Norethindrone Acetate-Ethinyl Estradiol1 trials Testosterone Undecanoate1 trials Placebo semaglutide pen injector1 trials Allogeneic Human E-islet (E-islet 01)1 trials Anti-VEGF treatment1 trials GZR-331 trials DermaBind TL1 trials Low calorie meal replacement plan1 trials Gastrin 171 trials Allogenic Human Islet Cells1 trials Glucagon-like peptide-1 receptor agonist：Semaglutide1 trials Placebo + additive coformulation1 trials MK-1403 + additive coformulation1 trials ILT1011 trials Cyclosporin1 trials ROSUVASTATIN CALCIUM1 trials BERLIM 25/20 ASSOCIATION1 trials Investigational Product - MIB 6261 trials Dichloroacetate1 trials Diazoxide, 3 mg/kg per dose1 trials BGM05041 trials [6,6-2H2] D-glucose1 trials [1-13C] sodium acetate1 trials Alpelisib 300 mg1 trials guideline-based treatment for DM1 trials Lispro Prandial Insulin1 trials Insulin Lispro1 trials Humalog1 trials Novorapid1 trials Bempedoic acid1 trials C-peptide1 trials Suvorexant1 trials Neovasculgen®1 trials ALN-43241 trials DPP-4 inhibitor1 trials Thiazolidinedione1 trials Insulin Lispro 100 UNT/ML1 trials Olanzapine 2.5Mg Oral Tablet1 trials Anti-CD20 (rituximab)1 trials ex vivo expanded CD4+CD25+CD127- regulatory T cells (Tregs)1 trials Placebo 150μg1 trials AP303 150μg1 trials BB-1011 trials Esmolol Injection [Brevibloc]1 trials Sodium bicarbonate1 trials CNK-UT009 cell injection1 trials Isuzinaxib1 trials Saxagliptin1 trials Ketone Monoester (KE)1 trials Ezetimibe Tablets1 trials Atorvastatin Calcium Tablets1 trials Evolocumab Cartridge1 trials PATAS Trifluoroacetate1 trials LY40869401 trials Empagliflozin 10 MG [Jardiance] + Pioglitazone 15 MG [Actos]1 trials Empagliflozin 10 MG [Jardiance]1 trials Pioglitazone 15 MG [Actos]1 trials Placebo of HM152751 trials HM152751 trials Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor1 trials Lactulose oral solution1 trials Aspirin 162 mg EC Tab once daily for 7 days1 trials Aspirin 40Mg Chew Tab twice daily for 7 days1 trials Aspirin 81Mg Ec Tab twice daily for 7 days1 trials Urine sample1 trials CPX101 or placebo 360mg Q4W1 trials CPX101 or placebo 360mg Q2W1 trials CPX101 or placebo 240mg Q2W1 trials CPX101 or placebo 240mg Q4W1 trials CPX101 or placebo 160mg Q2W1 trials CPX101 or placebo 160mg Q4W1 trials CPX101 or placebo 120mg Q2W1 trials ALV-1001 trials Semaglutide, Empagliflozin1 trials Anagliptin1 trials Empagliflozin/Metformin1 trials Sitagliptin (DPP4 inhibitor)1 trials Semaglutide (1 Mg Dose)1 trials GLP-1 Therapy1 trials Botulinum toxin A1 trials Inhaled Technosphere Insulin1 trials local antibiotic application of topical minocycline1 trials Aflibercept (Eylea®) - US only1 trials Sham comparator to BI 7645241 trials BI 7645241 trials Late Dinner tracer1 trials Early Dinner tracer1 trials Pueraria lobata radix1 trials Dorzagliatin tablets1 trials NOX1416 and SOC1 trials Active comparator Taurine1 trials THN391 MAD1 trials Resveratrol1 trials Intradermal Microdialysis1 trials Chlorhexidine oral care1 trials Para-probiotic oral care1 trials RAS-antagonist and beta-blocker up-to maximal dosages1 trials Empagliflozin (EMPA)1 trials Pioglitazone (PIO)1 trials Dihuang Baoyuan Granules matched placebo1 trials Dihuang Baoyuan Granules1 trials Fuling Yunhua Granules matched placebo1 trials Fuling Yunhua Granules1 trials Tadalafil 10 MG1 trials Propolis drops1 trials PIEMONTE1 trials Human Pancreatic Islet Transplantation1 trials Clonidine Pill1 trials Hydrochlorothiazide 12.5Mg Tab1 trials ZE63-03021 trials Lyumjev1 trials Pramlintide1 trials Humulin R U-5001 trials Portal Insulin U-5001 trials Capsaicin 8%1 trials Dextran 401 trials Iohexol Inj 300 MG/ML1 trials Trehalose1 trials Intranasal OXT1 trials Dorzagliatin1 trials ZT-01, 22 mg1 trials ZT-01, 15 mg1 trials ZT-01, 7 mg1 trials ELU42 Topical Spray1 trials Drug: Semaglutide Administered SC1 trials Henggliflozin1 trials Aspirin tablet1 trials Dapagliflozin or Empagliflozin1 trials RGB-50881 trials GNTI-1221 trials Glucagon, 0-0.5 ng/kg/min1 trials Dextrose 20 % in Water1 trials Octreotide Acetate, 6-45 ng/kg/min1 trials Insulin regular, 32 mU/m2/min (hyperinsulinemia)1 trials Insulin regular, 2.0-3.2 mU/m2/min (euinsulinemia)1 trials Alpha-Lipoic Acid/Vitamin/Mineral Supplement PolyMVA1 trials DWP160011 trials 68Ga-exendin-41 trials Yunnan Baiyao1 trials Sitagliptin 100mg1 trials Standard group1 trials Combination group1 trials Amino acid peritoneal dialysis solution1 trials Linagliptin1 trials UP4211 trials Fecal microbiota transplant (FMT)1 trials Metformin TEVA 850 mg1 trials HGR41131 trials Intervention Period 3: Semaglutide Placebo + Empagliflozin1 trials Intervention Period 2: Semaglutide + Empagliflozin Placebo1 trials Intervention Period 1: Semaglutide + Empagliflozin1 trials Standard Treatment (Guideline-Based)1 trials Vinpocetine1 trials AZD42481 trials MADALENA ASSOCIATION1 trials Hyperglycemic clamp1 trials Mirabegron 100 mg1 trials Protocol-based treatment1 trials Dulaglutide 0.75Mg/0.5Ml Inj Pen1 trials Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)1 trials Triamcinolone Acetonide- Immediate Release;TCA-IR1 trials Inpatient newly diagnosed type 2 diabetes subjects1 trials Outpatient newly diagnosed type 2 diabetes subjects1 trials R3R011 trials Generation of inducible pluripotent stem cells1 trials KL13331 trials Liraglutide Pen Injector1 trials Placebo 10mg Tab1 trials the ATMP Protrans1 trials Ephedrine1 trials New sustained-release metformin tablets (Ⅲ)1 trials Glucophage (Metformin Hydrochloride Tablets)1 trials HD-6277 25mg1 trials HD-6277 50mg1 trials HD-6277 100mg1 trials DW6012(Dasidiem tab. 10/100mg)1 trials Intravitreal injection of Faricimab or Aflibercept 2 mg1 trials Actos1 trials Jardiance 25Mg Tablet1 trials Rybelsus Tablet1 trials Insulin producing stem cells infusion1 trials Cilostazol / Ginko Leaf Dried Ext.1 trials Placebo of YJ001 for Spray Use1 trials YJ001 for Spray Use1 trials Linagliptin and Metformin1 trials Henagliflozein and Metformin1 trials Cadisegliatin 800 mg BID1 trials Cadisegliatin 800 mg QD1 trials HDM1002 100 mg1 trials BGM0504 placebo1 trials 15 mg BGM0504 injection1 trials 5 mg BGM0504 injection1 trials Placebo with 4 meal strategies1 trials Semaglutide with 4 meal strategies1 trials Naronapride1 trials MKP102411 trials RO77950811 trials Semaglutide Subcutaneous Injection1 trials TrophiPatch: allogeneic adipose-derived stromal cell patch1 trials Insulin Degludec Injection1 trials SHR-3167 Injection1 trials Composition of peripheral blood immune cells1 trials Metabolome composition1 trials Residual islet function1 trials Chronic hyperglycemia1 trials Edetate Disodium1 trials Dapagliflozin 10 milligrams [Farxiga]1 trials albumin injection1 trials mesenchymal stem cells with OCN-191 trials Empagliflozin (oral)1 trials Nicorandil 10 MG1 trials Drug Metabolizing Enzyme1 trials TLC-6740 Tablet1 trials TLC-6740 Oral Solution1 trials Basal insulin analogues1 trials Amimestrocel1 trials Collection of samples1 trials VX-8801 trials Weight loss1 trials Gla-100 (insulin glargine)1 trials iGlarLixi (insulin glargine/lixisenatide)1 trials Dose escalation of moderate-intensity statin1 trials Hydroxychloroquine Oral Tablet1 trials GS-45711 trials Intraosseous Vancomycin1 trials Degludec1 trials Insulin injections1 trials Placebo pretreatment before ovarian stimulation1 trials Metformin pretreatment before ovarian stimulation1 trials Type 2 DM drugs1 trials Volagidemab1 trials vasopressin - standard initiation1 trials vasopressin - early initiation1 trials MET2331 trials MET233 and MET0971 trials Tofogliflozin1 trials Sanggua tablets1 trials Lisdexamfetamine1 trials Vasopressin; Methylprednisolone; Hydrocortisone1 trials MTX-1011 trials Liraglutide injection1 trials allogeneic islet1 trials High dose Qishen Yiqi Dripping Pills 3 bags1 trials Low dose Qishen Yiqi Dripping Pills 3 bags1 trials Qishen Yiqi Dripping Pills placebo 3 bags1 trials Dipeptidyl Peptidase 4 inhibitor1 trials Matching placebo capsules1 trials Dimethyl Fumarate Enteric-coated Capsules1 trials Placebo matching Vicadrostat1 trials 160 units nasal insulin spray1 trials Ertugliflozin 5 mg, 15mg1 trials Aspirin Placebo1 trials moxifloxacin1 trials glucose1 trials WAL09211 trials GZR4 injection1 trials Levocetirizine1 trials Valsartan 80 mg1 trials ENERGI-F703 matched vehicle1 trials ENERGI-F703 GEL1 trials Vaxigrip Tetra Sanofi Pasteur Europe1 trials Semaglutide 7 MG1 trials AZD6793 Placebo1 trials Metformin dose escalation1 trials Cofrogliptin+SGLT2i+Metformin1 trials TZIELD (teplizumab-mzwv)1 trials ARO-INHBE1 trials Xuezhikang1 trials Zinc Gluconate 30 MG1 trials Standard bolus of insulin then extended bolus of insulin1 trials Extended bolus of insulin then standard bolus of insulin1 trials CSII in the empirical group1 trials CSII in the prediction model group1 trials GZR33 Injection1 trials GZR101 Injection1 trials Ex vivo Expanded Human Autologous Regulatory T Cells1 trials Aleniglipron1 trials ganagliflozin1 trials Triple Therapy of Other Oral Antidiabetic Drugs1 trials Biological/Vaccine1 trials Plasma-Lyte 1481 trials Xcell Amnio Matrix1 trials Lucentis1 trials Ranibizumab 10mg/ml Injection1 trials Nicorandil 10 MG Oral Tablet1 trials PRP + ASCs injection1 trials PRP + SVF injection1 trials Only PRP injection1 trials Dulaglutide 1.5 MG1 trials HDM1005 41 trials HDM1005 31 trials Triple-combination therapy1 trials Dual-combination therapy1 trials Acetazolamide1 trials CELZ-201 Administration1 trials MK-28281 trials Capsulized placebo transfer containing dilution solution1 trials Metformin HCI XR1 trials Atorvastatin-Ezetimibe1 trials Omega 3-Atorvastatin1 trials VX-011 trials Pre-study basal insulin SC1 trials Degludec IV1 trials Lispro SC1 trials Degludec SC1 trials LY4057996 IV1 trials LY4057996 SC1 trials Chorioretinal diseases1 trials GL0034 Dose Level 61 trials GL0034 Dose Level 51 trials GL0034 Dose Level 41 trials GL0034 Dose Level 31 trials GL0034 Dose Level 21 trials GL0034 Dose Level 11 trials Empagliflozin 25 MG with Ezetimibe/Rosuvastatin 10/10mg1 trials Ezetimibe/Rosuvastatin 10/10mg1 trials Fluoxetine and DHEA1 trials DHEA1 trials Xianglei Tangzu Gao1 trials optimized medical management1 trials MD-181 trials Envlomet SR Tablet1 trials Envlo Tablet1 trials DWP16001 Placebo1 trials DWP16001 0.3mg1 trials QX12061 trials RZ-6291 trials NNC0519-01301 trials Nigetella salivata1 trials Sodium Chloride 0.9%1 trials Arginine hydrochloride1 trials UCMSCs1 trials Vildagliptin1 trials Imeglimin1 trials Beinaglutide1 trials 0.75% MDI-1228_mesylate gel plus Standard of Care1 trials Renin-angiotensin-aldosterone system inhibitors1 trials Norepinephrine and Vasopressin for Rescue1 trials Early Vasopressin1 trials Eloralintide Placebo1 trials Macupatide Placebo1 trials Macupatide1 trials Biological check-up1 trials Usual insulin treatment1 trials Insulin + semaglutide treatment1 trials ertugliflozine1 trials Semaglutide Oral Tablet1 trials NNC0471-0119 H1 trials MTX2281 trials Rosuvastatin/Dapagliflozin placebo1 trials Comparator 1: Dapagliflozin/Rosuvastatin placebo1 trials CMG190303(Dapagliflozin/Rosuvastatin)1 trials Initiation of noradrenaline as a first vasoconstrictive drug1 trials Initiation of vasopressine as a first vasoconstrictive drug1 trials A fiixed combination of Chinese herbal medicine1 trials Mineralocorticoid Receptor Antagonists(MRAs)1 trials Glucagon-like peptide-1 receptor agonists (GLP 1 RA)1 trials Renin-angiotensin-aldosterone system blockade1 trials Sodium-glucose cotransporter 2 inhibitors (SGLT2i)1 trials exendin(9-39)amide1 trials ALLO-ASC-DFU1 trials Pioglitazone placebo + Empagliflozin placebo1 trials Empagliflozin 25 mg/d plus Pioglitazone (15/30 mg/d)1 trials Empagliflozin 25 MG plus Pioglitazone placebo1 trials QLS-111 Ophthalmic Solution (0.075%)1 trials QLS-111 Ophthalmic Solution (0.015%)1 trials NNC9733-00011 trials Diluted U-500 Humulin Insulin1 trials Diluted Humalog U-200 Insulin1 trials Decubal1 trials Oviderm1 trials Canoderm1 trials Iohexol 300 Mg/mL Injectable Solution1 trials Aminohippurate Sodium 20 % Injection1 trials Metformin Hcl 1000Mg Tab1 trials Other drugs1 trials Semaglutide placebo1 trials verapamil extended release capsule1 trials Anti-thymocyte globulin (ATG)1 trials CSL3001 trials THP-001061 trials THP-001051 trials THP-001041 trials THP-001031 trials THP-001021 trials THP-001011 trials responders group and nonresponders group1 trials LY32095901 trials CNP-1031 trials Low Dose SAB-1421 trials High Dose SAB-1421 trials Semaglutide Auto-Injector1 trials Apabetalone1 trials Dapagliflozin/Sitagliptin1 trials Dapagliflozin/Pioglitazone1 trials Amnio-Maxx® Dual Layer Amnion Patch1 trials 10 mg glipizide ingestion1 trials Policosanol1 trials Choline fenofibrate1 trials Reamberin1 trials VA（anesthesia with sevoflurane and remifentanil）1 trials TIVA ( anesthesia with propofol and remifentanil)1 trials Incobotulinumtoxin-A 100 UNIT Injection1 trials ACE Reno1 trials Verapamil (Part A)1 trials High intensity statin monotherapy1 trials Metformin Oral Tablet1 trials Semaglutide Oral Product1 trials esthinylestradiol1 trials estradiol valerate1 trials Recombinant Humanized Type III Collagen Injection1 trials Chemoradiotherapy (small pelvic) + Zimberelimab1 trials Chemoradiotherapy + Adjuvant chemotherapy and Zimberelimab1 trials Fludarabine + Cyclophosphamide + CD7-specific CAR-T Cells1 trials Theophylline1 trials Mecapegfilgrastim1 trials Efavirenz1 trials Sodium Cromoglicate1 trials Choline1 trials CAR-T Cells infusion（CAR2219,CAR2019, CAR19 etc）1 trials pyrotinib dalpiciclib letrozole1 trials BT55281 trials ET mono ± LHRH1 trials abemaciclib + ET ± LHRH1 trials ribociclib + AI ± LHRH1 trials Extended Letrozole Therapy1 trials Traditional Letrozole Therapy1 trials Aromatase inhibitor and Fulvestrant1 trials Zumsemetinib1 trials FS2221 trials anti-CD19 CAR-T1 trials LBL-034 for Injection1 trials NAI1 trials R, 260 mg/m2, paclitaxel for injection (albumin bound).1 trials T, 260 mg/m2, paclitaxel for injection (albumin-bound)1 trials Maraviroc1 trials Mitoxantrone Hydrochloride1 trials Gilteritinib Fumarate1 trials Fluoro Uracil1 trials Actinium-225 Prostate-Specific Membrane Antigen 6171 trials 177 Lutetium Prostate-Specific Membrane Antigen 6171 trials TLN-1211 trials Gallium Ga 68 FAPi-461 trials Transarterial Chemoembolization1 trials KTX-2001 + Darolutamide (NUBEQA®)1 trials KTX-20011 trials Adjuvant durvalumab1 trials Imatinib tablets1 trials Cemiplimab-Rwlc1 trials Treatment with CD200AR-L1 trials ALK2021 trials Liposomal daunorubicin and cytarabine1 trials EGFR-TKI inhibitor based on investigator's choice1 trials SHR-48491 trials concurrent chemoradiotherapy (CCRT)1 trials Non-myeloablative Lymphodepletion (NMA-LD) Regimen1 trials NEXTGEN-TIL1 trials HLA-mismatched GPBMC infusion1 trials MSGV1-PSCA-8T28Z1 trials 1.48 GBq of 177Lu-AB-3PRGD21 trials Spray of placebo1 trials Spray of spirulina derivatives1 trials Namodenoson 25mg1 trials M3T011 trials Antagonist protocol for IVF1 trials First or third generation EGFR-TKIs1 trials Elemene plus first or third generation EGFR-TKIs1 trials ARSI1 trials IA Carboplatin + IA Etoposide Phosphate1 trials IA Carboplatin + IA Caelyx1 trials modified FOLFIRINOX (mFOLFIRINOX)1 trials Pembrolizumab Monotherapy1 trials ABSK043 in combination with Firmonertinib1 trials Biological/Vaccine: Blood sample and tissue sample1 trials Relapsed glioblastoma1 trials HB0045 Drug Product1 trials metamizole1 trials Tucidinostat, Azacitidine combined with CHOP1 trials Amrubicin1 trials XON71 trials Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002)1 trials VRN1010991 trials BMS-9864891 trials SMT-NK inj.+Pembrolizumab1 trials Gem/nab-P Chemotherapy1 trials Tec-RVd1 trials Dara-RVd1 trials AUTO11 trials infusion of melphalan and dactinomycin1 trials TJ033721 (givastomig), durvalumab, chemotherapy1 trials TJ033721 (givastomig), chemotherapy1 trials TJ033721 (givastomig) , nivolumab, chemotherapy1 trials TJ033721 (givastomig)1 trials AVA60001 trials Calcium Formate1 trials STX-2411 trials TGRX-8141 trials LY43377131 trials [18F]FMISO PET/MRI imaging1 trials Chemotherapy Cisplatin1 trials Chemotherapy 5-Fluorouracil1 trials MBS314 Injection1 trials Bacillus Calmette-Guerin: Strain TICE1 trials Bacillus Calmette-Guerin: Strain Russian BCG-I1 trials LPM66901761 trials Adebrelimab, Oxaliplatin, Fluorouracil,Leucovorin1 trials Replicative Adenovirus Vector (RGDCRAdCOX2F)1 trials Disitamb Vedotin ,pyrotinib1 trials AcNK-Sup003 cell injection solution1 trials Levetiracetam (Keppra)1 trials PRaG-11 trials UTD1 combined with capecitabine1 trials Loncastuximab tesirine 75µg/Kg1 trials Loncastuximab tesirine 150 µg/Kg1 trials H1 Antihistaminics1 trials clofarabine, fludarabine and busulfan, CloFluBu1 trials busulfan, cyclophosphamide and melphalan, BuCyMel1 trials Fully human CD5 chimeric antigen receptor T cell injection1 trials NK cell preparation1 trials 5-fluorouracil cream1 trials Combination cream of 5-fluorouracil and calcipotriene1 trials triptorelin, goserelin, leuprorelin1 trials Lugol's Solution (1.5%)1 trials Autologous total tumor mRNA loaded DOTAP liposome vaccine1 trials DS3610a1 trials GEH200520 Injection / GEH200521 (18F) Injection - Part B1 trials GEH200520 Injection / GEH200521 (18F) Injection - Part A1 trials Tb-PSMA-I&T (Tb-PSMA)1 trials Drug: Tagitanlimab Drug: Capecitabine1 trials SKB315 for injection1 trials QLC11011 trials Gemcitabine/Nab-paclitaxel Treatment Regimen1 trials Anti-Infective Drugs1 trials Cadonilimab, LM-302, S-1, paclitaxel1 trials Bevacizumab+mFOLFOX61 trials fezolinetant - reference formulation1 trials B4T2-001 autologous CAR-T1 trials SV-1011 trials Standard antiemetic treatment1 trials DPV-0011 trials INCAGN018761 trials SoC-based immunotherapy (+/- chemotherapy)1 trials Verteporfin Injection1 trials Antibiotics1 trials Durvalumab (MEDI4736)1 trials Adebrelimab combined with DOS1 trials CD19/CD22-CAR-transduced T cells1 trials Lutetium [177Lu] oxodotreotide/dotatate1 trials nab-paclitaxel combined with carboplatin1 trials Consolidation Toripalimab1 trials Albumin paclitaxel/neutrophil drug1 trials Senza5 CART51 trials Vibegron1 trials TFHX Regimen1 trials FOLFOX6/FOLFOX71 trials S2416561 trials Supportive Care: Prophylaxis against infections1 trials Supportive Care: Seizure prophylaxis1 trials Supportive Care: Growth Factors1 trials Post-transplant Ruxolitinib1 trials Post-transplant Abatacept1 trials Post-transplant Mycophenolate mofetil1 trials Post-transplant Tacrolimus1 trials PTCy (25 mg/kg D3, D4)1 trials PTCy (50 mg/kg D3, D4)1 trials Conditioning Regimen E1 trials Conditioning Regimen D1 trials Conditioning Regimen C1 trials Conditioning Regimen B1 trials Conditioning Regimen A1 trials Naloxegol1 trials Lubiprostone1 trials VS-1011 trials Systemic treatment (FTD-TPI and bevacizumab)1 trials CER-12361 trials Gemcitabine-Oxaliplatin Regimen1 trials REC-12451 trials STRIDE (durvalumab + tremelimumab)1 trials SHR-A1912 Injection1 trials DF62151 trials Nivolumab (OpdivoTM, 40 mg/4mL solution)1 trials Ipilimumab (YervoyTM, 50 mg/10 mL solution)1 trials CAR.B7-H3T cells infusion1 trials testosterone pellet (100 mg)1 trials chemotherapy sequential CAR-NK cell infusion1 trials Full course of PD-1 monoclonal antibody1 trials Vandetanib1 trials VX15/25031 trials RGT-419B in combination with hormonal therapy1 trials RGT-419B1 trials Blood sampling for pharmacokinetics1 trials GS-53191 trials Dapagliflozin Propanediol1 trials Ribociclib (adjuvant)1 trials Chemotherapy (adjuvant)1 trials Ribociclib (neoadjuvant)1 trials Sintilimab plus bevacizumab biosimilar1 trials Adriamycin-based chemotherapy1 trials Sintilimab plus chemotherapy1 trials Farletuzumab ecteribulin1 trials Anti-PD-(L)1 based immunotherapy1 trials SYN8181 trials Adebrelizumab1 trials gemcitabine and cisplatin (Induction chemotherapy)1 trials TMP-SMX DS1 trials Topotecan IT1 trials A2/4-1BBL melanoma vaccine1 trials fruquintinib＋trastuzumab + XELOX1 trials anlotinib, fulvestrant1 trials Non-Dasatinib(Sprycel) arm1 trials Dasatinib(Sprycel) arm1 trials Tislelizumab + Capecitabine1 trials DM0011 trials KL-A1671 trials Azacytidine1 trials BG18051 trials Concurrent chemo-radiotherapy1 trials Toripalimab plus concurrent chemo-radiotherapy1 trials VG20251 trials KD-0251 trials Realgar Indigo naturalis formula1 trials FPI-22651 trials Purinostat Mesylate 8.4 mg/m21 trials Purinostat Mesylate 6 mg/m21 trials Purinostat Mesylate 4 mg/m21 trials Tislelizumab + Nab-Paclitaxel1 trials IPN012031 trials Liposomal Irinotecan + Bevacizumab1 trials Liposomal Irinotecan + rmhTNF-NC1 trials liposomal irinotecan monotherapy1 trials Ansastrozole1 trials BP1001 plus decitabine1 trials BP1001 in combination with Ventoclax plus decitabine1 trials Ipilimumab (3 mg/kg)1 trials FOLFIRI and Bevacizumab1 trials SIRT with Yttrium-90 Microspheres1 trials OR5021 trials S-5310111 trials IDOV-SAFE1 trials 177Lu-DFC4131 trials 68Ga-NNS3091 trials 1327 microCi of 225Ac-MTI-2011 trials 998 microCi of 225Ac-MTI-2011 trials 750 microCi of 225Ac-MTI-2011 trials 564 microCi of 225Ac-MTI-2011 trials 424 microCi of 225Ac-MTI-2011 trials 254 microCi of 225Ac-MTI-2011 trials 152 microCi of 225Ac-MTI-2011 trials 76 microCi of 225Ac-MTI-2011 trials 38 microCi of 225Ac-MTI-2011 trials 19 microCi of 225Ac-MTI-2011 trials 9.5 microCi of 225Ac-MTI-2011 trials 4.7 microCi 225Ac-MTI-2011 trials Focal Cryoablation1 trials Immuno-chemotherapy1 trials Recombinant human endostatin1 trials PD-1 inhibitor， bevacizumab1 trials CD19-IL7Ra CAR-T cells1 trials Chemotherapy Prednisone1 trials gemcitabine and oxaliplatin.1 trials DZD90081 trials Abemaciclib 150 MG1 trials Ribociclib 200Mg Oral Tablet1 trials Systemic therapy (Gemcitabine plus oxaliplatin)1 trials Systemic therapy (Gemcitabine plus Cisplatin)1 trials QN-3021 trials GARDASIL®1 trials Curcuminoid Capsules1 trials Pembrolizumab, Sintilimab1 trials Alcohol1 trials IA session1 trials Orellanine1 trials TQB3702 tablets+Chemotherapy regimen1 trials Radium Ra 223 Dichloride1 trials Tagrisso1 trials Daratumumab and Recombinant Human Hyaluronidase1 trials HPV vaccine1 trials Antineoplastic Vaccine1 trials Iparomlimab1 trials CD-GA-1021 trials Tislelizumab + platinum-based chemotherapy1 trials Healthy Donor Fecal Microbiota Transplant (hdFMT)1 trials 18F-TRX1 trials DB-13171 trials M74371 trials HX009+IN100181 trials MEN23121 trials SGR-15051 trials Radiotherapy, Temozolomide, Doxorubicin1 trials Blinatumomab (Group B)1 trials Venetoclax (nonRand Group)1 trials Blinatumomab (Group A)1 trials Intraperitoneal infusion of FAST CEA-targeted CAR-T1 trials Micronized progesterone suspension1 trials APG-12521 trials VEN+AZA-51 trials Targeted Therapy Agent (Fruquintinib)1 trials Immunotherapy (Sintilimab)1 trials ABBV-2911 trials Camrelizumab, gemcitabin, cisplatin1 trials KK22601 trials AMXI-5001:Dose Expansion Phase II1 trials AMXI-5001:Dose Escalation Phase I1 trials Super1 TCR-T1 trials Fruquintinib, TAS1021 trials Capsaicin 8% Patch1 trials Tafinlar/Mekinist1 trials Oral cannabis THC/CBD1 trials Oral cannabis high THC1 trials Oral cannabis low THC1 trials Naproxen1 trials CAR-T treatment1 trials Lobaplatin1 trials TRANEXAMIC ACID 1 G in 10 mL INTRAVENOUS INJECTION, SOLUTION1 trials NX-16071 trials tislelizumab + zanubrutinib + rituximab + lenalidomide1 trials Predinsone/Prednisolone1 trials BMS-9863651 trials Trifluridine-tipiracil plus Bevacizumab Alone1 trials enoxaparin or tinzaparin or dalteparin1 trials Vaginal Lactobacillus capsules1 trials Steroid Drug1 trials Taxotere® (100 mg/m2)1 trials Nanosomal Docetaxel Lipid Suspension (100 mg/m2)1 trials Nanosomal Docetaxel Lipid Suspension (75 mg/m2)1 trials Epirubicin hydrochloride1 trials Single drug chemotherapy plus immunotherapy1 trials Sunitinib, Imatinib dosage, Dasatinib, Reveratinib1 trials tumor-specific TCR-T cells1 trials Intense androgen deprivation therapy1 trials Trastuzumab+Nivolumab+Gemcitabine+Cisplatin1 trials Moluodan granules1 trials Fuzhegn Nizeng Decoction1 trials Treatment by regorafenib and best supportive care1 trials Immunomodulatory DC vaccines to target prostate cancer1 trials CAPOX regimen1 trials SGR-35151 trials JV-2131 trials AK129 IV infusion1 trials Sotevtamab1 trials IL-22BP1 trials GIM-5311 trials Nilotinib and Paclitaxel1 trials Ceramide NanoLiposome (Ceraxa)1 trials INM1761 trials SG19061 trials Darotamide1 trials Prednisolone tablets1 trials SBRT1 trials Lvonescimab (AK112)1 trials ch14.18/CHO1 trials Glycerol "OBA"1 trials bulumtatug fuvedotin1 trials BMS-9863691 trials Tamoxifen, Letrozole, Anastrozole, or Exemestane1 trials Ondansetron (Oral soluble film OR injections) ,Dexamethasone1 trials Placebo SH-1028 tablets1 trials SH-1028 tablets1 trials AZD67501 trials AMT-6761 trials Atezolizumab 1200 mg e.v. q211 trials Immunotherapy: adjuvant durvalumab1 trials Ifosfamide/mesna1 trials ARD1031 trials Anticoagulant1 trials WJ220961 trials ERAS-0015 in combination1 trials ERAS-00151 trials LUTATHERA® by intra-arterial hepatic (IAH) injection1 trials Fasudil Hydrochloride1 trials Sotorasib 120Mg Tab1 trials UCPVax1 trials Vitamin A1 trials Actinomycin1 trials [ Lu-177]-Catalase1 trials SHR-4602 for injection1 trials Utidelone Capsule (Part 3)1 trials Drug B Utidelone Injection (Part 2: Group B-A)1 trials Drug B Utidelone Injection (Part 2: Group A-B)1 trials Drug A Utidelone Capsule (Part 2: Group B-A)1 trials Drug A Utidelone Capsule (Part 2: Group A-B)1 trials Utidelone Capsule (Part 1)1 trials Merck 3475 Pembrolizumab1 trials Cyclophosphamide (Conditional therapy)1 trials Fludarabine (Conditional therapy)1 trials DuoCAR20.19.22-D951 trials Androgen Therapy1 trials standard of care chemotherapy plus gemtuzumab ozogamicin1 trials Venetoclax plus Azacitidine1 trials pH Low Insertion Peptide-exatecan Conjugate CBX-121 trials Triptorelin Injection1 trials Carbon Nanoparticle Suspension Injection1 trials Allogeneic transplant1 trials CBI-12141 trials 177Lu-AB-3PRGD2 radioligand therapy1 trials Halneuron1 trials Placebo+endocrine therapy1 trials Capecitabine+endocrine therapy1 trials Single Agent Asciminib1 trials CUCART191 trials Bortezomib-bendamustine-melphalan1 trials CX10031 trials Sample collection1 trials Thalidomide+cetuximab+FOLFOX/FOLFIRI1 trials RB1 trials RB/RBAC alternating1 trials Docetaxel, cisplatin, fluorouracil1 trials Docetaxel, nedaplatin, fluorouracil1 trials Diclofenac Potassium1 trials Gemcitabine, Nab-paclitaxel, Irinotecan1 trials transfusion of 2×10^9 PD-1 edited TILs per kg body weight1 trials transfusion of 1×10^9 PD-1 edited TILs per kg body weight1 trials transfusion of 5×10^8 PD-1 knockout TILs per kg body weight1 trials CHT102 allogeneic CAR T cells1 trials Placebo matching for Selinexor (continuous therapy)1 trials Selinexor (continuous therapy)1 trials Cisplatin (combination therapy)1 trials Dexamethasone (combination therapy)1 trials Gemcitabine (combination therapy)1 trials Rituximab (combination therapy)1 trials Placebo matching for Selinexor (combination therapy)1 trials Selinexor (combination therapy)1 trials Nab-paclitaxel 80 mg/m^21 trials D-1553 Tablet1 trials pralatraxate,1 trials Pembrolizumab (KEYTRUDA(R))1 trials BI 17038801 trials Mosunetuzumab in combination with Zanubrutinib1 trials Carbon Nanoparticle-Loaded Iron1 trials Carbon Nanoparticle-Loaded Iron [CNSI-Fe]1 trials HRS-38021 trials Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes1 trials Biological1 trials oncolytic virus1 trials Adebrelimab: 20mg/kg day1, Q3W, 3 times1 trials XKDCT2931 trials Adjuvant Treatment Phase1 trials neoadjuvant therapy with Pembrolizumab/Lenvatinib1 trials MRX-28431 trials rondecabtagene autoleucel1 trials Paclitaxel polymer micelle immunocombination1 trials Venclexta 100 MG Oral Tablet1 trials WSD0922-FU Tablets, Dose level B1 trials WSD0922-FU Tablets, Dose level A1 trials Zoledronate1 trials Tuvonralimab/Iparomlimab combination with GEMOX chemotherapy1 trials FLT1 trials Cisplatin (CDDP)1 trials Bortezomib (B)1 trials GFH3751 trials TAS-102 (trifluridine and tipiracil, Lonsurf®)1 trials RetroNectin active Killer cells1 trials Androgen receptor signaling inhibitor (ARSI)1 trials Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells1 trials Standard of Care Neoadjuvant Chemotherapy (NAC)1 trials Multivitamin1 trials Ca-EDTA1 trials DMSA1 trials 177Lu-LNC1004 Injection1 trials Omega 3 FA (Fish Oil)1 trials Tart Cherry1 trials Culture of organoids1 trials Neural Stem Cells-expressing CRAd-S-pk71 trials AK104 - Chemotherapy1 trials Lenalidomide capsule1 trials GLB-0021 trials KeraStat cream1 trials Ruxolitinib Phosphate1 trials Karelizumab+Apatinib1 trials nivolumab combined with SOX1 trials Pediatric-type of chemotherapy1 trials IBI310&Sintilimab1 trials sintilimab+IBI310+chemotherapy1 trials Mini-hyper-CVD1 trials Hyper-CVAD1 trials Liquid Biopsy1 trials Lymphodepletion with Cyclophosphamide1 trials Lymphodepletion with Fludarabine1 trials Palbociclib 125Mg Tab1 trials HF158K1 /Arm 60 mg/m²1 trials HF158K1 /Arm 45 mg/m²1 trials HF158K1 /Arm 30 mg/m²1 trials HF158K1 /Arm 15 mg/m²1 trials HF158K1 /Arm 6 mg/m²1 trials HF158K1 /Arm 2 mg/m²1 trials LM-2991 trials Non-myeloablative lymphodepleting chemotherapy1 trials NY-ESO-1 TCR redirected autologous T cell product1 trials Dara-CyBorD1 trials Intrathecal injection of pemetrexed1 trials OH2+BS0061 trials B0191 trials TR1281 trials Vemurafenib in combination with cobimetinib1 trials Trastuzumab in combination with pertuzumab1 trials Hetrombopag Olamine1 trials HPV16 Ct-DNA dosing1 trials Cell therapy for solid tumors1 trials B7-H3CART Dose (Intravenous)1 trials IX001 TCR-T cells1 trials GT201 injection1 trials BBO-85201 trials HMPL-4531 trials Oseltamivir1 trials Baloxavir Marboxil1 trials BioTTT001 injection1 trials EU1011 trials CIML-NK Cells1 trials Levofolinate1 trials CART301 trials Clostridium butyricum (live) Tablets(Meiya)1 trials Dabrafenib, trametinib, nivolumab1 trials Trametinib and Nivolumab1 trials CBP-10081 trials AZA capsules1 trials L218CAR191 trials CDK4/6i1 trials High-dose Cyclophosphamide1 trials Attenuated-dose Cyclophosphamide1 trials Signal Switch Receptor Modified TIL1 trials Induction Chemotherapy (modified FLOT or modified FOLFOX-6)1 trials DZD9008+AZD42051 trials Phenoxybenzamine1 trials dualCAR-NK19/70 cell1 trials Cetuximab (Erbitux, C225)1 trials ABO21021 trials ATG-0371 trials PIPAC1 trials SIM0610 for Injection1 trials Rituximab or Rituximab biosimilar1 trials LP-1841 trials CMGV1 trials TNG4561 trials Abatacept (Orencia)1 trials HMBD-0011 trials Zilbrysq1 trials REGN43361 trials Apatinib Mesylate Tablets1 trials SIACI of cetuximab and bevacizumab1 trials Tecartus1 trials contrast agent perflutren lipid1 trials Aromatase Inhibitors1 trials Placebo (Matching for Propranolol & Etodolac)1 trials Propranolol (Beta-Blocker) and Etodolac (COX-2 Inhibitor)1 trials Chemotherapy selected by the physician1 trials rhuGM-CSF1 trials AST-3011 trials 700 mg leronlimab1 trials 350 mg leronlimab1 trials anti-GD2-800CW1 trials Prednisone, Olverembatinib, Blinatumomab, Chidamide1 trials Lateral quadratus lumborum block1 trials Intramuscular quadratus lumborum block1 trials QH10304-BAL-011 trials Combination Agent1 trials AVZO-1031 trials GIGA-5641 trials Fecal microbiota transplantation (FMT)1 trials GC012F (AZD0120)1 trials Irinotecan liposome combined with bevacizumab1 trials NEROFE1 trials Consolidation Therapy with Toripalimab and Surufatinib1 trials Angio-immuno kinase inhibitor1 trials Sutab1 trials Sulfave1 trials Nab-paclitaxel + Epirubicin1 trials L-TIL cells injection1 trials Cetuximab + mFOLFOX61 trials Cetuximab + Envafolimab + mFOLFOXIRI1 trials Post-CR Consolidation Regimens1 trials Pre-Treatment Regimen1 trials Induction Therapy Regimen1 trials Ibrutinib and obinutuzumab1 trials GC203 TIL1 trials DA-4505 + Pembrolizumab1 trials DA-45051 trials Chemotherapeutic drug, ADC or PARP inhibitor1 trials Induction chemotherpay with FOLFOX1 trials Neoadjuvant chemotherapy with mFOLFOXIRI plus bevacizumab1 trials MSC11FCD1 trials GT201 in combination with PD-1 inhibitors1 trials PET/CT ([F-18]FAPI-74)1 trials Cord Blood-derived Expanded Allogeneic Natural Killer Cells1 trials Infusion of CD34 selected hematopoietic stem cells1 trials NHWD-870 HCl1 trials Psilocybin therapy1 trials 6-Mercaptopurine (6-MP)1 trials Hydroxyurea, Hydroxycarbamide1 trials Standard dosages of piperacillin-tazobactam or meropenem1 trials Ruxolitinib Oral Tablet1 trials Neratinib Oral Tablet1 trials Capecitabine monotherapy1 trials WS-CART-CS11 trials Ivosidenib 500mg1 trials CD79b-19 CAR T cells1 trials unrelated umbilical cord blood1 trials DC vaccine subcutaneous administration1 trials Arexvy powder and suspension for injection1 trials Cell infusion1 trials CAR.k.281 trials Adenosine Stress Cardiac Magnetic Resonance Imaging1 trials rhPSMA-7.3 (18F)1 trials RAG-011 trials Osimertinib (Tagrisso®)1 trials MBS3031 trials Cadonilimab combined with SRS1 trials NRC-2694-A1 trials Experimental: COLONYVAQ-CRC + mFOLFOX6 or CAPOX + Nivolumab1 trials 2.59 GBq (70 mCi) of 177Lu-PSMA-EB-011 trials 1.85 GBq (50 mCi) of 177Lu-PSMA-EB-011 trials 1.11 GBq (30 mCi) of 177Lu-PSMA-EB-011 trials YL2111 trials Part B: Safusidenib Erbumine1 trials Part A: Safusidenib Erbumine1 trials Transcatheter Arterial Chemoembolization1 trials Gecacitinib1 trials Afimkibart1 trials Enhertu1 trials BI 7703711 trials Capecitabine Pill1 trials Drugs Cyclophosphamide1 trials Venetoclax, Azacitidine and Homoharringtonine1 trials PIC1 Injection1 trials NTQ2494 tablet1 trials DS-2243a1 trials Zotatifin1 trials LY30234141 trials RC118-ADC1 trials Temozolomide and Radiation Alone1 trials Green Tea Extract1 trials Sintilimab (approved)1 trials Etoposide, Cyclophosphamide, Carboplatin/Cisplatin1 trials Aconite pain oil1 trials CM336_RP2D1 trials CM336_group 91 trials CM336_group 8b1 trials CM336_group 8a1 trials CM336_group 71 trials CM336_group 6b1 trials CM336_group 6a1 trials CM336_group 51 trials CM336_group 4b1 trials CM336_group 4a1 trials CM336_group 3b1 trials CM336_group 3a1 trials CM336_group 2b1 trials CM336_group 2a1 trials CM336_group 11 trials Hypomethylating agent, Azacitidine or Decitabine1 trials Ga-68-DOTATATE1 trials [68Ga]Ga-Sa-DABI-41 trials CX-20511 trials Platinum chemotherapy (cisplatin or carboplatin)1 trials BBO-118181 trials ALETA-0011 trials panitumumab (EGFR inhibitors)1 trials Anlotinib combined with Sintilimab1 trials Tigilanol Tiglate1 trials GM-CSF + Naxitamab1 trials Indoximod1 trials OBT076, a CD205-directed antibody-drug conjugate1 trials Trastuzumab-rezetecan Treatment Group1 trials Purified regulatory T-cells (Treg) plus CD34+ HSPC1 trials HRS-4642+AG+Nimotuzumab1 trials BMS-9861581 trials CC-924801 trials P-BCMA-ALLO1 CAR-T cells1 trials AMG 5091 trials TR1151 trials Cobicistat 150 MG [Tybost]1 trials Allogeneic anti-CD7 CAR-T cells (BEAM-201)1 trials IBI30051 trials ReT01 ACT1 trials Selinexor Tablets1 trials Purinostat Mesylate for Injection1 trials Fluciclovine F181 trials SBRT + atezolizumab and bevacizumab1 trials Four week alternating FOLFOX and FOLFIRI (sFOLFOXIRI)1 trials Topical herbal plaster1 trials CAR19-BCMA dual-target CAR-T1 trials Etodolac1 trials Gadolinium-Chelate1 trials Fucoidan extracted from U. Pinnatifida1 trials Fucoidan extracted from F. Vesiculosus1 trials Armored and GPC3-targeted autologous CAR T-cell1 trials Floxuridine (FUDR)1 trials CAR-NKT Cells treatment1 trials STAT3 Inhibitor WP10661 trials TC-G203 cells treatment1 trials Mycophenolate Mofeti1 trials MPB-17341 trials HAIC-GEMOX+Cadonilimab+Regorafenib1 trials ABT-1011 trials Anlotinib capsules1 trials TQB2868 injection1 trials DD-4A Chemotherapy Regimen1 trials Paclitaxel/Paclitaxel-albumin/Paclitaxel liposome1 trials Amino acid-derived lipids1 trials Fulvestrant 50 Mg/mL Intramuscular Solution1 trials GX1 trials Molgramostim1 trials Clomiphene Citrate and letrozole1 trials NSC-CRAd-S-pk71 trials Darolutamide (BAY 1841788)1 trials Chemotherapy drug of EP regimen1 trials Chemotherapy,Gemcitabine based regimen1 trials Immunotherapy,Toripalimab Injection1 trials Autologous alpha-DC1/TBVA vaccine1 trials VB10.161 trials XL3091 trials BTK Inhibitor1 trials Investigator's Choice of Therapy1 trials RK-5821 trials Ficerafusp alfa1 trials QTORIN 3.9% Rapamycin Anhydrous Gel1 trials Phase II part1 trials Phase I part1 trials bi-4SCAR CD19/22 T cells1 trials IL-22BP mRNA vaccine injection1 trials L19IL2/L19TNF1 trials Docetaxel combined + Trastuzumab +Pertuzumab1 trials variability-based lenvatinib regimen1 trials Carboplatin for Injection1 trials Inqovi1 trials TQB3455 tablet+Azacitidine for Injection1 trials IOV-40011 trials Modafinil1 trials Calaspargase pegol-mknl1 trials T3011 low dose1 trials T3011 middle dose1 trials T3011 high dose1 trials Lymphodepleting Conditioning1 trials SC-1021 trials STM-4161 trials 177Lu-CTR-FAPI therapy1 trials PMD-0261 trials Tumescent local anesthesia1 trials local anesthesia using 2% lidocaine1 trials 8-Chloroadenosine1 trials AK112 with SCRT1 trials AK112 with SCRT and CapeOX1 trials BI 38109441 trials MBS8(1V270) and pembrolizumab combination1 trials MBS8(1V270)1 trials DC05F011 trials DR-02021 trials Therapeutic Estradiol1 trials Fluorine F 18 Fluoro Furanyl Norprogesterone1 trials Neoadjuvant Epigenetic Therapy1 trials VC004 Capsules1 trials Eganelisib in combination with cytarabine1 trials Eganelisib1 trials Phesgo 600 MG / 600 MG / 20,000 UNT in 10 mL Injection1 trials Phesgo 1,200 MG / 600 MG / 30,000 UNT Per 15 ML Injection1 trials QL1706 Combined With Lenvatinib1 trials Photodynamic Therapy1 trials GenSci140 for Injection1 trials Imlygic1 trials TQB3107 Tablets1 trials Tislelizumab plus Huaier granule1 trials Givinostat1 trials Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine1 trials Polatuzumab Vedotin, Rituximab, Lenalidomide1 trials CIML NK1 trials Control Rx1 trials Experimental drug1 trials IFN-γ and CIK cells, Tcm cells or CAR T cells1 trials Onivyde1 trials Pneumonia vaccine1 trials ddEC-ddT1 trials Loratadine + Diosmin-Hesperidin1 trials Diosmin-Hesperidin1 trials three cycles (toripalimab + cetuximab + platinum)1 trials JAK1 Inhibitor1 trials Diphereline1 trials Triprorelin for injection1 trials PEPIDH1M vaccine + vorasidenib1 trials Ladarixin1 trials Adjuvant tislelizumab1 trials Nebivolol 5 mg1 trials 225Ac-FAPI-XT1 trials Combination 21 trials Combination 11 trials JNJ-878014931 trials JNJ-955666921 trials Probenecid1 trials O-15 Radioisotope1 trials FET F-181 trials DARZALEX FASPRO®1 trials QL21091 trials Pembrolizumab (200mg IV for 30 minutes1 trials HYML-1221 trials CS20091 trials APG-2575(Lisaftoclax )1 trials HP518 -Dose Expansion1 trials HP518 - Dose Escalation1 trials Polysaccharide Iron Complex Pill1 trials Iron Isomaltoside 10001 trials Pucotenlimab combined with GP regimen1 trials US- sourced Opdivo®1 trials EU-Opdivo®1 trials MB11 (Proposed Nivolumab Biosimilar)1 trials Divalproex Sodium1 trials JMKX0001971 trials GB18 injection1 trials Relacorilant1 trials Trilaciclib combined with Docetaxel1 trials Tetrathiomolybdate1 trials HM163901 trials Indocyanine Green Solution1 trials psilocybin 1 mg sod1 trials psilocybin 25 mg sod1 trials targeted drug1 trials Oxaliplatin, calcium folinate, 5-fluorouracil1 trials Cisplatin, paclitaxel1 trials sintilimab+metronomic PLOF1 trials Pelcitoclax1 trials Flt3/MerTK Inhibitor MRX-28431 trials Gemcitabine, Vinorelbine, Eribulin, or Utidelone1 trials Cohort 2 (ASCT--ineligible)1 trials BCL regimen1 trials R-CHOP chemotherapy1 trials GNS561 + Trametinib1 trials Human CD19-CD22 Targeted T Cells Injection1 trials XZB-00041 trials Relugolix placebo1 trials HMPL-A2511 trials Decartes-081 trials Thymalfasin (Thymosin alpha 1, Ta1)1 trials ODM-2121 trials Tepotinib plus paclitaxel1 trials ZW1911 trials PSMA-UCAR T (BRL-302)1 trials Mitoxantrone liposome1 trials Bendamustine + Rituximab1 trials Zebetuzumab1 trials Low-dose teclistamab1 trials OFS continues to use group after 5 years use1 trials CRB-601 monoclonal antibody1 trials Tamoxifen 10 MG1 trials Panitumumab IRDye 8001 trials 60 kBq/kg Ac-225 rosopatamab tetraxetan1 trials 55 kBq/kg Ac-225 rosopatamab tetraxetan1 trials 45 kBq/kg Ac-225 rosopatamab tetraxetan1 trials In-111 rosopatamab tetraxetan1 trials 89Zr-TLX250 PET/CT1 trials ADCX-0201 trials Fruquintinib or Regorafenib1 trials AK112 high dose1 trials AK112 low dose1 trials ESO-T011 trials High dose PD-1 mRNA LNP vaccines1 trials Medium dose PD-1 mRNA LNP vaccines1 trials Low Dose PD-1 mRNA LNP Vaccine1 trials Standard of Care Anticancer Therapies1 trials LY42574961 trials JNJ-885499681 trials Artificial Tears Methylcellulose1 trials STK-0121 trials Nirogacestat oral tablet1 trials LY40648091 trials H002 capsule1 trials PTX-1001 trials Fluorodeoxyglucose F181 trials Levonorgestrel-releasing IUD.1 trials Progestin1 trials T-1301 Capsules1 trials HRS-62091 trials HRS-80801 trials Fluvustat1 trials HRS-21891 trials Glufosfamide1 trials GnP1 trials GS1 trials Combination of PTT-936 and anti-PD-1/L1 therapy1 trials PTT-9361 trials Elrantamab1 trials Irinotecan hydrochloride (HCl)1 trials aminolevulinic acid HCL (ALA)1 trials HW2110261 trials BH-302361 trials Autologous Anti-CD83 CAR T-cells1 trials Alpha Lipoic Acid 600 MG Oral Capsule1 trials standard quadruple antiemetic therapy1 trials caramel dyed starch placebo1 trials Bu Zhong Yi Qi Tang1 trials Esomeprazole 40 mg1 trials CL-NK-0011 trials [177Lu]Lu-DOTATATE1 trials Trastuzumab + CAPOX (Capecitabine + Oxaliplatin)1 trials AUR103 Calcium1 trials LY40520311 trials Tisotumab Vedotin1 trials Nab-PE1 trials TQB3002 Tablets1 trials NG2 and DLL3 CAR-T cells1 trials FLOT-CROSS or CROSS-FLOT1 trials ProAgio1 trials TGI-6 Injection1 trials LP-2841 trials PET/CT with 18F-DOPA1 trials eRapa1 trials KH6171 trials Personalized Neoantigen Peptide Vaccine1 trials XKH002 Injection1 trials Irinotecan Liposomal Injection [Onivyde]1 trials Reduced Dose of Chemotherapy and Immunotherapy1 trials Galunisertib plus capecitabine1 trials Albumin paclitaxel+SOX+BEV+ PD-1 monoclonal antibody therapy1 trials GO3061 trials Daunorubicin,Ara-Cytarabine, azacitidine1 trials mitoxantrone liposome, Ara-Cytarabine and azacitidine1 trials tislelizumab, and platinum-based chemotherapy1 trials SHR-8068，adebelizumab and platinum-based chemotherapy1 trials Trifluridine/Tipiracil /Experimental1 trials Ramucirumab /Experimental1 trials nal-IRI /Experimental1 trials IDOV-Immune (oncolytic vaccinia virus)1 trials Lenvatinib plus cadonilimab1 trials Irinotecan liposome (ll) + 5-FU/LV + bevacizumab1 trials SHR-4506 Injection1 trials NBL-0281 trials PF-080325621 trials PD-1 Combined With Pyrotinib1 trials Gemcitabine and cisplatin / carboplatin1 trials SHR-A2102 and Adebrelimab1 trials CL41 trials B1 trials A1 trials Pharmacokinetics blood samples1 trials Osilodrostat 1 MG1 trials ONC206: Dose 21 trials ONC206: Dose 11 trials NW-101C1 trials FG-32461 trials Oncolytic virus VRT1061 trials IM-10211 trials Therapeutic Autologous Dendritic Cells1 trials Pneumococcal 13-valent Conjugate Vaccine1 trials Immunochemotherapy combined with antiangiogenic1 trials Cryoablation1 trials TGW1011 trials CIV chemotherapy1 trials TGI chemotherapy1 trials L-lysine/L-arginine-containing Amino Acid1 trials Actinium Ac 225 DOTATATE RYZ1011 trials DNX-24011 trials Norepinephrine or phenylephrine1 trials PCS6422 and capecitabine1 trials SCG1011 trials MK-56841 trials Eligard1 trials PSW-10251 trials AK109+AK1041 trials JAB-82631 trials TACE with adebrelimab and bevacizumab1 trials SCTB39-11 trials HEC1690961 trials Dalbavancin1 trials Gilteritinib (GILT)1 trials KQ-2002 CAR-T cells （CD19/CD22 CAR T-Cells）1 trials FMT Protocol1 trials engineered red blood cell1 trials KLN-10101 trials Selinexor 20 MG1 trials Ibrutinib, Acalabrutinib, Zanubrutinib1 trials RP2 Monotherapy1 trials Bipolar Androgen Therapy (BAT)1 trials JSKN0221 trials 68Ga-PSMA-11//68Ga-PSMA-6171 trials 68Ga-AAZTA-0931 trials Gilteritinib Oral Tablet1 trials Universal CAR-T cells injection for treating HCC and NSCLC1 trials Recombinant Humanized Bispecific antibody against HER2，KN0261 trials Irinotecan liposome II combination therapy regimen1 trials MK-7075 (miransertib)1 trials Relatilmab1 trials UCT-03-0081 trials Cryoprecipitate1 trials CSL511 Fibrinogen concentrate (human)1 trials Mecapegfilgrastim, day 51 trials Mecapegfilgrastim, day 21 trials HS3871 trials Paclitaxel + Carboplatin + Radiotherapy1 trials Benmelstobart+ Paclitaxel + Carboplatin+ Radiotherapy1 trials ZM0081 trials CR-0011 trials Endoscopic injection of Indocyanine green1 trials arfolitixorin (ARFOX + bevacizumab)1 trials Gleolan1 trials QL1706 combined with Chemotherapy1 trials Tegafur, Gimeracil and Oteracil Potassium Capsules1 trials LM-3021 trials [111In]In-FL-0201 trials Blood samples for PK1 trials [225Ac]Ac-FL-0201 trials Niraparib 100mg Oral Capsule1 trials Prednisone 5mg Tab1 trials Abiraterone Acetate 250mg1 trials Apalutamide 60mg Tab1 trials BiCNU1 trials VI-06091 trials Nipocalimab SC-LIV1 trials SOA1011 trials SHR-32761 trials Standard anti-tumor treatment1 trials BND-351 trials Local anesthesia1 trials Lenalidomide combined with G-CHOP (LO CHOP)1 trials JYP00151 trials CEA-targeted CAR-T (Intrapleural)1 trials CEA-targeted CAR-T (Intravenous)1 trials Golicitinib combined with Pomadomide1 trials RYZ101 Dose Level 31 trials RYZ101 Dose Level 21 trials RYZ101 Dose Level 11 trials LY010151 trials RC148/Bevacizumab+RC88 Combination Therapy1 trials RC148+RC88 Combination Therapy1 trials RC148+RC48 Combination Therapy1 trials RC148+docetaxel Combination Therapy1 trials RC148 Monotherapy1 trials SCTB141 trials HLX371 trials SN301A1 trials monoclonal antibodies GD21 trials CVM-11181 trials Am801 trials 68Ga-DOTA-FAPI1 trials 177Lu-FAP-22861 trials 68Ga-FAP-22861 trials rHSC-DIPGVax1 trials COM5031 trials Lopinavir and Ritonavir Tablets1 trials DB-13111 trials MT-401-OTS1 trials SB171701 trials CD19-BCMA Targeted CAR-T Dose 21 trials CD19-BCMA Targeted CAR-T Dose 11 trials Dabrafenib plus Trametinib1 trials Tucatinib plus Trastuzumab Subcutaneous (SC)1 trials Atezolizumab and Talazoparib1 trials Nivolumab and Ipilimumab1 trials Vemurafenib and Cobimetinib1 trials nab-Palitaxel/Capecitabine/Eribulin Mesylate/Carboplatin1 trials Trilaciclib Injection1 trials Fludarabine and Busulfan1 trials Fludarabine, busulfan and melphalan1 trials BMS-9865171 trials Tiselizumab1 trials AntiPD11 trials 9 cycles of Camrelizumab as adjuvant therapy.1 trials EVM141 trials SC-1011 trials Cohort A1 trials Dositinib mesylate tablets1 trials Cephalexin1 trials mirdametinib and vorinostat1 trials BA13011 trials Cadonilimab combined with cisplatin1 trials GDP1 trials VERT-0021 trials Ketotifen Oral Tablet1 trials PBP1510 (400mg/16mL)1 trials QLS319031 trials Azacitidine (AZA) with Ruxolitinib1 trials BGT007H Cell Injection1 trials GM103 and Pembrolizumab (Part C)1 trials GM103 (Part B)1 trials GM103 (Part A)1 trials Folfiri/Cetuximab1 trials Enoblituzumab1 trials CD20/BCMA-directed CAR-T cells1 trials TC-D101 CAR-T1 trials PF-07220060 300 mg1 trials PF-07220060 100mg1 trials IPH45021 trials Omegaven® (fish oil triglycerides) Injectable Emulsion1 trials Surufatinib Combined With Standard chemotherapy1 trials Fulvestrant Run-In1 trials BAY34982641 trials BG-C90741 trials Camrelizumab combined with chemotherapy1 trials Copper 61-PSMA PET/CT1 trials DZD9008 plus Bevacizumab1 trials solifenacin1 trials GT201 injection in combination with teraplizumab injection1 trials JY232 Injection1 trials Fruquintinib in combination with Sintilimab and CAPEOX1 trials Maintenance first-line treatment plus radiation therapy1 trials Everolimus 5 MG1 trials Lenvatinib and Sintilimab1 trials CD-8011 trials Virus-specific Cytotoxic T-lymphocytes1 trials Palbociclib(100mg)1 trials CAR-T Autologous T cell injection1 trials oxaliplatin-based chemotherapy1 trials pyrotinib,Trastuzumab，carboplatin，Albumin paclitaxel1 trials Furmonertinib 160mg QD plus Chemotherapy1 trials Furmonertinib 240mg QD1 trials Furmonertinib 160mg QD1 trials Eliglustat+Immune checkpoint inhibitor +Regorafenib1 trials Eliglustat+Immune checkpoint inhibitor1 trials Regorafenib+Immune checkpoint inhibitor1 trials Chemotherapy + vitamin D21 trials Partially Engineered T-regulatory Cell Donor Graft TRGFT-2011 trials Herpes virus T3011 injection1 trials QTX30341 trials 5-FU, leucovorin, docetaxel, oxaliplatin (FLOT)1 trials Dydrogesterone Pill1 trials capecitabine + camrelizumab + apatinib1 trials Bortezomib (Velcade®)1 trials Daratumumab SC (Darzalex)1 trials 177Lu-edotreotide1 trials VVD-1332141 trials Tegafur-gimeracil-oteracil potassium1 trials Atezolizumab, Etoposide, Carboplatin, Tarlatamab1 trials EU307 CAR-T Cell1 trials Lutetium Lu 177-PSMA-6171 trials SBRT+PD-1 Inhibitor + Chemotherapy1 trials OC-IgT cells1 trials DNAJB1-PRKACA peptide vaccine1 trials cisplatin or carboplatin + pemetrexed1 trials eftilagimod alfa1 trials HRS-2189 Tablets1 trials HRS-6209 Capsules1 trials Paclitaxel for injection (albumin-bound type)1 trials Fluorethyltyrosine (18-F)1 trials ctDNA analysis1 trials Lenvatinib plus TACE1 trials Lenvatinib, sintilimab plus TACE1 trials SV-1021 trials LN-145-S11 trials 4 cycles of ESA regimen with sandwiched radiotherapy1 trials Blood and bone marrow sample1 trials CS50011 trials Combination 5-azacytidine and nivolumab1 trials Etoposide; Oral, 50 Mg1 trials 64Cu-DOTA-AE1051 trials Trastuzumab combined with Pyrotinib and chemotherapy1 trials EBV-TCR-T Cell Injection1 trials MHB042C for Injection1 trials Irinotecan liposome Capecitabine1 trials Atezolizumab - 21 Day Cycle1 trials Atezolizumab - 28 Day Cycle1 trials STX-07121 trials YH323671 trials Anisodamine1 trials SNV15211 trials ALLR31 trials Nanocrystalline Megestrol Acetate Oral Suspension1 trials Liposomal daunorubicin1 trials Temozolomide 24month1 trials Temozolomide 3 month1 trials Temozolomide 50mg/m2/day1 trials Pravastatin 40 Mg Oral Tablet1 trials JD123 injection1 trials SHR-1316（Adebrelimab）+SHR-A20091 trials Apatinib+ SHR-1316（Adebrelimab）1 trials Apatinib+ SHR-1210（Camrelizumab）1 trials Glioma-related multi-target mRNA vaccines1 trials Autologous BAFFR-targeting CAR T Cells1 trials Alteplase1 trials ASK1200671 trials ASKC2021 trials GT801 Injection1 trials TQB2450 +Androtinib Placebo+Docetaxel1 trials TQB2450 +Anlotinib+Docetaxel1 trials 99mTc-QULIC-5-P11 trials Copper-64 labeled Granzyme B (64Cu-GRIP B)1 trials DCC-30091 trials ADT + Enzalutamide1 trials ADT + Apalutamide1 trials ADT + Abiraterone + Methylprednisolone1 trials ADT + Abiraterone + Prednisone1 trials ADT + Docetaxel +/- prednisone1 trials Degarelix & Relugolix1 trials ADT + Nilutamide, Flutamide, & Bicalutamide1 trials Goserelin, Histrelin, Leuprolide & Triptorelin1 trials Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG)1 trials Idarubicin and Lipiodol1 trials Visugromab 6mg/kg1 trials Visugromab RDE (recommended dose for expansion)1 trials Capecitabine and Neratinib.1 trials IMA402 (Phase II)1 trials IMA402 (Phase Ib)1 trials IMA402 (Phase Ia)1 trials [68Ga]Ga DOTA-5G1 trials BAFF-R CAR-T cells1 trials Urinary sample1 trials Radiprodil1 trials lenvatinib + anti-PD-1 antibodies1 trials Enzalutamide Soft Capsules1 trials Rezvilutamide Tablets1 trials Prizloncabtagene autoleucel (Prizlo-Cel)1 trials Placebo、Chemotherapeutic1 trials SHR-1316、Chemotherapeutic1 trials SHR-1316、Paclitaxel (Albumin Bound)、Carboplatin1 trials high - dose vitamin C1 trials Gallium 68 Dotatate1 trials Adebrelimab combined with the GC regimen and Apatinib1 trials Gadoteridol1 trials Gadoterate meglumine1 trials Gadodiamide1 trials Gadobenate dimeglumine1 trials Gadoxetate disodium1 trials PF-077995441 trials PMC-309 Dose Expansion1 trials PMC-309 monotherapy1 trials Debio 01231 trials BC008-1A1 trials D07001-softgel capsules + Xeloda (or TS-1)1 trials LB-1001 trials ES1021 trials SLV-1541 trials ORB-0211 trials Escalating Doses1 trials albumin paclitaxel, cispatin, tislelizumab1 trials P1101 (Ropeginterferon alfa-2b)1 trials Enzalutamide capsule and Talazoparib capsule1 trials Enzalutamide capsule1 trials Furmonertinib Mesilate Tablets1 trials LCB841 trials Mesenchymal Stem Cell1 trials Liposomal ARA-C1 trials OrcaGraft (Orca-Q)1 trials mFOLFOXIRI plus Cetuximab1 trials Loncastuximab Tesirine (Anti-CD19 Antibody-Drug Conjugate)1 trials BCMA-Targeted Chimeric Antigen Receptor Autologous T-cell1 trials C3 (Metformin, Simvastatin, and Digoxin) only1 trials Gemcitabine and C3 (Metformin, Simvastatin, and Digoxin)1 trials Albumin-Bound Paclitaxel /nab-Paclitaxel1 trials Finolizumab1 trials CART therapy1 trials Induction Carboplatin1 trials OKN43951 trials Institutional standard care1 trials N-Acetyl-Cysteine with Institutional standard care1 trials HTL0039732 Capsules and atezolizumab infusion1 trials HTL0039732 Capsules1 trials PD-1 antibody+ HDAC inhibitor1 trials Docetaxel or cabazitaxel1 trials Etoposide + cisplatin/carboplatin1 trials Blood sample and tissue sample1 trials Bv-NAVD-R, Cycle 1-21 trials Bv-NVD-R, Cycle 1-4 RER1 trials Bv-AVD-R1 trials Bv-NVD-R, Cycle 1-4 SER1 trials Bv-NVD-R, Cycle 1-21 trials Bv-AVD-R 1 and 2: COHORT IIa1 trials AD CP1 trials Pv-Cytarabine/etoposide1 trials MAD CP1 trials Pv-R CYVE-MTX 1 and 21 trials Pv-R CYVE 1 and 21 trials MAD CPR 1 and 21 trials DOC Group C1 trials Pv-R-CYM 1 and 2 Group B1 trials Pv-COMRAD 1 and 2 Group B1 trials DOC Group B1 trials Oxaliplatine1 trials Lacutamab1 trials PE0116&PE01051 trials AK1271 trials VV11 trials High-dose Methotrexate (8 gm/m2; HD-MTX)1 trials TAR-2101 trials Bcl-XL Proteolysis Targeting Chimera DT22161 trials ethinyl estradiol/levonorgestrel1 trials INR102 injection1 trials SK-NK Cell Injection1 trials Carboplatin AUC101 trials Human T Lymphoid Progenitor (HTLP) injection1 trials RGL-3051 trials Polio Boost Immunization1 trials Tetanus Diptheria Vaccine1 trials BDC-41821 trials Belumosudil mesylate1 trials Rimiducid (AP1903)1 trials BPI-4603721 trials C402-CD19-CAR1 trials RO75668021 trials CAR-T cell immunotherapy1 trials 2LVERU® or 2LVERU® JUNIOR1 trials NRT6008 Injection + Systematic chemotherapy1 trials γδ T-PD-1 Ab cells1 trials neoadjuvant anti-PD-1 plus chemotherapy1 trials PPMX-T0031 trials combination of Surufatinib and Envolizumab1 trials Letrozole 2.5Mg Tab1 trials Modified Si Jun Zi Tang1 trials Low intensity therapies1 trials High intensity therapies1 trials chemotherapy + PD-1 inhibitors1 trials JMKX0054251 trials BGB-114171 trials PD1/PDL1 antibody monotherapy, up to 24 weeks1 trials GEN10791 trials Super Hi-TCR-T cells1 trials MASCT-I1 trials Full course of PD-1blockades1 trials Talquetamab and Lenalidomide1 trials Doxorubicin Hydrochloride Liposome+Irinotecan1 trials MT-6011 trials QPOP category 21 trials QPOP category 11 trials XELOX/SOX Chemotherapy Regimen1 trials CAR-T cells therapy1 trials [177Lu]Lu-AKIR0011 trials HER3 Monoclonal antibodies-Dose C1 trials HER3 Monoclonal antibodies-Dose B1 trials HER3 Monoclonal antibodies-Dose A1 trials FRD0011 trials BGB-268081 trials Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy1 trials Ixazomib plus low-dose lenalidomide1 trials Tislelizumab in Combination with Bacillus Calmette-Guérin1 trials Pembrolizumab alone1 trials PRGN-2009 plus Pembrolizumab1 trials Goserelin Microspheres for Injection1 trials PQ2031 trials US-Keytruda®1 trials BAT33061 trials OriV508 Injection1 trials PD-L1 inhibitor combined with apatinib1 trials SOC + TSC-1011 trials SOC + TSC-1001 trials Utidelone Capsule Plus Capecitabine1 trials FCTX-CL19-1 (Tarcidomgen Kimleucel)1 trials tofacitinib 2% cream1 trials Asciminib Adult formulation group1 trials Asciminib Pediatric formulation group1 trials Genetic: MB-1051 trials albuterol nebulizer1 trials TAS-102+bevacizumab+local treatment1 trials Neoadjuvant Chemotherapy Combined with Immunotherapy1 trials DT-70121 trials SY-35051 trials HPV vaccine, Imiquimod, and metformin combination therapy1 trials Ide-cel (bb2121)1 trials AGEN14231 trials EGFR-TKI1 trials Third-generation EGFR-TKI1 trials BRAF inhibitor dabrafenib and MEK inhibitor trametinib1 trials Multitarget Tyrosine Kinase Inhibitors1 trials Florastamin[18F] Injection1 trials EP316701 trials Fludarabine and cyclophosphamide1 trials Cytalux1 trials HLX-15021 trials Intravenous (IV) Etentamig1 trials Subcutaneous (SC) Etentamig1 trials Cohort 2: Bevacizumab1 trials Cohort 2: Atezolizumab1 trials Cohort 1: Atezolizumab1 trials Trimipramine1 trials HDM20201 trials UTAA07 injection1 trials CAR-T cell infusion1 trials Radotinib HCl1 trials TmPSMA-02 CAR T Cells1 trials Adebrelimab + Apatinib1 trials Shenqi Fuwei Mixture Placebo1 trials Shenqi Fuwei Mixture1 trials JNJ-875627611 trials RZ-001 Dose 31 trials RZ-001 Dose 21 trials RZ-001 Dose 11 trials Anticancer Agents1 trials BG-C1371 trials Ramucirumab+ paclitaxel1 trials Sindilizumab1 trials Trifluorouracil tepidopyrimidine1 trials [68Ga]Ga-NOTA-EPCD61 trials [18F]F-RESCA-EPCD61 trials RC48 + Tislelizumab1 trials HLX421 trials Antigen-specific CAR T, CTL and DCvac to treat melanoma.1 trials Cold-stored platelet concentrate1 trials GFS202A injection1 trials PEP081 trials ODC-IL21 trials ABL001/Asciminib1 trials peptide specific dendritic cell1 trials placebo injection level dose 21 trials HPVDC injection level dose 21 trials placebo injection level dose 11 trials HPVDC injection level dose 11 trials Estrogen Receptor Antagonist1 trials CDK4 Inhibitor1 trials BG-752021 trials anlotinib combined with penpulimab1 trials Furmonertinib/Pemetrexed/Carboplatin/Bevacizumab1 trials Furmonertinib/Pemetrexed/Carboplatin1 trials Intramuscular ACM-CpG Monotherapy (Expansion)1 trials Intramuscular ACM-CpG Monotherapy (Escalation)1 trials Screening Platform1 trials VenObi+Ven or VenObi+VenZan1 trials Dimethicone1 trials Dimethicone+Pronase1 trials Seneca Valley Virus-001 (SVV-001)1 trials BMS-9865251 trials AUR1031 trials Ibrutinib 420 mg1 trials Imatinib 400 MG Oral Tablet1 trials VACl Alternating With VACh1 trials VACh1 trials VACl1 trials MDX20041 trials IN10018 in combination with PLD1 trials C2251 trials SG0011 trials Irinotecan Hydrochloride Liposome1 trials CDR4041 trials Penpulimab combined with TP1 trials Cadonilimab combined with TP1 trials Ivonescimab combined with TP1 trials SIBP-A191 trials Sacituzumab Tirumotecan (sac-TMT)1 trials TT-7021 trials Selpercatinib Monotherapy1 trials ACR246 for injection1 trials BP1001-A (Liposomal Grb2 Antisense Oligonucleotide)1 trials Inaticabtagene autoleucel1 trials BI 18311691 trials bi-4SCAR GD2/CD56 T cells1 trials Photo-responsive nanozyme1 trials VG1611 trials dose expansion of SIM0609 in positive other solid tumors1 trials dose expansion of SIM0609 in PDAC cohort1 trials dose expansion of SIM0609 in GC/GEJC cohort1 trials dose expansion of SIM0609 in CRC1 trials SIM0609 for injection1 trials SKB264 Plus Inetetamab1 trials Iberdomide Hydrochloride1 trials Nalbuphine1 trials long-acting Octreotide.1 trials Darolutamide (BAY1841788)1 trials IMC-P115C1 trials Hydroxydaunomycin1 trials [18F]F-PSMA-10071 trials zanubrutinib, rituximab and lenalidomide1 trials chemotherapy treatment called rapid COJEC1 trials chemotherapy treatment called GPOH1 trials IR-1011 trials Succimer1 trials Edetate Calcium Disodium1 trials enpulimab+ Oxaliplatin+Capecitabine1 trials LM-108 injection 600mg + penpulimab1 trials LM-108 injection 10mg/kg +penpulimab1 trials Tislelizumab+Oxaliplatin+Capecitabine1 trials LM-108 injection+Penpulimab+ Oxaliplatin+Capecitabine1 trials BCL-2 inhibitors combined with the HyperCVAD regimen1 trials NEO-8111 trials JNJ-90301900 (NBTXR3)1 trials cis Platinum/Carboplatin, Pemetrexed Disodium1 trials Nivolumab + Relatlimab FDC1 trials 2141-V11 Antibody1 trials Randomization + Blinatumomab + Ponatinib + chemotherapy1 trials Randomization + Blinatumomab + chemotherapy1 trials 18F-rhPSMA-7.31 trials KN0351 trials Double Umbilical Cord Transplant1 trials pioglitazone-metformin1 trials PF-07850327, ARV-471, vepdegestrant1 trials M-CENK1 trials Regorafenib 30 MG Oral Tablet1 trials Folic Acid1 trials ENB0031 trials BA30211 trials BA30111 trials Azacitadine1 trials Targeted and immunotherapy1 trials Coriolus Versicolor Extract1 trials TP+PD1+CCRT1 trials Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin1 trials TILT-1231 trials HHT1 trials MTZ1 trials Pegylated liposomal doxorubicin plus adebrelimab1 trials Ixazomib DX/Lenalidomide DX1 trials Cisplatin (100 mg/m2)1 trials Cisplatin (80 mg/m2)1 trials BMX-0011 trials Rintatolimod1 trials Non-Investigational Antibody-Drug Conjugates (ADC)1 trials 9-valent HPV vaccine, 3 doses standard timing1 trials 9-valent HPV vaccine, 2 doses alternate timing1 trials Epirubicin or Pirarubicin1 trials BM201 injection1 trials Oncolytic Adenovirus Ad5-DNX-24011 trials ICG angiography1 trials Trastuzumab Biosimilar1 trials HRS-8080; Dalpiciclib Isethionate Tablets1 trials Sintilimab combined with Bevacizumab1 trials AGX1011 trials QLS23091 trials Fruquintinib plus camrelizumab and capecitabine1 trials Adrenocorticotropic hormone1 trials SHR-A1912; R-Chemo1 trials Brodalumab1 trials CC>0 - Cisplatin (IP/IV)- Epirubicin (IV)1 trials CC>0 - Carboplatin (IV)- Paclitaxel (IV)1 trials CC0 - Cisplatin (IP) - Epirubicin (IV)1 trials CC0 - Carboplatin (IV) - Paclitaxel (IV)1 trials PEGLyte bowel preparation1 trials dornase alfa i.v. and cisplatin1 trials Nanoliposomal Irinotecan, Oxaliplatin plus Capecitabine1 trials GTB-3601 trials Darzalex Faspro (Daratumumab and hyaluronidase-fihj)1 trials HJ-004-02 tablets1 trials Rutin1 trials Radical concurrent chemoradiotherapy1 trials Nab-paclitaxel, cisplatin and Pembrolizumab combination1 trials Nanoparticle albumin-bound-paclitaxel1 trials Narlumosbart1 trials Anti-CD19/CD20/CD22 CAR T-Cells1 trials GP plus placebo induction therapy1 trials TORIPALIMAB INJECTION (JS001 ) combine with GP chemotherapy1 trials MVX-ONCO-21 trials MMC1 trials AB8211 trials Pembrolizumab Injectable Product1 trials O-(2-[18F]Fluoroethyl)-L-tyrosine, [18F]-FET with PET/MRI1 trials Gamitrinib1 trials Obinutuzumab (G)1 trials fufuquitinib1 trials trifluridine/tipiracil combined with fufuquitinib1 trials AK104 and cetuximab or bevacizumab and FOLFIRI1 trials Revlimid (lenalidomide)1 trials ERAS-6011 trials 18-FDG1 trials 68Ga-TATE-RGD1 trials Human BCMA targeted CAR-NK cells injection1 trials Stem Cell Mobilization Therapy1 trials Hematopoietic Cell Transplantation Conditioning Regimen1 trials Standard of care first-line systemic therapy1 trials BIO-1061 trials INP121 trials The fourth dose1 trials The third dose1 trials Second dose1 trials First dose1 trials Standard of care drug1 trials 18F-rhPSMA-7.3 (Posluma)1 trials Ficlatuzumab1 trials Gardasil91 trials Standard-Dose Interval Immunotherapy1 trials Extended-Dose Interval Immunotherapy1 trials Sirolimus Pill1 trials Bone Marrow Cell Transplant1 trials Allopurinol 300 MG1 trials Peripheral Blood Stem Cell Transplant1 trials SoC chemotherapy treatment 21 trials SoC chemotherapy treatment 11 trials BNT3141 trials Sapu0031 trials Donor Leukocyte Infusion (DLI)1 trials Interferon gamma-1b1 trials abiraterone acetate with prednisone1 trials Tinengotinib1 trials Chemo-light Maintenance 21 trials Reinduction-2 omission1 trials SHR-1316 (sc) Injection1 trials TAS-102, oxaliplatin, irinotecan with bevacizumab1 trials ATG-0221 trials TQB3122 Capsules1 trials [ 161 Tb]Tb PSMA I&T1 trials Pembrolizumab/Olaparib1 trials Naive HBI0101 CAR-T1 trials JNJ-954374461 trials Doxorubicin (Adriamycin)1 trials RC2201 trials MB-CART19.1 Cellular Therapy1 trials Neoantigen-based DC immune preparation1 trials Oral Arsenic Trioxide Formulation1 trials UCMYM802 Injection1 trials Brentuximab Vedotin 50 MG [Adcetris]1 trials Discontinuation of the anti-HER2 maintenance therapy1 trials QLS1304 tablet+Fulvestrant，AI or QLC1401+CDK4/6i1 trials QLS1304 tablet+Fulvestrant or QLC14011 trials SCR-6920 capsule1 trials HRS-2329 Tablet1 trials Pre-operative chemotherapy1 trials Neoantigen mRNA Vaccine1 trials ACT0011 trials IN10018 in combination with D-15531 trials 61Cu-NODAGA-LM31 trials NB004 tablets1 trials CS2312951 trials IMGN1511 trials fluzopanib and bevacizumab1 trials IPN011951 trials Mozobil (TM)1 trials phase II1 trials Dose Expansion31 trials Dose Expansion21 trials Dose Expansion11 trials Dose Escalation1 trials Association of ADT and EBRT1 trials Association of darolutamide and EBRT1 trials Daratumumab/daratumumab and hyaluronidase-fihj1 trials Rabbit Anti-Human T-Lymphocyte Immunoglobulin (ATLG)1 trials Bexarotene1 trials CIML-NK cell therapy1 trials Atezolizumb1 trials Blinatumomab and Inotuzumab Ozogamicin1 trials NP-G2-044 Combination therapy1 trials Anti-PD-1 Therapy1 trials NP-G2-044 Monotherapy1 trials RAD301 ([68Ga]-RAD301)1 trials LMV-12(HE003)1 trials Durvalumab (Cohort 4/5)1 trials Bacillus Calmette-Guérin (BCG)1 trials Durvalumab (Cohort 1-3)1 trials Epstein-Barr Virus Specific T-Lymphocytes1 trials Cytomegalovirus Specific T-Lymphocytes1 trials Adenovirus Specific T- Lymphocytes1 trials HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate1 trials Anlotinib plus the new Immune Checkpoint Inhibitors.1 trials Anlotinib plus the same Immune Checkpoint Inhibitors.1 trials Capivasertib plus Docetaxel1 trials Niraparib plus Abiraterone acetate plus Prednisone1 trials Radium Chloride Ra-2231 trials Docetaxel Injectable Solution1 trials Cabazitaxel 60 mg Solution for Injection1 trials Abiraterone Oral Tablet1 trials Enzalutamide Oral Capsule1 trials Eliglustat, CD30 target immunotherapy1 trials CD180 CART1 trials Spedox-61 trials TC-N201 cells1 trials BI 764532, dose 21 trials BI 764532, dose 11 trials ARV-3931 trials Vorbipiprant1 trials CAPOX (oxaliplatin/capecitabine)1 trials JNJ-871894011 trials Pomalidomide plus R-ICE1 trials Tofacitinib plus R-ICE1 trials Chidamide plus R-ICE1 trials Decitabine plus R-ICE1 trials Zanubrutinib plus R-ICE1 trials Fenofibric acid1 trials Pembrolizumab + Cisplatin/Carboplatin + 5-FU1 trials Tocilizumab Injectable Product1 trials CD22 CAR T cells1 trials CD19 CAR T-cell1 trials TIP treatment (paclitaxel/ifosfamide/cisplatin)1 trials RhPDGF-BB1 trials Injection of 18F-FDG1 trials Injection of 68Ga-FL-0311 trials TOLINAPANT (ASTX660)1 trials Tumor Infiltrating Lymphocytes1 trials Pembrolizumab+Carboplatin+albumin-bound paclitaxel:2 courses1 trials Pembrolizumab+Carboplatin+albumin-bound paclitaxel:4 courses1 trials 125gm HDAA1 trials 100gm HDAA1 trials 75gm HDAA1 trials Ibrutinib and Thalidomide1 trials BR and Ibrutinib1 trials FCR and Ibrutinib1 trials CDH17 CAR-T1 trials XTX3011 trials CJRB-1011 trials MT-304 + Nivolumab1 trials MT-3041 trials ECT-001-CB1 trials CAR-BCMA1 trials Pyridostigmine Bromide 5 MG/ML1 trials Bridion 200 MG in 2 ML Injection1 trials Leflunomide Pill1 trials Biological NILK-23011 trials Nab-paclitaxel and Cisplatin1 trials IN10018（Ifebemtinib）1 trials D15531 trials Interferon gamma1 trials Tumor necrosis factor alpha1 trials VIR-55251 trials D3S-0011 trials AUR1051 trials blood samples collection1 trials blood plasma sample1 trials Fusion-VAC-XS151 trials liposomal mitoxantrone1 trials T-DXd 5.4 mg/kg, IVD, 1 cycle every 21 days.1 trials HG3811 trials IPG72361 trials LV20.19 CAR T cells1 trials Autologous or Allogeneic tumor cells1 trials LVIVO-TaVec100 product1 trials immunity therapy1 trials TQB2210 Injection1 trials HR+ HER2 breast cancer1 trials ESK9811 trials TQB2101 for Injection1 trials MAGNOLIA-trial: conventional chemotherapy (AraC+DNR)+GO1 trials TL-8951 trials FS-8002 injection1 trials Beta-Adrenergic Antagonist1 trials Nanocrystalline Megestrol Acetate1 trials REGN105971 trials SOT2011 trials venetoclax combining chidamide and azacitidine (VCA)1 trials Camrelizumab+chemotherapy1 trials AK129(RP2D)1 trials AK129(dose 2)1 trials AK129(dose 1)1 trials GX-I71 trials SL-T101 trials Gemcitabine, albumin-bound paclitaxel, S-11 trials ALTA26181 trials T-Dxd(Trastuzmab deruxtecan), Ramucirumab1 trials ICG-Cisplatin Nanoprobe (NIR-II NanoM)1 trials Carilizumab and Apatinib1 trials PD-1 inhibitor, Venetoclax, Decitabine, Azacytidine1 trials IDE8921 trials Danvatirsen1 trials BITE and DLI1 trials Nivolumab and Relatlimab1 trials Elranatamab-bcmm1 trials SKB107 for injection1 trials Low dose doxorubicin1 trials SC-CAR.GPC3xIL15.21 CAR T cells1 trials B group Purinostat Mesylate 15mg/m21 trials B group Purinostat Mesylate 11.2mg/m21 trials B group Purinostat Mesylate 8.4 mg/m21 trials B group Purinostat Mesylate 6 mg/m21 trials A group Purinostat Mesylate 15 mg/m21 trials A group Purinostat Mesylate 11.2mg/m21 trials A group Purinostat Mesylate 8.4mg/m21 trials A group Purinostat Mesylate 6mg/m21 trials A0/B0 group Purinostat Mesylate 15mg/m21 trials A0/B0 group Purinostat Mesylate 11.2mg/m21 trials AUBE001 trials HSK465751 trials Interferon1 trials JNJ-898621751 trials HW071021 Tablets1 trials Peptide Alarm Therapy (PAT)1 trials BB-17051 trials UTAA09 injection1 trials SMS0011 trials Glutaminase-1 Inhibitor IACS-62741 trials Autologous Natural Killer Cell Therapy1 trials QH103 Cell Injection1 trials Multiple cardiovascular drugs related to "Golden Triangle"1 trials TK216+Vincristin1 trials Trabectedin 0.25 MG/1 VIAL Intravenous Powder for Solution1 trials Nivolumab IV Soln 100 MG/10ML1 trials Abiraterone Acetate Tablets 500 mg1 trials Oxycodone oral capsule 15 mg1 trials carboplatin (Cb)1 trials docetaxel (T)1 trials pertuzumab (P)1 trials trastuzumab (H)1 trials CM46201 trials Dose-dense regimen1 trials BEP Protocol1 trials NST-6281 trials Theanine1 trials hepatic arterial infusion chemotherapy (HAIC)1 trials Belantamab mafodotin 1.0 mg/kg (12 weeks)1 trials Belantamab mafodotin 1.9 mg/kg (12 weeks)1 trials Belantamab mafodotin 1.4 mg/kg (12 weeks)1 trials Belantamab mafodotin 1.9 mg/kg (8 weeks)1 trials Belantamab mafodotin 2.5 mg/kg (8 weeks)1 trials Postoperative EGFR-TKI Therapy1 trials Usual Practices1 trials Orelabrutinib in combination with rituximab1 trials Inetetamab Combined With Pyrotinib and Vinorelbine1 trials Efgartigimod PH20 SC1 trials Cabazitaxel and carboplatin1 trials G2071 trials Copper Cu 64 Anti-CEA Monoclonal Antibody M5A1 trials Consolidation durvalumab1 trials Fixed neoantigen tumor vaccine1 trials IDE1611 trials IDE8491 trials EBX-1021 trials 89Zr-daratumumab PET/CT1 trials CL-NK-0031 trials DVRd1 trials Autologous Tolerogenic Dendritic cells1 trials aerosolized vancomycin1 trials aerosolized aztreonam1 trials Tripegfilgrastim1 trials MTX/ARA-C1 trials Mini-CVD1 trials Capecitabine combined with Pyrotinib1 trials Fulvestrant combined with Pyrotinib1 trials FOLF+B1 trials CD5-targeted CAR-T cells1 trials FLT PET/CT1 trials pTVG-AR1 trials Ipilimumab 1mg/kg and nivolumab 3mg/kg1 trials Nivolumab 480mg and relatlimab 160mg1 trials Ipilimumab 1mg/kg Nivolumab 480mg and relatlimab 160mg1 trials Ipilimumab 3mg/kg and nivolumab 1mg/kg1 trials AST2303 Tablets(ABK3376 Tablets) ，125mg1 trials AST2303 Tablets(ABK3376 Tablets) ，100mg1 trials AST2303 Tablets(ABK3376 Tablets) ，75mg1 trials AST2303 Tablets(ABK3376 Tablets) ，50mg1 trials AST2303 Tablets(ABK3376 Tablets) ，25mg1 trials LY41011741 trials [177Lu]Lu-SN2011 trials MPB-2043 of 3.0 mg/kg1 trials MPB-2043 of 2.0 mg/kg1 trials MPB-2043 of 1.0 mg/kg1 trials MPB-2043 of 0.5 mg/kg1 trials CAR-T cells Infusion1 trials SHR-7367 Injection1 trials Capecitabine/Eribulin/Gemcitabine/Paclitaxel/Nab-paclitaxel1 trials EGL-0011 trials AB0011 trials PD-1/PD-L1 monoclonal antibodies1 trials Pemetrexed 500 mg/m^21 trials Pembrolizumab 200 mg Q3W1 trials Matching placebo for visugromab1 trials Visugromab1 trials Signifor1 trials AdHER2DC vaccine1 trials TQB2934 injection (subcutaneous injection)1 trials Iscador*P1 trials EU-sourced Keytruda®1 trials MB12 (Proposed Pembrolizumab Biosimilar)1 trials Abiraterone + Prednisolone/Prednisone1 trials Immune checkpoint inhibitors plus Iscador® Qu.1 trials CAR20(NAP)-T1 trials Darolutamide Oral Tablet1 trials Abiraterone acetate tablets1 trials Enzalutamide Oral Tablet1 trials Apalutamide Oral Tablet1 trials GPBMC infusion1 trials Idarubicin（IDA）1 trials lidocaine infusion1 trials spinal analgesia with morphine and bupivacaine1 trials Regorafenib Pill1 trials TAS-102 pill1 trials TATE and pembrolizumab1 trials BHV-15301 trials PD1+ TILs (NUMARZU-001) product infusion1 trials Platinum/pemetrexed based chemotherapy1 trials Dendritic cell vaccination1 trials HMPL-5061 trials PD-L1/PD-1 inhibitor and chemotherapy1 trials Hibiscus Sabdariffa1 trials CC-2201 trials Anti-Thymocyte Globulin1 trials Allogeneic Natural Killer Cell Line NK-921 trials Gemcitabine + cisplatin Or carboplatin1 trials BT80091 trials Standard chemotherapy regimen1 trials Cetuximab and irinotecan1 trials AT101(Anti-CD19 Chimeric Antigen Receptor T cell)1 trials Gonadotropin-releasing hormone agonist1 trials NI-1801 in combination with paclitaxel1 trials NI-1801 in combination with anti-PD1 (Pembrolizumab)1 trials Biological NI-18011 trials Oxybutynin1 trials PSMA PET/MR - Gallium-68 labeled PSMA-HBED-CC1 trials ATM Kinase Inhibitor AZD13901 trials C-CAR0881 trials MAQ-0011 trials Regorafenib Tablets1 trials AST-34241 trials durvalumab, tremelimumab, bevacizumab1 trials DeepTag-GPRC5D Targeted CAR T-cells1 trials 68Ga-AAZTA-NI-0931 trials YL202 for injection; Furmonertinib Mesilate Tablets1 trials YL202 for injection; Toripalimab injection1 trials Adalimumab (Humira) 100 mg/mL1 trials Adalimumab (BCD-057) 50 mg/mL1 trials Adalimumab (BCD-057) 100 mg/mL1 trials Fentanyl Citrate1 trials Oral dabrafenib and trametinib1 trials mimic capsules1 trials Xinlikang capsules1 trials SHR-A2009; SHR-13161 trials HRS-8080; SHR-A20091 trials HRS-8080; SHR-A18111 trials CM518D11 trials IMC-0011 trials Pembrolizumab IV infusion Q3W, with daily oral Olaparib.1 trials ADP adoptive cell therapy1 trials TQB2102 for injection combined with Benmelstobart injection1 trials STX-721/PFL-721 (RP2D)1 trials STX-721/PFL-721 (3 dose levels)1 trials STX-721/PFL-721 (Escalated)1 trials Trastuzumab/Hyaluronidase-oysk1 trials Hyaluronidase-zzxf/Pertuzumab/Trastuzumab1 trials TQB2922 injection (subcutaneous injection)1 trials LM1011 trials EP1021 trials FDA022-BB051 trials CLDN6 uRNA-LPX/CLDN6 modRNA-LPX1 trials CLDN6 CAR-T1 trials Leucovorin/levofolinate calcium1 trials FLOT combined with toripalimab1 trials DC1 native/mutated ESR11 trials Combination of ASWD and DOXIL1 trials Ashwagandha1 trials Withaferin A1 trials Linperlisib and chidamide1 trials 81-mg aspirin twice daily1 trials 81-mg aspirin once daily1 trials SYS6020 injection1 trials GH2616 Tablets1 trials Topical 0.005% calcipotriol ointment1 trials Topical 5% fluorouracil cream1 trials CCS14771 trials IN10018 in combination with RNK089541 trials Dalcilib+letrozole+HP treatment group1 trials Claudin18.2-targeted CAR-DCs1 trials Pancreatic neuroendocrine tumor1 trials Pancreatic adenocarcinoma1 trials Hepatocellular carcinoma1 trials BG-750981 trials azactidine1 trials Induction chemoimmunotherapy1 trials BMS-9860161 trials Gemcitabine combined with carboplatin plus placebo1 trials Gemcitabine and carboplatin plus antibiotic (moxifloxacin)1 trials Spermidine simulants1 trials Spermidine1 trials Tucatinib 150 MG1 trials 177Lu-NRT6020 Injection (stage 3)1 trials 177Lu-NRT6020 Injection (stage 2)1 trials Vaccine Therapy1 trials Elritercept1 trials Pazopanib Oral Tablet1 trials GenSci128 tablets1 trials BL-B01D1 for Injection1 trials estazolam 1-2 mg1 trials 7.40 GBq (200 mCi) of 177Lu-JH041 trials 5.55 GBq (150 mCi) of 177Lu-JH041 trials 3.70 GBq (100 mCi) of 177Lu-JH041 trials Tislelizumab, Carboplatin /Cisplatin, Etoposide1 trials LG0021 trials Enoxaparin, warfarrin, or apixaban1 trials Venetoclax 4001 trials HRS-6209 in Combination with HRS-80801 trials HRS-6209 in Combination with Letrozole1 trials HRS-6209 in Combination with HRS-13581 trials HRS-6209 in Combination with Fulvestrant1 trials irinotecan liposomes+capecitabine1 trials Anti-PD-1 antibody drug named Serplulimab1 trials Apple Cider Vinegar1 trials Chemotherapy （Albumin bound paclitaxel and Carboplatin）1 trials Standard ADT treatment1 trials EMB071 trials Zirconium Zr 89-Df-Crefmirlimab1 trials Immunotherapy (ipilimumab and nivolumab)1 trials Immunotherapy (nivolumab and relatlimab)1 trials Chemotherapy (dacarbazine or temozolomide)1 trials LNS88011 trials XNW5004 placebo; Chidamide1 trials XNW5004 ; Chidamide placebo1 trials aza-TdC1 trials Pembrolizumab - anti-PD-1 antibody1 trials Photosensitizer1 trials AC6761 trials IBI30031 trials 68-Ga PSMA111 trials Semaglutide Injectable Product (Wegovy and/or Ozempic)1 trials Part C: OSE-279 600 mg - HLA-A2 negative1 trials Part C: OSE-279 600 mg - HLA-A2 positif1 trials Part C: OSE-279 600 mg and OSE2101 - HLA-A2 positive1 trials Part B: OSE-279 600 mg and OSE21011 trials Part A: OSE-279 600mg1 trials Part A: OSE-279 300mg1 trials Part A: OSE-279 100mg1 trials Zipalertinib Matching-placebo1 trials Paclitaxel+Cisplatin(Concurrent Chemoradiotherapy)1 trials Paclitaxel+Cisplatin (Neoadjuvant Chemotherapy)1 trials NB02 (Poseltinib)1 trials Palliative Chemotherapy1 trials oxaliplatin , fluorouracil, and leucovorin1 trials Rituximab, ibrutinib1 trials Dexamethasone, cyclophosphamide, rituximab1 trials O6-benzylguanine1 trials P140K-MGMT1 trials BBO-102031 trials Autologous Tumor Membrane Vesicles Vaccine1 trials RO75021751 trials Anitocabtagene Autoleucel1 trials Prospidelong1 trials [68Ga]N1881 trials ²¹²Pb-DOTAM-GRPR11 trials Pemetrexed+ (carboplatin or cisplatin)1 trials KTE-X191 trials HSV-tk +Valacyclovir in Combination with Brachytherapy1 trials RD13-02 cell infusion1 trials Aescuven1 trials Daphnetin1 trials DKF-MA1021 trials Standard Medical Therapy1 trials Novobiocin Sodium1 trials hematologic malignancy1 trials PTX-9908 Injection1 trials 68Ga-Her2-affibody1 trials Allo-RevCAR01-T1 trials R-TM1231 trials ABBV-9691 trials BCA1011 trials CAR.5/IL15-transduced CB-NK cells1 trials Administration of CC-31 trials patients received D-COP regimen chemotherapy1 trials CAR-NK1 trials PRRT with 177Lu-DOTATATE1 trials Allogeneic CART-NKG2D cells1 trials Autologous CD19/CD22 CAR T cells1 trials MBF-RIC1 trials Radioiodine1 trials L-Ornithine L-Aspartate1 trials Lutetium (177Lu) vipivotide tetraxetan1 trials AL588051 trials Imiquimod Topical1 trials Autologous CCR4 CAR T cells1 trials Xenon MRI1 trials VEN + DEC1 trials APVO4361 trials 5 FU continuous1 trials Oxaliplatin intra-arteriel1 trials 5 FU bolus1 trials Oxaliplatin intravenous1 trials Accelerated partial breast irradiation1 trials Tislelizumab (i.v. 200mg)1 trials Futibatinib orally administered1 trials Adbelimumab, Albumin paclitaxel, Carboplatin, Apatinib1 trials Xospata1 trials AzaCITIDine Oral Tablet1 trials Adebrelimab + GEMOX + TKI1 trials HSK419591 trials Sham Comparator1 trials Bupivacaine-Epinephrine 0.5%-1:200,000 Injectable Solution1 trials Nab-paclitaxel/Paclitaxel1 trials Lenvatinib 10 mg1 trials YCJ-01 Full Spectrum cannbis Extract1 trials Ivonescimab（AK112，a PD-1/VEGF bispecific antibody）1 trials Epirubicin combined with docetaxel1 trials Albumin-bound paclitaxel combined with carboplatin1 trials NV-0011 trials SHR-1701 Injection1 trials SHR-A1904 Injection1 trials VIP943 (BIW)1 trials VIP943 (QW)1 trials Synthetic long peptide personalized cancer vaccine1 trials Vitamin C1 trials Vitamin B12B1 trials [212Pb]VMT011 trials [203Pb]VMT011 trials ADT + NHT1 trials ADT + NHT + Docetaxel1 trials Epidiolex 100 mg/mL Oral Solution1 trials Mifepristone1 trials Alintegimod1 trials NRG-1031 trials Intraoperative Injection of Carbon Nanoparticles1 trials Preoperative Injection of Carbon Nanoparticles1 trials MGC026 Dose for Expansion1 trials MGC026 Dose Escalation1 trials orelabrutinib combined with rituximab regimen1 trials Clifutinib Besylate1 trials HLD-09151 trials Zuberitamab1 trials Sitagliptin+BeiDouGen1 trials BeiDouGen1 trials Pembrolizumab (PD-1 Blocking Antibody)1 trials Chemotherapy Prior to RAPA-201 Therapy1 trials RAPA-201 Rapamycin Resistant T Cells1 trials ATG Combined with Tacrolimus and Mini Methotrexate1 trials Tropisetron1 trials Fosaprepitant1 trials debry single antibody + VEX metronomic chemotherapy1 trials CHT1021 trials ABSK1311 trials CHOP Plus Famotidine1 trials CHOP Plus Lanzoprazole1 trials NHS-IL121 trials BC2027 for Injection1 trials 177Lu-RAD2021 trials hNeo-T1 trials therapeutic tumor vaccine1 trials Recombinant Human Interleukin-2 Injections1 trials Losartan 25 milligram capsule1 trials Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET1 trials Fluoruracil1 trials Diphencyprone (DPCP)1 trials Liposomal doxorubicin containing regimen1 trials docetaxel, cisplatin and 5-fluorouracil1 trials ERAS-4001 in combination1 trials ERAS-40011 trials Rivoceranib (Apatinib)1 trials Hyperpolarized 13-C-pyruvate1 trials IO102-1031 trials locally manufactured adoptive cellular therapy (ACT) product1 trials Observational Assessment of Standard R-CHOP Treatment1 trials Iptilimumab1 trials DFP-149271 trials TCC1727 tablet（2）1 trials TCC1727 tablet（1）1 trials PRL-02 injection1 trials ADCE-T021 trials Ribociclib Oral Tablet1 trials CD33 CAR T-cells1 trials U-13C-glucose1 trials LV009 Injection Infusion1 trials NabPE1 trials Monotherapy, Dose-reduced (75%)1 trials Monotherapy, Standard Dose (100%)1 trials Doublet Chemotherapy, Dose-reduced (75%)1 trials Doublet Chemotherapy, Standard Dose (100%)1 trials Chimeric antigen receptor modified T cells Infusion1 trials 3HP-28271 trials Rosiglitazone1 trials MGC0281 trials Metronomic capecitabine group1 trials Anti-HER2/HER3 Dendritic Cell Vaccine1 trials Ziconotide [Prialt]1 trials Pembrolizumab with Optional Crossover Period1 trials Lifileucel plus Pembrolizumab1 trials Efbemalenograstim Alfa1 trials Chidamide Maintenance1 trials Docetaxel+ carboplatin+ trastuzumab + patuzumab1 trials Nab-paclitaxel+ trastuzumab+ patuzumab1 trials endocrine therapy and trastuzumab1 trials capecitabine and trastuzumab1 trials 177Lu-TLX5911 trials DR303031 trials ASG-22CE1 trials Zelenectide pevedotin1 trials 3 cycles of EP1 trials Carboplatin AUC71 trials ALTA32631 trials TIL therapy1 trials Gemcitabine and nab-paclitaxel1 trials Pelareorep1 trials Arm III Pembrolizumab1 trials Arm II Carboplatin, Paclitaxel, Cetuximab1 trials Arm I Carboplatin, Paclitaxel, Pembrolizumab1 trials Liso-cel1 trials Procarbazine1 trials SLOG chemotherapy1 trials SLOG + Allogeneic NK cell1 trials 3H-100001 trials Guadecitabine1 trials JS0071 trials Vancomycin and Gentamicin1 trials EP00421 trials GD2-CAR-T cell1 trials CS235461 trials BC001+Sintilimab+XELOX1 trials Givastomig1 trials FORX-4281 trials SDX-73201 trials Cell therapy with bispecific antibodies1 trials LM-350 for injection1 trials Paltusotine1 trials Tislelizumab+liposomal doxorubicin+ifosfamide1 trials AB1541 trials TAS-1151 trials TAS-1161 trials AB1221 trials Namenda1 trials ASCT+CD7-CART1 trials lenalinomide1 trials OnLife®1 trials HER2 Vaccine1 trials Anti-CDH17 CAR-T cells infusion1 trials Combination Drug Therapy1 trials Fluorouracil (5FU)1 trials testosterone 1.62% gel1 trials WEF-0011 trials Tumor antigen-sensitized DC vaccine1 trials Evexomostat1 trials Maribavir1 trials Nucleotide Analogues1 trials Peg-IFNα-2b combined with NA1 trials Senl-T71 trials SHR-3792 Injection1 trials Ataluren + Pembrolizumab1 trials Pemetrexed, Cisplatin, Bevacizumab Plus Pembrolizumab1 trials HAIC of FOLFOX1 trials Recombinant Human Adenovirus Type 51 trials 68Ga-XT7711 trials 111In-ETN0291 trials 225Ac-ETN0291 trials Chidamide Tablets combined with AK1121 trials XC1 trials Placebo of IN100181 trials Concomitant chemotherapy (Capecitabin + Mitomycin-C)1 trials induction chemotherapy (mDCF)1 trials M03241 trials Anti-STEAP1 CAR T-cells1 trials Oral HS-105161 trials LEU0111 trials Dendritic Cell (DC) Vaccine1 trials Serplulimab immunotherapy1 trials Targeted therapy with bevacizumab1 trials Lenvatinib mesylate capsules1 trials Pico-Salax1 trials Fleet Enema1 trials Blinatumomab Injection [Blincyto]1 trials NEPA1 trials Recombinant Human Papillomavirus Nonavalent Vaccine1 trials HPV16 RG1 VLP Vaccine1 trials Metformin with Semaglutide1 trials SHR-4849、SHR-1316、SHR-8068、BP102、carboplatin、cisplatin1 trials Targeted drugs1 trials PD-1 and PD-L1 inhibitor1 trials BG-C4771 trials Carbetocin (Intramyometrial Injection)1 trials Methylergometrine (Intramyometrial Injection)1 trials miR-126 Inhibitor miRisten1 trials bone marrow sample1 trials ENI using IMRT with or without chemotherapy1 trials Trastuzumab+ chemotherapy1 trials TQB2930+ chemotherapy1 trials SHR-43751 trials High-Dose Insulin Therapy1 trials anito-cel1 trials Cisplatinum1 trials OPT-8211 trials Vincristine Sulfate Liposome1 trials tocopherol1 trials Pirfenidoneone1 trials ketoprofen1 trials Pravastatin (drug)1 trials Anastrozole 1mg1 trials Three-cycle induction chemotherapy + immunotherapy1 trials Two-cycle induction chemotherapy + immunotherapy1 trials Osimertinib Third-Line1 trials Platinum + Pemetrexed Chemotherapy Second-Line1 trials Osimertinib First-Line1 trials Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA]1 trials Zoledronic Acid 4 MG/100 ML Intravenous Solution [ZOMETA]1 trials memory-like natural killer cells1 trials Rabbit Anti thymocyte globulin1 trials NP-1011 trials Preoperative chemotherapy1 trials 68GaNOTA-Anti-MMR-VHH21 trials Hexaminolevulinate hydrochloride (HCL)1 trials EGFR/B7H3 CAR-T1 trials Standard of care (Fruquintinib)1 trials Standard of Care (Trifluridine/Tipiracil-Bevacizumab)1 trials Testosterone + Anastrazole1 trials Anastrazole1 trials Fluorothymidine F-181 trials SIM05001 trials Golidocitinib plus CHOP1 trials BC31951 trials CB-03-101 trials MB-CART20.11 trials EG-70 (phase 2)1 trials EG-70 (phase 1)1 trials Efineptakin alfa1 trials PD-L1 t-haNK cells1 trials BiTE-EV1 trials Microneedle Array Doxorubicin (MNA-D)1 trials NKT39641 trials Superparamagnetic Iron Oxide1 trials TQB3616 capsule1 trials TQB2930 for injection1 trials Ketamine Injectable Solution1 trials Lidocaine IV1 trials cCTL treatment1 trials blood and intestinal biopsy sampling1 trials LK101 injection1 trials Neoadjuvant chemoradiotherapy based on irinotecan1 trials immunization1 trials DL51 trials DL41 trials DL31 trials DL21 trials Dose level (DL)11 trials KM11 trials Pembrolizuma1 trials IO102-IO1031 trials Follow-Up Monitoring Parameters1 trials 18F-Fluoro Dopa PET/MRI Imaging1 trials Levocarnitine1 trials DRC1 trials Venetoclax; Rituximab1 trials TD0011 trials CD38-SADA:177Lu-DOTA Complex1 trials Placebo combined with androgen deprivation therapy1 trials TRX1031 trials AP2031 trials DCSZ111 trials BMS-9864601 trials [14C]-AZD5305 (therapeutic dose)1 trials [14C]-AZD5305 microtracer1 trials CMAB0171 trials INT230-61 trials CY1 trials FT5361 trials T3P-Y058-739 (IT)1 trials T3P-Y058-739 (IV)1 trials Pembrolizumab+T3P-Y058-7391 trials Eflapegrastim1 trials Chemotherapy, anti-targeted agents and immunotherapy1 trials EBV immunological agent1 trials Surufatinib Administration1 trials CA19-9-targeting monoclonal antibody1 trials BNT3291 trials Q9011 trials GNC-0351 trials DB107-RRV1 trials Dual-targeting HER2 and PD-L1 CAR-T cells1 trials Fuzhengquye Fang Recipe simulant1 trials Fuzheng Quxie Recipe1 trials cadonilimab，bevacizumab，docetaxel1 trials ALK2011 trials uCD7 CART1 trials Zanubrutinib+Pola-R-CHP1 trials Doxorubicin Hydrochloride [HCl]1 trials DZD8586+BR1 trials DZD8586+R-GemOx1 trials DZD8586+R-CHOP1 trials Eltanexor1 trials LYL3141 trials JNJ-877049161 trials mRNA-28081 trials Irinotecan and temozolomide1 trials Antibody-Drug Conjugate Therapy1 trials CM350 group31 trials CM350 group21 trials CM350 group11 trials RE002 T cell1 trials ADI-PEG 201 trials VT10211 trials VAL-0831 trials Injection of humanized nerve growth factor (NGF) antibody1 trials CTX-7121 trials standard-dose HHT1 trials Reduced-dose HHT1 trials BGT007H Injection1 trials Lipo-MIT combination regimen1 trials Invivo CAR-T1 trials Olutasidenib + TMZ1 trials [68Ga] B7H3 Affibody-BCH1 trials Vancomycin powder1 trials HB-2021 trials HB-2011 trials Nab-paclitaxel + Capecitabine1 trials Recombinant Human Adenovirus 5 Injection1 trials Moisturizer1 trials Estrogen + probiotics1 trials dehydroepiandrosterone1 trials Estrogen1 trials Placebo Part B1 trials IM-101 Part B1 trials Placebo Part A1 trials IM-101 Part A1 trials Echo-guided Botox injection1 trials CTX-83711 trials Herombopag Olamine Tablets1 trials Adjuvant systemic therapy1 trials PEG-rhG-GSF1 trials remimazolam combined with propofol and alfentanil1 trials propofol and alfentanil1 trials ONC-8411 trials Methotrexate 1 GM Injection1 trials Avelumab Injection1 trials AM-9281 trials RNA loaded lipid particles, RNA-LPs (Drug Product 2 or DP2)1 trials DS-3939a1 trials nal-IRI,5-fu,LV, benmelstobart, anlotinib1 trials Aromatase Inhibition Therapy1 trials PREVENAR201 trials Prevenar 13 + Pneumovax 231 trials Adoptive therapy with autologous MC2 TCR T cells1 trials Platinum Compound1 trials chidamide, regorafenib, and iparomlimab/tuvonralimab1 trials EBNK-001 + IL-15 + Pembrolizumab1 trials 3-doses Group among 20-26 years1 trials 3-doses Group among 9-19 years1 trials 2-doses Group among 9-14 years1 trials Placebo Almonertinib1 trials Nucleos(t)ide analogue1 trials Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue1 trials POLA-R-CHP1 trials Tamoxifen 20mg1 trials Recombinant Thyrotropin Alfa1 trials Placebo 40 mg1 trials AK112, nab-paclitaxel, gemcitabine1 trials AK112, Cadonilimab, nab-paclitaxel, gemcitabine1 trials DISC-34051 trials RAD101 (18F-FPIA)1 trials Conversion or neoadjuvant therapy.1 trials tTF-NGR1 trials Terbium 1611 trials RNA Transcription Modulator AU-4091 trials Ibrutinib (Maintenance)1 trials ASCT conditioning1 trials Ibrutinib (Induction)1 trials R-CHOP/R-DHAP1 trials blood intake1 trials Molecular analysis of exon 9 and 20 of PI3K1 trials placebo intake1 trials aspirin intake1 trials YH323641 trials ABL0011 trials AZD36321 trials Zinc-64 Aspartate1 trials GIC-1021 trials Saline Solution for Injection1 trials Lidocaine Hydrochloride1 trials QL0605(PEG-rhG-CSF)1 trials MDNA111 trials GemCis plus PD-1/PD-L1 inhibitor1 trials Pembrolizumab combined with Chemotherapy1 trials Disitamab Vedotin(RC48) Plus Tratuzumab1 trials Cediranib1 trials KD-4961 trials Mylotarg1 trials Zeaxanthin1 trials Oral arsenic trioxide1 trials mocravimod1 trials Capecitabine，Pyrotinib1 trials Eflornithine (DFMO)1 trials CD70-CAR T cell infusion (Autologous)1 trials KQB3651 trials human single chain IL-12 mRNA-multiple dose1 trials human single chain IL-12 mRNA-single dose1 trials MIRV1 trials Sofetabart Mipitecan1 trials Endostar and Envafolimab1 trials Atezolizumab combined with bevacizumab1 trials 131-I Apamistamab1 trials Fluzoparib Monotherapy1 trials Azacitidine (AZC)1 trials Itraconazole Oral Product1 trials Everolimus Oral Product1 trials Bicalutamide Oral Product1 trials Letrozole Oral Product1 trials E-coli L-asparaginase1 trials Open Label Placebo1 trials TQB2223 injection+ Penpulimab Injection1 trials NK cell infusions1 trials IVX0371 trials Any Chinese government-recommended COVID-19 booster vaccine1 trials 89Zr˗DFO˗REGN50541 trials ZX-81771 trials AN9025 oral capsule1 trials No maintenance Vitamin D1 trials Maintenance Vitamin D1 trials Lenvatinib plus pucotenlimab1 trials Adebrelimab (SHR-1316) + Nab-paclitaxel + Cisplatin1 trials standard CHOP1 trials CHOP+chidamide+tislelizumab1 trials CHOP+duvelisib+5-Azacitidine1 trials CHOP+selinexor+5-Azacitidine1 trials 177Lu-RAD2041 trials Nintedanib, gefitinib, erlotinib, afatinib, osimertinib1 trials neoadjuvant immunotherapy1 trials NEO212 Oral Capsule1 trials Apalutamide Oral Tablet [Erleada]1 trials RO76733961 trials QL2109 or Daratumumab1 trials Anthracycline-based chemotherapy1 trials Allogeneic CD34+-enriched and CD45RA-depleted PBSCs1 trials Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone1 trials CD70-targeted CAR-T cells1 trials JK061 trials ABBV-4531 trials 3 cycles chemotherapy1 trials Oxaliplatin + 5-Fluorouracil/Leucovorin1 trials PD-1/CTLA-4 Dual Functional Antibody1 trials BBI-9401 trials BH-306431 trials TARA-0021 trials KRAS vaccine1 trials denosumab combined anti-PD-1 inhibitor with chemotherapy1 trials Bendamustine or gemcitabine1 trials JS004 in combination with Toripalimab1 trials BRC-0011 trials Nab-paclitaxel 100 mg/m^21 trials Induction chemotherapy - modified FOLFIRINOX regimen1 trials Deoxyadrenaline1 trials Sacituzumab Govitecan (SG)+Toripalimab1 trials CB-0111 trials Systematic chemotherapy1 trials cRGD-ZW800-1.1 trials CSCJC3456 tablet1 trials ZL-62011 trials placebo (XLJDOD mimetic agent)1 trials XLJDOD compound granule1 trials Gemcitabine, Cisplatin, Nab-paclitaxel, and Tislelizumab.1 trials Standard1 trials Docetaxel + Ebastine1 trials Adjuvant transarterial chemoembolization1 trials Hyperpolarized Pyruvate1 trials TBD Compound1 trials IMids1 trials OT-A2011 trials SOC Chemotherapy1 trials NTX-10881 trials BMS-9864631 trials Indocyanine Green (IC-Green)1 trials ECI8301 trials CTA1011 trials Second and later-line palliative chemotherapy1 trials DCC-28121 trials RS-01391 trials AKR1C3-activated Prodrug AST-34241 trials AZD8205 in combination with AZD95741 trials AZD8205 and AZD5305 (saruparib) and AZD2936 (rilvegostomig)1 trials AZD8205 and AZD5305 (saruparib)1 trials AZD8205 and AZD2936 (Rilvegostomig)1 trials AZD82051 trials EN38351 trials Nestlé NESCAFÉ® TASTER'S CHOICE® House Blend capsule.1 trials OL-101 infusion1 trials 5-Hydroxytryptophan1 trials SSS591 trials Microbubble1 trials GF-CART011 trials KRAS-mutated mRNA vaccine1 trials Atorvastatin 40 Mg Oral Tablet1 trials EVOLVE1041 trials ASP15701 trials Amrubicin (Japan only)1 trials D3L-0011 trials FTL0011 trials safusidenib1 trials Intrathecal triple1 trials Asparaginase Erwinia Chrysanthemi (recombinant)1 trials MEC Regimen1 trials CAV Regimen1 trials Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells1 trials FH-006 ; SHR-1316 ; BP1021 trials FH-006 ; SHR-1316 ; BP102 ; Cisplatin ; Carboplatin1 trials Belantamab mafodotin, Venetoclax1 trials Thiotepa ;busulfan;fludarabine1 trials Pembrolizumab & Enfortumab Vedotin (PEV)1 trials Natural Killer Cells1 trials Sandostatin LAR@1 trials SYHX2008 injection1 trials T-Cell therapy1 trials Pepinemab1 trials Dendritic Cell (DC1) Vaccine1 trials Low-dose ASA1 trials Orelabrutinib and obinutuzumab1 trials Linperlisib in combination with CHOP1 trials Cangpo Liujun Prescription1 trials Ifosfamide for Injection1 trials Ifupinostat Hydrochloride for Injection1 trials [18F]F-DCFPyL1 trials [18F]AlF-PSMA-N51 trials Oral or short-acting granulocyte-stimulating agents1 trials Oncologic drugs administered for treatment of breast cancer1 trials Mitazalimab1 trials system therapy1 trials Atezolizumab 1200 mg1 trials Polyethylene Glycol 33501 trials paclitaxel combined with platinum1 trials the opioid-free anesthesia group1 trials the opioid-based control group1 trials Starch powder 50 mg1 trials Megestrol Acetate and olanzapine1 trials IL21 trials Erenumab-Aooe Matching Placebo1 trials Siltuximab Matching Placebo1 trials Erenumab-Aooe1 trials FG001 prior to surgery1 trials Volonib combined with Everolimus Formation1 trials collection of blood, urines, stool and tumor samples1 trials interferon α-2b1 trials GINAKIT cells + Etanercept1 trials RC19D2 cell injection1 trials Escitalopram Oral Capsules1 trials DXC0081 trials RGT-611591 trials AZD05161 trials A2B5431 trials A2B6941 trials HRS-5041 Single dose of HRS-5041 orally administered1 trials Lipiodol1 trials T-ACE Oil1 trials Tislelizumab, Lenvatinib1 trials ADC + PD1 monoclonal antibody +anti-angiogenic drug1 trials ADC +anti-angiogenic drug1 trials Anti-PD-1/PD-L1 treatment1 trials Sagramostim1 trials UV11 trials Carboplatin + Pemetrexed + Pembrolizumab1 trials VS-73751 trials DS3790a1 trials Gemcitabine + albumin-paclitaxel+PD-11 trials nal-IRI+Oxaliplatin+5-FU/LV+PD-11 trials OCT-5981 trials Interferon beta-1a1 trials Apatinib+Camrelizumab+SOX1 trials Palifermin1 trials Goat Milk1 trials Systemic chemotherapy combined with immunotherapy1 trials Pegcrisantaspase1 trials HEKT cell1 trials NPX8871 trials Serabelisib1 trials sintilimab combined with bevacizumab and XELOX1 trials SOC plus trastuzumab and pembrolizumab1 trials ABSK043 single agent1 trials Fimepinostat1 trials chemotherapy according to Stupp protocol1 trials Anti-LILRA6 CAR-T cells1 trials DISC-09741 trials Vactosertib1 trials BNT3241 trials High-risk group1 trials Intermediate-risk group1 trials Low-risk group1 trials Very low-risk group1 trials Mesalamine1 trials Gemcitabine + cisplatin (GP)1 trials Fludarabine + Cyclophosphamide combination1 trials CT-951 trials BCD-2361 trials INCA0368731 trials Adebelimab (SHR-1316)1 trials [18F]PSMA-PET1 trials LY40507841 trials Lisinopril Tablets1 trials BMS-9864841 trials Vusolimogene oderparepvec (RP1)1 trials Intermediate-dose Cytarabine in Combination with Venetoclax1 trials Blood collection on admission and longitudinally1 trials Sodium Valproate1 trials OKI-2191 trials anti-BCMA/FcRL5 CAR T1 trials Methotrexate for Injection1 trials TR-0021 trials PD1/PDL1 inhibitor1 trials Acalabrutinib monotherapy1 trials Acalabrutinib combination with Rituximab1 trials Acalabrutinib + R-CHOP standard of care1 trials 18Fluorocholine1 trials D-05021 trials OT-1011 trials Extended Release Metformin Hydrochloride1 trials Adjuvant Atezolizumab-Bevacizumab Therapy1 trials Tunlametinib plus Vemurafenib1 trials RCHOP o R-miniCHOP at standard doses1 trials HLA-matched VSTs1 trials DM51671 trials Control (1% lidocaine with 1:100,000 epinephrine)1 trials Nabiximols-matched placebo1 trials Nabiximols1 trials cisplatin and gemcitabine1 trials Oncolytic Virus injection(IDOV-SAFETM)1 trials Nimotuzumab+Adebrelimab+Chemotherapy1 trials EU-approved Keytruda1 trials CT-P511 trials First-Line Systemic Therapy1 trials Iomab-B1 trials Relatlimab FDC + Nivolumab1 trials 68Ga-FAPI-JNU1 trials R-CHOP Regimen1 trials R-CMOP Regimen1 trials CDK4/6i plus ET1 trials Trastuzumab deruxtecan (T-DXd, DS-8201a)1 trials Module 1 (GRWD5769 on its own as monotherapy)1 trials YL242; Pembrolizumab; 5-FU1 trials YL242; 5-FU; LV1 trials YL242; Pembrolizumab1 trials YL2421 trials Teniposide Injection1 trials Oral Antibiotics cefdinir or trimethoprim/sulfamethoxazole1 trials Innocell Autologous Cellular Immunotherapy1 trials DCR-PDL11 trials AFP Specific T Cell Receptor T Cells1 trials GEN-725 tablets1 trials Treatment by Regorafenib1 trials Procarbazine Hydrochloride1 trials Standard of Care Therapy1 trials BGB-580671 trials IBI363 + Furuitinib1 trials IBI363 combined with Bevacizumab1 trials sintilimab combined with bevacizumab biosimilar1 trials CAR-T-19 cell injection1 trials DB-1303/BNT3231 trials LYT-2001 trials Anti-CD19 gene injection1 trials Placebo given1 trials NGM120 Q8W1 trials NGM120 Q4W1 trials RSC-1255 Dose Expansion1 trials RSC-1255 Dose Escalation1 trials 1.0% IP-001 for injection1 trials STC-1010 + IS regimen + SOC therapy1 trials Trichostatin A1 trials Androgen receptor targeted therapy1 trials AG1 trials 4-[18F]Fluoro-1-Naphthol1 trials Placebo Solution1 trials Tempol1 trials SHR-A1904; CAPOX; Adebrelimab1 trials SHR-A1904; Adebrelimab1 trials single dose of Inaticabtagene autoleucel1 trials Lipitor 40mg Tablet1 trials Continuation of somatostatin analogues1 trials Cessation of somatostatin analogues1 trials CALR allele burden quantification1 trials IMSA1011 trials ADRX-04051 trials PF-079340401 trials Desflurane + Normal Saline1 trials Dexmedetomidine + Desflurane1 trials FDA-approved gadolinium-based intravenous contrast agent1 trials MR001 Bispecific Antibody for Injection1 trials GPC3 CD146 CAR-T cells1 trials LB43301 trials Quizartinib Low Dose1 trials Quizartinib High Dose1 trials ALX20041 trials HVA1 trials SGM-101 op top of ICG1 trials 177Lu-DOTA-JR11 (Phase I/II)1 trials 177Lu-DOTA-JR11 (Phase 0); Cycle 1 and Cycle 2 (cross-over)1 trials Drug: B10 L-BPA Injection1 trials Anti-aromatase inhibitor1 trials KRAS Vaccine with Poly-ICLC adjuvant1 trials HRS23981 trials adjuvant chemotherapy regimens1 trials PT05111 trials VRD1 trials Chidamide+VRD1 trials Transporter Cocktail1 trials CYP Cocktail1 trials 6-tioguanine+Standard Maintenance Therapy1 trials Inotuzumab Ozogamicin+Standard Maintenance Therapy1 trials Omitted Vincristine+Dexamethasone pulses1 trials Omitted Doxorubicin1 trials Atezolizumab 1680 MG1 trials Sintilimab 100MG1 trials Vemurafenib 240 MG1 trials Pyrotinib 160/80 MG1 trials Dacomitinib 45 MG1 trials Almonertinib 110 MG1 trials Vosilasarm1 trials Anti-angiogenic drug1 trials Chemotherapy (control)1 trials Nilutamide1 trials Histrelin Acetate1 trials Autologous tumor infiltrating lymphocytes (TILs)1 trials CAPEOX/Capecitabine1 trials Lu-17-PSMA-6171 trials ASCT1 trials Venetoclax, Azacitidine1 trials ETX-636 dose expansion in combination with fulvestrant1 trials ETX-636 dose escalation in combination with fulvestrant1 trials ETX-636 dose escalation1 trials TriPRIL CAR T Cells1 trials Temozolomide Oral Product1 trials Selinexor Oral Tablet [Xpovio]1 trials Calaspargase1 trials Inotuzumab1 trials maintenance therapy with niraparib1 trials maintenance therapy with bevacizumab1 trials Follicle Stimulating Hormone Receptor T Cells1 trials Adze1.C1 trials [11C]AZ1419 33911 trials T-1201 Injection 100 mg Kit1 trials AZD07541 trials Intrathecal pemetrexed1 trials BDTX-1535 combined with temozolomide and radiation therapy1 trials BDTX-1535 combined with radiation therapy1 trials BDTX-15351 trials Peluntamig (PT217)1 trials BNT32121 trials ZZ061 trials AZD0240: Autologous, engineered T Cells targeting KRAS G12D1 trials NT-112: Autologous, engineered T Cells targeting KRAS G12D1 trials HS-103701 trials IM96 CAR-T Cells1 trials SPH74851 trials Trastuzumab and neratinib1 trials FB-16031 trials Ivosidenib 500mg Oral Tablet1 trials KSX01-TCRT injection1 trials AK112 + Neoadjuvant chemotherapy1 trials TIL Product1 trials Tislelizumab, paclitaxel, Carboplatin1 trials Tislelizumab, Carboplatin, Pemetrexed1 trials Dose expansion1 trials A novel hGIIA-Vimentin Inhibitor1 trials MK-04721 trials ADU-18051 trials JS207 in combination with Albumin paclitaxel1 trials JS207 in combination with 9MW28211 trials huMNC2-CAR44 CAR T cells or huMNC2-CAR22 CAR T cells @ RP2D1 trials huMNC2-CAR44 CAR T cells or huMNC2-CAR22 CAR T cells1 trials Laboratory tests and in vitro studies1 trials Pembrolizumab + sEphB4-HSA1 trials Calcium Folinate Injection1 trials SHR-46421 trials Transplant acellular dermal matrix(ADM)1 trials SHR-1316 Placebo Injection1 trials CAN21091 trials Etentamig (ABBV-383)1 trials GH56 Capsule1 trials KSQ-004EX1 trials Methoxsalen Injection1 trials Taxane-Based Neoadjuvant Chemotherapy1 trials Dalpiciclib + Aromatase Inhibitor with ctDNA-Guided Therapy1 trials Orelabrutinib, obinutuzumab, lenalidomide1 trials QL1706 plus chemotherapy and anlotinib regimen1 trials NisinZ® P1 trials autologous hematopoietic stem cell1 trials [18F]RCCB61 trials CHiR-DEL1 trials Obinutuzumab Combined With Bendamustine1 trials TOS-3581 trials HMPL-415S11 trials ABX-0011 trials IBI3181 trials Omega-3-Acid Ethyl Esters1 trials Darzalex Faspro(Daratumumab)1 trials CT-P44(Daratumumab)1 trials Regorafinib1 trials MT027 CAR-T cells1 trials Piperacillin/tazobactam1 trials Ceftolozane/tazobactam1 trials Azer-cel1 trials SHR43941 trials combination of Trilaciclib and Pemetrexed1 trials XB0101 trials AZD45121 trials 68Ga-FAPI-RGD1 trials HRS-7172 Tablets1 trials HBV mRNA vaccine1 trials Intravenous ascorbic acid/vitamin C1 trials SKB518 for injection1 trials CD123 targeted CAR-NK cells1 trials HS-105021 trials MT-302 (A)1 trials Tagitanlimab1 trials mFOLFOX regimen1 trials mFOLFOXIRI regimen1 trials Intraperitoneal chemotherapy PLUS systemic chemotherapy1 trials Chimeric Antigen Receptor1 trials Premedication1 trials GEN10571 trials Next Generation Sequencing (DNA and RNA)1 trials Pyrotinib maleate, dalpiciclib, Trastuzumab, letrozole1 trials CDK4/6 Inhibitor SHR63901 trials FOLFOX/ nal-IRI1 trials B7H3 specific CAR T cell with IL-7Ra signaling domain1 trials CAdVEC1 trials Iparomlimab and Tuvonralimab (QL1706)1 trials Evaluation of cytokine production1 trials EBC-1291 trials ISM82071 trials Minoxidil1 trials TURALIO™1 trials Radiochemotherapy1 trials MRG0071 trials DFP-109171 trials Rituximab SC1 trials gemcitabine,nimotuzumab, toripalimab1 trials [18F]FPyQCP1 trials DOMVANALIMAB + ZIMBERELIMAB + FOLFOX-41 trials DOMVANALIMAB + ZIMBERELIMAB1 trials HMPL-3061 trials Granulocytes1 trials SIBP-A13 formulation for injection1 trials IV nivolumab1 trials Intratumoral injection of ipilimumab and AS01b1 trials intratumoral injection of autologous CD1c (BDCA-1)+ myDC1 trials LY010051 trials Zoladex1 trials pembrolizumab, pazopanib1 trials LM3031 trials CD33 FPBMC1 trials IBR900 cell injection1 trials JS207 injection1 trials JS207 injection +JS004 injection1 trials JS207 injection +docetaxel1 trials HRS-4642+AG +Adebrelimab1 trials SIM0237 and BCG1 trials SIM02371 trials TQB2922 injection+TAS-102 tablets ± Bevacizumab1 trials TQB2922 injection ± TAS-102 tablets1 trials pre-implementation baseline including opioid1 trials Honokiol1 trials ONO-74281 trials TQB2450 injection + Anlotinib Hydrochloride Capsule1 trials TQB2450 injection + Chemotherapy1 trials BOLD-100 in combination with FOLFOX Chemotherapy (Arms I-VI)1 trials BOLD-100 +/- FOLFOX Chemotherapy (Arm VII)1 trials Albumin-Bound Paclitaxel, cisplatin, Sintilimab1 trials Radiopharmaceutical 68Ga-PSMA1 trials GEMNabP1 trials INCB1617341 trials UCART221 trials FOLFOX plus targeted therapy1 trials NALIRIFOX plus targeted therapy1 trials RC2781 trials eRapa (encapsulated rapamycin)1 trials H1710 for Injection1 trials Axl/Mer/CSF1R Inhibitor Q7021 trials iC9-CAR.B7-H3 T Cell Therapy1 trials Autologous CAR-T cell therapy expressing the BAFF-ligand.1 trials Mirvetuximab soravtansine plus Bevacizumab1 trials LM-108 antibody and sintilimab and chemotherapy1 trials LM-108 antibody and sintilimab1 trials Pembrolizumab biosimilar1 trials PF-080460501 trials Autogene cevumeran1 trials Cetrelimab and Erdafitinib combination1 trials Erdafitinib monotherapy1 trials Nelmastobart 800 mg+Trifluridine/Tipiracil+ Bevacizumab1 trials JMT203 Injection1 trials SHR-46021 trials HRS-45081 trials TQB28681 trials TQB21021 trials LEM1 trials 5-FU Analog based chemotherpay1 trials Consolidation Therapy1 trials WBC100 QD1 trials T-DXd, Durvalumab and Capecitabine Combination1 trials Trastuzumab Deruxtecan (T-DXd) monotherapy1 trials Immune checkpoint inhibitor targeting PD11 trials NK cell therapy1 trials LN-145/LN-1441 trials Thrombin Generation Assay (TGA)1 trials 18-F FDG1 trials DWC202510 (Olaparib 150mg)1 trials DWZ2501 (Olaparib 150mg)1 trials Trilaciclib + Cisplatin1 trials HRS-60931 trials Cohort D: KTX-1001+ pomalidomide (Pomalyst, Imnovid)1 trials Cohort C1 & C2: KTX-1001 + Carfilzomib (KYPROLIS®)1 trials Cohort B1 & B2: KTX-1001+Mezigdomide1 trials Cohort A1 & A2: KTX-10011 trials MT027 cells suspension1 trials Fruquintinib Combined With Chemotherapy1 trials RC881 trials Docetaxel,Cisplatin1 trials Acupoint application1 trials CTC detection1 trials Placebo Fecal microbiota transfer1 trials Placebo Vancomycin Oral Capsule1 trials Vancomycin Oral Capsule1 trials Fecal microbiota transfer1 trials REGN7945+Linvoseltamab1 trials Etoposide + carboplatin; Etoposide + cisplatin1 trials APR-10511 trials ABBV-3241 trials Other approved anti-cancer therapy1 trials BP-1021 trials Ametinib mesylate1 trials adjuvant chemotherapy for MRD- patients1 trials adjuvant tislelizumab and chemotherapy for MRD+ patients1 trials Fluorine F 18 2-deoxy-2-(18F)fluoro-D-glucose1 trials Carbon C 11 Acetate1 trials Fluorine F 18 L-glutamate Derivative 18F-FSPG1 trials Megestrol Acetate 40 MG1 trials Claudin 18.2 CAR-T1 trials Azercabtagene zapreleucel (azer-cel)1 trials JSKN0161 trials LM1031 trials Regorafenib and DIBIRI1 trials Neoadjuvant therapy + vitamin D21 trials GCC20051 trials B-Cell Lymphoma 2 Protein Inhibitor1 trials Bruton's tyrosine kinase inhibitor1 trials autologous hematopoietic stem cells added to planned CAR T1 trials JS111 capsules (AP-L1898)1 trials Brexucabtagene Autoleucel1 trials ALL, High risk1 trials ATX-2951 trials Allogeneic BK-specific Cytotoxic T-lymphocytes1 trials Sevoflurane/Ultane1 trials Propofol 1%1 trials Systemic chemotherapy1 trials Fruquintinib+Sintilimab+Chidamide1 trials Copper-64 labeled (64Cu-) FAP-22861 trials Gallium-68 labelled (68Ga-) FAP-22861 trials SY0011 trials VC plus herbal medicine1 trials 18F-Fluciclovine PET/CT Scan1 trials EphA2-targeted CAR-DCs1 trials EphA2-targeted CAR-T Cells1 trials Carboplatin (or cisplatin if carboplatin is not tolerated)1 trials Adjuvant Pembrolizumab1 trials Neoadjuvant Pembrolizumab1 trials Neoadjuvant Lenvatinib1 trials Enlonstobart injection1 trials SYS6010 injection1 trials Injection, 161Tb-SibuDAB, Dose Escalation1 trials Injection, 177Lu-PSMA-I&T, 1GBq1 trials Injection, 161Tb-SibuDAB,1GBq1 trials Palbociclib 75mg-125mg1 trials Fulvestrant 500g1 trials Ipatasertib 300mg1 trials CD123/CD33 CART1 trials Nesuparib1 trials Malic acid Famitinib1 trials Nivolumab (240 mg)1 trials SHR-25541 trials SHR-03021 trials Placebo + docetaxel1 trials green tea and quercetin + docetaxel1 trials HRS-7058 capsule/ HRS-7058 tablet1 trials Talazoparib Oral Capsule1 trials PHOX2B PC-CAR T Cells1 trials Taxanes1 trials ([18F]-6F-DA)1 trials 68Ga-R10602 injection1 trials Ligufalimab1 trials pTVG-HP DNA vaccine1 trials Tislelizumab combined with Levatinib1 trials 5-HT3 Antagonist1 trials Lenvatinib, sintilimab plus SIRT1 trials urine samples1 trials SLV-324 intravenous (IV infusion)1 trials Devimistat1 trials 68GaNOTA-Anti-HER2 VHH11 trials DB-14191 trials Tirosin Kinase Inhibitors1 trials ATLCAR.CD30 T cells1 trials Androgen Suppression Therapy1 trials Debio01231 trials Lunresertib1 trials Maximum Tolerated Dose1 trials Dose Level 31 trials Dose Level 11 trials Dose Level 2 (starting dose)1 trials ET140203 T Cells1 trials Furmonertini Mesilate1 trials Alomnertinib Mesilate1 trials SSGJ-705 combined with chemotherapy1 trials PD-1/L1 inhibitor combined with chemotherapy1 trials BMD006 in combination with PD-1/VEGF antibody1 trials BMD006 in combination with PD-1 antibody1 trials BMD006 monotreatment1 trials Sacituzumab Tirumotecan (SKB264)1 trials Sacituzumab Tirumotecan (SKB264) plus Tislelizumab1 trials Clostridium Butyricum Tablets1 trials Abacavir1 trials Cetuximab β；Fruquintinib；anti-PD1/CTLA4 antibody1 trials Cetuximab β；Fruquintinib；anti-PD1 antibody；1 trials Cetuximab β；Fruquintinib；1 trials Programmed Cell Death-1 (PD-1) Inhibitor1 trials ABBV-CLS-4841 trials BCD-2481 trials APL-51251 trials TQB2825 injection + GemOx1 trials TQB2825 injection +R-CHOP regimen1 trials VS-60631 trials Fruquintinib, Adebrelimab, Oxaliplatin, Capecitabine1 trials 6 cycles chemotherapy1 trials 3 cycles chemotherapy instead of 6 cycles chemotherapy1 trials Donafenib Tosilate Tablets1 trials Lomustine Pill1 trials Lerapolturev1 trials Befotertinib combined platinum-based double chemotherapy1 trials Befotertinib combined Bevacizumab1 trials 3-year abemaciclib without chemo1 trials GB5005 CART1 trials During Venetoclax1 trials Nonavalent HPV vaccine (9vHPV/Gardasil-9™).1 trials Pomalidomide 4 MG1 trials Dratumumab / Hyaluronidase Injection [Darzalex Faspro]1 trials IDP-1211 trials CTX1311 trials Phase I Arm B1 trials Phase I Arm A1 trials ANV600 + pembrolizumab (KEYTRUDA®)1 trials ANV6001 trials HWK-0071 trials Epirubicin+CTX+5-Fu1 trials Goserelin+TAM+AI1 trials mFOLFOX6 Plus Bevacizumab1 trials Hormone replacement therapy1 trials NKT5097 CDK2/CDK4 dual degrader1 trials [89Zr]Zr-DFO-emapalumab1 trials PF-080468761 trials Folinic acid (leucovorin or local equivalent)1 trials Intravenous immunoglobulin (IVIG)1 trials Intravenous immunoglobulin1 trials BMS-9865231 trials Cabotamig (ARB202)1 trials Avasopasem1 trials Niraparib oral capsule1 trials Cladribine High Dose1 trials Cladribine Low Dose1 trials EOC2371 trials 68Ga-dPNE1 trials High-dose corticosteroids (HDCS) and PLEX1 trials High-dose corticosteroids (HDCS)1 trials Standard systemic treatment for advanced lung cancer1 trials ABBV-7061 trials HX008 injection1 trials Collection of blood and bone marrow1 trials Oxaliplatin With S-1 （SOX）1 trials TACE-HACI, plus atezolizumab-bevacizumab1 trials AXT-10031 trials Proflavine1 trials Radvax1 trials CHOEP protocol1 trials DA-EPOCH Protocol1 trials Dacomitinib+Anlotinib1 trials OMO-1031 trials TKI+Cardunilimab1 trials 186RNL1 trials Yttrium-901 trials Bethanechol1 trials CD19/CD20/BCMA CAR-T1 trials Antivascular therapy1 trials TRE-5151 trials Gemcitabine (1000 mg/m2)1 trials Niacin 100mg1 trials Psilocybin 25 mgs1 trials Tislelizumab combined with S-11 trials 111In-XYIMSR-011 trials anti-CD19 CAR-NK1 trials BG-685011 trials Lenvatinib and Sorafenib1 trials Zabadinostat (CXD101) and Geptanolimab1 trials HRS-4642 Injection1 trials Systematic RAI-treatment1 trials donor-derived NK cell infusion1 trials elacestrant, palbociclib, abemaciclib, ribociclib1 trials Erdafitinib Intravesical Delivery System1 trials TCC1727 tablet 160mg1 trials TCC1727 tablet 120mg1 trials TCC1727 tablet 90mg1 trials hepatic artery infusion chemotherapy1 trials Sevoflurane intravenous anesthesia1 trials Propofol-based total intravenous anesthesia1 trials BEBT-209 Placebo capluses1 trials Probiotics1 trials Pyrotinib dose normal1 trials Pyrotinib dose escalation1 trials Anlotinib, Everolimus and Tislelizumab1 trials Cisplatin, Carboplatin, Paclitaxel, Docetaxel1 trials ZR2-ICE1 trials Ori-C1011 trials [64Cu]Cu-AKY-1189 (imaging)1 trials [225Ac]Ac-AKY-1189 (therapeutic)1 trials KIVU-1071 trials HX0441 trials Pemetrexed plus Pembrolizumab1 trials GS-02011 trials Intrathecal Morphine1 trials VB150101 trials R-CDOP+intrathecal MTX1 trials Anti-CEA CAR-T Cells1 trials Blood, nasopharyngeal swab and saliva1 trials AV-3801 trials Enhanced autologous PSMA-CAR T1 trials DSP107 + Atezolizumab1 trials Epcoritamab, tafasitamab and lenalidomide1 trials CVA1 trials S-488210/S-4882111 trials CAP-1001 trials GC203 TIL(gene-edited TIL) or autologous TILs1 trials Deep-sea fish oil1 trials Mitoxantrone Hydrochloride Liposome+Irinotecan+Vincristine1 trials OTS167PO1 trials IBI1301 trials [212Pb]VMT-α-NET1 trials [203Pb]VMT-α-NET1 trials PTM-1011 trials Botulinum Toxin A (Botox )1 trials bi-4SCAR GD2/CD70 T cells1 trials Orelabrutinib Oral Tablet1 trials AMG 4101 trials BNT323/DB-13031 trials MB-dNPM1-TCR.11 trials Efbemalenograstim alfa Injection1 trials Reference Treatment: IV fosaprepitant infusion1 trials Reference Treatment: IV ondansetron infusion1 trials IV NEPA (fosnetupitant/palonosetron)1 trials CYTALUX™ (pafolacianine) injection preoperatively1 trials HSCT with Non-TBI Regimen1 trials HSCT with TBI Regimen1 trials CC-1 Infusion1 trials FOLFOX chemotherapy1 trials Epacadostat1 trials OK-11 trials MK-47161 trials CYC1 trials 68Ga-PSMA-CYC1 trials IBI-323 combined with bevacizumab plus Platinum1 trials Prednisone (or equivalent)1 trials Bel-sar1 trials Endocrine therapy + Abemaciclib1 trials Ceritinib1 trials JYP0322 150mg tid1 trials JYP0322 200 mg bid1 trials JYP0322 150 mg bid1 trials JYP0322 100 mg bid1 trials JYP0322 200 mg qd1 trials JYP0322 100 mg qd1 trials JYP0322 50 mg qd1 trials RLS-1496 1.0% cream1 trials MEM-288 Intratumoral Injection1 trials Pacliltaxel or Nab-paclitaxel1 trials TQB2450 injection + oral progestin1 trials cadonilimab+paclitaxel/albumin-bound paclitaxel+carboplatin1 trials neoantigen-loaded dendritic cell vaccine (NeoDC-Vac)1 trials U87 autologous CAR T-cell1 trials Paclitaxel + Bevacizumab1 trials ASKG9151 trials 68Ga-JH121 trials Talazoparib + Avelumab1 trials ISM63311 trials PI3K inhibitor1 trials Memantine -Twice Daily or Extended Release1 trials AB89391 trials Octreotide long-acting injection1 trials Sirolimus for injection (albumin bound)1 trials BXCL7011 trials AZD22841 trials AZD22751 trials Triple-targeted CAR-T Therapy1 trials rhCG1 trials ACTH1 trials Chemotherapy Stupp Protocol1 trials 89Zr-DFO-girentuximab1 trials Autologous DC Therapy1 trials TPC plus Toripalimab Induction chemotherapy+CCRT1 trials TP plus Toripalimab Induction chemotherapy+CCRT1 trials GP plus Toripalimab Induction chemotherapy+CCRT1 trials CBA-1535+Pembrolizumab1 trials CBA-15351 trials Anastrozole Tablets1 trials Everolimus Tablets1 trials HRS-8080 Tablet1 trials Cisplatin/pemetrexed or Carboplatin/pemetrexed1 trials Durvalumab 1500 mg IV1 trials Oral Restorative Microbiota Therapy (RMT) Capsules1 trials DPTX31861 trials Luteinizing Hormone-Releasing Hormone Analog1 trials 89Sr1 trials HDM2011 trials Huachansu1 trials SHR-8068； Adebrelimab ； Bevacizumab ；HRS-105161 trials SHR-8068；Adebrelimab ；HS-105161 trials SHR-8068；Adebrelimab ；Bevacizumab1 trials Petrozumab1 trials Panobinostat1 trials RD06-03 cell injection1 trials MP0533 with Obinutuzumab pretreatment1 trials EBC1 trials JANX0081 trials AgenT-7971 trials • Drug: Savolitinib • Drug: Osimertinib Mesylate Tablets1 trials Loperamide Hydrochloride1 trials Apatinib, Irinotecan, Temozolomide1 trials Cyclin-Dependent Kinase 6 Inhibitor1 trials Cyclin-Dependent Kinase 4 Inhibitor1 trials CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine1 trials Abiraterone acetate plus prednisone (AAP)1 trials GI-101A1 trials GI-1011 trials Al18F-NOTA-FAPI1 trials Darolutamide (BAY1841788) + docetaxel + ADT1 trials 89Zr-DFO-Atezolizumab1 trials SHR-62091 trials SHR-11671 trials Aromatase Inhibitors or Fulvestrant1 trials Carrelizumab1 trials AKT inhibitor1 trials PIK3CA inhibitor1 trials Paclitaxel (albumin-bound) combined with Oxaliplatin and S-11 trials TQB3019 capsules1 trials PBA-01111 trials TS-20211 trials New donor-derived CD7 CAR T-cell1 trials Prior-HSCT donor-derived CD7 CAR T-cell1 trials Autologous CD7 CAR T-cell1 trials irinotecan liposome (II)1 trials BCG for Therapeutic Use ( BI SAI JI )1 trials mFOLFIRINOX or Gemcitabine nab-paclitaxel1 trials Everolimus (Afinitor®)1 trials SIM02701 trials IMC0081 trials Allogeneic γδ T (ABOUT) cells1 trials YZJ-5053 tablets1 trials Arm B: Palbociclib or Ribociclib + Fulvestrant1 trials Arm A: Gedatolisib + Palbociclib or Ribociclib + Fulvestrant1 trials Tislelizumab combined with GEMOX (GOT) regimen1 trials Arlocabtagene Autoleucel1 trials Inhaled budesonide1 trials Azacitidine or decitabine1 trials DR-011 trials Fadraciclib1 trials Lirilumab1 trials Vistusertib1 trials Adavosertib1 trials UTAA09 cells for infusion1 trials Chlorophyllin1 trials Pioglitazone 15mg1 trials Esketamine at low dose1 trials Alectinib Oral Product1 trials ALE.P021 trials ABD-30011 trials ICP-248+Orelabrutinib+Rituximab1 trials ICP-248 +Rituximab1 trials ICP-248+Orelabrutinib1 trials Dapagliflozin 10mg1 trials irinotecan liposome (II) + temozolomide + fluzoparib1 trials 67Cu-SAR-bisPSMA1 trials NKTR-2551 trials HiDAC1 trials Chemotherapy Regimen1 trials [177Lu]Lu-NNS3091 trials [68Ga]Ga-NNS3091 trials TAS0953/HM061 trials PF-029213671 trials PF-080526671 trials Serplulimab Combined With FOLFIRI and Bevacizumab1 trials Hormonal Antineoplastics1 trials HB00361 trials JY2311 trials CAR-T cells targeting CD19 and CD221 trials ADT+second-generation antiandrogens ± chemotherapy1 trials BEACOPP-like1 trials Nivo-AVD1 trials ProAgio Dose Expansion1 trials AZD01711 trials Oleclumab1 trials GW52821 trials ESO-T01 Injection1 trials topical testosterone1 trials Pluvicto1 trials Reduced dose intensity of IO1 trials SIBP-A171 trials Octreotide1 trials anti-KRAS G12D mTCR PBL1 trials Approved Non-small Cell Lung Cancer (NSCLC) therapies1 trials Cemiplimab (maintenance)1 trials U32 CAR-T1 trials ABX1961 trials Bicalutamide in combination with Sunitinib1 trials Investigators choice of SoC1 trials Adebrelimab and Chidamide Combined with Gemcitabine and S11 trials Tamsulosin - 3 days1 trials Tamsulosin - 1 week1 trials VS-6766/avutometinib1 trials 161Tb-DOTA-LM31 trials YL2171 trials Capecitabine oral administration1 trials NG-350A IV administration1 trials SG29181 trials NT-I71 trials Eravacycline1 trials TPC combined with Tislelizumab1 trials GP combined with Tislelizumab1 trials bi-4SCAR PSMA/CD70 T cells1 trials Leuprolide, Degarelix or Relugolix1 trials MRG003+HX0081 trials MRG0031 trials Stupp regimen (oral temozolomide)1 trials Intrathecal injection of thiotepa1 trials Triapine1 trials CMOEP1 trials 18F-FAPIBiotin1 trials topical timolol maleate1 trials CIK cell1 trials peripheral blood lymphocytes1 trials Vinegar 40ml1 trials Vinegar 20ml1 trials anti-CD40 antibody 2141-V111 trials Selinexor 40 mg1 trials ABP 2341 trials Saccharomyces Boulardii Oral Powder1 trials Furazolidone1 trials Tetracycline1 trials JBZ-0011 trials Interferon-Alpha1 trials Hydroxycarbamide1 trials PREVENT1 trials Levothyroxine1 trials ASP10021 trials Indocyanine Green Tracer1 trials NMS-035978121 trials JMT1011 trials Lutetium (177Lu) rhPSMA-10.1 Injection1 trials MTS1051 trials Transplant, Autologous1 trials [89Zr]Zr-Df-Crefmirlimab PET imaging1 trials [18F]F-AraG PET imaging1 trials Radiopharmaceutical 68Ga-DOTATATE1 trials mFOLFOX/FOLFIRI ( Standard Chemotherapy)1 trials Yttrium-90 (Y-90) resin microspheres1 trials 6*Nab-P (d 1,8,15)+6*Cb ( d 1)+6*PD1 (d 1)1 trials 6*Nab-P (d 1)+6*Cb ( d 1)+6*PD1 (d 1)1 trials Standard of care immune checkpoint inhbitors1 trials Metformin hydrochloride (HCl) 500mg tablet1 trials GTAEXS6171 trials Post-Intervention Medication1 trials Pre-Intervention Medication1 trials Mupirocin 2% Ointment1 trials Chlorhexidine gluconate (4%)1 trials EU1031 trials Polyethylene Glycol1 trials Ganitumab1 trials Zidesamtinib (NVL-520)1 trials Neoadjuvant toripalimab monotherapy for 12 cycles1 trials Neoadjuvant toripalimab plus celecoxib for 12 cycles1 trials Neoadjuvant toripalimab monotherapy for 6 cycles1 trials Neoadjuvant toripalimab plus celecoxib for 6 cycles1 trials Avatrombopag1 trials Fuzuloparib1 trials KN50011 trials ABBV-1551 trials ABBV-6371 trials ERAS-8011 trials Valacyclovir1 trials HRS-4642 and adebrelimab combination therapy1 trials HRS-4642 monotherapy1 trials AI-0811 trials Epcoritamab, lenalidomide and rituximab1 trials Toripalimab combined with celecoxib1 trials Short course of blinatumomab1 trials LCAR-HL30 cells1 trials iC9-CAR.B7-H3 T cells1 trials MB0151 for injection1 trials YL201 and atezolizumab1 trials Toremifene1 trials CAR-GPRC5D1 trials 3 cycles of AI1 trials Ovarian function suppression(OFS)1 trials Human Papillomavirus Tumor Antigen Vaccine1 trials DNA Vaccine1 trials Neoadjuvant endocrine therapy1 trials Chimeric antigen receptor (CAR) T-cell therapy1 trials Itacitinib1 trials thrombogram1 trials TT125-8021 trials Antihistamine1 trials ARPI1 trials Abiraterone 250 mg with food + prednisone1 trials ORIC-1141 trials 4-Aminopyridine1 trials AK104+ Paclitaxel+Cisplatin or Carboplatin1 trials LUCAR-20SP cells1 trials Amino Acid infusion1 trials CLIC-22011 trials Pregnancy test1 trials Blood sample for liver function tests1 trials Blood samples for Chemistry1 trials Blood samples for Hematology1 trials Cabozantinib 80 MG1 trials Expanded haploidentical NK cells1 trials Poteligeo 20mg1 trials Atezolizumab (adjuvant)1 trials Bevacizumab (adjuvant)1 trials Atezolizumab (neoadjuvant)1 trials Cemiplimab Plus Gemcitabine1 trials Tocilizumab at emerging CRS1 trials Tocilizumab before CAR-T cell infusion1 trials Maintenance treatment1 trials PD-1antibody plus GEMOX1 trials FCN-1591 trials TP or PF regimen depended on investigator's choice.1 trials Zanubrutinib plus Lenalidomide as Maintenance Therapy1 trials R906289 Monosodium (R289 Na)1 trials Opemalirsen (AZD2373)1 trials Sipuleucel-T Injection1 trials KK22691 trials Tislelizumab-jsgr1 trials Lidocaine 20mg/ml1 trials Retinoic Acid1 trials 13C,15N-Urea1 trials Gcsf1 trials CD19-CAR(Mem) T-cells1 trials Venetoclax 100 mg d1，200 mg d2，400 mg d3-28；1 trials 225Ac-ABD1471 trials Anti-CD5 CAR NK cells1 trials Binimetinib 15 MG1 trials cladribine, cytarabine,venetoclax1 trials 68Ga-FAPI-Biotin1 trials Tinzaparin Injectable Solution1 trials CPA1 trials DPX-Survivac1 trials RD-Cy7 fluorophore1 trials Fam-Trastuzumab Deruxtecan-Nxki1 trials ALX1481 trials Avelumab first-line maintenance1 trials Platinum + Gemcitabine1 trials AZD84211 trials PEMBROLIZUMAB (alone or when added to a regimen above)1 trials NIVOLUMAB (alone or when added to a regimen above)1 trials CT7439 Capsules (0.5 mg, 1mg, 3mg)1 trials HRYZ-T101 Injection1 trials SonoVue®1 trials ETH-1550081 trials attIL2-T cells1 trials Dual-targeting BCMA-GPRC5D CAR-T cell infusion1 trials Group C: Patients with SD/PD after posterior treatment1 trials SYS6040 for injection1 trials aglatimagene besadenovec + valacyclovir1 trials orelabrutinib combined with the Pola-R-CHP regimen1 trials analysis of BTN and BTNL status1 trials Chidamide combined with Linperlisib1 trials Immunotherapy （Envafolimab）1 trials Chemotherapy （Etoposide and Carboplatin）1 trials ARI-00011 trials JAB-2485 (Aurora A inhibitor)1 trials IA therapy of HCC with CSR02-Fab-TF1 trials Administering Lutetium-177-PSMA-617 (PLUVICTO)1 trials CBP-10191 trials QL1706 combined with chemotherapy ± Bevacizumab1 trials 5-Fluorouracil + leucovorin1 trials [89Zr]Zr-BI 7645321 trials Sevoflurane group1 trials Propofol group1 trials [18F]-αvβ6-BP1 trials IAM13631 trials Encorafenib Oral Capsule + Cetuximab1 trials Fludarabine (FLU)1 trials NK0421 trials SD-1011 trials Intraventricular Dexamethasone1 trials Intraventricular Nivolumab1 trials Intraventricular Pemetrexed1 trials CAR-T cell reinfusion1 trials ISM34121 trials [225Ac]Ac-A9-34081 trials Standard of care agent1 trials QL1706 plus chemotherapy1 trials ID cytarabine1 trials vosaroxin1 trials Mycophenolic acid (MPA)1 trials HD Cytarabine1 trials TU22181 trials sorafenib, gefitinib1 trials 177Lu-PSMA1 trials [177Lu]Lu-OncoFAP-231 trials Autologous CAR123 T lymphocytes1 trials Glivec1 trials Carcemia1 trials Mucoadhesive fenretinide-releasing system (FMS)1 trials CTIM-761 trials Ultra-Short-Term Androgen Deprivation Therapy with Relugolix1 trials Al18F-octreotide1 trials PH FDC SC1 trials Samuraciclib1 trials CBX-121 trials ICIs(Immune checkpoint inhibitors)1 trials DEG64981 trials Gemcitabine + Cisplatin + Durvalumab1 trials MP0317 + Gemcitabine + Cisplatine + Durvalumab1 trials Systemic therapy (Standard of Care)/Observation1 trials AZD43601 trials Sonesitatug vedotin1 trials Albumin-bound Paclitaxone1 trials JNJ-898534131 trials TYRA-4301 trials Pelabresib1 trials Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy1 trials IMGN8531 trials WSD06281 trials bezuclastinib1 trials Evorpacept1 trials ABSK0611 trials MAPK inhibitors1 trials 9-HPV vaccine1 trials High dose for 15-HPV vaccine1 trials Medium dose for 15-HPV vaccine1 trials Difluoromethylornithine1 trials Anthracyclines or anthraquinones1 trials Lutetium Lu 177 JH020002 Injection1 trials Stool collect1 trials Salvage Chemotherapy Regimen1 trials HMPL-306 Regimen1 trials mini-hyperCVD1 trials MRG003 in combination with pucotenlimab1 trials I-124 PET/CT imaging1 trials MEK Inhibitor1 trials EGFR Monoclonal antibody1 trials BRAF Inhibito1 trials ALK inhibitor1 trials MET inhibitor1 trials Sapropterin Dihydrochloride1 trials R-pola-mini-CHP1 trials Talazoparib with enzalutamide1 trials Tazemetostat Hydrobromide1 trials Tislelizumab plus Bevacizumab1 trials Rhenium Liposome Treatment1 trials FOLFIRINOX or gemcitabine-nab-paclitaxel1 trials Adjuvant Chemotherapy + Ovarian Function Suppression1 trials Ovarian Function Suppression + Aromatase Inhibitor1 trials PD-1 monoclonal antibody consolidation therapy1 trials Collection of blood samples for the study of HBV biomarkers1 trials Alpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside1 trials Iohexol 350 Mg/mL Injectable Solution1 trials Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine1 trials YTS104 Cells injection1 trials Adjuvant chemotherapy (optional)1 trials CD19 Directed CAR T Cell1 trials Calcium and Vitamin D Supplementation1 trials Ropivacaine Hydrochloride 10 MG/ML [Naropin]1 trials celecoxib and metformin combination1 trials celecoxib monotherapy1 trials Trastuzuma1 trials AI1 trials SERD1 trials SHR63901 trials FOLFIRI Regimen1 trials Darotamine Capsule1 trials Enzalutamide Tablet1 trials SHR2554 Tablet1 trials Abiraterone Tablet1 trials SHR3680 Tablet1 trials HS-20093 for Injection1 trials Claudin18.2 CAR-T cells1 trials bi-4SCAR CD19/79b T cells1 trials VS-67661 trials RC48-ADC and JS0011 trials Cannabisextrakt Avextra 10/10 Lösung1 trials IL12-L19L191 trials Adolescent PCOS group receiving oral contraceptives1 trials EDV-GC1 trials E-EDV-D6821 trials SP-0021 trials T-DM1 adjuvant1 trials SHR-1501, Adebrelimab1 trials CRN096821 trials OMTX7051 trials CRX100 suspension for infusion1 trials Sacituzumab tirumotecan (iv)+Putolizumab injection (iv)1 trials HRS-62131 trials Human Serum Albumin Infusion for HAT Group1 trials Human Serum Albumin Infusion for LAT Group1 trials CHOP Regimen1 trials ADCT-7011 trials IMP90641 trials STRO-0021 trials Camrelizumab Plus Chemotherapy and Famitinib1 trials RC1012 injection (allo-DNT cells)1 trials CUSP061 trials Human CD19Targeted T Cells Injection1 trials Sintilimab+mFOLFOX6 or FOLFIRI+bevacizumab or cetuximab1 trials Cadonilimab + bevacizumab + FOLFOX1 trials SHR-A2009 ; Aumolertinib1 trials GEN-725 tablets + Dositinib mesylate tablets1 trials FOLFIRI ± Bevacizumab1 trials FOLFIRI + Vemurafenib + Cetuximab1 trials [18F]FluorThanatrace ([18F]FTT)1 trials Toripalimab （12weeks）1 trials Sequential CTX1 trials Sequential Epirubicin1 trials Disitamab Vedotin Injection （12 weeks）1 trials Toripalimab （18weeks）1 trials Disitamab Vedotin Injection （18 weeks）1 trials XMT-20561 trials UTD11 trials ZEN-36941 trials PHN-0121 trials Liposomal Doxorubicin (Doxil)1 trials Copper Gluconate1 trials CD30.CAR-EBVST cells1 trials Fludarabine and Melphalan1 trials Venetoclax in combination with fludarabine and melphalan1 trials Ribociclib combined with AI±OFS1 trials Alpha/Beta T Cell-Depleted Hematopoietic Stem Cells1 trials Intensified protocol1 trials Aromatase inhibitors or tamoxifen1 trials Androgen Deprivation Therapy (ADT) - Goserelin1 trials TSL-1502 capsules(high dose)1 trials TSL-1502 capsules(low dose)1 trials SPH50301 trials Zanubrutinib Oral Product1 trials Perillyl alcohol1 trials ANS031 trials Pirfenidone/Placebo1 trials TACE combined with Acoradine1 trials GC012F1 trials Systematic drug treatment1 trials Intraperitoneal chemotherapy during surgery1 trials TL118 Capsule1 trials SYS60051 trials FZ-AD0041 trials [89Zr]-Df-Trastuzumab1 trials Umbilical Cord Blood (UCB)1 trials Apatinib monotherapy1 trials Gallium Ga 68-DOTA-FAPI-041 trials ASD1411 trials TQB3909 tablet1 trials Furmonertinib 80 mg placebo1 trials Drug: Furmonertinib 80 mg1 trials AZD77891 trials Anti-BCMA-GPRC5D CAR-T cells infusion1 trials Cardenilimab Combined With Chemotherapy1 trials FH-0061 trials LCAR- F33S cells intravenous infusion1 trials Precision therapy1 trials Selinexor + High-dose Methotrexate + Rituximab + WBRT1 trials M0321 trials Utomilumab1 trials Anti-OX40 Antibody PF-045186001 trials NP-G2-0441 trials Association of pembrolizumab + cabozantinib1 trials PLB-0021 trials Personalized drug combination1 trials Topical treatment1 trials Chemotherapy (wP-EC)1 trials Intercostal nerve block1 trials Erector Spinae (ESP) Block with Bupivacaine (Marcaine®)1 trials Leucovorin (LV) or levoleucovorin1 trials Recombinant Interferon Alpha 2b-like Protein1 trials Paclitaxel, platinum-based drug1 trials SWA12111 trials STI-85911 trials GenSci1391 trials IMA 401 (Phase Ib)1 trials Pembrolizumab (Phase Ia)1 trials IMA401 (Phase Ia)1 trials TCMCB071 trials Target Gene1 trials PD-1/PD-L1/PD-1&CTLA4 inhibitor1 trials Palbociclib Pill1 trials Pazopanib Pill1 trials Lenvatinib Capsules1 trials Sacituzumab Govitecan-Hziy 180 MG1 trials Alpelisib Pill1 trials Vebreltinib Enteric Capsules1 trials Varenicline 1mg BID1 trials TJ1011 trials sodium glycididazole1 trials Tinengotinib 10 mg1 trials Tinengotinib 8 mg1 trials PhOx4301 trials Anti-CFH Monoclonal Antibody GT1031 trials padeliporfin VTP1 trials Pembrolizumab + Enfortumab Vedotin1 trials Poly-ICLC, Intertumoral (IT) injection1 trials Poly-ICLC intramuscular (IM) injection1 trials Anti-PD1 armored CD19 CAR-T cells1 trials Toripalimab and axitinib1 trials Clarithromycin1 trials [²¹²Pb]Pb-ADVC001 (Phase 2a)1 trials [²¹²Pb]Pb-ADVC001 (Phase 1b)1 trials GT101 injection1 trials Super DC Vaccine1 trials Anti-GARP Chimeric Antigen Receptor-T Cells1 trials Standard First-Line Chemotherapy1 trials CAV/IE alternate chemotherapy1 trials Toripalimab Combined With CAV/IE chemotherapy1 trials BA11061 trials AG-1201 trials Ifosfamide/cisplatin/etoposide1 trials Somatostatin analog; chemotherapy1 trials Allogeneic cytomegalovirus-specific T cells1 trials Tretinoin1 trials Tinzaparin1 trials Dalteparin1 trials Omeprazole 80 mg twice daily1 trials Nanobody-Based CD19/CD22 Tandem Dual CAR-T1 trials Cusatuzumab1 trials LICSBR1 trials platinum-based dual-agent chemotherapy1 trials SHR-A2009 monotherapy1 trials Vepugratinib1 trials Immunohistochemical staining1 trials IMV101 treatment1 trials Carboplatin/Nedaplatin1 trials Paclitaxel/Paclitaxel-albumin1 trials FOLFOX or FOLFIRI1 trials XH0011 trials Senaparib1 trials DANYELZA1 trials FID-0221 trials PCC1 trials ATG 4.01 trials ATG 5.01 trials Lidocaine 1% Injectable Solution1 trials Glumetinib Tablets1 trials Vinorelbine Tartrate1 trials QL1706 injection1 trials XS-04 tablet1 trials PTX-9121 trials SPH43361 trials 68Ga-BC11 trials MOMA-3411 trials LAM5611 trials Utidelone in combination with capecitabine1 trials Maintenance therapy1 trials Course B3 +Vin1 trials Course A3 + Vin1 trials Course B2 +Vin1 trials Course A2 + Vin1 trials Course B1 +Vin1 trials Course A1 + Vin1 trials P regimen1 trials FOG-0011 trials CIS-DPI1 trials Denosumab；SHR-2017 placebo1 trials SHR-2017、Denosumab placebo1 trials Nivolumab [Opdivo]1 trials Lenvatinib + Letrozole1 trials Decapeptyl1 trials Ultomiris1 trials PUL-0421 trials PM541 trials ACE-232 tablets1 trials Fasudil1 trials PANK-003 cell injection1 trials Revaree Plus1 trials Targeted Therapy Agent1 trials IBI30261 trials FP008 for injection1 trials 18F-fluoromisonidazole1 trials CD7 CAR-T cells infusion1 trials Orelabrutinib Consolidation and Maintenance Therapy1 trials Other Targets: precise treatment based on the target1 trials lenvatinib plus anti-PD-1 antibody1 trials anlotinib or anlotinib plus anti-PD-1 antibody1 trials dabrafenib plus trametinib with or without PD-1 antibody1 trials Fruquintinib+ Lonsurf (trifluridine and tipiracil)1 trials GnRH agonist1 trials nab-Paclitaxel (nab-P)1 trials Lanreotide (Autogel formulation) or Octreotide LAR1 trials Amino acid solution1 trials Testosterone Enanthate 100 MG/ML Injectable Solution1 trials Placebo combined with Chemotherapy1 trials Serplulimab Combined With Chemotherapy1 trials GenSci143 for injection1 trials IDE-1611 trials Osimertinib + Sacituzumab Tirumotecan1 trials Losartan 50mg Tab1 trials Cooled Sodium Chloride Injection1 trials Chemotherapy Drug, Cancer - Physician's Choice1 trials IA Carbo+ Radiation1 trials Surufatinib, gemcitabine, nab-paclitaxel1 trials Thoracic epidural block1 trials Erector spinae plane block (ESPB)1 trials QL0911 plus Placebo1 trials QL09111 trials SAL-0951 tablets 5mg1 trials SAL-0951 tablets 4mg1 trials TUB-0401 trials Irinotecan Injection1 trials KN026/Placbo Injection1 trials NC4101 trials RMC-55521 trials JNJ-894026381 trials MK-82941 trials CC-1, PSMAxCD31 trials MPD-11 trials Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin1 trials LAT010 + ICI1 trials LAT0101 trials Cisplatin for injection 100 mg/m21 trials RRx-0011 trials pembrolizumab plus axitinib1 trials [18F]FMISO-PET with contrast-enhanced MRI1 trials zorifertinib1 trials Iodinated Contrast Media (ICM)1 trials GB2011 trials Codrituzumab1 trials CD1a-CAR T1 trials SynKIR-3101 trials PIPAC with Nal-IRI1 trials SG301 placebo1 trials SG301 Injection1 trials GP350 CAR-T1 trials ABL5031 trials AZD5363+Olaparib+Durvalumab1 trials R-miniCHOP1 trials R-miniCHOP + Acalabrutinib1 trials Combination of Cardonizumab with Lenvatinib and SOX regimen1 trials 18F-FES1 trials B0071 trials Gliolan1 trials IMGS-0011 trials Oba011 trials PITAC1 trials SHR36801 trials LT-002 (Lactobacillus reuteri ATG-F41 trials Fianlimab 1600 MG Intravenous Solution1 trials Cemiplimab 350 MG Intravenous Solution1 trials Sacituzumab1 trials Afatinib 40 MG1 trials S-1, leucovorin, oxaliplatin and gemcitabine1 trials Placebo followed by Fisetin1 trials Fisetin followed by Placebo1 trials palliative care group first-line scheme1 trials first-line scheme+compound kushen injection1 trials Bevacizumab Injectable Product1 trials E77771 trials Erlotinib Hydrochloride1 trials HC-11191 trials Azacitidine and Venetoclax and APL-40981 trials Azacitidine and APL-40981 trials APL-40981 trials LUM0151 trials GnRH Antagonist Protocol1 trials Progestin-Primed Ovarian Stimulation (PPOS)1 trials KEYTRUDA® (pembrolizumab) 25 mg/mL Solution for Injection1 trials Pegylated interferon α-2b1 trials Placebo in combination with Cytarabine Injection1 trials Magnesium Chloride-based Lotion1 trials Lenalidomide 25 MG Oral Capsule1 trials ABBV-1011 trials Immuncell-LC1 trials L-NMMA1 trials TQB3909 Tablets + Azacitidine1 trials sham mPENTOCLO1 trials modified PENTOCLO (mPENTOCLO)1 trials olaparibp, embro1 trials CLL1 CAR-NK cell injection1 trials RJK-RT2831 Dose Expansion Phase Ib1 trials RJK-RT2831 dose-escalation phase Ia1 trials SHR-A1811and 5-FU1 trials SHR-1316 and SHR-A18111 trials SHR-A1811, SHR-1316, and 5-FU1 trials SHR-A1811, SHR-1316, capecitabine,and oxaliplatin1 trials SHR-A1811, SHR-1316, and capecitabine1 trials SHR-A181, SHR-1701, and capecitabine1 trials SHR-A1811 and capecitabine1 trials SHR-A1811 and SHR-17011 trials LhRH-antagonist1 trials Prostate hyperplasia medication1 trials ALA1 trials chemotherapy regimen selected by the investigator1 trials EGFR-TK Inhibitor1 trials QL1706 combined with SOX1 trials IBB09791 trials TPF group1 trials 89-zr-dfo-star polyethylene glycol (StarPEG)1 trials TKI-Based Therapy1 trials FOLFIRINOX regimen1 trials AG regimen1 trials NMD6701 trials CTD402 CAR T Cell Injection1 trials Offering HPV vaccine1 trials Dostarlimab-Gxly 50 MG/1 ML Intravenous Solution [JEMPERLI]1 trials MT218 injection1 trials SM-020 1% Gel1 trials Consolidation chemotherapy with FOLFOX1 trials Chemotherapy with 5-fluorouracil1 trials WZTL-002 CAR T-cells1 trials PHST0011 trials Elenestinib1 trials FES1 trials Sonazoid1 trials Irinotecan Liposomal1 trials Irinotecan liposoma1 trials various neoadjuvant therapies1 trials IDP-0231 trials JCXH-212 Injection1 trials Immune checkpoint inhibitor (ICI)1 trials Topical application of a fluorescent imaging agent1 trials D-CMG1 trials Asciminib 80 MG daily1 trials Asciminib 40 MG Twice Daily1 trials Asciminib 40 MG1 trials Gadopiclenol1 trials tumor neoantigen specific T cell1 trials nivolumab-GX-188E-GX-I71 trials BR111 for Injection1 trials Fuzaparib1 trials JS212 for Injection1 trials Pembrolizumab after randomization1 trials Pembrolizumab before randomization1 trials ES0141 trials Celecoxib (Celebrex)1 trials PAS-004 Capsules1 trials Tunlametinib+PD-1 mAb1 trials BL01751 trials gemcitabine + docetaxel1 trials SC16.56, Phase II1 trials SC16.56, Phase I, Cohort 31 trials SC16.56, Phase I, Cohort 21 trials 89Zr-DFO-SC16.561 trials systemic therapy alone1 trials Proton Pump Inhibitor (PPI) Therapy1 trials Probiotic1 trials Vonoparazan1 trials QY-1-T1 trials Talimogene Laherparepvec1 trials BG-603661 trials Turmeric1 trials IBD03331 trials 68Ga-aGPC3-scFv/Fab1 trials Casdozokitug1 trials BRY812 for injection1 trials Zimberelimab (AB122)1 trials Etrumadenant (AB928)1 trials α-PD-L1/4-1BB DLL3 CAR-T (BHP01)1 trials ADP-TILIL71 trials Orelabrutinib combined with obinutuzumab1 trials Orelabrutinib combined with bendamustine and rituximab1 trials Peripheral immunological assessment on venous blood1 trials Inactivated Influenza Vaccine1 trials Pucotenlimab combination with Vorolanib1 trials Postoperative adjuvant lenvatinib1 trials Metarrestin1 trials Pegylated G-CSF (Pegfilgrastim)1 trials Bleomycin (active name: Bleomycin Sulfate)1 trials Paclitaxel + Ifosfamide + Cisplatin & Toripalimab1 trials Tegodor1 trials Atezolizumab 1200 mg abs day 1 q22 (iv)1 trials TA-CIN1 trials Triamcinolone Acetonide/5-fluorouracil mixture1 trials Triamcinolone Acetonide1 trials 5-fluorouracil Injection1 trials Disitamab Vedotin + tislelizumab + bevacizumab1 trials Late post-transplant vaccination with Gardasil 9®1 trials Early start post-transplant vaccination with Gardasil 9®1 trials SIGX1094R1 trials Abemaciclib + Fulvestrant1 trials Abemaciclib + Aromatase Inhibitor1 trials Cadonilimab+S-1or Capecitabine1 trials SIBP-A181 trials HDM20171 trials mFOLFOX71 trials CA-49481 trials Topical Adapalene Gel 0.1%1 trials 177Lu-CTR-FAPI1 trials JV-3941 trials NHWD-8701 trials Aumolertinib；midazolam1 trials Switch1 trials ZE 50-01341 trials AUR1121 trials Thyrogen1 trials Chidamide + Tislelizumab + chemotherapy (CapeOX )1 trials IX001 TCR-T injection1 trials SHR-A2102, HRS4642 and Adebrelimab1 trials SHR-A1811 or/and HRS-46421 trials SHR-A1904 or/and HRS-46421 trials SHR-A2102 or/and HRS-46421 trials Ersodetug1 trials GEN30181 trials LBL-007 Injection1 trials Standard Reagents, Pancreatic Cancer1 trials BC008-1A 1200mg1 trials BC008-1A 900mg1 trials Lenvatinib + Envafolimab1 trials Chemo-radiotherapy alone1 trials Camrelizumab plus chemo-radiotherapy1 trials Cadonilimab Injection1 trials Nardraparin calcium injection1 trials TURALIO(R)1 trials Apatinib and Adebrelimab in Combination With chemotherapy1 trials SSGJ-6121 trials AST-0011 trials Belumosudil1 trials Cidabenamine, Azacitidine1 trials 5-Flurouracil1 trials STM-416p1 trials Haematopoietic growth factor1 trials FOLFIRINOX treatment1 trials [177Lu]Ludotadipep 3.7 GBq1 trials IO-108 1200 mg1 trials NKT21521 trials IO-108 1800 mg1 trials Tobemstomig 1200 mg1 trials Tobemstomig 600 mg1 trials Tobemstomig 2100 mg1 trials TPST-11201 trials Bevacizumab 15 mg/kg1 trials BNT3231 trials VMD-928 Tablet and Pembrolizumab (200 mg)1 trials VMD-928 100 mg Tablet1 trials EXTERNAL BEAM RADIATION1 trials Hydromorphone 10 mcg/mL epidural solution1 trials Bupicavaine 0.125% epidural solution1 trials Bupivacaine 0.25% Preservative-Free Injectable Solution1 trials Bupivacaine 0.75% in Dextrose Inj 8.25%1 trials TTX-0801 trials Navelbine oral,Pembrolizumab1 trials Raltitrexed-PIPAC1 trials Mitomycin-PIPAC1 trials Cytarabine Injection1 trials HY05350 for injection1 trials Donor-derived Natural Killer Cell1 trials Ethiodized Oil1 trials irinotecan liposome II combined with 5-FU/LV and oxaliplatin1 trials DA-EPOCH1 trials TNhYP217 CAR T Cells1 trials CCI-0011 trials albumin-bound Paclitaxel injection1 trials Darolutamide intermittent1 trials Darolutamide continuous1 trials BP-C21 trials CD19x22 CAR T Cells1 trials Universal CAR-T cells injection for treating mCRC1 trials coformulation favezelimab/pembrolizumab1 trials coformulation pembrolizumab/quavonlimab1 trials Placebo+G-CSF1 trials Motixafortide+G-CSF1 trials PD-L1/IDO Peptide Vaccine1 trials Clinical standard-of-care (physician's choice)1 trials Axitinib (VEGF-TKI)1 trials Enfortumab vedotin-ejfv (EV)1 trials GenSci122 tablet 250mg1 trials GenSci122 tablet 50mg1 trials Postoperative flurbiprofen axetil1 trials Preemptive flurbiprofen axetil1 trials SHR-A1811+Adebrelimab1 trials Unconjugated belantamab antibody and belantamab mafodotin1 trials Unconjugated belantamab antibody1 trials Imaging Agent1 trials Sintilimab + IL-2 Combined with CAPOX1 trials Cyclophosphamide 50mg1 trials Technetium (99mTc)1 trials patients were assigned to receive TNT or iTNT management1 trials EIK10051 trials ROS-scavenging Nanoenzymes1 trials Camrelizumab plus apatinib Cohort B1 trials Camrelizumab plus apatinib CohortA1 trials Abiraterone acetate + Prednisone or Prednisolone1 trials Anti-PD1 Monoclonal Antibody1 trials ORIC-114 Dose 3 + amivantamab1 trials ORIC-114 Dose 2 + amivantamab1 trials ORIC-114 Dose 1 + amivantamab1 trials IMM25101 trials IMM27M1 trials ponsegromab1 trials Enzalutamide；Abiraterone1 trials HRS-4357 injection1 trials Tart Cherry Juice1 trials Anti-CTLA4 Monoclonal Antibody1 trials TP53-EphA-2-CAR-DC1 trials Thoracic Epidural Analgesia1 trials Iopamidol1 trials mRNA HBV/TCR T-cells1 trials Palbocicilib1 trials Fruquintinib+mFOLFOX6/FOLFIRI1 trials LTZ-3011 trials 5-FU, Leucovorin, Oxaliplatin, Docetaxel1 trials DB-1311/BNT3241 trials TSN16111 trials HLX171 trials TH96191 trials HER2, pyrotinib + pertuzumab/trastuzumab1 trials alpelisib+fulvestrant1 trials CDK4/6 inhibitor+AI or fulvestrant1 trials ivonescimab + investigator-choice platinum doublet+1 trials AR,darolutamide +goserelin +docetaxel1 trials AR,darolutamide + goserelin+pertuzumab/trastuzumab1 trials HER2,trastuzumab deruxtecan± pertuzumab1 trials albumin-bound paclitaxel+trastuzumab+pyrotinib1 trials Albumin-paclitaxel + carboplatin + apatinib + camrelizumab1 trials Albumin-paclitaxel + platinum1 trials Cohort 2 (NTRK-fusion or NTRK-mutant)1 trials Cohort 1 (HER2-positive, RC48-ADC)1 trials CX-54611 trials WBF-0381 trials Adebrelimab;decitabine;1 trials sac-TMT1 trials Sintilimab adjuvant1 trials SOX adjuvant, Sequential S-11 trials Sintilimab neoadjuvant1 trials SOX neoadjuvant1 trials Oxaliplatin by arterial infusion plus S-11 trials Melphalan Hydrochloride1 trials Autologous Platelet-Rich Fibrin (PRF)1 trials Biological: InnoPCV1 trials Biological: PD-11 trials TT-41 trials TT-101 trials Osilodrostat (Isturisa)1 trials APA + ADT1 trials pTTL1 trials Pembrolizumab (+) Berahyaluronidase alfa1 trials Infusion of alloreactive NK cells1 trials bi-4SCAR GD2/PSMA T cells1 trials 0.9% Sodium Chloride 20mL Injection1 trials Levo-Bupivacaine Hydrochloride (HCl) 0.5 % in 20mL Injection1 trials SHR-1701 + Rivoceranib1 trials SHR-1701+Rivoceranib + SHR-25541 trials Cabozantinib and Temozolomide1 trials Oxaliplatin 100 MG1 trials BEN1011 trials HDM20061 trials BNT317 DL7 (additional)1 trials BNT317 DL6 (intermediate)1 trials BNT317 DL5 (intermediate)1 trials BNT317 DL41 trials BNT317 DL31 trials BNT317 DL21 trials BNT317 DL11 trials AT021 trials Sapylin1 trials Enasidenib Mesylate1 trials Fecal swab collection1 trials Radiolabelled tracer, 68Gallium-FAPI-46 PET/MRI1 trials Tarlatamab treatment1 trials SNV48181 trials TBI-20011 trials mRNA-42031 trials mFOLFOX6/XELOX adjuvant chemotherapy1 trials mFOLFIRINOX adjuvant chemotherapy1 trials Toripalimab (anti-programmed death-1 inhibitor)1 trials Dacarbazine, temozolomide, paclitaxel, carboplatin/cisplatin1 trials LM103 TILs Injection1 trials KL-7SHRNA injection solution1 trials AZD66211 trials Cladribine, Cytarabine, Mitoxantrone, G-CSF (CLAG-M) regimen1 trials LioCyx-M, HBV antigen-specific TCR-redirected T cells1 trials Placebo in combination with Pembrolizumab1 trials AK117 in combination with AK1121 trials Secretin1 trials Paclitaxel and Carboplatin1 trials LY4066434.1 trials HS-103861 trials EB1031 trials Q7021 trials Autologous CAR19 T lymphocytes1 trials Placebo of Darolutamide1 trials Radiotracer Injection1 trials Injection of a gadolinium contrast agen1 trials PD11 trials GEMOX Regimen1 trials SMP3124LP1 trials Olanzapine 5 MG1 trials TVB-26401 trials Standard disease-directed therapy1 trials INCB1600581 trials Vigabatrin1 trials ACE18311 trials APG-1571 trials epirubicin,cyclophosphamide,paclitaxel1 trials epirubicin,cyclophosphamide,paclitaxel,Carrelizumab1 trials biopsy liquid1 trials Relugolix 120 MG [Orgovyx]1 trials AT10191 trials ATTR-011 trials Niraparib oral tablets1 trials Antibody-drug conjugate (ADC)1 trials Loncastuximab1 trials Infusion of Axicabtagene Ciloleucel1 trials stroke-physiological saline solution (SPSS)1 trials CP-5061 trials XNW290161 trials Ara-C1 trials Amsacrine1 trials Oxaliplatin 130mg/m2 + Capecitabine 1000mg/m21 trials Tc-99m Pentetate1 trials SAF-189s1 trials AT-1965 Liposome Injection1 trials Mutant KRAS G12V-specific TCR transduced autologous T cells1 trials Platinum chemotherapy: carboplatin (preferred) or cisplatin1 trials RNK08954-011 trials CNP-1061 trials Oral Aminolevulinic Acid Hydrochloride1 trials Aminolevulinic Acid Intravenous Formulation SONALA-0011 trials Camonsertib1 trials Neoadjuvant chemotherapy combined with Toripalimab1 trials Osimertinib (Osi)1 trials Navtemadlin Placebo1 trials Navtemadlin1 trials RNDO-5641 trials Mosunetuzumab (IV)1 trials Single dose injection of certain dose of UWD-191 trials Docetaxel and Carboplatin1 trials DS9051b1 trials CARCCR9 T cells1 trials Belzutifan 120mg1 trials Pembrolizumab/Vibostolimab coformulation1 trials Abiraterone acetate 1000 mg1 trials Olaparib 300 mg1 trials Enzalutamide 160 mg1 trials Prednisone 5 mg1 trials Docetaxel 75 mg/m^21 trials Olaparib 400 mg1 trials AMT-2531 trials Organoid-guided treatment1 trials No anticoagulation1 trials Apixaban 5 mg once daily1 trials Apixaban 2.5 mg twice daily1 trials Fluorescein + ALA1 trials Fluorescein1 trials Vabametkib1 trials Pembrolizumab + Carboplatin + Pemetrexed1 trials Mavrostobart (PT199)1 trials Lactobacillus1 trials Chinese medicine1 trials Chinese medicine and Lactobacillus1 trials approved PD-1/PD-L1 inhibitors (e.g., Tislelizumab, etc.)1 trials Standard treatment（SoC）1 trials STI-73491 trials Nicotine Replacement Product1 trials Bojungikki-tang(BJIKT)1 trials Blood sampling C121 trials Blood sampling C11 + FFPE1 trials Blood sampling C91 trials Blood sampling C81 trials Blood sampling C61 trials Blood sampling C51 trials Blood sampling C4/7/10/131 trials Blood sampling C31 trials Pafolacianine Sodium1 trials Toluenesulfonamide (PTS) Intratumoral Injection1 trials MK-4280A1 trials MK-42801 trials Intermittent PD-1/PD-L1 ICI + VEGFR-TKI1 trials [177Lu]Lu-DPI-44521 trials [68Ga]Ga-DPI-44521 trials ICP-1921 trials VRD for first-cycle induction therapy1 trials Oral Vitamin C1 trials Melphalan/HDS (Percutaneous Hepatic Perfusion)1 trials Peptide-based vaccine1 trials Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver1 trials microbubble CEUS Contrast Enhanced Ultrasound (CEUS)1 trials Trifluridine/tipiracil (TAS-102) plus bevacizumab1 trials MGD0241 trials Placebo 0.9% normal saline1 trials PG2 Lyo. Injection 500mg1 trials SCG142 TCR-T cells1 trials Propranolol and etodolac1 trials 5-Azacitidine1 trials CD19-CAR-NK/T1 trials SHR2554+ SHR17011 trials Antitumor treatment plan1 trials TST0011 trials Bendamustine Injection1 trials chidamide and azacitidine1 trials CART-EGFR-IL13Ra2 T cells1 trials Phase II:[177Lu]Lu-XT033 Injection1 trials Phase I:[177Lu]Lu-XT033 Injection1 trials BI12061 trials Inhaled preparation for COPD1 trials Antitumor therapy1 trials CX-8011 trials Mesenchymal Stem Cell Transplantation1 trials BGT007 Injection1 trials Cisplatin based chemottherapy1 trials Denosumab / Zoledronic Acid1 trials ETC-1591 trials Pertuzumab/Trastuzumab/Hyaluronidase-zzxf1 trials Test product: HYP-2090PTSA1 trials SHR-A2102 ; Adebrelimab injection1 trials rmhTNF-NC1 trials CD-0011 trials Diclofenac Sodium Gel1 trials Regorafenib (BAY73-4506)1 trials Lapatinib+Capecitabine1 trials Hemay022+AI1 trials EI-1071 tablet, oral1 trials HLX53 (2000mg)1 trials HLX53 (1000mg)1 trials WU-CART-0071 trials IBI3081 trials Al18F-PSMA-BCH PET/CT1 trials Subcutaneous Blinatumomab1 trials Pemetrexed Disodium Injection1 trials MRG0021 trials Targeted Systemic Therapy1 trials BA12021 trials VBC1011 trials HS-20089 (Phase Ib: Dose expansion)1 trials HS-20089 (Phase Ia：Dose escalation )1 trials capecitabine plus oxaliplatin after surgery1 trials capecitabine plus oxaliplatin before and after surgery1 trials GD2-CART01 (iC9-GD2-CAR T-cells)1 trials YH429461 trials Therapeutic Intervention1 trials TR641 trials Medication optimization1 trials Autologous HB-adMSCs1 trials GLS-0101 trials GLS-0121 trials LM-1681 trials Discontinuation of CDK4/6 inhibitor Abemaciclib1 trials Continuation of CDK4/6 inhibitor Abemaciclib1 trials Discontinuation of CDK4/6 inhibitor Palbociclib1 trials Continuation of CDK4/6 inhibitor Palbociclib1 trials Anticancer therapy 41 trials Anticancer therapy 31 trials Peptide vaccine1 trials Zunsemetinib1 trials CTL0191 trials LNCB741 trials BIO 3001 trials FACT Complex-targeting Curaxin CBL01371 trials Ripretinib1 trials Inlexisertib1 trials Cisplatin pleural infusion1 trials M701 pleural infusion1 trials KSV01 Injection1 trials Pantoprazole high dose1 trials Pantoprazole low dose1 trials Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/15631 trials QLS1304 tablet1 trials SBP-1011 trials 177Lu-BetaBart1 trials HQP13511 trials Xembify1 trials Keynatinib1 trials Coagadex(R)1 trials 1 mg 89Zr-DFO-Nimotuzumab1 trials 50 mg 89Zr-DFO-Nimotuzumab1 trials Conventional treatment with Western medicine1 trials SC cytarabine +Venetoclax1 trials TERN-7011 trials Sintilimab (PD-1 Antibody)1 trials Pazopanib (800 mg QD)1 trials Lapatinib (1500 mg QD)1 trials Sorafenib (400 mg BID)1 trials Everolimus (10 mg QD)1 trials Nilotinib (400 mg BID)1 trials decitabine plus venetoclax1 trials mFOLFOX ：Oxaliplatin,leucovorin calcium,5-fluorouracil1 trials Acetaminophen 500mg1 trials Meloxicam 15 mg1 trials Meloxicam 7.5 mg1 trials Personalized Synthetic Long Peptide Vaccine1 trials CPX-3151 trials Cytarabine and Idarubicin1 trials DT22161 trials ABSK0211 trials ALE.P031 trials CLSP-10251 trials Chemoplaque also referred to as Episcleral Topotecan1 trials Gemcitabine combined with cisplatin or oxaliplatin1 trials Levofloxacin-based triple1 trials Standard triple therapy1 trials Levofloxacin-based quadruple therapy1 trials Bismuth-based quadruple therapy1 trials FGFR4-CAR T Cells1 trials Afatinib(RP2D)1 trials Afatinib(40mg)1 trials Afatinib(30mg)1 trials Cohort 6, GNR-0841 trials Cohort 5, GNR-0841 trials Cohort 4, GNR-0841 trials Cohort 3, GNR-0841 trials Cohort 2, GNR-0841 trials Cohort 1, GNR-0841 trials Placebo+BSC1 trials ABSK-011+BSC1 trials etoposide combined with adebrelimab and carboplatin1 trials ZG0895 Hydrochloride for Injection1 trials White Button Mushroom Extract1 trials Relmacabtagene autoleucel (relma-cel)1 trials intrathecal (IT) chemotherapy1 trials CHO-H01 at RP2D1 trials CHO-H011 trials ABBV-5251 trials TmCD19-IL181 trials Memantine-HCl1 trials Puxitatug Samrotecan1 trials CP-3831 trials ACE-86225106 tablet1 trials Gemcitabine, Docetaxel, or Capecitabine1 trials MRG003 + Pucotenlimab1 trials Lenvatinb1 trials TORL-4-5001 trials AU-0071 trials HLX43 DOSE 2 (2.5 mg/kg)1 trials HLX43 DOSE 1 (2.0 mg/kg)1 trials Lenvatinib tablet1 trials Aromatase inhibitor Letrozole1 trials Eltrombopag (EPAG)1 trials AG-01 Compound1 trials Chemotherapy: Carboplatin1 trials iNeo-Vac-R01 in combination with standard adjuvant therapy1 trials DAPT regimen plus radiotherapy1 trials sunvozertinib 200mg1 trials sunvozertinib 300mg1 trials Ezetimibe1 trials Vytorin1 trials "novel" MAB (alone or in combination)1 trials HS-10502 + Bevacizumab1 trials HS-10502 + nab-paclitaxel or Docetaxel or Irinotecan1 trials HS-10502 + Platinum + Bevacizumab1 trials HS-10502 + HS-200891 trials HS-10502+ Apatinib1 trials HS-10502 + HS-200931 trials HS-10502 + NHA1 trials Atezolizumab Injection1 trials Calcium levofolinate1 trials STRO-0041 trials CD20/CD22 dual Targeted CAR T-cells1 trials FOLFOX (Oxaliplatin/Leucovorin/5-Fluorouracil)1 trials Cetuximab (Erbitux)1 trials Imatimib Mesylate1 trials Pyrotinib 320mg1 trials Trastuzumab (or biosimilar)1 trials Trastuzumab SC1 trials Cohort1: ATRA+Toripalimab+chemo1 trials Cohort2: ATRA+Toripalimab+TPC1 trials CART-138/BCMA/19/more1 trials Sacituzumab Govitecan with pegfilgrastim1 trials Placebo+cisplatin/carboplatin+paclitaxel+Bevacizumab1 trials Socazolimab+cisplatin/carboplatin+paclitaxel+Bevacizumab1 trials abemaciclib, olaparib and endocrine therapy1 trials Ivonescimab, AK117, Albumin-bound Paclitaxel, Gemcitabine1 trials FOLFIRI plus target therapy only1 trials Metformin Pill1 trials Vitamin E1 trials OSE21011 trials Optional Endocrine Therapy of Investigator's Choice1 trials Taxane-based Chemotherapy1 trials BA31821 trials FOLFIRI (5-Fluorouracil, Folinic acid, Irinotecan)1 trials FOLFOX (Folinic acid + Fluorouracil + Oxaliplatin)1 trials Erbitux (Cetuximab)1 trials LOXO-4351 trials OTP-011 trials PD-1 with chemotherapy1 trials Umbilical cord blood1 trials Mycophenylate mofetil1 trials Surufatinib plus chemotherapy1 trials CM3691 trials Tremelimumab i.v. at 300 mg1 trials Durvalumab 1500 mg1 trials Durvalumab 1120 mg1 trials Programmed death receptor-1 inhibitor1 trials Oncolytic Adenovirus H1011 trials Reduced ATG plus mini PTCy1 trials lenvatinib plus pembrolizumab1 trials GI-1081 trials Glofitamab/Obinutuzumab1 trials BMS-9864581 trials CT0594CP1 trials Piflufolastat1 trials Docetaxel plus S-11 trials Oxaliplatin plus S-11 trials Methylnaltrexone1 trials WTX212A1 trials IBI30201 trials Nilotinib Hydrochloride Monohydrate1 trials SHR-A2102；Adebrelimab1 trials DM0021 trials TXN101281 trials HBI 0201-ESO TCRT1 trials CYCLOPHOSPHAMIDE and FLUDARABIN1 trials Adebrelimab combined with Etoposide Capsules1 trials Centipeda minima+PD-1/PD-L1 inhibitor1 trials AVM07031 trials Relugolix and Enzalutamide1 trials Asciminib single agent pediatric formulation1 trials Asciminib single agent1 trials FID0071 trials PT02531 trials CD45RA depleted donor lymphocyte infusion (DLI)1 trials Cosiporfin Sodium for injection, DVDMS1 trials UGN-1041 trials Fludarabine + Cyclophosphamide + TAA05 Cell Injection1 trials MSC-IFNα1 trials GS-21211 trials CBP-10181 trials EBV-specific T cells: B1 trials EBV-specific T cells: A1 trials Brimonidine tartrate ophthalmic solution eye drops1 trials Prednisolone acetate ophthalmic suspension 1% eye drops1 trials Lubricating Eye Drops1 trials OP-31361 trials Abiraterone acetate (Zytiga®) 250 mg or 500 mg tablets1 trials ORIC-9441 trials AP6011 trials IPN011941 trials SLC-30101 trials Placebo + Capecitabine1 trials Carrellizumab + Capecitabine1 trials Gemcitabine and Cisplatin Chemotherapy1 trials Anti-PD-1/PD-L1 antibody1 trials IBI30091 trials HLA-G-CAR.BiTE allogeneic γδ T cells1 trials Intensive Chemotherapy Regimen1 trials Maplirpacept1 trials AZD58631 trials A2B3951 trials Sintilimab+irinotecan+leucovorin folinate+fluorouracil1 trials TCR1 trials CAR1 trials HER-2 pulsed DC11 trials CRD38741 trials 18F-fluciclovine injection1 trials QL1706+Lenvatinib+AG Regimen1 trials UCB-NK cells1 trials mirvetuximab soravtansine (MIRV; IMGN853)1 trials Adjuvant treatment1 trials Neoadjuvant treatment1 trials AREXVY, ABRYSVO1 trials PREVNAR 201 trials PNEUMOVAX 231 trials Fluarix1 trials FluLaval1 trials Pfizer-COVID-19 Vaccine1 trials Heplisav -B1 trials PREVNAR 131 trials Afluria1 trials Flucelvax1 trials Shingrix1 trials Fluzone1 trials PD-1 inhibitor 200mg per three to four weeks, for one year1 trials CAPOXIRI1 trials Antitinib Hydrochloride Capsules1 trials Penplimab Injection1 trials MNPR-101-DFO*-89Zr1 trials Leuprorelin acetate + Sintilimab1 trials AVZO-0231 trials Ga-68-FAPI-461 trials LXP1788 is administered intravenously via Port-A1 trials Imzokitug1 trials PLX0381 trials CPO3011 trials pIFN (peginterferon alfa-2a)1 trials CLIC-19011 trials placebo TY-95911 trials placebo Osimertinib1 trials BCMA/GPRC5D double CAR-T1 trials DisitamabVedotinForIicction Toripalimab1 trials Low Molecular Weight Heparin (LMWH)1 trials Direct Oral Anticoagulant (DOAC)1 trials EVM161 trials 153Sm-DOTMP1 trials XELOX intensive treatment group1 trials 6-month adjuvant chemotherapy with 5-FU monotherapy1 trials Ametinib Mesylate Tablets1 trials IMNN-0011 trials NEO-201 in combination with pembrolizumab1 trials EGFR FPBMC1 trials Liposomal doxorubicin, Paclitaxel or Topotecan1 trials paclitaxel/Gemcitabine/Liposomal doxorubicin1 trials Dara-VRd induction1 trials AHCT intensification, Dara-R maintenance1 trials Dara-VRd intensification, Dara-R maintenance1 trials Berberine Hydrochloride1 trials E70901 trials Oral Contraceptives, Low-Dose1 trials Venetoclax combined with Orelabrutinib1 trials Venetoclax combined with Acalabrutinib1 trials Venetoclax combined with Zanubrutinib1 trials Venetoclax combined with Ibrutinib1 trials anti-CD19 IL10/IL15 CAR-NK1 trials Tucatinib Oral Tablet1 trials SAR4485011 trials Lifileucel (LN-144/LN-145)1 trials Hypotensive Drugs1 trials Trastuzumab deruxtecan (DS-8201a)1 trials Cetuximab/avelumab1 trials SHR-A2102；Adebrelimab；Cisplatin1 trials viscum album1 trials DC50292A1 trials Guarana1 trials Balanced anesthesia1 trials TIVA1 trials Investigators Choice1 trials Tebentafusp with Pembrolizumab1 trials IL-5 CAR-T cells1 trials TT-01488 Tablets1 trials EIK1004-001 (IMP1707-001)1 trials Autologous DC vaccine1 trials Irinotecan Liposomes (II)+Cetuximab+Bevacizumabl1 trials Neoadjuvant placebo plus perioperative SOX1 trials Neoadjuvant cadonilimab combined with perioperative SOX1 trials ASP58341 trials Phase II-solid tumors or lymphomas1 trials Phase II-Advanced melanoma1 trials Phase II-HNSCC1 trials Phase I dose escalation1 trials IIB：Other Gastrointestinal tumors1 trials IIC2：3E9 PFU of oncolytic virus, early combination1 trials IIC1：1E9 PFU of oncolytic virus, early combination1 trials IIA2：3E9 PFU of oncolytic virus, sequentially combination1 trials IIA1：1E9 PFU of oncolytic virus, sequentially combination1 trials cabozantinib and nivolumab1 trials PD-1/CTLA-4 inhibitor (Aiparolitoworixureli injection)1 trials Metformin 750 mg and herbal formulation 500 mg1 trials Herbal Formulation1 trials MHB046C1 trials Metabolically Armed BCMA CAR-T cells.1 trials αPD1/CTLA4-MSLN-CAR T cells1 trials Additional blood sampling1 trials bi-4SCAR CD19/70 T cells1 trials Filsuvez1 trials MK-04821 trials Boserolimab1 trials Vibostolimab1 trials Obinutuzumab 25 MG/1 ML Intravenous Solution [GAZYVA]1 trials ST-0671 trials JMKX0018991 trials MHB118C for Injection1 trials Anti-KRAS G12V mTCR PBL1 trials Analgesic Agent1 trials Chemotheraphy1 trials red yeast rice，RYR1 trials ST-011561 trials Ivonescimab plus chemotherapy1 trials Toripalimab (JS001 )1 trials Zanubrutinib, Bendamustine and Rituximab1 trials Brachytherapy1 trials ACHOP1 trials 18F-FDG PET/CT1 trials 68Ga-NY104 PET/CT1 trials Tapioca Flour1 trials Short Chain Fatty Acid1 trials Dual-Target Antigen-Selected CAR-NK1 trials EB-SELECT Single-Target CAR-NK Cells1 trials Allogeneic Adipose-derived Mesenchymal Stem Cells1 trials [68Ga]Ga-PSMA1 trials [68Ga]Ga-NOTA-CD70 antibody fragment1 trials [68Ga]Ga-DOTA-CAIX peptide1 trials Ascorbate1 trials Dihydroartemisinin1 trials Disitamab Vedotin combined with Bicalutamide1 trials Sacituzumab Tirumotecan and Limertinib1 trials cemiplimab+fianlimab1 trials Donor lymphocyte infusion1 trials CLN-0491 trials At the discretion of the investigator1 trials Ifosfamide or dacarbazine1 trials MDX20011 trials Intravenous anti-PD-1 and chemotherapy1 trials BGB-B4551 trials GDC-05871 trials PLB10011 trials Azacitidine for Intravenous Infusion1 trials Tuspetinib1 trials IKS031 trials INCB0817761 trials Docirbrutinib1 trials vilastobart (XTX101)1 trials Repeated intravenous immunoglobulin/plasma exchange therapy1 trials Ofatumumab combined with daratumumab1 trials Neoantigen Personalized Cancer Vaccine1 trials F182112+CD381 trials F182112+P1 trials Sacituzumab Govitecan-Hziy 180 MG plus bevacizumab1 trials MET1 trials Diane-351 trials GnRHa1 trials CD7-CART011 trials HS-20124 (Phase Ib: Dose expansion)1 trials HS-20124 (Phase Ia：Dose escalation )1 trials Savolitinib, Crizotinib.1 trials BAT8008 for Injection1 trials PolyICLC1 trials Infusion of iNKT cells and CD8+T cells1 trials Idarubincin1 trials Consolidation Doublet Therapy:1 trials Induction Chemotherapy Triplet Therapy1 trials AGuIX1 trials nab-paclitaxel + cisplatin1 trials Decitabine Injection1 trials Nanvuranlat1 trials CK08041 trials Ga-68 PSMA ligand1 trials Avutometinib (VS-6766) + defactinib1 trials mKRASvax1 trials AGEN2373 (RP2D)1 trials GVAX1 trials AGEN23731 trials Tetracycline 500mg tid1 trials Vonoprazan1 trials Vismodegib 150 MG Oral Capsule1 trials [68]Ga-HA-DOTATATE1 trials Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)1 trials SHR25541 trials SHR17011 trials Adjuvant temozolomide1 trials Dendritic cell immunization1 trials Intravenous infusion anti-CEA-CAR-T cell1 trials Tumor-associated antigen-specific T cell (TAA-T)1 trials GV20-0251 and Pembrolizumab [KEYTRUDA®]1 trials Pediatric lymphoma protocol1 trials Nilotinib 400mg1 trials Nilotinib 300mg1 trials Nilotinib 200mg1 trials Nilotinib 100mg1 trials Maintenance(12 Weeks/Cycle)1 trials Intensification course1 trials Blinatumomab-Salvage 2nd (Very High Risk Group)_4 Weeks1 trials Blinatumomab-Salvage 1st (Very High Risk Group)_4 Weeks1 trials Blinatumomab 2nd (High Risk Group)_4 Weeks1 trials Blinatumomab 1st(High Risk Group)_4 Weeks1 trials Consolidation 2nd(3weeks)1 trials Cosolodation 1st(3weeks)1 trials Reinduction(4weeks)1 trials Uromitexan1 trials CC-381 trials Androgen Receptor Signalling Inhibitor (ARPI)1 trials Etrumadenant (ETRUMA)1 trials Domvanalimab (DOM)1 trials Zimberelimab (ZIM)1 trials Intravenous Methadone1 trials Inrathecal Morphine1 trials Darzalex1 trials BCD-2641 trials XELOX+Sintilimab+HBOT1 trials TAB0041 trials Antiemetic Therapy1 trials JNJ-878903871 trials SAR4448811 trials Telpegfilgrastim1 trials SC rilvegostomig + rHu1 trials SC Rilvegostomig1 trials Recombinant Human Hyaluronidase (rHu)1 trials IV Rilvegostomig1 trials Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-11 trials 177Lu-R112281 trials 68Ga-R112281 trials Teniposide administration1 trials Chemoradiotherapy1 trials IBI363 + Investigator's Choice SOC1 trials TGFBR-2 KO CD70 CAR NK1 trials Cyclophosphamate1 trials Palazestrant matching-placebo1 trials Letrozole-matching placebo1 trials Eflornithine (Dose Level 2)1 trials Eflornithine (Dose Level 1)1 trials Chidamide plus R-CHOP1 trials Acute Normovolemic Hemodilution/ANH1 trials SoC systemic therapy1 trials AP402 (Part 2 Dose Expansion)1 trials AP402 (Part 1 Dose esclation)1 trials Blood sampling for venetoclax drug dosage (venous puncture)1 trials RP1, intra-tumoral injection, oncolytic virus1 trials Autologous Dendritic Cell (DC) Vaccine1 trials CTX-0091 trials cisplatin plus radiotherapy1 trials HB00251 trials Lapine T-Lymphocyte Immune Globulin1 trials Apatinib (anti-VEGFR inhibitor)1 trials Camrelizumab (anti-PD-1 inhibitor)1 trials Autologous hALK.CAR T cells1 trials LVGN6051 Monoclonal Antibody Injection1 trials Candida antigen vaccine1 trials 99mTc-based PSMA Imaging and Surgery Agent1 trials Triprolizumab1 trials TSN0841 trials Filgrastim, peg-filgrastim1 trials Multi-epitope HER2 Peptide Vaccine H2NVAC1 trials GVM±R regimen1 trials ODX (Osteodex)1 trials Mirvetuximab Soravtansine-gynx1 trials Placebo vaginal insert1 trials Artesunate vaginal insert1 trials Valproic Acid (VPA)1 trials Cadonilimab+regorafenib1 trials DF10011 trials GM11 trials BAFFR-CAR T cells1 trials 0.06mg/kg ZOPOCIANINE given days prior to surgery1 trials 0.03mg/kg ZOPOCIANINE given day prior to surgery1 trials 0.06mg/kg ZOPOCIANINE given day of surgery1 trials 0.03mg/kg ZOPOCIANINE given day of surgery1 trials CBL01371 trials KSX01-TCRT cell therapy1 trials Linperlisib combined with CPT regimen1 trials Concurrent cisplatin1 trials Induction Cisplatin1 trials LY42148351 trials mFOLFOX6 plus cetuximab1 trials mCapOX plus cetuximab1 trials JYP0035 Experimental Drug Treatment1 trials human papillomavirus vaccine, recombinant1 trials [177]Lu-DOTA-TATE1 trials Fentanyl + Dexmedetomidine1 trials Digoxin (0.25mg)1 trials Midazolam 2 mg for CYP3A4 phenotyping1 trials AL3818 or placebo1 trials AL38181 trials Arsenic trioxide Tablet +Fuzuloparib Capsules1 trials Amivantamab and Recombinant Human Hyaluronidase1 trials Nanobody-based biepitope BCMA-targeting CAR-T cells1 trials Salvage chemotherapy or best supportive care1 trials OH21 trials [Ac 225]RTX-23581 trials Treatment of Encorafenib & Binimetinib & Cetuximab1 trials Treatment of Encorafenib & Binimetinib & Ribociclib1 trials Encorafenib & Binimetinib Treatment1 trials Encorafenib only Treatment1 trials Binimetinib only treatment1 trials Control treatment arm1 trials Experimental treatment arm1 trials Tetanus Diphtheria Vaccine1 trials PEP-CMV1 trials Opioid-free Anesthesia-Analgesia Strategy1 trials Opioid-Based Anesthesia-Analgesia Strategy1 trials Hydrogen Peroxide1 trials pharmacokinetics blood sample assessment1 trials SHR2554/CHOEP1 trials SHR2554/CHOP1 trials Adebrelimab combined with Apatinib1 trials EO24631 trials TROP2-CAR-NK1 trials SIM0508 in combination with olaparib1 trials SIM0508 Tablets1 trials SUPRPEP1 trials NBT-NM1081 trials 64Cu-LLP2A1 trials CRC011 trials Ribociclib combined with NSAI±OFS1 trials TQB2916 Injection1 trials Cyclophosphamide and fludarabine1 trials CT103A cells1 trials SIBP-A101 trials ERX-3151 trials PT-1121 trials blinatumomab for B-ALL, venetoclax for T-ALL1 trials Active Comparator: endocrine therapy1 trials Experimental: chemotheyapy1 trials RGL-270 Injection1 trials 225Ac-PSMA-Trillium (BAY3563254)1 trials Immunonutrition1 trials DC vaccines1 trials Immunotherapy combined with chemotherapy1 trials 1-(2-[18F]FLUOROETHYL)-L-Tryptophan1 trials Nituzumab1 trials FL115+PD-11 trials LTX-315 + pembrolizumab1 trials Personalized Parenteral Nutritional Supplementation1 trials HCB3011 trials Drug therapy1 trials PRG23021 trials Debio 42281 trials 14C-bleximenib1 trials Eltrombopag olamine1 trials B10 L-BPA Injection1 trials Pemetrexed Phase 21 trials TCR-MAGE-A4 T-Cells1 trials orelabrutinib maintenance1 trials BEAM (carmustine (BCNU), etoposide, cytarabine, melphalan)1 trials Lazertinib+Pemetrexed+Carboplatin1 trials All-trans Retinoic Acid in combination with the KPD Regimen1 trials Ruxolitinib (JAKAVI®)1 trials Cyclosporine A (CsA)1 trials Urea cream1 trials Liangxue ointment（Traditional Chinese Ointment）1 trials PD1 Inhibitor1 trials AT-021 trials Donafenib + Envafolimab1 trials [212Pb]Pb-PSV3591 trials [203Pb]Pb-PSV3591 trials High dose testosterone1 trials MEN17031 trials XNW280121 trials Surgeon-Initiated Local Anesthetic1 trials TAP Anesthesia1 trials treatment Carboplatin1 trials treatment Doxorubicin1 trials treatment Actinomycin-D1 trials treatment Vincristin1 trials CART-PSMA cells1 trials Hydrogen Peroxide 3 % Topical Solution1 trials 19-28z/IL-18 CAR T cells1 trials HRS-67191 trials Pembrolizumab + Lenvatinib1 trials U161 trials SHR-3821 injection1 trials SCTB411 trials Chemoimmunotherapy1 trials T-cell Receptor-engineered T-cells1 trials VAL-4131 trials Vorasidenib Placebo1 trials LK101 injection (personlized neoantigen pulsed DC vaccine )1 trials BR1 trials R-CVP1 trials R-CHOP1 trials ABBV-7111 trials Iruplinalkib1 trials Anlotinib hydrochloride capsules, Penpulimab injection1 trials Gemcitabine hydrochloride and albumin binding paclitaxel1 trials Chemotherapeutic Agent1 trials 89Zr-Patritumab deruxtecan1 trials Cardunolizumab1 trials Epidiferphane1 trials Palbociclib Isethionate1 trials Cedazuridine1 trials ASTX030 (cedazuridine + azacitidine)1 trials BB102 tablet1 trials M35541 trials L-folinic acid1 trials Bispecific antibody for PD-L1 and VEGF-A1 trials anti-HER3 antibody conjugated to topoisomerase I inhibitor1 trials anti-B7-H3 antibody conjugated to topoisomerase I inhibitor1 trials BNT3161 trials BNT1161 trials NEPA (300mg netupitant/0.5mg palonosetron)1 trials LS301-IT 0.1 mg/kg1 trials 5-FU 50 MG/ML Topical Cream1 trials 5FU-Calcipotriol1 trials Osimertinib alone1 trials RZ-0011 trials Icotinib + Befotertinib placebo1 trials Befotertinib + Icotinib placebo1 trials ACE-I and/or ARB antihypertensive treatment1 trials Zilongjin tablet combined with immunotherapy1 trials Azacitidine + irinotecan1 trials Azacitidine + paclitaxel1 trials Azacitidine + docetaxel1 trials OPN-66021 trials Phase I - Mirdametinib - Level 41 trials Phase I - Mirdametinib - Level 31 trials Phase I - Mirdametinib - Level 21 trials Phase II - Mirdametinib1 trials Phase I - Mirdametinib - Level 11 trials UCB45941 trials Deferoxamine (DFO)1 trials JWCAR2011 trials anlotinib and sintilimab1 trials MetFORMIN 500 Mg Oral Tablet1 trials Alpha Lipoic Acid 600 MG Oral Tablet1 trials anlotinib +TQB2450 + Oxaliplatin+S-11 trials pyrotinib combined with Capecitabine1 trials Standard chemotherapy+bevacizumab1 trials TAS-102+bevacizumab1 trials RO7198457 intravenous (IV)1 trials Cyclosporin A1 trials Rabbit antithymocyte globulin1 trials Me-CCNU1 trials SEA-CD701 trials Bacillus Calmette Guerin Vaccine1 trials Placebo combined with Letrozole1 trials GB491 combined with Letrozole1 trials STX-0011 trials Tumor samples (archival FFPE) and blood samples1 trials Gonadotropin-releasing hormone (GnRH) antagonists1 trials Gonadotropin-releasing hormone (GnRH) analogues1 trials B：pCR patients1 trials A：pCR patients1 trials B：non-pCR patients1 trials A：non-pCR patients1 trials Mirvetuximab Soravtansine (MIRV)1 trials SNUH-CD19-CAR-T1 trials Immunoglobulins1 trials amoxycillin/clavulanic acid and ciprofloxacin1 trials trimethoprim-sulfamethoxazole (co-trimoxazole)1 trials CB-1031 trials Difluoromethylornithine (DFMO)1 trials HAIC+STRIDE+Len1 trials mFOLFIRINOX plus IMRT1 trials ACE20161 trials hypofractionated radiotherapy with immunotherapy1 trials Pravastatin1 trials GSK54600251 trials Fruquintinib and Everolimus1 trials Omeprazole 20mg Capsule1 trials Pregabalin 75mg1 trials Ketorolac 10 Mg Oral Tablet1 trials Methoxyamine1 trials Penpulimab combined with cetuximab1 trials Ipilimumab and nivolumab1 trials Atezolizumab and Bevacizumab1 trials Dabrafenib and trametinib1 trials Vemurafenib and Cobimetinib (combination treatment)1 trials Trastuzumab and Pertuzumab (combination treatment)1 trials Pembrolizumab 25 mg/ml1 trials DXC0061 trials FLOT1 trials Alternately treated with VA/low CHA regimen1 trials XELOX regimen1 trials anti-FcRL5 CAR-T1 trials Capecitabine-based chemotherapy1 trials Glumetinib Combined with Fruquintinib1 trials olaparib+pembrolizumab+paclitaxel1 trials Extended Phase Dose Group1 trials Flonoltinib 125mg1 trials Flonoltinib 100mg1 trials Flonoltinib 75mg1 trials Fecal Microbiota Transplantation Capsule1 trials Cardonilizumab1 trials OBI-9021 trials Erwinase1 trials Tioguanin1 trials Myocet1 trials Best Supportive Care (BSC)1 trials Maintenance Therapy with Capecitabine1 trials Maintenance Therapy with Toripalimab and Capecitabine1 trials nivolumab plus relatlimab1 trials SHR-A1904 for Injection1 trials Tinodasertib1 trials Vitamin E-creme (Remederm®) vs Vaseline (Placebo)1 trials Radspherin1 trials Toripalimab combined with Endostar1 trials Camrelizumab ＋Immunotherapy1 trials Semaglutide, 1.34 mg/mL and Metformin Hydrochloride 500 MG1 trials Semaglutide, 1.34 mg/mL1 trials 177Lu-TATE-RGD1 trials CD22CART cell infusion1 trials CAPOX 6 month1 trials mFOLFOX6 6 month1 trials CAPOX 3 month1 trials mFOLFOX6 3-6 month1 trials Metronidazole Oral1 trials CLL1 and CD38 Dual-Target CAR-T Cell Injection1 trials SHR-1701；Capecitabine；Oxaliplatin1 trials SYN818 and Olaparib will be administered1 trials AZD29621 trials CD19&CD20 bispecific CAR-T cells1 trials Serplulimab + chemotherapy1 trials BMS-9865001 trials FHD-2861 trials 68Ga-FAPI-46 for PET / CT scan and 177Lu-EB-FAPI for therapy1 trials DB-13101 trials SYNCAR-100 Injection1 trials Combined PIPAC / IV chemotherapy treatment1 trials Nivolumab starting at day -11 trials JZP8981 trials Tegafur-Gimeracil-Oteracil1 trials Bosentan1 trials Pirtobrutinib and rituximab1 trials CD19-CAR_Lenti_ALLO1 trials BMS-9864901 trials Humanized CD19 CAR-T cells1 trials NN32011 trials Anti-PD-1/PD-L1 antibodies1 trials IBI1101 trials TAK-1881 trials Relugolix/estradiol/norethisterone acetate1 trials BA13021 trials CUE-1021 trials ARC1011 trials Tumor sample1 trials encorafenib + cetuximab + FOLFIRI1 trials Vusolimogene Oderparepvec (VO)1 trials VLS-14881 trials XMT-16601 trials DF60021 trials YY2011 trials MK-6204 (SKB535) for Injection1 trials Antitumor therapy guided by organoid drug sensitivity test1 trials Grafalon1 trials ATG Thymoglobulin1 trials VP161 trials taxane drug1 trials HRS-4642+AG1 trials HM976621 trials Balstilmab1 trials Ivermectin1 trials 225Ac-PSMA-XT1 trials Hypericin1 trials HRS-5041 tablets1 trials Zirconium Zr 89 Girentuximab1 trials Universal Donor (UD) TGFβi NK Cells1 trials Test Product HY071211 trials FOLFOXIRI and Bevacizumab1 trials SPGL0081 trials SKB571 for injection1 trials IC1 trials XmAb8191 trials BNT1131 trials Autologous Dendritic Cells (DC) vaccine1 trials eFT2261 trials Pyrotinib normal dose group1 trials Pyrotinib low dose group1 trials alpha beta depletion1 trials IDX-1197+Irinotecan1 trials IDX-1197+XELOX1 trials NUC-77381 trials XB3711 trials XELOX combined with Fruquintinib and Sintilimab1 trials Antiinfectives1 trials Lenvatinib, tislelizumab, gemcitabine and cisplatin1 trials MRG006A1 trials FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin)1 trials LP-168 tablet1 trials Adjuvant standard treatment for HER2+1 trials Neoadjuvant standard treatment for HER2+1 trials RP-63061 trials CBX-2501 trials Alternative medications: carboplatin1 trials Alternative medications: carboplatin + 5-fluorouracil (5FU)1 trials cisplatin + 5-fluorouracil (5FU)1 trials IgPro201 trials adebrelimab, camrelizumab plus apatinib1 trials TILs（Tumor Infiltrating Lymphocytes）1 trials Cadonilimab plus Pemetrexed and Anlotinib1 trials paclitaxel cationic liposomes1 trials YKST021 trials CAR-T Cell Injection1 trials Botensilimab + Balstilimab1 trials Human BCMA Targeted T Cells Injection1 trials SHR-A19041 trials SCD1 Inhibitor MTI-3011 trials iC9.GD2.CAR.IL-15 T-cells1 trials Arsenous Acid plus Chemotherapy1 trials supCD7 CART cells1 trials iobenguane I 1311 trials Neoadjuvant sintilimab combined with perioperative SOX1 trials SSGJ-7091 trials KD-025 cell injection1 trials CD19x22 CAR T1 trials Herzuma1 trials Docetetaxel1 trials SDT-M001 injection1 trials XKDCT2251 trials FK-PC1011 trials Pegsitacianine1 trials Platinum Doublet1 trials KK-LC-1 TCR-T cells1 trials OH2 injection, with or without irinotecan or HX0081 trials capecitabine and oxaliplatin1 trials Docetaxel and capecitabine and oxaliplatin1 trials Concurrent Chemo/Radiation Therapy (cCRT): Paclitaxel1 trials Concurrent Chemo/Radiation Therapy (cCRT): Carboplatin1 trials ACOU085 (bimokalner)1 trials QHRD107 capsule，Venclexta and Azacitidine1 trials CAR-NK cell1 trials clofutriben1 trials Denikitug1 trials IMC-0021 trials QXL138AM Injection every 2 weeks by IV Infusion1 trials [212Pb]Pb-MP07121 trials ART03801 trials CD7 CAR-T cells injection1 trials Ixovex-11 trials Acolbifene Hydrochloride1 trials Continuous PD-1 inhibitor therapy1 trials Intermittent PD-1 inhibitor therapy1 trials Whole Agonist-Stimulated T (WAST) cells injection1 trials Thyroxine1 trials 177Lu-DOTA-EB-TATE1 trials Consolidation therapy-Pro-pola regimen1 trials Induction therapy-Pro regimen1 trials oxaliplatin+capecitabine+bevacizumab+PD-1 antibody1 trials 1.1 GBq (30 mCi) of 177Lu-P17-0881 trials 1.1 GBq (30 mCi) of 177Lu-P17-0871 trials SNC115 injection1 trials 5FU/LV1 trials Triprorelin Acetate1 trials Medroxyprogesterone Acetate 500 MG1 trials Drug-Eluting Embolic Bead1 trials Zopapogene imadenovec (Zopa)1 trials pCAR-19B cells1 trials IOC1 trials mRIC1 trials ATL-RIC1 trials Solid tumor and CT DNA1 trials Pressured Intraperitoneal Aerosol Chemotherapy1 trials scalp nerve block with 0.50% hydrochloride bupivacaine1 trials Standard dose: standard XELOX + sintilimab1 trials Experimental dose: modified XELOX + sintilimab1 trials ACR-23161 trials FUL1 trials OFS+AIs1 trials AIs1 trials CARv3-TEAM-E T cells1 trials AUR109 400mg1 trials AUR109 300mg1 trials AUR109 200mg1 trials LY41701561 trials ARV-8061 trials Background Chemotherapy1 trials Standard of Care Antiemetic Therapies1 trials LY35370211 trials HRS-4642;nab-paclitaxel; gemcitabine1 trials HRS-4642;Adebrelimab Injection; nab-paclitaxel; gemcitabine1 trials rhTSH1 trials Sodium Iodine I-1311 trials Triptorelin Pamoate1 trials RMC-51271 trials Pegylated SN-38 Conjugate PLX0381 trials golidocitinib with PD-1 inhibitors1 trials mFOLFIRINOX regimen1 trials GVV8581 trials Fluzoparib Camrelizumab Temozolomide1 trials Anlotinib Plus Toripalimab1 trials combined chemotherapy1 trials Perfluten1 trials HRS-70581 trials Mervometostat (PF-06821497)1 trials Consolidative therapy1 trials Cladribine s.c. injection, HCL treatment1 trials [177Lu]Lu-ABY-2711 trials UTAA17 Injection1 trials Prasterone1 trials CID-078 Monotherapy1 trials Elranatamab (PF-06863135)1 trials Calcipotriene1 trials AT03-651 trials dose-dense nab-paclitaxel followed by EC1 trials Valganciclovir (Valcyte)1 trials Valacyclovir (Valtrex)1 trials Sintilimab Plus mFFN or NALIRIFOX and Radiation1 trials surufatinib + camrelizumab + nab-paclitaxel + S-11 trials OVM-2001 trials NXC-201 CAR-T1 trials Lorlatinib 100 mg1 trials AUR1081 trials Osimertinib + Chemotherapy1 trials 68Ga-NB3811 trials 5-AMINOLEVULINIC ACID (5-ALA), is a non fluorescent prodrug.1 trials Rivoceranib Mesylate, Paclitaxel1 trials Ponatinib Hydrochloride1 trials Olaparib + Elacestrant1 trials INI-40011 trials OriCAR-0171 trials Adebrelimab Combined With Albumin Paclitaxel1 trials Osimertinib 80Mg Tab1 trials GK021 trials Prophylaxis C1 trials Prophylaxis B1 trials Prophylaxis A1 trials Omnipaque 350mgI/mL Solution for Injection1 trials Durvalumab with etoposide and Carboplatin/Cisplatin1 trials FD-0011 trials Retreatment Rhenium Liposome1 trials Blood and saliva1 trials [89Zr]Panitumumab Tracer1 trials GCC19CART1 trials Methotrexate Oral Product1 trials Methotrexate (Intravenous Administration)1 trials Methotrexate (Intrathecal Administration)1 trials Spevatamig (PT886)1 trials Capecitabine 825 mg/m2 twice daily on weekdays1 trials addition of rituximab if recurrence1 trials immediate treatment with corticosteroids1 trials Autologous CAR-T cells1 trials Fianlimab + Cemiplimab1 trials Placebo capsules, Letrozole, Anastrozole, Tamoxifen1 trials TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen1 trials Small molecule tetrazine trigger component1 trials [111In]In-DOTA-TCO-trastuzumab1 trials BMS-936558-011 trials BMS-9863401 trials Vevoctadekin1 trials CD19-CAR novel oncolytic vaccinia virus1 trials Placebo for QLS319051 trials QLS319051 trials Senl_B19 autologous CAR-T (S1904) treatment1 trials Relugolix Combination Tablet1 trials Anti-CD123 CAR NK cells1 trials Dose Level 3A: 2 x 10^8 cells/m21 trials Dose Level 3B: 2 x 10^8 cells/m21 trials Dose Level 2B: 6 x 10^7 cells/m21 trials Dose Level 2A: 6 x 10^7 cells/m21 trials Dose Level 1A: 2 x 10^7 cells/m21 trials Standard of Care - C1 trials Standard of Care - B1 trials Standard of Care - A1 trials Extended Dosing Interval - C1 trials Extended Dosing Interval - B1 trials Extended Dosing Interval - A1 trials Testosterone gel1 trials treatment of TKI in CML1 trials MT-303 +Atezolizumab + Bevacizumab1 trials MT-3031 trials Monalizumab (anti-NKG2A monoclonal antibody)1 trials Gem/nab-PTX1 trials Nal-IRI/FL1 trials Ryeqo treatment1 trials Azelaic Acid1 trials IMM011 trials AMB-05X1 trials SHR-A1811 Subcutaneous Injection1 trials Azacytidine plus CAOLD regimen1 trials MHB048C for Injection1 trials AST-2011 trials SH0091 trials INBRX-1091 trials Tipifarnib1 trials HRS-62081 trials Pegfilgrastim (drug)1 trials CD19/BCMA Targeted CAR T-cells and dasatinib1 trials Epirubicin Hydrochloride Injection1 trials Standard Of Care targeting driver mutations1 trials Systemic Chemotherapy Standard of Care1 trials Paclitaxel Micelles for Injection1 trials Mogamulizumab (subsequent cycles post TSEB)1 trials Tucatinib (ONT-380)1 trials l-leucovorin1 trials ISB 20011 trials Fludarabine (non-investigational)1 trials Cyclophosphamide (non-investigational)1 trials E-SYNC T Cells1 trials Systemic Hormonal Therapy1 trials Systemic Chemohormonal Therapy1 trials GI-1021 trials GI-102 subcutaneous (SC)1 trials Copper Cu 64 PSMA I&T1 trials M108 monoclonal antibody1 trials Adebrelimab + chemotherapy1 trials Doxorubicin, Cisplatin1 trials Doxorubicin, Cisplatin, Methotrexate1 trials creon 35.000 Ph.U (R)1 trials AZD03051 trials SHR-7782 Injection1 trials HLX431 trials Visugromab (CTL-002)1 trials Lutetium Lu 177 dotatate therapy1 trials AMG 5101 trials NKG2D-CAR-NK92 cells1 trials Ivonescimab+Radiotherapy1 trials IPH65011 trials adjuvant concurrent chemoradiotherapy1 trials ILB-21091 trials RC48 + Carboplatin1 trials Recombinant Human Granulocyte Colony-Stimulating Factor1 trials HS-10365 capsules1 trials [14C]-BMS-9865041 trials Fasudil hydrochloride combined with immunotherapy1 trials [18F]F-FAPI PET-CT1 trials Binimetinib Pill1 trials Encorafenib Pill1 trials aminolevulinic acid1 trials CAN10121 trials Sorbitol1 trials ZIV-Aflibercept1 trials Nivolumab and Entinostat1 trials Apatinib Combined With Temozolomide and Etoposide Capsules1 trials DS5361b1 trials MOv18 IgE1 trials Revlimid1 trials Myeloablative conditioning regimen1 trials XRD-03941 trials GTE001 injection1 trials Furmonertinib Mesilate Tablets Monotherapy1 trials RC1081 trials pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine1 trials LM-1081 trials Imiquimod (topical use)1 trials 68Ga-FAPI for PET / CT scan and 177Lu-EB-FAPI for therapy1 trials Platinum Doublet Chemotherapy (PDC)1 trials TCR-T therapy1 trials isunakinra1 trials Chemotherapy Regimen 21 trials Chemotherapy Regimen 11 trials Elranatamab injection1 trials Placebo mouthwash1 trials Copaíba mouthwash1 trials Fluorine F 18 Flotufolastat1 trials Abemaciclib 150 MG + Giredestrant 30 MG1 trials FZ-AD0051 trials Peptide vaccine IPX1 trials Fluoroglutamine [18F]F-GLN1 trials ABBV-9011 trials OPB-1011 trials Bevacizumab Zirconium Zr-891 trials Combined therapy of anlotinib and aumolertinib1 trials Regorafenib combined with Toripalimab and Albumin paclitaxel1 trials ABT-3011 trials MDX20031 trials EC to docetaxel or paclitaxel1 trials Hydroxytyrosol1 trials SIM03881 trials Anti-HER2 CAR-T cells1 trials 68Ga-NI-FAPI1 trials VIR-58181 trials Anti-PD-11 trials CRB-7011 trials SKB5001 trials MnSOD Mimetic BMX-0011 trials CDK4/6 Inhibitor (Palbociclib, Ribociclib, Abemaciclib)1 trials JK-1201I1 trials Telpegfilgrastim Injection1 trials infusional 5-FU/FA "de Gramont" (adjuvant)1 trials infusional 5-FU/FA "AIO" regimen (adjuvant)1 trials Capecitabine (adjuvant)1 trials XELOX (adjuvant)1 trials mFOLFOX (adjuvant)1 trials XELOX (neoadjuvant)1 trials mFOLFOX (neoadjuvant)1 trials CAR T-cells (TBC)1 trials Megestrol acetate/Medroxyprogesterone acetate1 trials Dexamethasone/Dexamethasone acetate1 trials Fludrocortisone/ Fludrocortisone acetate1 trials SLS0091 trials Standard supportive therapy1 trials LV009 Injection1 trials Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney1 trials Cabo + Dostarlimab1 trials S0950351 trials Lutetium Lu 177-Edotreotide1 trials HAIC (GEMOX)1 trials Durvalumab Plus Tremelimumab1 trials CD30 CAR-T Cells1 trials IGI, 10%1 trials Anti-TRBC1 CAR-T cells1 trials Imipramine Hydrochloride1 trials ZZSW-01 injection1 trials DAY3011 trials mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody1 trials Encorafenib/Binimetinib/Cetuximab Protocol1 trials Nivolumab Protocol1 trials LBL-033 for Injection1 trials adebrelimab plus chemotherapy (nab-paclitaxel + carboplatin)1 trials BAT1006 for Injection1 trials BAT8010 for Injection1 trials Gemcitabine+Abraxane1 trials SJ-Neo0061 trials Nelistotug1 trials Belrestotug1 trials Remzistotug1 trials HAIC + Tislelizumab +lenvatinib1 trials Fluorouracil/folic acid1 trials Polyphenol whole tumor cell vaccine1 trials research drug in combination with Toripalimab1 trials Anti-VEGF 7.5mg/kg1 trials Anti-VEGF 15mg/kg1 trials Oxaliplatin and Capecitabine1 trials HRS-67681 trials STX-4781 trials Chemotherapy regimen that includes ddAC1 trials TCHP1 trials TC1 trials ddAC/ddT1 trials TTP4881 trials SXRN Injection1 trials Toripalimab, nab-paclitaxel, carboplatin1 trials AK127 Q3W IV infusion ,AK104 10mg/kg Q3W IV infusion1 trials Gotistobart1 trials Liposomal Irinotecan and Apatinib1 trials AGuIX gadolinium-based nanoparticles1 trials Universal CD19-specific CAR gene-engineered T cells1 trials Teclistamab Monotherapy1 trials group without alveolar recruitment strategy1 trials Sonelokimab1 trials Cell Therapy1 trials Daratumumab/rHuPH20 Co-formulation1 trials NRM-8231 trials Romiplostim (AMG-531)1 trials AZD53051 trials Olaparib Oral Tablet [Lynparza]1 trials Iptacopan1 trials SY-50071 trials HS-103751 trials Bevacizumab + Erlotinib1 trials Remdesivir1 trials SPH5030 tablets1 trials PTT-42561 trials HypoSti.CAR-HER2 T cells1 trials LUTATHERA® (Lutetium Lu 177 dotatate)1 trials EGFR Inhibitor ERAS-8011 trials Naldemedine, an peripherally acting opioid antagonist1 trials Sodium Thiosulfate Anhydrous1 trials Larotrectinib monotherapy1 trials AraC1 trials Anti-mesothelin CAR-T cells1 trials Liraglutide and metformin1 trials JMT106 Injection1 trials intravenous (IV) infusion1 trials Haplo-Identical / Cord Blood Transplant1 trials Bio-0081 trials 18F-Fluoroestradiol1 trials Nivolumab/relatlimab/rHuPH201 trials Nivolumab and rHuPH201 trials BMS-9864821 trials Anti-PD-1/PD-L1 monoclonal antibody1 trials Tucatinib in Combination of Oral VP16 and trastuzumab1 trials DaraVRD/DaraVCD1 trials RP2D of FC084CSA+Tislelizumab combination (dose expansion)1 trials FC084CSA+Tislelizumab combination (dose escalation)1 trials Disitamab Vedotin combined with Toripalimab1 trials F-DCFPyL Injection1 trials SY-56091 trials Epirubicin+Cyclophosphamide1 trials Fluzoparib+Paclitaxel1 trials Engineered mitochondria vaccine1 trials 68Ga-RM21 trials EBV gp350-ferritin vaccine with ALFQ adjuvant1 trials Consolidation #4(with daunorubicin)1 trials Consolidation #4(without daunorubicin)1 trials ASTX6601 trials HY-2003 (5 mg/ml) and placebo1 trials HY-2003 (10 mg/ml), BELKYRA and placebo1 trials ADCLEC.syn1 CAR T cells1 trials Aclacinomycin1 trials Avapritinib, azacitidine, Venetoclax1 trials High-dose chemotherapy (TI- 2 cycles, CE- 3 cycles )1 trials Surufatinib with Nab-paclitaxel, and Gemcitabine1 trials Nab-paclitaxel Plus Gemcitabine1 trials Toripalimab/Tirelizumab1 trials LM-24171 trials Realgar-Indigo Naturalis Formulation1 trials Gemox Chemotherapy（Gemox or GC）1 trials Thalidomide and methotrexate1 trials Envafolimab+Lenvatinib1 trials Tireilizumab（PD-1 inhibitor）1 trials CGT42551 trials GH551 trials Omission of Granulocyte Colony-Stimulating Factor (G-CSF)1 trials TER-20131 trials niraparib/abiraterone acetate1 trials Chemoradiation1 trials CD19-targeted chimeric antigen receptor T-cell1 trials Alpha lipoic acid1 trials mBU/CY1 trials mBU/CY and ATG1 trials ADT plus continued ARPI1 trials ADT plus only 12 months of ARPI1 trials Targeted TKI therapy1 trials Fluorescein Sodium1 trials COM7011 trials LTC004+Toripalimab1 trials anti Tim-3/CD123 CAR-T cell therapy1 trials DEB-TACE1 trials DEB-TACE+HAIC1 trials REC-48811 trials Drugs Nivolumab1 trials Combination Agent 21 trials AVZO-14181 trials tiosulfate1 trials cilastatine1 trials TRX-2211 trials Association atezolizumab + BDB001 + RT1 trials Soquelitinib1 trials Quadrivalent Inactivated Influenza Vaccine1 trials PD-1/PD-L1 inhibitor plus chemotherapy1 trials Evofosfamide1 trials Neratinib Pill1 trials APL-101 Oral Capsules1 trials Levothyroxine 25 Mcg (0.025 Mg) Oral Tablet1 trials Cis-Retinoic acid1 trials Pembrolizumab Extended1 trials Nivolumab Extended1 trials Pembrolizumab Standard1 trials Nivolumab Standard1 trials 90Y-NM6001 trials Drug: Bevacizumab Injection1 trials Drug: Ivonescimab Injection1 trials IC-Green (ICG)1 trials Combination zimberelimab + domvanalimab1 trials Single agent zimberelimab1 trials TGRX-19421 trials RO76565941 trials Physicians Choice (PhC).1 trials dacarbazine, temozolomide, paclitaxel ,platinum or cisplatin1 trials GC101 TIL1 trials Curcumin plus Piperine1 trials Ceftazidime1 trials CNA3103: 6.75 × 10^8 cells1 trials CNA3103: 2.5 x 10^7 cells1 trials CNA3103: 1.5 x 10^9 cells1 trials CNA3103: 4.5 x 10^8 cells1 trials CNA3103: 1.5 x 10^8 cells1 trials CNA3103: 5 x 10^7 cells1 trials JPI-5471 trials BMS-9865071 trials Engineering Tumor Infiltrating Lymphocytes1 trials Pembrolizumab 200 mg Q3W or 400 mg Q6W1 trials Pemetrexed 500 mg/m^2 Q3W1 trials Pembrolizumab 200 mg Q6W1 trials Technetium991 trials Yttrium-90 (Y-90)1 trials Autologous Stem Cell Infusion1 trials Lovastatin1 trials Immunotherapy - PD-1 Blocker1 trials Misoprostol 200mcg Tab1 trials Vesanoid1 trials FLOT (Fluorouracil+Leucovorin+Oxaliplatin+Docetaxel)1 trials Topical Tretinoin1 trials NX-21271 trials JSB462 QD1 trials JSB462 Dose 2 QD1 trials JSB462 Dose 1 QD1 trials Tulmimetostat RP2D QD1 trials Tulmimetostat Doses 1 or 2 QD1 trials Tulmimetostat DL3 QD1 trials Tulmimetostat DL2 QD1 trials Tulmimetostat DL1 QD1 trials Docetaxel+Carboplatin+trastuzumab+Parstuzumab1 trials Albumin paclitaxel+trastuzumab+pyrrolitinib1 trials Single-agent chemotherapy1 trials 17b-estradiol1 trials ICG fluorescence imaging technology1 trials Risvutatug rezetecan1 trials Crystallized phenol + Exosome + Stem Cell1 trials Crystallized phenol + Stem Cell1 trials Crystallized phenol + Exosome1 trials Other Therapeutic Agents1 trials Drug: BG-T1871 trials SHR-9539 for injection1 trials Lupron Depot1 trials LNTH2403 Phase 1 dose1 trials Decitabine (in combination with BP1002)1 trials BP1002; Liposomal Bcl-2 Antisense Oligodeoxynucleotide1 trials Targeting NUDT21 siRNA drugs1 trials Etoposide + Platinum-based Therapy1 trials Adebrelimab + Etoposide + Platinum-based Therapy1 trials 18F-Clofarabine1 trials tauroursodeoxycholic acid (TUDCA)1 trials Neoantigen Dendritic Cell Vaccine1 trials INV-99561 trials Polatuzumab, bendamustin und rituximab1 trials HS-105041 trials Tafolecimab1 trials CD19/CD20/BCMA CAR T cells1 trials Tislelizumab + Sitravatinib1 trials Endostatin and Capecitabine1 trials Azacitidine in Combination With Venetoclax1 trials BAL08911 trials METR-NK cell(Metabolic Remodeling Nature Killer Cells)1 trials Karonudib1 trials AV-MEL-11 trials Paclitaxel and Cisplatin1 trials Lu-177-DOTA-Octreotide1 trials ABSK1121 trials SHR-20051 trials Predinisone1 trials Zanubrutinib Oral Capsule1 trials Venetoclax Oral Product1 trials DC cell Vaccine1 trials Prednisone tablet1 trials JCAR017 (lisocabtagene maraleucel) + venetoclax1 trials JCAR017 (lisocabtagene maraleucel) + ibrutinib1 trials JCAR017 (lisocabtagene maraleucel)1 trials 0.5 mL Candin®/injection1 trials Fermented Wheat Germ Extract1 trials M17741 trials SKB5181 trials MVR-C52521 trials Venetoclax MTD with Dexamethasone1 trials Dexamethasone Oral, 20 mg1 trials Dexamethasone Oral, 10 mg1 trials Venetoclax Oral Tablet, 400 mg1 trials Venetoclax Oral Tablet, 200 mg1 trials TNG2601 trials Magnesium hydroxide 724mg1 trials Macrogol Only Product in Oral Dose Form1 trials neoadjuvant anti-PD-1 with LDRT1 trials neoadjuvant anti-PD-11 trials ipilimumab +pembrolizumab +durvalumab1 trials Lopinavir / Ritonavir1 trials HS-IT101 Injection1 trials Cemiplimab + Fianlimab [Fixed Dose Combination (FDC)]1 trials REGN56681 trials CD371-specific/YSNVz/I-18 CAR T cells1 trials [177Lu]Lu-PSMA-617 (Pluvicto, Novartis)1 trials XER-0011 trials SL-4011 trials Association of berzosertib with gemcitabine1 trials Trifluridine/Tipiracil Hydrochloride1 trials Panitumumab 20 milligram/ML1 trials neoadjuvant chemotherapyI1 trials CD33KO-HSPC; CART331 trials JS201 combine with Lenvatinib1 trials VT39891 trials RE104 for Injection1 trials Tislelizumab,Platinum1 trials EP00311 trials Tremelimumab Plus Durvalumab (MEDI4736)1 trials zanubrutinib, bendamustine, and obinutuzumab1 trials NWY0011 trials IRE + intratumoral mitazalimab (CD40 antibody) injection1 trials Administration of Vorolanib1 trials SYS60021 trials Linperlisib1 trials FOLFOX 1d1 trials FOLFOX 2d1 trials FX-9091 trials cisplatin, gemcitabine1 trials Trifluridine/tipiracil + bevacizumab1 trials Trifluridine/Tipiracil + Regorafenib1 trials [89Zr]Zr-DFO-RD061 trials [89Zr]Zr-DFO-R8B41 trials [89Zr]Zr-DFO-RB61 trials [68Ga]Ga-NOTA-RD061 trials [68Ga]Ga-NOTA-R8B41 trials [18F]F-RESCA-RD061 trials [18F]F-RESCA-R8B41 trials [18F]F-RESCA-RCCB61 trials JANX0071 trials KLH-2109 Placebo + Leurprorelin acetate1 trials KLH-2109+ Leurprorelin acetate Placebo1 trials SB-48261 trials Pimicotinib (ABSK021)1 trials mFOLFOX7+Camrelizumab+Apatinib1 trials Autologous MUC1-activated T-cells1 trials Low-Dose Cisplatin1 trials High-Dose Cisplatin1 trials SAFE (Saline assisted fascial engorgement)1 trials APX-343A1 trials SPH4336 Tablets 400mg1 trials Synthetic MVA-based SARS-CoV-2 Vaccine COH04S11 trials mRNA COVID-19 Vaccine1 trials Fedratinib1 trials IPG10941 trials Orelabrutinib combined with R-CDOP regimen1 trials Concurrent cisplatin chemotherapy1 trials EXS735651 trials A1661 trials Phase 1b: LB-LR1109 and Atezolizumab1 trials Phase 1a: LB-LR11091 trials SCLEROSTIN1 trials Zanubrutinib combined with Obinutuzumab1 trials KSD-1011 trials zanubrutinib, obinutuzumab,combined with CVP1 trials [211At]NaAt1 trials SIM0505 for injection1 trials KK2845_61 trials KK2845_51 trials KK2845_41 trials KK2845_31 trials KK2845_21 trials KK2845_11 trials ABO2011 Injection1 trials Mesopher1 trials Copper Cu 64 Dotatate1 trials XPO1 inhibitor1 trials HYML-122; cytarabine1 trials IAH09681 trials ST-021 trials Adebrelimab and capecitabine1 trials Microcrystalline cellulose (MCC)1 trials Epigallocatechin-3-Gallate (EGCG)1 trials Benmelstobart combined with Bevacizumab and chemotherapy1 trials Benmelstobart combined with chemotherapy1 trials 64Cu-PORPHYSOMES1 trials PORPHYSOMES1 trials Anti-CD19 CAR T Cells Preparation1 trials Immune Globulin Infusion (Human), 10% Solution1 trials Modi-1 Moditope1 trials Ivonescimab Combined With TROP2 ADC1 trials GSK54717131 trials MT-45611 trials Non-GLP-1 RA based glucose lowering drugs1 trials VAX0141 trials Systemic application of simultaneous chemotherapy1 trials Chemotherapy + Immune checkpoint inhibitor1 trials Trastuzumab Subcutaneous Subcutaneous1 trials Long-term course of antiandrogen drugs1 trials 6-month course of antiandrogen drugs1 trials JBI-8021 trials IMP17341 trials [225Ac]-FPI-20681 trials [111In]-FPI-21071 trials FPI-20531 trials SHR-16811 trials Anti-CD56 CAR T1 trials Fingolimod 0.5 milligram (mg) [Gilenya]1 trials Biological tests1 trials TTV DNAemia1 trials FOLFIRINOX/mFOLFIRINOX1 trials Trastuzumab plus Pertuzumab (combination)1 trials Vemurafenib plus Cobimetinib (combination)1 trials Therapeutic drug monitoring (TDM) of adalimumab1 trials Indocyanine green solution administered at 2.0mg/kg.1 trials SHR-A1811 Injection + Adebrelimab Injection1 trials ETX-194771 trials Quisinostat1 trials Clonidine HCL1 trials Ropivacaine HCL1 trials RNK050471 trials Biological samples collection1 trials PVX71 trials HRS-7058 +SHR-A2102 +SHR-1316 +BP1021 trials HRS-7058 +SHR-A2102 +BP1021 trials HRS-7058 +SHR-1316 +BP1021 trials HRS-7058 +SHR-9839(sc)+SHR-13161 trials HRS-7058 +SHR-A2102 +SHR-13161 trials HRS-7058 + SHR-98391 trials HRS-7058 + BP1021 trials HRS-7058 + SHR-A12021 trials HRS-7058 + SHR-1826 + SHR-13161 trials HRS-7058 + SHR-18261 trials HRS-7058 + Cetuximab1 trials HRS-7058 + SHR-13161 trials Pocenbrodib1 trials BHV-15101 trials Investigation agent 31 trials Investigation agent 21 trials Intravenous (IV) single dose1 trials mFOLFIRINOX infusion1 trials Gem/Nabpaclitaxel infusion1 trials Palonosetron hydrochloride capsules1 trials Ovarian function suppression with endocrine treatments1 trials iC9-CAR.B7-H3 T cell infusion1 trials Cyclophosphamide/Fludarabine1 trials MOv19-BBz CAR T cells1 trials Neoadjuvant lazertinib1 trials Bevacizumab combined with Sintilimab1 trials Etoposide Capsule1 trials Taitacept1 trials Sacituzumab Tirumotecan and Toripalimab1 trials Lorviqua1 trials Perjeta plus trastuzumab, carboplatin and docetaxel1 trials PERT-IJS plus trastuzumab, carboplatin and docetaxel1 trials GD2 CAR T cells1 trials Methylprednisolone IV1 trials Cyclophosphamide IV1 trials Immunoglobulins IV (CLAYRIG)1 trials SHR-4610 Injection1 trials albumin 20%1 trials albumin 5%1 trials acetated Ringers1 trials IPH5201 + durvalumab + standard chemotherapy1 trials Chemotherapy + immunotherapy1 trials First Induction (IAV or DAV Regimen)1 trials SHR-15011 trials Sintilimab, Nab-paclitaxel, Carboplatin1 trials SKB5711 trials Standard endocrine therapy combined with CDK4/6 Inhibitor1 trials Thromboprophylaxis1 trials BB-17091 trials One IM injection Lenti-HPV-071 trials Two IM injections Lenti-HPV-071 trials Target trough IgG level 4-6 g/L1 trials Target trough IgG level of 8-10 g/L1 trials KQB5481 trials TYRA-300 Dose TBD1 trials TYRA-300 50mg1 trials TYRA-300 60mg1 trials Fluzoparib+Camrelizumab1 trials Ciprofloxacin 500g1 trials Vancomycin 125mg1 trials Metronidazole 400mg1 trials Amoxicillin 500mg1 trials Enzalutamide 40mg1 trials PRTH-1011 trials [68Ga]Ga-FAPI-461 trials RN1101 injection1 trials CAR-GPC3 T cells1 trials in vivo CAR-T drug based on LNP-mRNA1 trials Anti-CD33 CAR T-cells1 trials Zirconium Zr 89 crefmirlimab berdoxam1 trials Combination anthracycline and/or taxane based treatment1 trials Consolidation with Brentuximab Vedotin1 trials Induction without Brentuximab Vedotin1 trials Induction with Brentuximab vedotin (BV)1 trials Allo-QuadCAR01-T1 trials Octreotide LAR1 trials Dexmedetomidine administered intranasally1 trials Two Component Product CLBR001 + ABBV-4611 trials Zirconium Zr 89-DFO-YS51 trials Ado-trastuzumab (T) emtansine (T-DM1)1 trials 0.9% saline solution1 trials Maxigesic1 trials Durvalumab 50 MG/ML1 trials Newly matched donor-derived FL-33 CAR T therapy1 trials prior-HSCT donor-derived FL-33 CAR T therapy1 trials autologous FL-33 CAR T therapy1 trials low molecular weight heparin (enoxaparin sodium)1 trials ROSE121 trials Pan-T booster co-expressing MSLN CAR T cell1 trials FH FOLR1 ST CAR T-cells1 trials Physicians Choice systemic chemotherapy1 trials Ex-vivo expanded allogeneic γδ T cells1 trials Gemtuzumab1 trials 225Ac-TR2205 Injection1 trials 64Cu-Dotatate1 trials MBQ-1671 trials Autologous HuCD19 ( Anti-CD19)CAR T cells1 trials adebrelimab and chemotherapy1 trials Afuresertib/placebo1 trials Afuresertib1 trials Intravenous infusion anti-HER2-CAR-T cell1 trials CDK 4/6 inhibitors1 trials Ipilimumab 200 MG in 40 ML Injection1 trials Nivolumab 40 mg in 4 ml Injection1 trials Experimental Group1 trials Premedication with simethicone1 trials Placebo (drinking water)1 trials Premedication with n-acetylcysteine1 trials target treatment1 trials Immunotherapeutic Agent1 trials cytotoxic t-lymphocytes1 trials B7H3-IL7Ra CAR-T cells1 trials 68Ga-ICAM-1pep1 trials Anti-Thymoglobulin1 trials Cycophosphamide1 trials Post-Transplant Cyclophosphamide1 trials Camrelizumab plus GEMOX1 trials ILB-31011 trials Avutometinib (VS-6766)1 trials TQB2922 for injection1 trials ATG-0311 trials R-57801 trials zelenirstat1 trials Zirconium Zr 89 Panitumumab1 trials HAI1 trials INCA0357841 trials Neoadjuvant chemoimmunotherapy1 trials Carboplatin/Cisplatin -Etoposide - Atezolizumab1 trials Chimeric Natural Killer Receptor Universal T-cells (CNK-UT)1 trials Blood sample/Liquid Biopsy1 trials 2X-1211 trials Same systemic therapy after secondary registration1 trials Systemic therapy for 12 weeks after primary registration1 trials TMT101 Injection1 trials DC/MM Fusion Vaccine1 trials HDM20121 trials Blinatumomab plus Reduced-dose Chemotherapy1 trials IV Glofitamab1 trials SC Mosunetuzumab1 trials Td vaccine1 trials TTRNA-xALT1 trials Autologous Hematopoietic Stem cells (HSCs)1 trials TTRNA-DC vaccines with GM-CSF1 trials VIR-55001 trials SDD1 trials SC-DARIC331 trials IDE1961 trials XNW270111 trials SZ011 CAR-NK1 trials Actinium Ac 225-DOTA-anti-CEA Monoclonal Antibody M5A1 trials "3+7"1 trials Investigator's Choice1 trials SOC+BSB-1001 Expansion Dose1 trials SOC + BSB-1001 Dose Escalation Cohort1 trials TBI-13011 trials Disitamab Vedotin and Cisplatin1 trials SW-6821 trials AUR1041 trials Vaccination1 trials LV5FU2 or capecitabine1 trials FOLFOX4 or XELOX1 trials LV5FU2 or capectitabine1 trials SA53-OS (phase 2)1 trials SA53-OS (phase 1)1 trials AHCC®capsules1 trials CHP1 trials TU2218 + KEYTRUDA® (Pembrolizumab)1 trials Anti-hCD70 CAR transduced PBL1 trials LY40667081 trials Relugolix-Containing Product1 trials AdAPT-0011 trials Utidelone and capecitabine1 trials propranolol (beta-blocker used treat high blood pressure)1 trials CTS34971 trials IMA203CD8 Product1 trials IMA203 product- flat dose1 trials IMA203 Product1 trials narmafotinib dose comparison1 trials narmafotinib ascending doses1 trials 68Ga-G231 trials 68Ga-G211 trials Metformin Hydrochloride ER1 trials ESG4061 trials cMAB1 trials iMAB1 trials Leucovorin and 5-FU1 trials CART-EGFR-IL13Ra2 cells1 trials CD117 CAR T-cells1 trials Taxotere1 trials CG001419 tablets1 trials T-allo10 cells addback1 trials Allogeneic Stem Cell Transplant1 trials FMISO PET CT1 trials CLN-6171 trials Medroxyprogesterone acetate + Atorvastatin1 trials pre-operative therapy1 trials Vaccination of Fusion-VAC-XS151 trials Oral DNA Vaccine1 trials EIS-126561 trials mBUCY conditioning regimen1 trials TmBU conditioning Regimen1 trials Cysview1 trials Placebo combined with androgen deprivation treatment group1 trials Homoharringtonine combined with androgen deprivation therapy1 trials Pentoxifylline 400mg plus chemotherapy1 trials HS-20117+mFOLFOX61 trials HS-20117+FOLFIRI1 trials HS-20117+CAPEOX1 trials HS-20117 combined HS-20093 and 5-FU1 trials HS-20117 combined Platinum-containing chemotherapy1 trials HS-20117 combined HS-200931 trials PM5341 trials Hydrocodone/Acetaminophen1 trials Oxycodone Acetaminophen1 trials CART-191 trials FL115+BCG1 trials FL1151 trials HF501 trials LV5FU21 trials TN-11 trials TN1 trials Lisaftoclax1 trials [177Lu]Lu-PSMA-XT1 trials enoxaparin/tinzaparin/dalteparin1 trials Larotrectinib Sulfate1 trials BGB-214471 trials Iodinated Contrast Agent1 trials Antiangiogenic Agent1 trials Kinase inhibitor1 trials IMC-R117C1 trials ETN1011 trials Androgen Receptor Pathway Inhibitors (ARPIs)1 trials Obeticholic Acid1 trials Lonsurf1 trials Nivolumab 10 MG/ML1 trials U3-14021 trials BPI-3711531 trials Flotufolastat F181 trials IOV-30011 trials JZP8151 trials Blood sampling & Chest CT without injection1 trials NT2191 trials Pivekimab Sunirine1 trials M1-c6v11 trials Etoposide, doxorubicin, cisplatin and Mitotane plus Placebo1 trials Cetuximab (CRC)1 trials Skin Repairing Cream1 trials Phase Ib dose-expansion of FB849 monotherapy1 trials Phase Ia dose-escalation part of FB849 Monotherapy1 trials ADT for 2 years1 trials ADT for 9 months and ARTA for 6 months1 trials Desmopressin acetate1 trials VBC1031 trials AO-2521 trials Kinisoquin™1 trials Ferumoxytol intravesical administration (5 mM)1 trials Gadobutrol intravesical administration (4mM)1 trials Mitoxantrone hydrochloride liposome injection1 trials Ivonescimab 20 mg/kg1 trials Ivonescimab 10 mg/kg1 trials Autologous RAK cells1 trials Human Derived anti-CI135 CAR-T Injection1 trials Kybella1 trials Ronkyla Plus1 trials Sulfamethoxazole trimethoprim1 trials Trimethoprim1 trials Nitrofurantoin1 trials Linezolid1 trials Pivmecillinam1 trials Androgen receptor (AR) inhibitor1 trials Prednisone acetate1 trials IPN603001 trials BCMA CART1 trials Herombopag1 trials Clobetasol1 trials Timolol1 trials Zinc gluconate1 trials Chlorhexidine1 trials Clindamycin1 trials Amivantamab SC1 trials a targeted probe B7H3-IRDye800CW1 trials Cytisine 1,5 mg1 trials Single dose injection of certain dose of UWD-00B1 trials Silmitasertib1 trials C7R.CD30.CAR-EBVST cells1 trials GPC3 and/or TGFβ targeting CAR-T cells1 trials NM1F Injection1 trials FLAG-IDA1 trials Ara-C±IDA1 trials LoDAC1 trials Clifutinib1 trials MSC-L1 trials ITNK cell therapy1 trials PLT0121 trials ONO-45781 trials Daraxonrasib (Cohort B1 only)1 trials Carboplatin/Cisplatin + Pemetrexed (Cohort B2 Only)1 trials cetuximab (Cohort C2 Only)1 trials Carboplatin/Cisplatin + Pemetrexed (Dose Expansion Only)1 trials Zoldonrasib1 trials Technetium [99mTc]-H7ND injection1 trials Hyperpolarized C131 trials recombinant human endostatin,temozolomide,irinotecan1 trials Blood sample/lliquid biopsy1 trials 18F-Pentixafor1 trials ABP1011T1 trials BMS-986489 (BMS-986012+Nivolumab)1 trials GD2-SADA:177Lu-DOTA Complex1 trials Vemurafenib plus Cobimetinib1 trials Trastuzumab plus Pertuzumab1 trials Nivolumab plus Ipilimumab1 trials JSKN016 injection1 trials Decitabine (DAC)1 trials Azacitidine (AZA) Days 1 - 51 trials VET3-TGI1 trials postoperative adjuvant chemotherapy1 trials TEV-562781 trials AN4005-food effect1 trials AN4005-dose level 41 trials AN4005-dose level 31 trials AN4005-dose level 21 trials AN4005-dose level 11 trials AN4005-dose level 01 trials Placebo ointment1 trials Artesunate ointment1 trials Camrelizumab+Chemotherapy→Camrelizumab1 trials Camrelizumab+Apatinib+Chemotherapy→Camrelizumab+Apatinib1 trials GP induction chemotherapy1 trials TPC induction chemotherapy1 trials humanized monoclonal anti-FGFR1 antibody OM-RCA-011 trials Claudin18.2 Targeted Activated Dendritic Cells1 trials 89Zr-DFO-N-Suc-C9scFv1 trials 89Zr-DFO-N-Suc-F8scFv1 trials Amiodarone Hydrochloride1 trials HX301+/Temozolomide1 trials TACE-HAIC, Envafolimab and Lenvatinib1 trials Azacitidine in combination with R-CHOP1 trials ICI plus Chemothearpy1 trials BG-C09021 trials [18F]F-RESCA-RND201 trials [68Ga]Ga-NOTA-RND201 trials [18F]F-RESCA-WWH3471 trials [68Ga]Ga-NOTA-WWH3471 trials [18F]F-RESCA-G51 trials [68Ga]Ga-NOTA-G51 trials [68Ga]Ga-DOTA-H2D31 trials Second-line Chemotherapy1 trials Mevrometostat1 trials Bria-OTS regimen and CPI (tislelizumab) expansion cohort1 trials Bria-OTS regimen and CPI (tislelizumab)1 trials BC1 cell line1 trials Immunotherapy Therapy1 trials BH0111 trials BGB-B20331 trials reparixin1 trials iPSC-NK cells1 trials No Intervention: Observational Cohort1 trials Orelabrutinib, obinutuzumab1 trials Autologous Anti-CD19/CD20/CD22 CAR T-cells1 trials Zotiraciclib1 trials CKD-5121 trials Augmented autologous stem cell transplant (ASCT-aug)1 trials Conventional autologous stem cell transplant (ASCT-con)1 trials Ixazomib, thalidomide, & dexamethasone (ITD) re-induction1 trials IBI3101 trials KRAS Neoantigen Nanovaccine1 trials Tislelizumab: 200mg, intravenous infusion, Q3W1 trials apantamide+ADT treatment1 trials apantamide+docetaxel+ADT1 trials Sequential PD-1 antibody1 trials Sequential Lenvatinib1 trials Concurrent PD-1 antibody1 trials Concurrent Lenvatinib1 trials Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU1 trials neoadjuvant and adjuvant chemotherapy1 trials Daromun1 trials KQB1681 trials CGT48591 trials Dexamethasone Placebo1 trials [18F]F-ARAG PET1 trials CD146/HER2 CAR-T cells1 trials relugolix or androgen deprivation therapy (ADT) + ARPI1 trials relugolix + ARPI1 trials Nivolumab, Pembrolizumab1 trials BGC5151 trials thymalfasin1 trials Cabergoline (Dopamine Agonist)1 trials Adagrasib oral dose of 400 mg twice daily tablets1 trials Recombinant Humanized Monoclonal Antibody MIL951 trials OPT-821 (QS-21)1 trials Hydroxychloroquine Sulfate 400Mg Tab1 trials zoledronic acid plus Sintilimab intraperitoneal injection1 trials 68Ga-MGS51 trials VEGFR and TPC1 trials Amoxycillin/clavulanic acid1 trials Carboplatin administered on Day 11 trials Melphalan or Melphalan + Topotecan1 trials Early antibiotic cessation alert1 trials Adebrelimab, Apatinib, Gemcitabine, cisplatin1 trials EGFR Antibody1 trials IBI3511 trials Radiotherapy and PCV chemotherapy1 trials PCV chemotherapy1 trials VSV-02 Injection1 trials IBI30011 trials AI plus ribociclib1 trials Fulvestrant plus AI plus ribociclib1 trials SHR-A1811 combined with other antitumor therapies1 trials SHR-A1811 combined with Pyrotinib.1 trials AD12081 trials Jelmyto (mitomycin) for pyelocalyceal solution1 trials TP1 trials Camrelizumab plus TP1 trials GM-CSF (Sargramostim)1 trials BI 764532 - parenteral 21 trials BI 764532 - parenteral 11 trials NBQ72S1 trials Low Dose Radiation Therapy1 trials L-Asparaginase1 trials Yttrium Y 90 Basiliximab1 trials Genetically Engineered Hematopoietic Stem Progenitor Cells1 trials Basiliximab1 trials IRDye800CW-nimotuzumab1 trials Ipilimumab Injection [Yervoy]1 trials PDD-TURBT with hexaminolevulinate (Hexvix®)1 trials Lonsurf & bevacizumab1 trials FOLFIRI regimen & bevacizumab1 trials ST3161 trials Ondansetron orodispersible film twice1 trials Ondansetron orodispersible film once1 trials Dexamethasone (2mg QD, d1-5,)1 trials Dexamethasone (12mg d1)1 trials GLSI-1001 trials FMC-3761 trials NKG2D CAR NK and NKG2D CAR T cells1 trials Fluorescein Sodium Injection1 trials Anti-CDH17 CAR-T cells1 trials mRNA-43591 trials ALN-BCAT1 trials Lenvatinib Combined with VIC-19111 trials Durvalumab / tremelimumab1 trials CPI-02091 trials BCMA targeted prime CAR-T cells1 trials CEA CAR-T cells1 trials Dopamine Agonists1 trials 177Lu girentuximab1 trials Trabedersen1 trials 68Ga-C11 trials Tigecycline 50 MG1 trials HS-201221 trials Pembrolizumab & ADG106 (Phase II)1 trials Pembrolizumab & ADG106 (Phase Ib)1 trials Nenocorilant 400 mg1 trials Nenocorilant 300 mg1 trials Nenocorilant 200 mg1 trials ZG2001 Tosilate Tablets1 trials ABO2203 Injection1 trials Docetaxel monotherapy1 trials LY41754081 trials Ibuprofen 400 mg, TID1 trials Mitomycin C (MMC)1 trials Surufatinib Combined With Temozolomide and S-11 trials Nano-crystalline megestrol acetate1 trials MEN16111 trials GP Combined With Camrelizumab1 trials TPC combined with Apatinib and Camrelizumab1 trials Misoprostol Tabets1 trials Glycyrrhizin - 150 mg1 trials Glycyrrhizin - 75 mg1 trials ECT-001-CB (UM171-Expanded Cord Blood Transplant)1 trials Experimental: tislelizumab+anlotinib1 trials Olanzapine (dose comparison: 2.5 mg, 5 mg, 10 mg)1 trials 89Zr-DFOsq-olaratumab (89Zr-TLX300-CDx)1 trials ENDOXAN1 trials CYAD-021 trials tislelizumab plus CapeOX chemotherapy1 trials lenvatinib and tislelizumab plus CapeOX chemotherapy1 trials 18F-Fluciclovine PET-MRI1 trials SHR-A1811 Injection ； Pertuzumab Injection1 trials ETV,TDF,TAF,TMF1 trials AB-30281 trials PCI 247811 trials Methimazole1 trials capecitabine or 5-FU1 trials TSR-042 or Dostarlimab1 trials Alpelisib + Pembrolizumab1 trials JNJ-952981771 trials Anti-GPC3-IRDye800CW1 trials OBX-1151 trials Gemcitabin/cisplatin1 trials MCLA-1581 trials fluzoparib monotherapy or combination therapy1 trials Pembrolizumab, Plinabulin plus Etoposide and Platinum1 trials LVIVO-TaVec200 product1 trials XP-DC vaccinations1 trials Erlotinib (150 mg daily)1 trials 30 μg OBI-833/100 μg OBI-8211 trials Poly (ADP-Ribose) Polymerase Inhibitor1 trials BH31201 trials Hyperpolarized 13C,15N2-urea1 trials SIM06861 trials GM-CSF with combination regimen1 trials Naxitamab in combination therapy1 trials Naxitamab monotherapy1 trials Dose expansion (IPM514 combined with tislelizumab)1 trials Dose escalation(IPM514 monotherapy)1 trials CD123-CAR T1 trials JMT6011 trials Darlifarnib1 trials ARM0111 trials XB6281 trials BAFF-R CART1 trials Roflumilast 500 Mcg Oral Tablet1 trials Carvedilol 50 mg1 trials Nadolol (1 x 80 mg) Tablets (Invamed, Inc)1 trials Bisoprolol Fumarate Tablet 10 mg1 trials Isoproterenol1 trials BAY 37133721 trials EBV TCR-T1 trials Interleukin-2 (IL-2)1 trials Cytokine Induced Memory-like Natural Killer (CIML NK) Cells1 trials TGI-51 trials HG1461 trials Irinotecan liposome injection1 trials HLX43 dose 51 trials HLX43 dose 41 trials H0021 trials YK1101 cells1 trials Abatacept plus1 trials BMS-9864971 trials A-CAR0281 trials Tirbanibulin ointment 1%1 trials CUE-1011 trials Single agent, adjuvant anti-PD1 therapy1 trials Unmodified donor T Cell1 trials Treg-enriched donor cell1 trials Androgen Receptor Signaling Inhibitor1 trials doxepin solution1 trials TIL injection1 trials Mesothelin and Claudin 18.2 CAR-T cells1 trials Recombinant glycosylated human interleukin-71 trials Capecitabine plus temozolamide1 trials Universal CD7-specific CAR gene-engineered T cells1 trials Sintilimab , Carboplatin, Nab-paclitaxel1 trials SER-1551 trials ASP29981 trials Zinc Acexamate1 trials Assessment of the epigenetic age1 trials Medroxyprogesterone Acetate1 trials VBI-19011 trials Lenvatinib Mesylate1 trials Neoadjuvant chemotherapy Program1 trials Paclitaxel and Cisplatin/ Carboplatin1 trials FAK Inhibitor GSK22560981 trials PCV1 trials CETEG1 trials RMC-62911 trials XZP-5955 tablets1 trials Daratumumab / Hyaluronidase Injection1 trials Ivosidenib combined with venetoclax and azacitidine1 trials 18F-NaF1 trials Treatment1 trials Up-front Chemotherapy1 trials Carbetocin1 trials Universal Donor Natural Killer Cells1 trials BCG( 50mg/Instillation)1 trials Tenalisib1 trials Glucagon-like peptide 1 receptor agonist1 trials Ibuprofen1 trials Non-interventional hormone therapy1 trials hyperpolarized pyruvate +/-urea (13C/15N)1 trials Ivosidenib 250 MG (milligram)1 trials REGN50931 trials Platinum drug1 trials Paclitaxel drugs1 trials Niclosamide1 trials ES2B-C0011 trials EMB-01 1600 mg administered once weekly throughout the study1 trials MEN25011 trials Olanzapine Actavis 5mg orodispersible tablet1 trials Haldol 2mg/ml oral solution1 trials Dalpiciclib 125mg1 trials Dalpicilib combined with cetuximab1 trials Pyrotinib and Trastuzumab1 trials Collection of biological sample (blood and/or CSF)1 trials YL-172311 trials NDI-2192161 trials Dual antibody B1 trials Dual antibody A1 trials FOLFIRI or FOLFOX1 trials Metronomic chemotherapies1 trials AMT-253 for injection1 trials VK-20191 trials ALPS121 trials AND019 PO QD1 trials Autologous, engineered T Cells targeting TP53 R175H1 trials HS-10382(Part 2: Dose expansion)1 trials HS-10382(Part 1: Dose escalation)1 trials Dordaviprone Hydrochloride1 trials AZD29361 trials IP-0011 trials Investigational Agent Administration1 trials GRT-C903/GRT-R9041 trials KRAS TCR-Transduced PBL1 trials BEBT-109 Capsule1 trials FT8251 trials GB12111 trials RC1181 trials Sugar pill1 trials Carmustine 7.7Mg Wafer1 trials RC48-ADC in Combination with gemcitabine1 trials ¹⁸F-Fluoromisonidazole1 trials VVD-1596421 trials CD5/CD7 CAR-T1 trials Tetanus and Diphtheria Toxoids Adsorbed1 trials blood and/or csf collection1 trials ZW2511 trials Tadalafil 20 MG1 trials Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin1 trials Cryopreserved Umbilical Cord Allograft1 trials R-miniCHOP-like regimen1 trials Pro-miniCHOP-like regimen1 trials XmAb5411 trials Vehicle Cream1 trials 1% Clascoterone1 trials DLI1 trials ESB Thoracic1 trials Low Dose OXIRI (LD-OXIRI)1 trials Venetoclax 100 mg d1，200 mg d2，400 mg d3-14；1 trials Donafenib； Sintilimab； HAIC1 trials P-CD19CD20-ALLO11 trials Anastrozole 1Mg Tab1 trials Adenosine A2B Receptor Antagonist PBF-11291 trials PD1/PDL1/CTLA4 inhibitors1 trials Neoantigen Peptides1 trials SSGJ-7061 trials DM0051 trials Midazolam oral solution1 trials Haplo-HCT1 trials Haplo-cord HCT1 trials GSK 5733584 + Dostarlimab1 trials GSK 57335841 trials Sarilumab + Cemiplimab + Paclitaxel1 trials Dan222 + Niraparib1 trials Rilvegostomig + TDXd1 trials Endoxifen + Abemaciclib1 trials ARV-471 + Abemaciclib1 trials ARV-471 + Letrozole1 trials ARV-4711 trials Lasofoxifene1 trials Datopotamab deruxtecan + Durvalumab1 trials VV1 + Cemiplimab1 trials ARX788 + Cemiplimab1 trials ARX7881 trials Amcenestrant + Letrozole1 trials Amcenestrant + Abemaciclib1 trials Amcenestrant1 trials SYD985 ([vic-]trastuzumab duocarmazine)1 trials Trilaciclib with or without trastuzumab + pertuzumab1 trials Cemiplimab plus REGN37671 trials Tucatinib plus trastuzumab and pertuzumab1 trials SD-101 + Pembrolizumab1 trials Durvalumab plus Olaparib1 trials Pembrolizumab - 8 cycle1 trials Patritumab and Trastuzumab1 trials Talazoparib plus Irinotecan1 trials Pembrolizumab - 4 cycle1 trials PLX33971 trials ABT-8881 trials Ganetespib1 trials Pertuzumab and Trastuzumab1 trials T-DM1 and Pertuzumab1 trials AMG 386 and Trastuzumab1 trials MK-2206 with or without Trastuzumab1 trials AMG 479 (Ganitumab) plus Metformin1 trials AMG 386 with or without Trastuzumab1 trials All-Trans Retinoic Acid (ATRA) Dose -11 trials All-Trans Retinoic Acid (ATRA) Dose 01 trials Adebrelimab (PD-L1 inhibitor)1 trials Test Product HYP-65891 trials Loratinib1 trials SHR2554; SHR-17011 trials SHR2554; Adabelimumab1 trials SHR2554; SHR-A21021 trials VENCLYXTO1 trials Decitabine for Injection1 trials Saline (0.9% sodium chloride)1 trials Tilsotolimod1 trials Seclidemstat1 trials Anti-PD-1 Monoclonal Antibody JS0011 trials Nivolumab 40mg1 trials Vebreltinib combined with Furmonertinib1 trials Anastrazole 1mg1 trials Dalpiciclib + Pyrotinib1 trials Sin-Bev-SIRT1 trials GEN11061 trials Teripalimab1 trials PLX-616391 trials anti-EGFR bispecific-armed T cells1 trials Palbociclib capsules1 trials TXA1 trials 4SCAR DLL3 T cells1 trials H1: TROP2 ADC1 trials G1: SHR-A18111 trials F1: TROP2 ADC1 trials E1: SHR-A18111 trials D2: TROP2 ADC with BP1021 trials D1: TROP2 ADC1 trials C2: SHR-A1811 with BP1021 trials C1: SHR-A18111 trials B2: TROP2 ADC with Camrelizumab1 trials B1: TROP2 ADC1 trials A2: SHR-A1811 with Camrelizumab1 trials A1: SHR-A18111 trials Ivocizumab1 trials HER3 - primed Dendritic cells1 trials HER2 - primed Dendritic cells1 trials DNP0021 trials Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin1 trials Fentanyl Citrate Injection1 trials Inhaled Fentanyl Aerosol1 trials Fruquintinib+PD-11 trials LP-3001 trials Irinotecan/Tegafur1 trials Lerotinib1 trials HSK39775 Monotherapy1 trials Neoadjuvant Chemotherapy (NACT)1 trials MOMA-3131 trials Suvemcitug placebo injection, trifluridine/tipiracil tablets1 trials Suvemcitug injection, trifluridine/tipiracil tablets1 trials Tumor associated antigen lymphocytes (TAA-T)1 trials JAB-303551 trials TQB2029 injection1 trials IFN-Α1 trials vvDD-hIL-2-RG-11 trials ABN4011 trials Personalized NeoAntigen Peptides1 trials CBM588 Capsules1 trials irinotecan, cetuximab, envafolimab1 trials Adebellizumab1 trials GVA + HDAC Consolidation & Gilteritinib Maintenance1 trials Treatment Period 4a1 trials Treatment Period 31 trials Treatment Period 21 trials Treatment Period 11 trials Interferon infiltration of the inoculation site1 trials SV-BR-1-GM1 trials 123I-ATT0011 trials Linperlisib combination with obinutuzumab1 trials Pyrotinib, trastuzumab, paclitaxel-albumin1 trials IPI3/NIVO11 trials IPI1/NIVO31 trials Mitomycin C, weight-based dose 12.5 mg/m21 trials Mitomycin C, flat dose 40 mg1 trials PD-1 antibody (Toripalimab)1 trials Irinotecan liposomes combined with cetuximab + vermofenib1 trials Nalbuphine and Sufentanil combination1 trials Dezocine and Sufentanil combination1 trials 68Ga-RM26-RGD1 trials Matching Placebo for selinexor1 trials Vitmain C plus herbal medicine1 trials fb-PMT1 trials Placebo for toripalimab1 trials Placebo for Tifcemalimab1 trials Tifcemalimab injection1 trials UBX-3030611 trials CD7 CAR-T cells1 trials Medical grade honey formulation (MGH) (L-Mesitran®)1 trials DSP-03901 trials The systemic therapy1 trials 12-Day Production of Car-T Cells1 trials 8/12-Day Production of Cryopreserved Car-T Cells1 trials 8/12-Day Production of Car-T Cells1 trials Dual-targeting CLDN18.2 and PD-L1 CAR-T cells1 trials BP102 Injection1 trials SHR-4849 Injection1 trials intraportal islet autotransplantation1 trials FTL008.161 trials COP1 trials Belinostat Injection1 trials TGFBR2 KO CAR27/IL-15 NK cells1 trials Nivolumab monotherapy1 trials IKS0141 trials Ruxolitinib Topical Cream1 trials LB21021 trials Hydrochloric Acid (2 M)1 trials APRIL CAR-T cells1 trials Post-transplant Cyclophosphamide (PTCy)1 trials Trilaciclib+mFOLFIRINOX1 trials [18F]PT23851 trials Olutasidenib Investigational Agent Administration1 trials AZD0486 IV1 trials YCT-5291 trials Intrathecal Resiniferatoxin1 trials Clomiphene Citrate1 trials ICI1 trials HBT-7081 trials CellProtect1 trials SRP10201 trials RPTR-1-2011 trials anti-CLL-1 CAR NK cells1 trials KB-GDT-011 trials TAVO4121 trials JS203 combined with lenalidomide1 trials JS203 in combination with gemcitabine and oxaliplatin1 trials Zanubrutinib plus RCHOP1 trials BTX-93411 trials HS-20110 (Phase Ib:Dose expansion )1 trials HS-20110 (Phase Ia：Dose escalation )1 trials JNJ-901898921 trials RiMO-3011 trials MDN-001 Injection(Yttrium-90 Microsphere Injection)1 trials ACE inhibitor1 trials BGB-530381 trials Dinituximab1 trials rhIL-151 trials Albumin-Bound Paclitaxel(ABX) intravenous drip1 trials Temozolomide（TMZ） injection or oral administration1 trials BCMA-CD19 cCAR T cells1 trials Zelenectide pevedotin (BT8009)1 trials BMS-9865061 trials Carboplatin / Paclitaxel Chemotherapy1 trials Investigator's Choice Chemotherapy1 trials Intrathecal Suspension1 trials Olaparib; 177Lu-DOTATATE1 trials Luprolide1 trials Topical Placebo1 trials BZ371A1 trials Isatuximab (for expansion)1 trials Isatuximab (for run-in portion)1 trials DSB24551 trials CALGE-VEN- RIC-conditioning1 trials Docetaxel/Oxaliplatin1 trials Gemcitabine/Carboplatin1 trials Isoquercetin1 trials ECT204 T cells1 trials Doctor-prescribed treatment1 trials 68Ga-HA-DOTATATE1 trials Relatlimab plus Nivolumab1 trials 13-cis-retinoic acid1 trials GNC-0391 trials Eribulin Mesilate injection1 trials Bortezomib + Lenalidomide + Dexamethasone1 trials second-line systemic therapy1 trials CD19-CD34t metabolically programmed CAR transduced T-cells1 trials Fludarabine Injection1 trials JIN-A021 trials Letrozole (L) or Anastrozole (A)1 trials Inavolisib (Dose #2)1 trials Ribociclib (Dose #2)1 trials Inavolisib (Dose #1)1 trials Ribociclib (Dose #1)1 trials Selicrelumab1 trials Chemotherapy (Gemcitabine + Carboplatin or Eribulin)1 trials HL-0851 trials Sintilimab (PD-1 inhibitor)1 trials Autoleucel (Relmacabtagene Autoleucel)1 trials Recombinant Humanized Monoclonal Antibody MIL62 Injection1 trials Adebrelimab；platinum-based chemotherapy1 trials SHR-8068；adebrelimab and platinum-based chemotherapy1 trials SHR-8068；Adebrelimab1 trials Polyamine Transport Inhibitor AMXT-1501 Dicaprate1 trials AUR1071 trials Lenalidomide, Bortezomib, Rituximab, Dexamethasone1 trials Allogenic NK cells infusion1 trials Fluzone Trivalent1 trials EMB-011 trials ATL administration1 trials BL00061 trials Temodar (Temozolomide)1 trials iC9.GD2.CAR.IL-15 T Infusion1 trials GSK54585141 trials JR86031 trials AMO9591 trials S-1 for 1 year1 trials S-1 for 9 months1 trials Dordaviprone (ONC201) + Placebo1 trials Dordaviprone (ONC201)1 trials Irinotecan regimen1 trials Xiao Chai Hu Tang (XCHT)1 trials Pembrolizumab + SOX1 trials NBM-BMX Capsule1 trials Anthracycline-based induction chemotherapy1 trials Tislelizumab combined with GP1 trials Tislelizumab combined with GX1 trials Sacituzumab govetican1 trials Nitric Oxide selected dose1 trials Nitric Oxide 100,000 ppm1 trials Nitric Oxide 50,000 ppm1 trials Nitric Oxide 25,000 ppm1 trials efgartigimod administration1 trials Darolutamide+ADT1 trials CT30011 trials IBI30141 trials BM2301 trials Murine CD19 CAR-T cells1 trials CHM-2101 CAR-T cells1 trials Karelizumab combined with etoposide and cisplatin1 trials AL2846 Placebo1 trials AL2846 Capsules1 trials Valsartan1 trials Induction of anesthesia with placebo spray prior to surgery1 trials Pembrolizumab (adjuvant)1 trials Pembrolizumab (neoadjuvant)1 trials VVD-1300371 trials Firmonertinib Mesilate Tablets1 trials Iron oxide nanoparticles1 trials doxorubicin、cisplatin、methotrexate、ifosfamide1 trials Osimertinib-based adaptive treatment1 trials mFOLFOXIRI+AK104+fruquintinib1 trials mFOLFOXIRI + Cadonilimab1 trials Eribulin Mesylate + Samfenet (Trastruzumab-biosimilar)1 trials Cyclophosphamide + Doxorrubicin1 trials JS001+Bevacizumab1 trials WJ471561 trials Placebo medication1 trials 68Ga-DOTA-NI-FAPI041 trials 18F-Fludarabine1 trials KQ-2003 CAR T-cells1 trials 177Lu-PMSA-6171 trials 4SCAR19 and 4SCAR301 trials 4SCAR19 and 4SCAR701 trials 4SCAR19 and 4SCAR1231 trials 4SCAR19 and 4SCAR201 trials 4SCAR19 and 4SCAR381 trials 4SCAR19 and 4SCAR221 trials Epigallocatechin gallate (EGCG)1 trials Hyperpolarized [1-13C] pyruvate (HP 13C)1 trials Renvastinib1 trials Taxol1 trials BT02 monoclonal antibody injection1 trials ONM-5011 trials TUB-0301 trials Trastuzumab+Pertuzumab/Trastuzumab1 trials Pyrotinib+Trastuzumab+Capecitabine1 trials Paclitaxel(Albumin Bound) and Gemcitabine1 trials Axitinib plus Toripalimab1 trials atumelnant1 trials Terelizumab (aka Tislelizumab)1 trials CC-1151 trials QBS10072S1 trials Tumor Treatment Vaccine; PD-1/L1 inhibitors1 trials Coenzyme I for Injection1 trials WJB0011 trials TIVDAK1 trials Pomalidomide with Zn-DDC1 trials Lanalidomide with Zn-DDC1 trials Zn-DDC1 trials Ascentage Pharma HQP1351 bioavailable inhibitor1 trials FT8361 trials NVL-3301 trials VAM_GROUP1 trials ABSK061+ABSK043 in combination with CAPOX1 trials ABSK061 + ABSK0431 trials Standard antibiotic prophylaxis1 trials Drug：Cisplatin1 trials AZD9793 Subcutaneous (SC) monotherapy)1 trials AZD9793 Intravenous (IV) monotherapy1 trials Triple therapy1 trials Nelmastobart and Docetaxel1 trials biological samples1 trials Trastuzumab Emtansine for Injection1 trials TQB2102 Injection1 trials AB2481 trials SKB445 for injection1 trials Orca-Q1 trials [18F]DK222 radiotracer1 trials Pasireotide1 trials azoles1 trials Enzomenib1 trials CAR-T (CAR-GPRC5D)1 trials Microvesicles analysis1 trials TLN-372 in combination with pembrolizumab1 trials TLN-372 in combination with cetuximab1 trials TLN-3721 trials SIRPant-M1 trials CBA-1205 Part 51 trials CBA-1205 Part 41 trials CBA-1205 Part 31 trials CBA-1205 Part 21 trials CBA-1205 Part 11 trials [18F]FAPI-74 PET/CT1 trials TRX-920 Oral Gel (10 mg and 30 mg)1 trials TG011 trials CT041 autologous CAR T-cell injection1 trials pp65/tumor mRNA RNA-LP (DP2)1 trials pp65 RNA LP (DP1)1 trials KRT-2321 trials Oxaliplatin + Irinotecan + 5-Fluorouracil/Leucovorin1 trials HS-201171 trials TCb regimen1 trials （Carrelizumab + TCb） regimen1 trials Pembrolizumab (KEYTRUDA® ) 25 Mg/mL Solution for Injection1 trials BI-18081 trials TAA-specific CTLs- fixed dose1 trials TAA-specific CTLs1 trials Triptoreline1 trials Busulfan (conditioning for ALLO Transplant)1 trials Fludarabine (Fludara)1 trials Recombinant Humanized Bispecific Monoclonal Antibody MBS3011 trials Nituzumab/placebo1 trials Orelabrutinib combined with rituximab1 trials lidocaine 2% and 10%1 trials GIM1221 trials PD-1 inhibitor based immunotherapy1 trials Psilocybin combined with Psychotherapy1 trials CG009301 for Injection1 trials STI-61291 trials CLR 1251 trials Iopofosine I 1311 trials 131I-IPA1 trials Osimertinib plus Dalpiciclib1 trials IL-2 analog1 trials High dose IL-21 trials NMA-LD regimen1 trials PDE5 inhibitor (tadalafil)1 trials Placebo as an adjunct to lifestyle intervention1 trials Tirzepatide as an adjunct to lifestyle intervention1 trials Paclitaxel Polymer Micelles + Gemcitabine + Anlotinib1 trials Paclitaxel Polymer Micelles + Gemcitabine + Lenvatinib1 trials KGX101 injection1 trials Firmagon 80 MG Injection1 trials Firmagon 120 MG Injection1 trials Depo-Eligard 7.5 mg1 trials Depo-Eligard 22.5 mg1 trials Depo-Eligard 45 mg1 trials Decapeptyl sustained release 11.25 mg1 trials Decapeptyl sustained release 22.5 mg1 trials Zoladex LA1 trials Zoladex 3.6Mg Implant1 trials Darolutamide matched placebo1 trials Afatinib plus chemotherapy as conversion treatment1 trials 60%Oxygen1 trials 30%Oxygen1 trials PLD Chemotherapy1 trials Consolidation (Carboplatin, Doxorubicin) -Group D11 trials Block 1 to 3 (Cisplatin, Doxorubicin) Group D1 trials mono CDDP- Group B1 trials Cisplatin, 5-Fluorouracil, Vincristine, Doxorubicin-Group C1 trials mono CDDP-Group A21 trials Sodium Thiosulfate Injection1 trials SYS60231 trials Iparomlimab and Tuvonralimab combined with chemotherapy1 trials NEO1001 trials Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan1 trials Iohexol1 trials QLC55081 trials INCB01236671 trials Azirkitug1 trials Ipilumimab1 trials NBL-020 for Injection1 trials ENV-5011 trials FP002 Injection1 trials Eutectic Mixture of Local Anesthetics1 trials Evorpacept (ALX148)1 trials OATD-021 trials Rituximab (where available)1 trials MQ7191 trials MNPR-101-PCTA-177Lu1 trials Afatinib/Dacomitinib1 trials Lenvatinib, Tislelizumab Combined with RALOX Regimen HAIC1 trials Binimetinib Oral Tablet [Mektovi]1 trials Mebendazole1 trials Folfox with avastin1 trials neoadjuvant chemotherapy and CCRT1 trials Fulvestrant in combination with abemaciclib1 trials Lasofoxifene in combination with abemaciclib1 trials HDP-1011 trials ADJUVANT ENDOCRINE THERAPY1 trials Anti-PD1 antibody, nimotuzumab and capecitabine1 trials 5-FU Analog based chemotherapy1 trials BY101921 tablets1 trials Decitabine, venetoclax and blinatumomab1 trials Dual-targeting BCMA-CD19 CAR-T cell infusion1 trials Chidamide combined with Duvillisib1 trials 2LEBV® / 2LXFS®1 trials Buserelin1 trials NWRD06 administered by electroporation1 trials JNJ-889983771 trials Tirelizumab ,+Carboplatin+albumin-bound paclitaxel1 trials Atorvastatin 80 Mg Oral Tablet1 trials GDC-41981 trials Anti-FLT3 CAR-T cells1 trials Immunotherapy (Camrelizumab)1 trials GP/PFLL+placebo1 trials GP/PFLL+AK1041 trials Glecirasib1 trials M28z1XXPD1DNR CAR1 trials HLX10+chemo1 trials Pyrotinib Maleate Tablets1 trials Fluzoparib Capsules1 trials Dalpiciclib Isetionate Tablets1 trials all approved chemotherapeutic agents from second line1 trials UCART20x221 trials B0131 trials Flotufolastat F-18 Gallium1 trials Carboplatin and Taxol (paclitaxel)1 trials QL1706+Carboplatin+Paclitaxel（Albumin-bound ）/ Pemetrexed1 trials Sintilimab+Anlotinib+Pemetrexed+Cisplatin1 trials Postoperative reintroduction of FOLFIRI based chemotherapy1 trials LND1011 trials Standard of Care Immune Checkpoint Blockade1 trials Niraparib Tosylate Monohydrate1 trials Amivantamab Intravenous1 trials Ipilimumab (1mg/kg)1 trials PRGN-20091 trials [68Ga]Ga-PSMA-111 trials LY39626731 trials B7-H3CART1 trials Hiltonol®1 trials MUC1 Peptide Vaccine1 trials PRV111 (Cisplatin Transmucosal System)1 trials PRV211 (Intraoperative Cisplatin System)1 trials INX-3151 trials Serplulimab+SOX1 trials Toripalimab (240mg day1, Q3W*3cycle)1 trials Cardioprotection1 trials Prednisone + Jakavi(ruxolitinib)1 trials 9MW30111 trials Crisugabalin1 trials Rulonilimab placebo +Lenvatinib1 trials Rulonilimab+Lenvatinib1 trials FOLFOX or CAPOX adjuvant chemotherapy1 trials mFOLFIRINOX-FOLFIRI intensified chemotherapy1 trials Dara SC1 trials Bortezomib (drug)1 trials Dara IV1 trials Vaccine + PolyICLC1 trials TY-2699a1 trials Fludarabine + Cyclophosphamide + BCMA-GPRC5D CAR-T Cells1 trials Regorafenib 40 MG Oral Tablet1 trials BAY 35479221 trials BAY 35479261 trials 64Cu-GRIP B1 trials Vaccine1 trials CD5 CAR-T cells infusion1 trials Debio 1562M1 trials Tc99m sestamibi1 trials DCFPyL PET/CT1 trials Daunorubicin/Idarubicin1 trials CTS2190 capsules1 trials 68-Gallium-DOTATATE-PET/CT1 trials The original treatment regimen1 trials CDK4/6 + Endocrine therapy1 trials Donafeib with Sintilimab1 trials Pucotenlimab ,Lenvatinib1 trials carboplatin AUC 5 and paclitaxel 175 mg/m21 trials Relatlimab 10 MG/ML Intravenous Solution1 trials Cytotoxic Chemotherapy1 trials Prolgolimab1 trials FOLFOX chemotherapy regimens1 trials Platinum chemotherapy: carboplatin or cisplatin1 trials BVEC1 trials